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Abstract 
 
 
We hypothesized that spirotetronate (+)-okilactomycin (1) and (–)-chrolactomycin (2) 
are biogenetically derived from a common intermediate, (–)-okilactomycin D (3), which 
in turn arises via an intramolecular Diels-Alder (IMDA) reaction from the linear 
precursor 4. Guided by this hypothesis, we have achieved an efficient synthesis of 
okilactomycin D by a route featuring a substrate-controlled, diastereoselective 
intramolecular Diels–Alder (IMDA) reaction of an analogue of polyene 4. The assigned 
absolute configuration of (−)-3 was confirmed. Conversion of (−)-3 toward 1 and 2 has 
also been explored. 
ortho-Benzyne (1,2-didehydrobenzene, 7 or 7’) is one of the oldest, most interesting, 
most useful and most well-studied of all reactive intermediates in chemistry. The 
multifaceted and efficient reactions of benzynes with suitable trapping reagents (7→8) 
have long been employed in the service of synthetic chemistry to give products that are 
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  v 
used as pharmaceuticals, agrochemicals, dyes, polymers, and other fine chemicals. An 
accidental observation made in this laboratory led us to establish an unorthodox yet 
general aryne-generating strategy—the hexadehydro-Diels–Alder (HDDA) reaction. This 
enabling transformation, which produces the highly reactive benzyne intermediate from 
the thermal [4+2] cycloisomerization of a 1,3-diyne (like 6) with a ‘diynophile’ (like 5) in 
the absence of any metals or reagents, has allowed us to uncover some unprecedented 
aryne reactivities. 
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Chapter I. Introduction and Background 
1.1. Historical background of okilactomycins 
The spirotetronate polyketides (e.g., chlorothricolides, kijanimicin, and abyssomicins) 
comprise a class of natural product compounds that are characterized by the presence of a 
five-membered tetronic acid moiety (ring A) spiro-linked to a cyclohexene ring (ring B, 
cf. 1001, Figure 1.1).1 Their biological activities (which include antitumor,2 
antibacterial,3 and cholesterol biosynthesis inhibition,4) coupled with unusual 
architectures render them interesting targets for total synthesis studies. 
Figure 1.1| Structures of (+)-okilactomycin and (-)-chrolactomycin. 
 
                                                
1 Kelly, W. L. Intramolecular cyclizations of polyketide biosynthesis: mining for a “Diels–Alderase”? 
Org. Biomol. Chem. 2008, 6, 4483–4493. 
2 Kang, M; Jones, B. D.; Mandel, A. L.; Hammons, J. C.; DiPasquale, A. G.; Rheingold, A. L.; La Clair,  
J. J.; Burkart, M. D. Isolation, structure elucidation, and antitumor activity of spirohexenolides A and B. 
J. Org. Chem. 2009, 74, 9054–9061. 
3  Igarashi, Y.; Ogura, H.; Furihata, K.; Oku, N.; Indananda, C.; Thanmchaipenet, A. Maklamicin, an 
antibacterial polyketide from an endophytic Micromonospora sp.. J. Nat. Prod. 2011, 74, 670–674. 
4  Kawashima, A.; Nakamura, Y.; Ohta, Y.; Akama, T.; Yamagishi, M.; Hanada, K. New cholesterol 
biosynthesis inhibitors MC-031 (O-demethylchlorothricin), -032 (O-demethylhydroxychlorothricin), -
033 and -034. J. Antibiot. 1992, 45, 207–212. 
O
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The okilactomycins (1002-1007, Figure 1.1), a subclass of spirotetronates, contain 
either a tri- or tetracyclic skeleton. In 1987, okilactomycin (1002) was isolated and 
structurally characterized by Imai and co-workers from a bioactive filtrate produced by 
Streptomyces griseoflavus, obtained from a soil sample on the island of Zamami, Japan.5 
Its structure  (1002, Figure 1.1), initially assigned by a combination of spectroscopic 
methods, contains a unique 13-membered ring (ring C) embedded with a 2,6-cis-
tetrahydro-γ-pyrone moiety (ring D), a highly functionalized cyclohexene ring (ring B), 
and a five-membered lactone (ring A). Single-crystal X-ray analysis confirmed its 
connectivity and relative configuration. The absolute configuration, however, was 
undefined until Smith’s total synthesis of (+)-okilactomycin.6 In 2001 Yamashita and co-
workers described the isolation of the structurally related chrolactomycin (1003) from 
Streptomyces sp. 569N-3.7 Structurally, (–)-chrolactomycin differs from (+)-
okilactomycin only by a C-11 methoxy group versus a methyl group (1002 vs. 1003, 
Figure 1.1). Both of the two compounds have interesting biological activities: 1002 and 
1003 showed modest antimicrobial activity against Gram-positive cells; compound 1002 
displayed significant cytotoxicity against lymphoid leukemia cells (IC50 = 0.037 µM) and 
leukemia P388 cells (IC50 = 0.09 µM); compound 1003 exhibited antiproliferative 
                                                
5  a) Imai, H.; K. Suzuki, M.; Morioka, Y.; Numasaki, S.; Kadota, K.; Nagai, T.; Sato, M.; Iwanami, T. 
Okilactomycin, a novel antibiotic produced by a Streptomyces species. I. Taxonomy, fermentation, 
isolation and characterization. J. Antibiot. 1987, 40, 1475-1482. b) Imai, H.; H. Kaniwa, T. Tokunaga, 
S. Fujita, T. Furuya, H. Matsumoto & M. Shimizu: Okilactomycin, a novel antibiotic produced by a 
Streptomyces species. II. Structure determination. J. Antibiot. 1987, 40, 1483-1489. 
6  a) Smith, A. B.; Basu, K.; Bosanac, T. Total synthesis of (–)-okilactomycin. J. Am. Chem. Soc. 2007, 
129, 14872-14874. b) Smith, A. B., Bosanac, T.; Basu, K. Evolution of the total synthesis of (–)-
okilactomycin exploiting a tandem oxy-Cope rearrangement/oxidation, a Petasis-Ferrier 
union/rearrangement, and ring-closing metathesis. J. Am. Chem. Soc. 2009, 131, 2348–2358.  
7  Nakai, R.; Kakita, S.; Asai, A.; Chiba, S.; Akinaga, S.; Mizukami, T.; Yamashita, Y. Chrolactomycin, a 
novel antitumor antibiotic produced by Streptomyces sp.. J. Antibiot. 2001, 54, 836-839. 
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activity against several human tumor cell lines with IC50 values ranging from 0.45 µM to 
1.6 µM. 
 In 2009 Singh et al.8 reported four additional members of this class—namely, 
okilactomycins A, B, C, and D (1004–1007) [along with okilactomycin (1002)] from the 
bacterium Streptomyces scabrisporus. Whereas congeners 1006 and 1007 contain an 
intact acyltetronic acid (ATA) structural subunit,9 compounds 1002, 1004, and 1005 have 
a modified tetronate moiety. From the perspectives of bioactivities, 1004-1007 displayed 
weak to modest antimicrobial activities against Gram-positive bacteria. Interestingly, all 
of these compounds exhibited preferential inhibition of RNA synthesis over DNA or 
protein synthesis.  
                                                
8  Zhang, C.; Ondeyka, J.; Zink, D.; Basilio, A.; Vicente, F.; Salazar, O.; Genilloud, O.; Dorso, K.; Motyl, 
M.; Byrne, K.; Singh, S. Discovery of okilactomycin and congeners from Streptomyces scabrisporus by 
antisense differential sensitivity assay targeting ribosomal protein S4. J. Antibiot. 2009, 62, 55-61.  
9  The structure for each of the compounds containing a free acyltetronic acid (ATA) (i.e., 6, 7, or 8) is 
arbitrarily (and for convenience) portrayed as an endocyclic enol; an internally hydrogen-bonded variant 
of that endocyclic enol (a rotamer about the C10–C11 bond) or E- or Z-exocyclic enols are also 
possible. 
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1.2 Previous studies directed to the total synthesis of okilactomycins     
Since the isolation and structural elucidation of okilactomycin (1002) was first 
reported 26 years ago, several groups have pursued the total synthesis of this natural 
product with different strategies, culminating in two completed syntheses of 
okilactomycin and confirmation of its absolute configuration.  
In 2009, the Smith6 group completed the first total synthesis of (+)-okilactomycin 
[(+)-1002], the antipode of the naturally occurring product. Smith’s synthesis started 
from the preparation of functionalized cyclohexane 1008 and β-hydroxy carboxylic acid 
1009 (Scheme 1.1). Transacetalyation between 1008 and 1009 furnished dioxanone 1010, 
the substrate for the key Petasis10–Ferrier11 union/rearrangement sequence.  
Scheme 1.1| Smith’s total synthesis of (-)-okilactomycin 
 
This union/rearrangement process, albeit proceeding in modest yield, gave the 
tetrahydropyranone intermediate 1011 in a highly diastereoselective fashion. The 
                                                
10  Petasis, N. A.; Bzowej, E. I. Titanium-mediated carbonyl olefinations. 1. Methylenations of carbonyl 
compounds with dimethyltitanocene. J. Am. Chem. Soc. 1990, 112, 6392-6394. 
11  Ferrier, R. J. Unstaturated carbohydrates. Part 21. A carboxylic ring closure of a hex-5-enopyranoside 
derivative. J. Chem. Soc., Perkin Trans. 1, 1979, 1455-1458. 
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following carbonylation, methylation, and lactone formation, ring-closing metathesis 
(RCM), and hydrogenation sequence delivered compound 1012, which contains all the 
carbon atoms and stereocenters of compound 1002. It might be surprising that one pitfall 
of this synthesis is the conversion of 1012 to 1002. Due to the difficulty of forming the 
C16/C17 double bond in 1002, the authors in the end had to resort to a 7-step, low-
yielding sequence to finish their total synthesis of (+)-1002 from 1012. This synthesis 
proceeds with 29 longest linear steps with an overall yield of 0.7%. This synthesis also 
confirmed the absolute configuration of naturally occurring (–)-okilactomycin. 
Scheme 1.2| Scheidt’s total synthesis of (-)-okilactomycin 
 
Later in 2011, Scheidt’s group12 reported a different approach to the total synthesis of 
(–)-okilactomycin. This strategy (Scheme 1.2) capitalized on a Prins union/cyclization 
cascade between aldehyde 1013 and alcohol 1014. Pyranone 1016 was formed in a highly 
diastereoselective fashion via the intermediacy of oxonium 1015. The following 
                                                
12  Tenenbaum, J. M.; Morris, W. J.; Custar, D. W.; Scheidt, K. A. Synthesis of (–)-okilactomycin by a 
Prins-type fragment-assembly strategy. Angew. Chem., Int. Ed. 2011, 50, 1-5. 
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modifications, which included lactone formation, methylation, and elimination, afforded 
the key intermediate 1017. Diene 1017 underwent a RCM reaction similar to the one used 
in Smith’s synthesis, giving (–)-1002 after common functional group manipulations.  
Besides the aforementioned efforts, the Paquette13 and the Rovis group14 have also 
pursued studies to the total synthesis of okilactomycin. In fact, the most relevant to my 
studies described here is the model study reported by Takeda and Yoshii,15 which will be 
discussed in more detail in section 2.2. 
  
                                                
13  a) Paquette, L.A.; Boulet, S.L. Toward a total synthesis of okilactomycin. 1. A direct, enantiocontrolled 
route to the western sector. Synthesis. 2002, 888-894. b) Paquette, L.A.; Boulet, S.L. Toward a total 
synthesis of okilactomycin. 2. A metathesis-based approach to the heavily functionalized cyclohexane 
ring. Synthesis. 2002, 895-900. 
14  Wheeler, P. A. M. Catalytically generated acyl triazoliums as versatile acylating reagents and progress 
toward the total synthesis of okilactomycin. Ph.D. dissertation, Colorado State University. U.S. 
ProQuest/UMI. (Publication No. 3565470.) 
15 Takeda, K.; Shimotani, A.; Yoshii, E. A. Lewis acid mediated intramolecular [2+2] cycloaddtion of 3-
(9-methylundeca-7,9-dienyl)-9-methylene-2,8-dioxabicyclo [4.3.0]nonane-5,7-dione. Heterocycles 
1992, 34, 2259-2261. 
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1.3 Biosynthetic hypothesis/synthetic plan of okilactomycins 
The unique architecture or the interesting biological activities of okilactomycins alone 
justify synthetic studies. Nonetheless, what further piqued our interest in this family of 
natural products is the possible biogenesis of these compounds; how are their unique 
structural architectures synthesized in Nature? Close scrutiny of the structures of the 
okilactomycins led us to consider that okilactomycin (1002) and other more advanced 
natural products in this family all biogenetically derive from a common intermediate, 
okilactomycin D (1007), via post polyketide synthase (PKS) modifications (Scheme 1.3). 
We then hypothesized that the tricyclic topology of okilactomycin D (1007) arises in 
Nature via an intramolecular Diels–Alder reaction1 (IMDA) from the tetraene 1018, and 
that this process is fast enough and stereoselective enough to occur under biologically 
relevant conditions without the assistance of an enzyme (i.e., a Diels–Alderase).  
Scheme 1.3| Biosynthetic hypothesis of okilactomycins 
 
The validity of our biosynthetic hypothesis is predicated upon the assumption that the 
two (highlighted) stereogenic centers in substrate 1018 could control the sense of 
diastereoselectivity of a Diels–Alder event that is fairly distant. If this hypothesis holds 
true, the synthesis of the topologically complex okilactomycin D (1007) is reduced to the 
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synthesis of okilactomycin D (1007) could in turn pave the road for the production of 
okilactomycin (1002) and other more advanced members in this family. 
Our studies may not only provide a straightforward syntheses of the okilactomycins, 
but they also might lend insights into the biogenesis of these structurally intriguing 
compounds. Along this avenue, we may also see opportunities for the development of 
some novel synthetic or analytical methods, which may see broader application in the 
synthetic studies of other natural and unnatural compounds. 
  Okilactomycin 
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CHAPTER 2. INTRAMOLECULAR DIELS–ALDER (IMDA) 
REACTIONS IN NATURAL PRODUCT SYNTHESES 
2.1 Diels–Alder reaction in biosynthesis of natural products  
A Diels–Alder (DA) reaction has been suggested as a key step for the biosyntheses of 
diverse classes of natural products.1,16,17 Some selected examples are shown in Figure 2.1, 
with the biosynthetic DA disconnections indicated by the squiggled lines.  
Figure 2.1| Examples of natural products for which biosynthetic IMDA reactions 
have been proposed. 
 
R = glycosyl groups  
The compounds shown in Figure 2.1 span from polyketides (2001, 2002, 2005, 2006, 
and 2008), to alkaloids (2004 and 2007), to terpenoids (2003 and 2004). Of these, the 
IMDA reactions in the biosyntheses of 2001, 2002, 2004, and 2006 result in the 
                                                
16  Williams, R. M.; Stocking, E. M. Chemistry and biology of biosynthetic Diels–Alder reactions. Angew. 
Chem., Int. Ed. 2003, 42, 3078–3115. 
17  Oikawa, H.; Tokiwano, T. Enzymatic catalysis of the Diels–Alder reaction in the biosynthesis of natural 
products. Nat. Prod. Rep., 2004, 21, 321–352. 
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formation of medium sized (5 or 6 membered) rings, while those involved in the 
formation of 2005, 2007, and 2008 incur the formation of macrocycles. A hetero-Diels–
Alder reaction was suggested in the biosynthesis of 2004. It is also noteworthy that an 
intermolecular Diels–Alder reaction was proposed to account for the biogenesis of 2003. 
Interestingly, despite the ubiquity of natural products whose biosyntheses apparently 
involve Diels-Alder reactions, the question whether Diels–Alderases (i.e., enzymes that 
catalyze biosynthetic Diels–Alder reactions) exist in Nature has been debated for a long 
time. Above all, a natural Diels–Alderase needs to address the potential product 
inhibition problem, because the product and transition structure of a Diels–Alder reaction 
have a high degree of resemblance. 
It seems that this dispute was settled recently: five enzymes with the ability to 
catalyze Diels–Alder reactions have been identified to date.18,19,20,21,22 In 1995, Oikawa 
and coworkers reported the identification of a partially purified, cell-free, extract that 
                                                
18  a) Oikawa, H.; Katayama, K.; Suzuki, Y. Ichihara, A. Enzymatic activity catalysing exo-selective Diels-
Alder reaction in solanapyrone biosynthesis. J. Chem. Soc. Chem. Comm., 1995, 1321–1322. b) 
Katayama, K.; Kobayashi, T.; Oikawa, H.; Honma, M.; Ichihara, A. Enzymatic activity and partial 
purification of solanapyrone synthase: first enzyme catalyzing Diels–Alder reaction. Biochim. Biophys. 
Acta, 1998, 1384, 387–395. c) Katayama, K.; Kobayashi, T.; Chijimatsu, M.; Ichihara, A. Oikawa, H. 
Purification and N-terminal amino acid sequence of solanapyrone synthase, a natural Diels-Alderase 
from Alternaria solani. Biosci. Biotechnol. Biochem., 2008, 72, 604–607. 
19  a) Auclair, K.; Sutherland, A.; Kennedy, J.; Witter, D. J.; Van den Heever, J. P.; Hutchinson, C. R.; 
Vederas, J. C. Lovastatin nonaketide synthase catalyzes an intramolecular Diels−Alder reaction of a 
substrate analogue. J. Am. Chem. Soc., 2000, 122, 11519-11520. b) Ma, S. M.; Li, J. W.-H.; Choi, J. W.; 
Zhou, H.; Lee, K. K. M.; Moorthie, V. A.; Xie, X.; Kealey, J. T.; Da Silva, N. A.; Vederas, J. C.; Tang, 
Y. Complete reconstitution of a highly reducing iterative polyketide synthase. Science, 2009, 326, 589–
592. 
20  a) Watanabe, K.; Oikawa, H.; Yagi, K.; Ohashi, S.; Mie, T.; Ichihara, A.; Honma, M. Macrophomate 
synthase: characterization, sequence, and expression in Escherichia coli of the novel enzyme catalyzing 
unusual multistep transformation of 2-pyrones to benzoates. J. Biochem., 2000, 127, 467–473. b) Ose, 
T.; Watanabe, K.; Mie, T.; Honma, M.; Watanabe, H.; Yao, M.; Oikawa, H.; Tanaka, I. Insight into a 
natural Diels–Alder reaction from the structure of macrophomate synthase. Nature, 2003, 422, 185–189. 
21  a) Eberhardt, S. Zingler, N.; Kemter, K.; Richter, G.; Cushman, M.; Bacher, A. Domain structure of 
riboflavin synthase. Eur. J. Biochem. 2001, 268, 4315–4323. b) Kim, R.-R.; Illarionov, B.; Joshi, M.; 
Cushman, M.; Lee, C. Y.; Eisenreich, W.; Fischer, M.; Bacher, A. Mechanistic insights on riboflavin 
synthase inspired by selective binding of the 6,7-dimethyl-8-ribityllumazine exomethylene anion. J. Am. 
Chem. Soc. 2010, 132, 2983–2990. 
22  Kim, H. J.; Ruszczycky, M. W.; Choi, S.-H.; Liu, Y.-N.; Liu, H.-W. Enzyme-catalysed [4+2] 
cycloaddition is a key step in the biosynthesis of spinosyn A. Nature, 2011, 473, 109-112.  
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could catalyze the [4+2] cyclization for the formation of solanapyrones (Scheme 2.1).18 
Subjecting prosolanapyrone II (2009) to the extract yielded solanapyrones A, B, D, and 
E. On the other hand 2009 was found to be inert under identical conditions in the absence 
of the extract.  
Scheme 2.1| Enzymatic IMDA reactions in the biosynthesis of solanapyrones  
 
Through careful isotope incorporation studies, the authors concluded that enzymes 
did not convert 2009 directly to compound 2013 and 2015, but rather through an 
oxidation–IMDA–reduction detour, via the intermediacy of 2010 and 2002/2014. The 
stereochemical-outcome of the IMDA reaction of 2010 is affected by the enzymes 
present in the extract: cyclization in the presence of the extract gave a mixture of 2002 
and 2014 in a 87/13 ratio, favoring the abnormal exo-adduct 2002 (cf. 2011), while 
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2010 is fast in aqueous medium. Therefore, it is believed that Diels–Alderase(s) in 
solanapyrones biosyntheses works by functioning as a chaperone to guide the 
stereochemical outcome of the IMDA reactions. 
In 2000 Vederas et al.19 reported the purification of lovastatin nonaketide synthase 
(LNKS) and demonstrated that this enzyme is capable of catalyzing the IMDA 
cyclization of triene thioester 2016 (Scheme 2.2). In the absence of LNKS, triene 2016 
cyclizes slowly in aqueous media to afford 2022 and 2023 in a 1:1 ratio (via 2018 and 
2019). Formation of decalin 2021 or 2024, which requires passing through the sterically 
less favored transition structures (2017 and 2020, respectively), was not observed under 
non-enzymatic conditions. In the presence of LNKS, however, 2021 was formed, albeit 
as a minor isomer and along with “undesired” 2022 and 2023. Importantly, the 
stereochemistry of 2021 is identical to that of dihydromonacolin L (2025), the key 
intermediate in the biosynthesis of lovastatin (2001). The authors noted that use of 
deactivated LNKS does not lead to the formation of 2021, confirming that LNKS does 
not function through a non-specific interaction with the substrate. LNKS is the first 
natural Diels–Alderase isolated to homogeneity. 
It is worth mentioning that triene 2016 is not the biosynthetic substrate of LNKS. The 
real substrate of LNKS should instead be one that is made in situ and covalently linked to 
the enzyme. The structural deviation might explain the observed low stereoselectivity of 
LNKS catalyzed IMDA reaction of 2016.  
  
  Okilactomycin 
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Scheme 2.2| Lovastatin nonaketide synthase (LNKS) as a Diels–Alderase. 
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Macrophomate synthase (MPS), a Mg2+ dependent enzyme, is the first natural Diels–
Alderase whose single crystal structure has been resolved.20 This enzyme catalyzes a 
complex cascade reaction, converting oxaloacetate 2026 and a 2-pyrone derivative 2027 
to the corresponding benzoate 2028 (Scheme 2.3). Oxaloacetate was initially converted 
through decarboxylation to enol 2029, which then underwent a net [4+2] addition with 
pyrone 2027, providing the bicycle 2030. Compound 2030 then released a molecule of 
CO2 (presumably via a retro-Diels–Alder reaction) and a molecule of H2O to afford the 
final benzoate 2028.  
It is still under debate if the [4+2] addition between 2029 and 2027 occurs via a 
stepwise Michael–aldol addition sequence23 or a true concerted cyclization mechanism. 
Nonetheless, this remarkable transformation attests to the power of the enzymatic 
machinery that Nature has evolved over the years.  
Scheme 2.3| Macrophomate synthase (MPS) as a Diels–Alderase. 
  
                                                
23 Guimares, C. R. W.; Udier-Blagovic, M.; Jørgensen, W. L. Macrophomate synthase: QM/MM 
simulations address the Diels–Alder versus Michael–aldol reaction mechanism. J. Am. Chem. Soc. 
2005, 127, 3577–3588. 
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Riboflavin synthase catalyzes the transfer of a four carbon unit (green) between two 
molecules of 2032, resulting the formation of riboflavin (2033) and a pyrimidinedione 
byproduct 2034 (Scheme 2.4).21 Kim et al. hypothesized that this enzyme works by a 
mechanism that involves a Diels–Alder reaction (Scheme 2.4). Specifically, they 
proposed this transformation occurs through a sequence that comprises 1) tautomerization 
and disproportionation of two molecules of 2032 to form 2032-taut and 2032-pro, 2) an 
intermolecular hydride transfer between 2032-taut and 2032-pro, giving diene 2035 and 
dienenophile 2036, 3) inverse electron demand intermolecular Diels–Alder cyclization 
between 2035 and 2036, affording a pentacyclic intermediate 2037, and 4) stepwise C-N 
bond cleavage to furnish riboflavin (2033) and 2034, via the intermediacy of 2038. 
Scheme 2.4| A propose catalyzing mechanism of riboflavin synthase. 
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All of the four enzymes discussed above demonstrated more than one catalytic 
activity, leaving their specific role in the observed Diels–Alder reactions uncertain. In 
2011 Liu’s group22 reported the identification of Spn F, an enzyme whose only identified 
role is to accelerate the intramolecular [4+2] cycloaddition event in spinosyn A 
biosynthesis.  When subjecting polyene substrate 2039 to Spn F, the authors observed an 
ca. 500-fold rate enhancement of the transannular [4+2] cyclization responsible for the 
formation of tricycle 2042, a key intermediate in the biogenesis of spinosyn A (2006, 
Scheme 2.5). It is still not clear if the reaction catalyzed by Spn F occurs via a concerted 
transition state (cf. 2040) or by a stepwise polar addition mechanism (cf. 2041).  
Scheme 2.5| Spn F enhances the transannular [4+2] cycloaddition rate of 2039 by 
500-fold.  
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unclear. To the best of my knowledge, no enzyme has been identified to catalyze the 
IMDA reactions in the biosynthesis of a spirotetronate. In summary, there is a lot more to 
be learned about natural Diels–Alderases.  
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2.2. IMDA in chemical synthesis of spirotetronates 
Nature has served as an inexhaustible source of inspiration for chemists.24 Not 
surprisingly, synthetic organic chemists often employ in their synthetic plans an IMDA 
reaction that mimics the (proposed) biosynthetic transformation. This biomimetic strategy 
has enabled many elegant total syntheses of complex natural products. These elegant 
efforts have been compiled in many recent comprehensive reviews.16,25,26,27 Only 
discussed in this section are the reported synthetic studies of spirotetronates where an 
(biomimetic) IMDA reaction is used.  
In their synthesis of chlorothricolide,28 Yoshii and co-workers attempted an IMDA 
reaction to form its macrocycle (Scheme 2.6). The pentacyclic skeleton of 
chlorothricolide was rapidly constructed from the much less complicated precursor 2043. 
Unfortunately, the IMDA reaction of polyene 2043 proceeded with only a low level of 
relative asymmetric induction, to give a mixture of the naturally configured 2044 and 
three additional diastereomers [dr = 1:3:2:1]. These differ in the relative configurations at 
the numbered atoms in structure 2044. Each of these products had a cis-relationship 
between the substituents at C18 and C21, implying that all arose from a concerted [4+2] 
cycloaddition (endo/exo and top/bottom). It is intriguing to wonder how much 2043 is 
deviating from the real IMDA precursor in the biosynthesis of chlorothricin. Especially 
                                                
24  a) De la Torre, M. C.; Sierra, M. A. Comments on recent achievements in biomimetic organic synthesis. 
Angew. Chem., Int. Ed., 2004, 43, 160–181. b) Bulger, P. G.; Bagal, S. K.; Marquez, R. Recent 
advances in biomimetic natural product synthesis. Nat. Prod. Rep., 2008, 25, 254–297. 
25  Nicolaou, K. C.; Snyder, S. A.; Montagnon, T.; Vassilikogiannakis, G. The Diels–Alder Reaction in 
total synthesis. Angew. Chem., Int. Ed., 2002, 41, 1668–1698.  
26  Takao, K.; Munakata, R.; Tadano, K. Recent advances in natural product synthesis by using 
intramolecular Diels−Alder reactions. Chem. Rev. 2005, 105, 4779−4807. 
27  Juhl, M.; Tanner, D. Recent applications of intramolecular Diels–Alder reactions to natural product 
synthesis. Chem. Soc. Rev., 2009, 38, 2983–2992. 
28  Takeda, K.; Igarashi, Y.; Okazaki, K.; Yoshii, E.; Yamaguchi, K. J. Org. Chem. 1990, 55, 3431-3434.  
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tantalizing is to consider the possibility of preparing pentacycle 2046 using the less 
oxygenated substrate 2045 (Panel B). 
Scheme 2.6| A) IMDA reaction in the total synthesis of chlorothricolide; B) A 
hypothetical IMDA reaction of a less oxygenated analogue 2046. 
  
In 1997, Uenishi’s group29 reported the total synthesis of two biosynthetically related 
natural products, (–)-ircinianin (2052) and (+)-wistarin (2053, Scheme 2.7). The key step 
in their synthesis was an IMDA reaction. A Nozaki–Hiyama–Kishi coupling30 between 
aldehyde 2047 and vinyl iodide 2048 gave the secondary alcohol 2049 and 2050 
smoothly.31 What was unexpected is the drastic reactivity difference between 2049 and 
2050, which differ from each other only by a C-16 stereocenter. The alcohol adduct 2049 
                                                
29  Uenishi, J.; Kawahama, R.; Yonemitsu, O. Total synthesis of (–)-ircinianin and (+)-wistarin. J. Org. 
Chem. 1997, 62, 1691–1701. 
30  Fürstner, A. Carbon−Carbon bond formations involving organochromium(III) reagents. Chem. Rev., 
1999, 99, 991–1046 
31 The ratio of 2049 to 2050 was later estimated to be ca. 3:2. 
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cyclizes in situ32 at room temperature, yielding exclusively the spirocycle 2051 that has 
the same relative configuration as does the natural product; the epimer 2050, on the other 
hand, was almost inert under the same reaction conditions, and isomerizes only upon 
heating to 150 °C in xylene, affording three (out of four possible) diastereoisomers in a 
nonselective fashion (2054:2055:2056 = 27:18:14).  
Scheme 2.7| Uenishi’s Total synthesis of (–)-ircinianin and (+)-wistarin. 
 
The following functional group manipulations furnished (–)-ircinianin and (+)–
wistarin uneventfully. The rapid total synthesis of these two natural products was enabled 
by the successful execution of the IMDA reaction of 2049. Additionally, the different 
                                                
32  CrCl3 in the reaction mixture presumably functions as a Lewis acid that catalyzes the IMDA reaction of 
2049. 
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reactivity profiles of 2049 and 2050 emphasize how dramatic influence a seemingly 
unimportant structure variation can exert on an IMDA reaction. 
Scheme 2.8| Total of abyssomicin C by Sorensen, Snider, and Couladouros groups. 
 
 The Sorensen, Snider, and Couladouros groups have each reported a remarkable total 
synthesis of abyssomicin C33 (2059) using a biomimetic IMDA strategy (Scheme 2.8).34 
The key step in each synthesis was the diastereoselective IMDA reaction of 2057, which 
provided macrocyclic 2058 in ca. 80% yield as a single diastereoisomer. Snider et al.34b 
observed that this conversion occurs at room temperature in chloroform with a 
measurable rate (40% conversion, 7 days). This extraordinarily successful IMDA reaction 
allowed a very quick synthesis of abyssomicin C from simple precursors. To the best of 
my knowledge, this is the only reported example of a diastereoselective IMDA 
macrocyclization used in the total synthesis of a spirotetronate natural product.  
Although the reaction temperature required for 205735 to isomerize at a 
(bio)synthetically useful rate is well above that of physiologically relevant conditions, the 
                                                
33 a) Bister, B.; Bischoff, D.; Strobele, M.; Riedlinger, J.; Reicke, A.; Wolter, F.; Bull, A. T.; Zahner, H.; P. 
Fiedler, H.; Süssmuth, R. D. Angew. Chem., Int. Ed. 2004, 43, 2574–2576; b) Riedlinger, J.; Reicke, A.; 
Zahner, H.; Krismer, B.; Bull, A. T.; Maldonado, L. A.; Ward, A. C.; Goodfellow, M.; Bister, B.; 
Bischoff, D.; Süssmuth, R. D.; Fiedler, H. P. J. Antibiot. 2004, 57, 271–279. 
34 a) Zapf, C. W.; Harrison, B. A.; Drahl, C.; Sorensen, E. J. Angew. Chem. Int. Ed. 2005, 44, 6533–6537; 
b) Snider, B. B.; Zou, Y. Org. Lett. 2005, 7, 4939–4941; c) Couladouros, E. A.; Bouzas, E. A.; Magos, 
A. D. Tetrahedron 2006, 62, 5272–5279.  
35 The reactivity of the free tetronate (O-demethylated version) of 2.57 was not reported.  
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exclusive formation of 2058 suggest that an enzyme is not required to control the 
stereoselectivity this reaction. 
Scheme 2.9| Takeda’s model study directed to the total synthesis of okilactomycin. 
 
As early as in 1992 Takeda’s group conceived using an IMDA strategy to synthesize 
okilactomycin.36 They attempted effecting an IMDA reaction of polyene 2060, expecting 
to obtain tetracycle 2061, a tetracyclic compound with the skeleton of (+)-okilactomycin. 
During this study, they observed that 1) 2060 was thermally unstable, and 2) upon 
treatment with SnCl4 at -78 °C, 2060 cyclizes in a [2+2] fashion, giving cyclobutanes 
2062 in a non-stereoselective fashion.  
The track record for IMDA reactions in spirotetronate synthesis is uneven. In 
particular, the failure in converting 2060 to 2061 seemingly obscured the prospect of 
synthesizing okilactomycin D from 2063 using an IMDA reaction, due to the high 
                                                
36 Takeda, K.; Shimotani, A.; Yoshii, E.; Yamaguchi, K. A Lewis acid mediated intramolecular [2+2] 
cycloaddition of 3-(9-methylundeca-7,9-dienyl)-9-methylene-2,8-dioxabicyclo[4.3.0]nonane-5,7-dione. 
Heterocycles 1992, 34, 2259–2261. 
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structural similarity between 2060 and 2063 (Scheme 2.10). Nonetheless, we still deemed 
that the efficiency inherent in the preparation and cycloaddition of 2063 to okilactomycin 
D warranted study. Our confidence in this proposed study was also bolstered by the 
notion that slight structural difference may have a large impact on substrate reactivity (cf. 
Scheme 2.7).  
Scheme 2.10| Takeda’s model study vs. our proposed study. 
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Chapter 3. Total Synthesis of (–)-Okilactomycin D 
3.1 First generation synthesis of IMDA substrate 
Our synthesis of okilactomycins (e.g., 3001) commenced with the preparation of the 
proposed IMDA substrate 3002. Our first generation strategy to 3002 is shown in Scheme 
3.1. The polyene 3002 was dissected by four key carbon-carbon bond forming reactions, 
which were: 1) an anionic addition by lithiated tetronate 3003;37 2) a Wittig olefination 
using known ylide 300438 to construct the α,β-unsaturated carbonyl moiety; 3) a Giese 
type reaction39 to unite iodide 300513 and acrylonitrile (3007); and 4) a Julia–Lythgoe 
olefination40 using allyl sulfone 3006 to construct the conjugate diene unit.  
Scheme 3.1| First generation synthetic plan of polyene 3002. 
 
                                                
37  Montgomery, L. J.; Challis, G. L. Concise synthesis of key 3-polyenoyl-5-methylenefuran-2,4-dione 
putative intermediates in quartromicin biosynthesis. Synlett 2008, 2164–2168. 
38  Smonou, I.; Khan, S.; Foote, C. S.; Elemes, Y.; Mavridis, I. M.; Pantidou, A.; Orfanopoulos, M. 
Reactions of phenyltriazolinedione with alkenes. Stereochemistry of methanol adducts to aziridinium 
imide intermediates. J. Am. Chem. Soc. 1995, 117, 7081–7087. 
39  Giese, V. B. Radicals in organic synthesis: Formation of C-C bonds; organic chemistry series, Baldwin, 
J. E., Series Ed.; Pergamon Press: Oxford, 1986.  
40  Keck, G. E.; Savin, K. A.; Weglarz, M. A. Use of samarium diiodide as an alternative to 
sodium/mercury amalgam in the Julia-Lythgoe olefination, J. Org. Chem., 1995, 60, 3194–3204, and 
references therein. 
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I prepared the iodide 3005 (in racemic form initially) by slight modification of known 
procedures (Scheme 3.2).13,41 Base catalyzed Michael addition of diethyl methylmalonate 
3008 to methyl methacrylate 3009 (both commercially available) provided triester 3010 
quantitatively, albeit with concomitant transesterification. Treating compound 3010 with 
conc. HCl in acetic acid at reflux for 36 hours effected ester hydrolysis and 
decarboxylation in one pot, to give a 1:1 diastereomeric mixture of 3011. Diacid 3011 
was then converted to anhydrides meso/dl-3012 through dehydrative cyclization. A 
solution of meso/dl-3012 in EtOAc was then treated with Hünig’s base, which enabled 
the equilibrium between dl-3012 and meso-3012. The latter, which is less soluble in 
EtOAc, precipitated from the solution, thereby driving the equilibrium to the desired 
direction. Overall, meso-3012 was prepared from compound 3008 and 3009 in 70% yield 
with over 95% de. Subsequent LiAlH4 reduction of 3012 gave diol 3013 in 92% yield. 
Scheme 3.2| Synthesis of (±)-3005. 
 
                                                
41  Prusov, E.; Rohm, H.; Maier, M. E. Chemoenzymatic synthesis of the C10-C23 segment of 
Dictyostation. Org. Lett., 2006, 8, 1025–1028.  
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Treating diol 3.13 with ca. 1 equiv of nBuLi followed by addition of ca. 1 equiv of 
TBSCl resulted in the formation of mono-TBS protected (±)-3014 in 73-85% yield. This 
far-above-statistical yield of (±)-3014 was surprising, considering the long spatial 
distance between the two hydroxy groups in an energy-minimized conformation of 3013 
(and by inference, that of the mono anion of 3013, see Scheme 3.2). Alcohol (±)-3014 
was then converted to iodide (±)-3005 under standard conditions. More than 10 grams of 
(±)-3005 could be made by this sequence in one batch.   
      With iodide (±)-3005 available in large quantities, I investigated its union with 
acrylonitrile (3007) to prepare (±)-3015 by the use of a radical-based Michael addition 
reaction (Giese reaction). Encouragingly, the desired nitrile 3015 was obtained in 35% 
yield by heating a mixture of iodide (±)-3005 (1 equiv) and 3007 (10 equiv) in benzene 
with nBu3SnH as the stoichiometric hydride donor and AIBN as the radical initiator. 
Under this condition, however, dinitrile 3016 was also formed in almost equal amount. 
To minimize the undesirable formation of dinitrile 3016, I gradually reduced the amount 
of acrylonitrile used to 5 equiv, and found that the ratio of 3015 to 3016 as well as the 
isolated yield of 3015 increased accordingly (entry 1-3). Further lowering the 
acrylonitrile to 3 equiv didn’t increase the yield of 3015, because the direct deiodination 
of 3005 became competitive. Lowering the reaction temperature is also beneficial for the 
formation of 3015 (entry 3 vs. entry 4). The best yield (78%) of 3015 was obtained by 
using 1.5 equiv of nBu3SnH (entry 5). To my delight, by using the conditions listed in 
entry 5, nitrile 3015 can be prepared on a gram scale, and byproduct 3016 could be easily 
separated using column chromatography.  
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Scheme 3.3| Radical addition of iodide (±)-3005 to acrylonitrile to give (±)-3015. 
 
a Reactions were conducted as a 0.25 M solution of 3.5 in benzene. AIBN (1% equiv) was used as 
the radical initiator. Detailed procedures can be found in the experimental section. b Isolated yield. 
c Ratios are determined by GC/MS. d An appreciable amount of deiodinated product were 
observed on GC.  
 
It is interesting to recall that I was initially concerned that primary radical 3017 might 
undergo an intramolecular 1,5-hydrogen atom transfer event42 to form a hetereoatom 
stabilized radical 3019 as a decomposition pathway (Scheme 3.4). To my delight, no 
byproduct resulting from this event was observed throughout this study. In retrospect, this 
potential decomposing pathway may be prevented by the unfavorable 1,3-dialkyl 
interaction inherent in the corresponding transition structure 3018. 
                                                
42 This 1,5-hydrogen shift is ubiquitous in carbohydrates syntheses. For instance, see: Barbaud, C.; Bols, 
M.; Lundt, I.; Sierks M. R. Synthesis of the first pseudosugar-C-disaccharide. A potential antigen for 
eliciting glycoside-bond forming antibodies with catalytic groups. Tetrahedron. 1995, 51, 9063-9078. 
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Scheme 3.4| A potential 1,5-intramolecular hydrogen atom transfer is not observed 
presumably because of the unfavorable 1,3-dialkyl interaction present in the 
transition structure 3018. 
 
To prepare for the following Julia-Lythgoe olefination, the nitrile (±)-3015 obtained 
from the previous step was converted to its corresponding aldehyde (±)-3020 (Scheme 
3.5). The other partner in the olefination step, sulfone 3022,43 was made by a two-step 
sequence from tiglic alcohol 3021 via the intermediacy of an allyl iodide (Scheme 3.5). 
This iodination-substitution sequence gave sulfone 3022 in a 3:1 isomeric ratio. The 
desired (E)-3022 could be purified with the assistance of MPLC separation. Because of 
the volatility and light sensitivity of the allyl iodide intermediate, I found it beneficial to 
conduct the two reactions in one pot.  
Scheme 3.5| Synthesis of diene 3023. 
 
The Julia-Lythgoe olefination40 between (±)-3020 and 3022 gave the key diene 3023 
in 65% yield over a three step sequence. The newly formed Δ4,5 C=C bond has a high E:Z 
                                                
43  Cox, C. M.; Whiting, D. A. Synthetic studies on electron transport inhibitors. Part 1. Chiral synthesis of 
a synthon for myxalamide D, piericidin A, and the actinopyrones. J. Chem. Soc. Perkin Trans. 1, 1991, 
1901–1905. 
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ratio. Unfortunately, the stereochemical integrity of the terminal Δ2,4 C=C bond eroded to 
3:1 during the reaction.  
Nevertheless, this strategy successfully delivered 3023 in the quantity of several 
hundred milligrams, enough for initial exploratory studies.  Pleasingly, the conversion of 
3023 to 3002 turned out to be very smooth (Scheme 3.6). Silyl ether 3023 was firstly 
subjected to TBAF deprotection–Swern oxidation44 sequence, which gave aldehyde 3024 
in 85% yield. Wittig olefination of aldehyde 3024 by the stabilized ylide 300445 and 
standard processing of the resulting enoate (DIBAL-H reduction and MnO2 oxidation) 
provided enal 3025 in 89% yield over 3 steps.  
Scheme 3.6| Conversion of 3023 to IMDA precursor 3002. 
 
                                                
44  Notably, attempted alcohol oxidation using Dess–Martin periodinane appeared to destroy the diene unit 
present in the substrate, and Parikh–Doering oxidation only gave a low yield of desired aldehyde.  
45  Smonou, I.; Khan, S.; Foote, C. S.; Elemes, Y.; Mavridis, I. M.; Pantidou, A.; Orfanopoulos, M. 
Reactions of phenyltriazolinedione with alkenes. Stereochemistry of methanol adducts to aziridinium 
imide intermediates. J. Am. Chem. Soc. 1995, 117, 7081-7087. 
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The protocol of Pattenden46 (as successfully implemented by researchers in the 
abyssomicin C studies34) was used to effect anionic addition of lithiated methyl tetronate 
300337 to 3025. MnO2 oxidation yielded acyltetronate 3026 in 55% yield47 over 2 steps. 
The obtained vinylogous carbonate/ester 3026 was treated with LiCl in d6-DMSO48 at 
50 °C to cleanly produce (according to 1H NMR analysis) the tetronate, presumably as its 
lithium salt, which, following a brine wash, was isolated, presumably as the sodium salt 
3027. Neutralization with TFA could be performed at a number of stages to give the 
neutral acyltetronic acid 3002.   
  
                                                
46  Clemo, N. G.; Pattenden, G. Vinylic carbanions in synthesis. Novel syntheses of iso-gregatin B, iso-
aspertetronin A and related O-methyl tetronic acids. Tetrahedron Lett. 1982, 23, 585–588. 
47  The anionic addition step occurred with >90% yield and 1:1 dr. The less than optimal isolated yield of 
3.26 may be caused by product absorption by MnO2 in the second step.  
48  Takeda, K.; Kawanishi, E.; Nakamura, H.; Yoshii, E. Total synthesis of tetronolide, the aglycon of 
tetrocarcins. Tetrahedron Lett. 1991, 32, 4925–4928. 
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3.2 Second generation synthesis of IMDA substrate  
Although the synthetic strategy in the previous section had provided sufficient 
amount of polyene 3002 to study its reactivity, the shortcomings of this strategy were 
also obvious. First, the radical Michael addition (cf. Scheme 3.3) requires the use of 
stoichiometric amount of toxic nBu3SnH. The stannous byproduct formed during this step 
also complicated the product purification process. Second, Na/Hg amalgam was used in 
the Julia olefination step, and the disposal of the mercuric waste of this reaction is 
tedious. In addition, the olefination reaction gave a mixture of non-separable isomers, 
which compromised the yield of desired diene 3002, and caused some additional 
challenges when studying the reactivity of 3002. 
Scheme 3.7| Second generation synthetic plan of 3002. 
 
The above shortcomings prompted me to pursue a better strategy to synthesize 3002. 
Key steps of our second-generation synthetic plan of 3002 are shown in Scheme 3.7. Two 
major modifications are made in this new plan: 1) a Schlosser-Fouquet coupling49 is used 
to construct the Csp3-Csp3 bond, replacing the Giese reaction; 2) the diene unit present in 
                                                
49  Fouquet, G.; Schlosser, M. Improved carbon-carbon linking by controlled copper catalysis. Angew. 
Chem., Int. Ed. 1974, 13, 82–83. 
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3002 is carried from compound 3028, which is prepared prior to the Csp3-Csp3 bond 
formation event.  
The synthesis of diene bromide 3028 capitalized on a cyclopropyl ring opening 
reaction (Scheme 3.8). Addition of Grignard reagent 3030 to tiglic aldehyde (3029) gave 
allyl alcohol 3031, which upon extractive workup was directly subjected to conc. aqueous 
HBr50 to yield the ring opened bromide 3028.  More than 20 grams of diene bromide 
3028 could be prepared and isolated in one batch. The 3028 obtained by this method is of 
very high purity, with only slight erosion of stereochemical integrity at the Δ2,3 double 
bond. The high E:Z ratio of the Δ4,5 double bond in the resulting 3028 is presumably a 
reflection of the relative stability of cationic intermediate 3032a/3032b. 
Scheme 3.8| Synthesis of diene bromide 3028.  
 
The rapid access of 3028 laid the ground for the next Schlosser-Fouquet coupling 
(Scheme 3.9). Bromide 3028 was initially converted to the corresponding Grignard 
reagent 3029, then incubated with a catalytic amount (0.01 equiv) of Li2CuCl4, and 
finally reacted with iodide 305 (0.25–0.33 equiv). These conditions afforded the key 
diene 3023 in over 90% yield. Several observations during this reaction are worth 
mentioning here. First, a superstoichiometric amount of 3029 was used to ensure the full 
                                                
50 Jung, M. E.; Miller, S. J. Preparation of N-alkadienyl N-E-2-arylethenylcarbamates via sulfoxide 
elimination in a synthetic approach to lycorine. Heterocycles 1990, 30, 839-853. 
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conversion of the more precious 305. The excess 3029 led to the formation of compounds 
with the molecular weight of 3030.51 Second, it is important to minimize the amount of 
Li2CuCl4 used in the reaction. When 0.1 equiv of Li2CuCl4 (with respect to 3029) was 
used, compound 3005 were not fully converted, and byproduct 3031 was formed in 
almost equal amount with 3023 (GC results). Third, some isomerization at Δ2,3 double 
bond (from 16:1 to 13:1) was noticed during the reaction. I presume this bond 
isomerization occurred when 3029 was incubated with Li2CuCl4: longer incubation with 
Li2CuCl4 (30 vs. <5 minutes, 0 °C) prior to the addition of 3005 led to a greater amount 
of E/Z-isomerization at Δ2,3 double bond, whereas prolonged heating (50-60°C for 2 h) 
during the preparation of 3029 had little to no effect on the stereochemical integrity of 
this bond.52 
Scheme 3.9| Synthesis of 3023 using a Schlosser–Fouquet coupling. 
 
Conversion of 3023 to the IMDA precursor 3002 was completed with the same 
conversions used in the first generation strategy as described in the previous section. The 
                                                
51 Besides the linear products like 3030, those with varying number of cyclopropyl rings could have also 
been formed. 
52 Howden, M. E. H.; Maercker, A.; Burdon, J.; Roberts, J. D. Small-ring compounds. XLV. Influence of 
vinyl and phenyl substituents on the interconversion of allylcarbinyl-type Grignard reagents. J. Am. 
Chem. Soc., 1966, 88, 1732–1742. 
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E:Z ratio of the double bonds in 3023 was retained throughout these operations. 
Compared with the first generation synthesis, this new synthetic strategy is more 
convergent and higher yielding, obviates the use of toxic stannous and mercuric reagents, 
and provides the desired 3002 in higher purity. Additionally, this new synthetic sequence 
is very scalable and could be conducted at multi-gram scale at each stage.  
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3.3. Endgame of (–)-okilactomycin D synthesis 
With tetraene 3002 and its close analogues 3026 and 3027 in hand, I next investigated 
the reactivity profiles of each compound toward an IMDA cyclization. The results are 
summarized in Table 3.1. 
Table 3.1| Summary of reactivity profiles of 3002, 3026, and 3027.  
 
Unfortunately, the free tetronic acid 3002, our initially proposed biosynthetic 
precursor to okilactomycin D (cf. Scheme 1.3 and Scheme 2.10), was found to be 
thermally unstable. It decomposed in various (aqueous or non-aqueous) solvents at 
ambient temperature before any sign of cyclization could be observed (entry 1). It was 
informative to learn that acyl tetronic acid moiety like that present in 3002 is rather acidic 
(pKa ≤ 1).53 The coexistence of this highly acidic unit and other acid sensitive functional 
groups (e.g., the diene group and the enol ether group) in 3002 might account for its 
                                                
53  Yamaguchi, T.; Saito, K.; Tsujimoto, T.; Yuki, H. NMR spectroscopic studies on the tautomerism in 
tenuazonic acid analogs. J. Heterocyclic Chem. 1976, 13, 533-537. 
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instability.  
Because of its strong acidity, compound 3002 should not exist in Nature as a neutral 
vinylogous acid. We thus modified our original hypothesis, and proposed that the natural 
biosynthetic precursor to okilactomycin D is a conjugate base of 3002, like 3027. We 
later found that this conjugate base, on the other hand, is rather inert. It stays intact in 
solution even after being heated to 180 °C for elongated time (entry 2). The surprisingly 
low reactivity of 3027 might be attributed to the elevated LUMO energy of the anionic 
dienophile moiety, which raised the activation energy of this normal electron demand 
biosynthetic IMDA reaction. Meanwhile, the inertness of 3027 under ambient conditions 
strongly suggests that the IMDA reaction in the biosynthesis of okilactomycin D is an 
enzymatic process. This possibility is currently under investigation in the Challis 
laboratory.  
Fortunately, we found that the methyl ester 3026 is a synthetically useful compound 
endowed with suitably balanced reactivity and stability. Although it has the tendency to 
polymerize at high concentrations, compound 3026 can be stored as a dilute solution at    
–20 °C indefinitely. After being heated at 110 °C for 96 h in toluene, 3026 completely 
isomerized, and yielded 3032, the tricycle with identical relative configuration to that of 
okilactomycin D, as the most predominant product (entry 4). Consistent with 
observations made before, the IMDA reaction of 3026 proceeds at a faster rate in aqueous 
media,54 albeit in lower and less reproducible yield (entry 5). In fact, 3026 cyclizes at a 
measurable rate even at room temperature (entry 3), although the rate is too slow to be 
biosynthetically viable.  
                                                
54 Blokzijl, W.; Blandamer, M. J.; Engberts, J. B. F. N. Diels-Alder reactions in aqueous solutions. 
Enforced hydrophobic interactions between diene and dienophile. J. Am. Chem. Soc. 1991, 113, 4241–
4246. 
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As in the case of abyssomicin C total synthesis,34 the (only) two stereocenters in 
precursor 3026 successfully controlled the sense of diastereoselectivity of the IMDA 
event. Compared with the IMDA reaction in abyssomicin C total synthesis, the 
macrocycle formed in this case is of even bigger size (13 membered vs. 11 membered), 
and the stereo-directing centers are even more distant from the reaction sites (3 Csp3 
atoms vs. 3 Csp2 atoms to diene center and 5 Csp2 atoms vs. 3 Csp2 atoms to dienophile 
center).  
It is noteworthy that the drastic reactivity difference between 3026 and 2060 (Scheme 
2.9 in section 2.2) reinforced the notion that very small structural variations may exert a 
huge impact on substrate reactivity. 
Scheme 3.10| Endgame of okilactomycin D synthesis. 
 
To complete the total synthesis of okilactomycin D (3001), the methyl ether 3032 
(200 mg) was dissolved in DMSO (15 mL) and LiCl (15 equiv) was added (Scheme 
3.10). Once the mixture became homogeneous, the solution was warmed to 55 °C for 48 
h. Partitioning between water and ethyl acetate and washing the organic phase with brine 
resulted in isolation of the conjugate base of okilactomycin D, presumably as its sodium 
salt. Alternatively, partitioning of the initial reaction mixture between 10% HCl (aq) and 
ethyl acetate cleanly gave okilactomycin D (3001) directly as the neutral acyltetronic 
acid. 
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Starting from the nonracemic 5-iodopentane derivative (+)-(2R,4S)-3005,55 and using 
the same route, I then synthesized enantiomerically enriched 3001. The resulting 
synthetic sample of okilactomycin D gave essentially identical 1H and 13C NMR spectral 
data (for tabulated differences in chemical shifts between the synthetic and natural 
sample, see page 174 in Experimental session) and had the same sign of optical rotation 
as that of the natural sample56 {[α]Dsynthetic = –32 (c = 0.3, MeOH); lit.8 [α]Dnatural = –50 (c 
= ca. 0.1, MeOH)}, supporting the assigned absolute configuration of (–)-3001.8 
  
                                                
55  Takagi, R.; Tsuyumine, S.; Nishitani, H.; Miyanaga, W.; Ohkata, K. Stereoselective synthesis of the 
hydrophobic side chain of scyphostatin. Aust. J. Chem. 2004, 57, 439–447. I prepared (+)-(2R,4S)-3.5 
using slightly modified procedures. These involved enantioselective, lipase-catalyzed (PPL) acetylation 
of diol 3.13 (the resulting mono-alcohol was measured to have an ca. 9:1 er by Mosher ester analysis), 
TBS protection, acetate methanolysis, and iodination. The sample of (+)-3.5 had [α]D (CHCl3, c = 2.0) = 
+3.1 [lit. [α]D22 (CHCl3, c = 2.09) = +3.50]. 
56  The sample of natural okilactomycin D was isolated after a final purification by HPLC using an eluent 
doped with trifluoroacetic acid. Thus, its structure is best formulated as 3001, having the neutral 
acyltetronic acid. We observed that the 1H NMR spectrum of the sodium salt of 3001 in CD3OD (or of 
the analogous cesium salt in CDCl3) contained a resonance for the enone β-proton (H6) that was ca. 0.6 
(or 0.2) ppm upfield of that for the sample of neutral 3001. 
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3.4 On the diastereoselectivity of the biomimetic IMDA reaction in okilactomycin D 
synthesis 
In fact, the IMDA reaction of polyene 3026 discussed in the previous section (Table 
3.1) gave a mixture of four diastereoisomers (3032–3035, Scheme 3.11). The structures 
of 3032, 3033, and 3034 have all been determined by X-ray crystallographic analysis. 
Compound 3035 could not be purified to homogeneity, and its structure was assigned 
with the assumption that this IMDA reaction occurs via a concerted mechanism.  In fact, 
the minor 2Z,4E-diene isomer (3026-Z)57 was typically observed in the crude IMDA 
reaction product mixture, and it was recovered and characterized from a thermal reaction 
in toluene (entry 2). Thus, the E-isomer 3026-E reacts faster than 3026-Z, supporting the 
assumption that this IMDA is a concerted process.58 
I also attempted using Lewis acids to accelerate the IMDA reaction of 3026 (Scheme 
3.11, entry 3-6). During this course of study, I found that 1) while the reagent BF3•Et2O 
(entry 3) or Cu(OTf)2 (entry 4) is not compatible with 3026,59 the use of LiClO4 (entry 5) 
or MeAlCl2 (entry 6) significantly lowered the activation energy of this reaction so that 
the reaction could be completed within a shorter period of time at ambient temperature or 
below; and 2) extremely surprisingly, when LiClO4 or MeAlCl2 was used, compounds 
3034 and 3035, the minor products formed under thermal conditions, were produced 
predominantly (cf. entry 1-2 with 5-6): the use of these two Lewis acids altered the sense 
of diastereoselectivity of this biosynthetically relevant IMDA reaction!  
                                                
57  This minor isomer was formed as a byproduct in both generations of substrate synthesis (see Scheme 
3.5 and 3.9). 
58  It is reasonable to assume that both isomers should react at similar rate if the IMDA reaction occurs via 
a stepwise mechanism. 
59  BF3•Et2O or Cu(OTf)2 is not tolerated presumably because both reagents would give rise to strong 
protic acids when reacting with adventitious amount of water.  
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Scheme 3.11| Diasteroselectivity of the IMDA reaction in okilactomycin D 
synthesis. 
 
This stereochemical dichotomy immediately piqued my interest. Upon a more careful 
analysis of the structural difference of each product, I noticed that both the most (3032) 
and the second most (3033) dominant isomers formed under thermal conditions (entry 1 
and 2) arose from the si-face attack at C16a of dienophile by the diene, whereas 3034 and 
3035, products preferred under Lewis acid catalyzed conditions result from re-face attack 
at C16a. We attempted to explain this unusual facial selectivity alteration with the two 
transition structures 3032_TS and 3034_TS shown in Scheme 3.11. In the absence of 
Lewis acids, the IMDA reaction should preferentially pass through the transition structure 
3032_TS, in which 1) the IMDA reaction occurs in an endo fashion with respect to the 
endocyclic double bond; 2) the dipole moment of the two carbonyl groups are 
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opposed;60,61 3) the A1,3 interaction is minimized; and 4) the unfavorable 1,3-dialkyl 
repulsions are avoided. Therefore, tricycle 3032 is produced predominantly. In the 
presence of Lewis acids (i.e., LiClO4 and MeAlCl2 in these experiments), however, the 
bis–chelating ability of the metal cations enforced the two carbonyl groups to take the s-
cis conformation, resulting in the revelation of the opposite face, i.e., re-face of C16 to 
the diene unit, leading to the formation of 3034 as the major product. In short, we 
presume that the different preferred orientation of the two carbonyl groups under each 
condition accounts for the observed switch in stereoselectivity.  
Scheme 3.12| Rationalization of the difference in facial selectivity under thermal 
conditions vs. under Lewis acid catalysed conditions.  
 
  
                                                
60 Preference to minimize dipole moment in non-polar solvents has been invoked to explain solvent effects 
on the reaction rate of certain IMDA reactions. For example, see: Jung, M. E.; Gervay, J. Solvent effects 
in intramolecular Diels-Alder reactions of 2-furfuryl methyl fumarates: evidence for a polar transition 
state. J. Am. Chem. Soc., 1989, 111, 5469–5470. 
61 This anti-relationship of the two carbonyls was also proposed in the transition structure of the IMDA 
reaction used in the abyssomycin C synthesis.34a  
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To substantiate the above rationale, I performed a computational study using density 
functional theory [M062X62/6-31+G(d,p), scrf=(cpcm63, solvent=toluene)]. I have located 
transition states for a pair of simple model reactions. Namely, the bimolecular 
cycloaddition between butadiene (3037) and the anti vs. syn conformation of the simple 
enoyltetronate (3036) was computed to locate the transition state geometries. That for the 
anti isomer 3038a-TS was favored over that for the 3038b-TS by 6.3 kcal/mol (Scheme 
3.13). In fact, this activation energy difference is largely a reflection of the relative 
stability of the two isomeric starting materials: the s-cis isomer 3036b is less stable than 
the s-trans isomer 3036a by 5.1 kcal•mol-1, presumably due to the larger dipole moment 
Scheme 3.13| Calculated transition structures for [4+2] cycloaddition of butadiene 
(3037) with a truncated model methylene acyltetronate (3036). 
 
                                                
62  Zhao, Y.; Truhlar, D. G. The M06 suite of density functionals for main group thermochemistry, 
thermochemical kinetics, noncovalent interactions, excited states, and transition elements: two new 
functionals and systematic testing of four M06-class functionals and 12 other functionals. Theor. Chem. 
Acc. 2008, 120, 215–241. 
63  Tomasi, J.; Persico, M. Molecular interactions in solution: An overview of methods based on 
continuous distributions of the solvent. Chem. Rev. 1994, 94, 2027–2094. 
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of the former (10.6 Debye vs. 4.4 Debye).64 The computed results of these two model 
reactions support our assumptions made in Scheme 3.12: under thermal conditions, the 
two carbonyl groups in 3026 adopt an anti-relationship preferentially, and 3032_TS is 
energetically favored over 3034_TS. 
Through studying these aspects of stereoselectivity, we have gained substantial 
mechanistic insights into this synthetically powerful and biosynthetically significant 
IMDA reaction. In view of our proposed models (3032_TS and 3034_TS in Scheme 
3.12), which are consistent with the observed stereoselectivity switch under different 
conditions, it is tempting to hypothesize that the anti-relationship of the two carbonyl 
groups in the acyltetronate subunit is actually adopted by all the transition structures of 
IMDA reactions that are responsible for the biosynthesis of relevant spirotetronates, and 
that such an anti-relationship is a key element Nature utilizes to control the 
diastereoselectivity of these IMDA reactions. It is especially pertinent to mention here 
that in each of the two “failed” attempts of applying the IMDA reaction in spirotetronate 
synthesis (see Scheme 2.628 and 2.936), the acyltetronate unit had been artificially 
modified in a way that this anti-relationship became not preferred or not attainable. 
  
                                                
64  Conformers with larger dipole moments are better stabilized in polar solvents. It is consistent to observe 
that the facial selectivity is lower in CH3OH/H2O than in toluene by a factor of two (compare entry 1 
and 2 in Scheme 3.11). 
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Chapter 4. Progress toward the Total Synthesis of 
Okilactomycins 
4.1. Attempted strategies to convert okilactomycin D to okilactomycin 
Having established a robust and scalable synthetic route to okilactomycin D (see 
Chapter 3), I then made attempts to convert it to other members in the okilactomycin 
family [e.g., okilactomycin (4002) and chrolactomycin (4003)]. However, this task turned 
out to be more complicated than it appeared.  
Scheme 4.1| Conversion of okilactomycin D to other okilactomycins 
 
 When comparing okilactomycin (4002) with okilactomycin D (4001), we noticed 
that both of the two additional substituents at C3 (a methyl) and C22 (a hydrogen) in the 
former occupy the α-face (i.e., face beneath the plane). Unfortunately, the α-face of the 
enolic double bond in okilactomycin D (4001) is largely shielded by the macrocyclic 
chain, as can be inferred from the X-ray crystal structure of o-methylated okilactomycin 
D (4001-Me, Scheme 4.2). Indeed, when treating okilactomycin D with C-methylating 
conditions65 (Li2CO3, MeI, DMF), the triketone 4003, which bears the incorrect 
configuration at C3, was formed exclusively. Reduction of 4003 with NaBH4 under 
carefully controlled conditions yielded the crystalline alcohol 4004, whose structure was 
                                                
65  Wymann, W. E.; Davis, R.; Patterson, J. W.; Pfister, J. R. Selective Alkylations of Certain Phenolic and 
Enolic Functions with Lithium Carbonate/Alkyl Halide. Synth. Commun. 1988, 18, 1379–1384. 
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unambiguously established by X-ray crystallography. Attempts to rectify the incorrect 
configurations of 4004 at C3 and C22, for example, through the retro-aldol/aldol 
sequence, were not successful. 
Scheme 4.2| First unsuccessful attempt to convert okilactomycin D to okilactomycin. 
 
Upon realizing it is hard to override the inherent facial selectivity at C3 and C22 in 
okilactomycin D (4001) imposed by its tricyclic structure, I then decided to convert 4001 
to the corresponding pyranone 4005 (Scheme 4.3), anticipating that the resulting 
tetracyclic structure would take a different posture and reveal the opposite face of its enol 
ether bond. However, this cyclization could not be realized by any of the basic conditions 
attempted: the skeleton of 4001 was left intact after treatment with various organic and 
inorganic bases even at elevated temperatures. The inertness of 4001 under basic 
conditions might be a result of the low nucleophilicity of acyl tetronic acid moiety.  
Interestingly, in our hands a solution of the neutral okilactomycin D (4001, pKa ≤ 153) 
in CDCl3 slowly, but fully, isomerized to the (more stable) C5–C6 Z-alkene 4006 
(Scheme 3.16, Keq(4006:4001) > 50:1). This transformation was noticeably slower in CD3OD. 
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methylating conditions (TMSCHN2, CH3OH) yielded a ca. 1:1 mixture of two isomeric 
methyl enol ethers 4007 and 4008. X-ray analysis of the crystalline compound 4008 
unambiguously determined its relative configuration, thereby confirming the structure of 
4006. Interestingly, the natural product itself has not undergone this exergonic E-to-Z 
enone isomerization, presumably because acyl tetronic acids exist largely as their 
conjugate bases in physiological environments. 
Scheme 4.3| Second unsuccessful attempt to convert okilactomycin D to 
okilactomycin 
 
Because 1) preparation of tetracycle 4005 from okilactomycin D (4001) could not be 
achieved, and 2) the β-face of C3 in the accidentally obtained isomer 4006 is also 
blocked (as suggested by the crystal structure of 4008), I turned to a third strategy, which 
is shown in Scheme 4.4. In this strategy I initially installed a chlorine atom at C3 of 
okilactomycin D, forming the tricarbonyl chloride 4009. This chlorination reaction 
should also occur at α-face of C3, but the chlorine atom attached could be removed at a 
late stage. Chemo-, regio-, and stereoselective reduction of 4009 with NaBH4 gave 
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alcohol 4010 in ca. 60% yield. Dechlorination of 4010 with Zn/HOAc smoothly gave 
alcohol 4011, which then underwent dehydration to afford the dienone 4012 under the 
catalysis of ZnI2. This 4 step sequence from 4001 to 4012 accomplished a net 
deoxygenation at C22 of okilactomycin D. Epoxidation of dienone 4012 under basic 
conditions gave 4013 regioselectively and stereoselectively, which has the correct 
configuration at C22 and could in principle serve as a common intermediate to both 
okilactomycin and chrolactomycin. However, methods to open the epoxide ring in 4013 
with concomitant introduction of a substituent at C3 have not yet been productive.  
Scheme 4.4| Third attempt to convert okilactomycin D to okilactomycin. 
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4.2 Future directions 
Although a total synthesis of okilactomycin from okilactomycin D has not been 
achieved yet, additional tactics to solve this problem have been conceived, some of which 
are discussed in this section.  
It is challenging to open the epoxide ring in 4013 (Scheme 4.4) presumably for 
twofold reasons: 1) the desired reactive center (C3) is quaternized and hence sterically 
encumbered; in addition, the macrocyclic ring in 4013 blocks the trajectory of an 
incoming nucleophile; 2) the C3 center is electronically less activated than the C22 center, 
so a regioselectivity issue must be addressed at the same time.  
Scheme 4.5| A Payne rearrangement/cyclization strategy to make tetracyclic skeleton 
of okilactomycin and chrolactomcyin from 4013 
 
A potential strategy to overcome both of the above two issues is based upon a Payne 
rearrangement/pyran ring formation cascade (Scheme 4.5). It is reasonable to assume 
enone 4013 could be reduced chemo- and stereoselectively to form allyl alcohol 4014. 
Allyl alcohol 4014 could then be treated with an appropriate base to undergo a Payne 
rearrangement,66 providing the isomeric alcohol 4015. Alcohols 4014 and 4015 might 
exist as an equilibrating mixture, but the latter is positioned to undergo an intramolecular 
                                                
66  a) Payne, G. B. Epoxide migrations with α,β-epoxy alcohols. J. Org. Chem., 1962, 27, 3819–3822. b) 
Hoye, T. R.; Jeffrey, C. S.; Nelson, D. P. Dynamic kinetic resolution during a vinylogous Payne 
rearrangement: A concise synthesis of the polar pharmacophoric subunit of (+)-scyphostatin,” Org. Lett. 
2010, 12, 52–55. 
O
OO
O
H
4013
O
OHO
O
H
4014
O
O
OH
H
4015
O
O
O
O
H
4016
OH
  Okilactomycin 
 50 
SN2’ displacement to form the epoxide ring opened tetracycle 4016, driving the 
equilibrium to the desired direction. It is noteworthy that tetracycle 4016 has all 
stereocenters present in chrolactomycin correctly installed. 
The total synthesis of okilactomycin C could be investigated in parallel. Studies in 
this direction is worthwhile for two reasons: 1) a robust strategy to install the oxidation 
states on C20 in 4001–Me is a prerequisite to accomplish the synthesis of any other 
members in okilactomycin family; 2) certain intermediates gleaned along this avenue 
may have unusual architectures or electronic properties that inspire new strategies to 
okilactomcyin and chrolactomycin synthesis. 
The most straightforward strategy to synthesize okilactomycin C is to directly oxidize 
the allylic C-H bonds in the C20 methyl group (Scheme 4.6). SeO2, the reagent 
conventionally utilized for this purpose has been tried, but with no success. Undesirable 
oxidation at the two tertiary allyl centers has been observed as the major competing 
pathways.  
Scheme 4.6| Unsuccessful attempt toward total synthesis of okilactomycin C. 
 
Indirect ways to oxidize the C20 methyl group have also been attempted (Scheme 
4.7). Although the oxidation of 4001-Me to epoxide 4018 could be realized in high 
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relatively low reactivity of an epoxide functional group. However, if a structurally 
analogous but more reactive chloronium bridge could be formed with N-chloro 
succinimde, an allyl chloride 4020 may be formed directly in the presence of a suitable 
base. Similar transformations to those used in Smith’s total synthesis of okilactomycin 
could then be adopted to convert allyl chloride 4021 to okilactomycin C.  
Scheme 4.7| Strategy toward total synthesis of okilactomycin C. 
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The Hexadehydro-Diels–Alder (HDDA) Reaction 
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Chapter 5. Introduction to o-Benzyne 
5.1 Historical background of o-benzyne 
Arynes comprise a class of reactive intermediates that are formally derived from 
aromatic rings by removal of two substituents (see Figure 5.1 for structures of benzynes). 
Depending on the relative position of the two substituents that are absent, arynes can be 
divided into three categories: ortho-arynes (cf. 5001), meta-arynes (cf. 5002), and para-
arynes (cf. 5003). These structurally unusual species have been continuously provoking 
the interests of research groups from all branches of chemistry.  
In spite of their identical composition, each class of arynes has its own distinctive 
physical and chemical properties. For example, the bonding interaction between the two 
electrons is considerably stronger in 5001 than in 5002 or 5003, and the structure of o-
benzyne is most often denoted as 5001’ as a result (vide infra). While more detailed 
discussion of m-arynes and p-arynes could be found elsewhere,67 this chapter will be 
focused mostly on o-arynes.  
Figure 5.1| Structures of benzynes. 
 
  
                                                
67  a) Wenthold, P. G. Thermal chemical properties of the benzynes. Aust. J. Chem. 2010, 63, 1091–1098. 
b) Wenk, H. H.; Winkler, M.; Sander, W. One century of aryne chemistry. Angew. Chem. Int. Ed. 2003, 
42, 502–528. c) Sander, W. m-Benzyne and p-benzyne. Acc. Chem. Res. 1999, 32, 669–676. 
5001' 50035002
o-Benzyne p-Benzynem-Benzyne
5001
  Hexadehydro-Diels–Alder Reaction 
 54 
o-Aryne (cf. 5001) is one of the oldest, most well-known, and most extensively 
studied reactive intermediates in chemistry. The first experimental evidence now 
interpreted as involving the formation of an aryne intermediate dates back to 190268 
(Scheme 5.1). When exploring the reactivities of bromobenzofuran derivatives, Stoermer 
and Kahlert observed the formation of 2-ethoxybenzofuran (5006) on treating 3-
bromobenzofuran (5004) with bases in ethanol. Inspired by the known reaction at the 
time between phenylacetylene (5007) and ethanol that gives enol ether 5008, the authors 
bravely postulated the formation of o-didehydrobenzofuran (5005), a species with a 
nonlinear triple bond, as an intermediate in their reaction (Scheme 5.1). 
Scheme 5.1| The first example where an aryne species (5005) was explicitly 
proposed as an intermediate. The proposed mechanism for the formation of 5006 was 
inspired by the known reaction between phenylacetylene (5007) and ethanol to form 
enol ether 5008.  
 
 Although the intermediacy of arynes had been speculated occasionally during the 
following years, definitive evidence for the existence of these unusual species was not 
obtained until ca. half a century later. In 1953, a classic isotope scrambling reaction 
reported by Roberts’ group69 for the first time solidified the intermediacy of o-benzyne 
(5009, Scheme 5.2). Upon treating the C14-labeled chlorobenzene 5008 with potassium 
                                                
68 Stoermer, R.; Kahlert, B. Ueber das 1- und 2-Bromcumaron. Ber. Dtsch. Chem. Ges. 1902, 35, 1633–
1640. 
69 a) Roberts, J. D.; Simmons, H. E.; Carlsmith, L. A.; Vaughan, C. W. Rearrangement in the reaction of 
chlorobenzene-1-C14 with potassium amide. J. Am. Chem. Soc. 1953, 75, 3290–3291. b) Roberts, J. D.; 
Vaughan, C. W.; Carlsmith, L. A.; Semenow, D. A. Orientation in aminations of substituted 
halobenzenes. J. Am. Chem. Soc. 1956, 78, 611–614. 
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amide in liquid NH3, the authors observed that the isomeric anilines 5010 and 5011 were 
formed in ca. 1:1 ratio. The formation of almost equal amounts of the two isomeric 
anilines could only be understood by the formation of a species whose 1- and 2-positions 
are equivalent, providing compelling evidence for the existence of o-benzyne. Almost 
simultaneous with Roberts’ work, Huisgen70 and Wittig71 discovered that o-benzynes 
could serve as potent dienophiles and participate in [4+2] cycloadditions with furan. 
These results provided additional support for the proposed structure of o-benzyne.  
Scheme 5.2| First definitive evidence for the intermediacy of o-benzyne. 
 
Later, o-benzyne was observed using physical methods. In 1963, Berry et al.72 
investigated the gas phase decomposition of benzenediazonium carboxylates under 
photoinitiated conditions and characterized the resulting o-benzyne by UV and mass 
spectrometry. Almost simultaneously, Fisher and Lossing73 studied the pyrolysis of 1,2-
diiodobenzene using mass spectrometry and identified the formation of o-benzyne based 
on the measured ionization potential.  
Using negative ion photoelectron spectroscopy, Leopold et al.74 determined the 
                                                
70 Huisgen, R.; Rist, H. Über Umlagerungen bei nucleophilen Substitutionen in der aromatischen Reihe 
und ihre Deutung. Naturwissenschaften 1954, 41, 358–359. 
71 Wittig, G. & Pohmer, L. Intermediäre Bildung von Dehydrobenzol (Cyclohexadienin). Angew. Chem. 
1955, 67, 348. 
72  a) Berry, R. S.; Clardy, J.; Schafer, M. E. Benzyne. J. Am. Chem. Soc. 1964, 86, 2738–2739. b) Berry, 
R. S.; Spokes, G. N.; Stiles, M. The absorption spectrum of gaseous benzyne. J. Am. Chem. Soc. 1962, 
84, 3570–3577. 
73  Fisher, I. P.; Lossing, F. P. Ionization potential of benzyne. J. Am. Chem. Soc. 1963, 85, 1018–1019. 
74  Leopold, D. G.; Miller, A. E. S.; Lineberper, W. C.  Determination of the singlet-triplet splitting and 
electron affinity of o-benzyne by negative ion photoelectron spectroscopy. J. Am. Chem. Soc. 1986, 
108, 1379–1384.  
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energy gap between singlet state and triplet state (ΔEST) of o-benzyne to be 37.6  
kcal•mol-1. This value was further supported by Wenthold and coworkers75 using 
ultraviolet photoelectron spectroscopy. Due to the less effective orbital overlap caused by 
ring constriction, the bonding interaction of the two electrons at the two adjacent Csp 
atoms in o-benzyne is significantly weaker than those in a typical π-bond (ca. 60 
kcal•mol-1). Nonetheless, the bonding interaction is strong enough to render diradical like 
structure 5001 (Figure 5.1) not a significant resonance contributor for o-benzyne.  
Infrared (IR) spectroscopy, a technique routinely employed to measure the vibrational 
frequencies of chemical bonds, provides valuable insights into the strengths of the bonds 
studied. Not surprisingly, the extremely high reactivity of o-benzyne posed significant 
challenge in its characterization with IR spectroscopy. By using photochemical 
transformations, Chapman et al.76 generated o-benzyne in an argon matrix at 77 K, and 
made the first direct IR spectroscopic characterization of o-benzyne. However, the 
vibration frequency of the strained Csp-Csp bond in o-benzyne could not be definitively 
assigned at the time because of the co-occurrence of other species with o-benzyne during 
the reaction. This problem bewildered the community for almost 20 years. In 1992, 
through a very careful study that combined the use of 1) high-resolution, single-site IR 
spectra, 2) isotopic shifts, 3) calculated frequencies, 4) experimental symmetries, 5) line 
shapes, and 6) in part intensities, Radziszewski et al.77 finally assigned the stretching 
                                                
75  Wenthold, P. G.; Squires, R. R.; Lineberger, W. C. Ultraviolet photoelectron spectroscopy of the o-, m-, 
and p-benzyne negative ions. Electron affinities and singlet-triplet splittings for o-, m-, and p-benzyne. J. 
Am. Chem. Soc. 1998, 120, 5279–5290. 
76  a) Chapman, O. L.; Mattes, K.; McIntosh, C. L.; Pacansky, J.; Calder, G. V.; Orr, G. Photochemical 
transformations. LII. Benzyne. J. Am. Chem. Soc. 1973, 95, 6134–6135. b) Chapman, O. L.; Chang, C. 
C.; Kolc, J.; Rosenquist, N. R.; Tomioka, H. A photochemical method for the introduction of strained 
multiple bonds: Benzyne C≡C stretch. J. Am. Chem. Soc. 1975, 97, 6586–6588. 
77  Radziszewski, J. G.; Hess, B. A. J.; Zahradnik, R. Infrared spectrum of o-benzyne: experiment and 
theory. J. Am. Chem. Soc. 1992, 114, 52–57. 
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frequency of this Csp–Csp bond in o-benzyne to an absorption at 1846 cm-1. The measured 
frequency indicates that the strength of this unusual Csp–Csp bond is closer to a typical C–
C triple bond (1974 cm-1 in acetylene) than to a typical C–C double bond (1623 cm-1 in 
ethylene). 
o-Benzyne has also been characterized by NMR spectroscopy. By using 
hemicarcerand as a “molecular container”, Warmuth78 reported the isolation and NMR 
characterization of o-benzyne in a THF solution!  The obtained NMR data from this work 
provided a valuable reference for future computational studies on o-benzyne. Using 
dipolar 13C NMR spectrometry, Orendt et al.79 determined the bond length of the Csp–Csp 
bond in argon matrix stabilized o-benzyne to be 1.24 Å. Again, this value is closer to that 
of a typical C–C triple bond (1.20 Å pm in acetylene) than that of a C–C double bond 
(1.34 Å in ethylene).  
Not surprisingly, computation has played a critical role in assessing certain properties 
of o-benzyne. For example, using DFT method (B3LYP/6 –311+G**//B3LYP/6–
311+G**), De Proft et al.80 has calculated the aromatic stabilization energy of o-benzyne 
to be 34.9 kcal/mol, suggesting o-benzyne has almost as much aromaticity as benzene. 
Houk, Warmuth, Schleyer, and coworkers81 estimated the strain energy of the bent bond 
in o-benzyne to be 53.6 kcal•mol-1 by comparing the energy difference between a fully 
                                                
78  Warmuth, R. o-Benzyne: Strained alkyne or cumulene?—NMR characterization in a molecular 
container. Angew. Chem. Int. Ed. 1997, 36, 1347–1350. 
79  Orendt, A. M.; Facelli, J. C.; Radziszewski, J. G.; Horton, W. J.; Grant, D. M.; Michl, J. 13C dipolar 
NMR spectrum of matrix-isolated o-Benzyne-1,2-13C2. J. Am. Chem. Soc. 1996, 118, 846–852.  
80  De Proft, F.; Schleyer, P. V. R.; Van Lenthe, J. H.; Stahl, F.; Geerlings, P. Magnetic properties and 
aromaticity of o-, m-, and p-benzyne. Chem. Eur. J. 2002, 8, 3402–3410. 
81 Jiao, H.; Schleyer, P. V. R.; Beno, B. R.; Houk, K. N.; Warmuth, R. Theoretical studies of the structure, 
aromaticity, and magnetic properties of o-benzyne. Angew. Chem. Int. Ed. 1997, 36, 2761–2764. 
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optimized and a partially optimized alkyne. Consistent with this result, Johnson et al.82 
estimated this strain energy to be 50.1 kcal/mol by calculating the ΔHR of an isodesmic 
reaction (o-benzyne + Z-2-butene à benzene + 2-butyne). The large strain energy in o-
benzyne is a major reason for its kinetic instability. Ab intio calculations revealed that the 
LUMO energy of o-benzyne is significantly lowered compared with that of 2-butyne, 
while HOMO energies of the two are largely the same. The extremely low LUMO energy 
explains that o-benzyne most frequently serves as the electrophile in the reported 
transformations.  
Figure 5.2| Summary of physical properties of o-benzyne. 
 
To conclude this section, I would like to dabble into a practical issue. At least three 
resonance structures (5001, 5001’ and 5001’’ in Figure 5.2) could be drawn for              
o-benzyne. Which one of the three structures reflects most faithfully the inherent 
properties of o-benzyne? From the review above, it became evident that structure 5001’, 
one with a strained triple bond, denotes o-benzyne most accurately. Indeed, this Lewis 
structure is the most widely used representation for o-benzyne by chemists, although the 
other two are encountered on certain occasions.  
                                                
82 Johnson, R. P.; Daoust, K. J. Interconversions of cyclobutyne, cyclopentyne, cyclohexyne, and their 
corresponding cycloalkylidenecarbenes. J. Am. Chem. Soc. 1995, 117, 362–367. 
 
5001'5001 5001''
υstretch 
bond length
aromatic stabilization energy
                  ΔEST
                         strain energy
5001' is the most widely accepted representation
= 1864 cm-1
= 1.24 Å
= 30–40 kcal•mol-1
= 37.6 kcal•mol-1
= ca. 50 kcal•mol-1
Me
Me
6.41 ev
-9.67 ev
-9.58 ev
1.33 ev
LUMO
HOMO
  Hexadehydro-Diels–Alder Reaction 
 59 
5.2 A brief review of o-benzyne trapping methods 
o-Arynes have attracted a tremendous amount of attention from the synthetic 
community because of their synthetic versatility. Because two functional groups can be 
installed in one operation, synthetic methods involving o-aryne intermediates are 
especially powerful in preparing poly-substituted arenes. In 1950s, seminal work from 
the groups of Huisgen, Wittig, and Roberts that proved the existence of o-benzyne fueled 
a large amount of in aryne research. By as early as in 1967, hundreds of aryne trapping 
reactions had already been developed, as elucidated by the manifold results compiled in 
the monograph by Hoffmann.83 In 1983, Kobayashi84 introduced what has become the 
most widely used aryne-making method. This involved treating 2-(trimethylsilyl)-phenyl 
triflate (and its derivatives) with fluoride ions. The mild conditions of this method, 
coupled with its operational ease, sparked a remarkable rebirth of interest in the study of 
aryne chemistry. This resurgence is exemplified by the plethora of major reviews on 
benzyne/aryne chemistry that have appeared even over just the past few years.  
It is neither practical nor necessary to give an extensive review of all aryne-trapping 
reactions in this document. Therefore, only several representative transformations that 
illustrate the most typical reactivities of o-arynes will be discussed in this section. For 
ease of orientation, I arbitrarily divide aryne-trapping reactions into three categories: 1) 
polar reactions, 2) pericyclic reactions, and 3) transition metal catalyzed reactions. 
Because arynes are species endowed with high strain energy, the products formed during 
the initial stage of aryne trapping are often reactive intermediates themselves, and could 
                                                
83  Hoffmann, R. W. Dehydrobenzene and Cycloalkynes (Organic Chemistry, A Series of Monographs, vol. 
11) (Academic Press, 1967). 
84 Himeshima, Y.; Sonoda, T.; Kobayashi, H. Fluoride-induced 1,2-elimination of o-trimethylsilylphenyl 
triflate to benzyne under mild conditions. Chem. Lett. 1983, 12, 1211–1214. 
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isomerize or react with other components to form more stable compounds. In other 
words, arynes are frequently engaged in multicomponent or cascade reactions, and a 
certain aryne-trapping transformation may involve, for example, both a polar addition 
step and a pericyclic reaction step. Some of these reactions are classified into one certain 
category or the other just for ease of discussion. 
1. Polar reactions.  
Polar addition is the most commonly encountered aryne reactivity in literature. 
Although o-arynes are electronically neutral species, their extremely low-lying LUMO 
render these species very potent electrophiles. In fact, the very first reported aryne 
trapping reaction is a polar addition to aryne by ethanol (Scheme 5.1).  
Scheme 5.3| Polar addition to benzyne by anionic species 
 
Later in 1940s, Gilman85 observed an unusual substitution reaction of 2-chloro 
anisole (5012) under basic conditions to give 3-diethylamino anisole (5013). In 
retrospect, this unexpected substitution reaction can be explained by the initial formation 
of the benzyne derivative 5013, followed by a regioselective addition to the polarized 
                                                
85 Gilman, H.; Avakian, S. Dibenzofuran. XXIII. Rearrangement of halogen compounds in amination by 
sodamide. J. Am. Chem. Soc. 1945, 67, 349–351. 
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triple bond by the external amide anion. Also in the 1940s, Wittig observed that 
subjecting fluorobenzene (5015) to C6H5Li yielded the organolithium species 5016. 
Apparently, this transformation involved the addition of phenyl anion to o-benzyne 
(5001’) generated under the reaction conditions.  
Scheme 5.4| Polar addition to benzyne by neutral species. 
 
Benzyne could also be efficiently trapped by neutral nucleophiles. Because the 
product resulting from the initial addition step in these transformations is bound to be a 
zwitterion, a cascade normally ensues. For instance, Greaney reported that benzyne 5001’ 
(generated from Kobayashi’s precursor 5017) could be trapped by the neutral amine 5018 
to furnish 5019 as an intermediate. Zwitterion 5019 is then protonated in situ to give 
cationic species 5020, which upon heating undergoes a facile aza-Claisen rearrangement 
to give aniline derivative 5021 as the final product after tautomerization. The same group 
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found that benzyne could be attacked by amides, which are deemed to be much less 
nucleophilic than amines. Reaction between 5001’ and amide 5022 results in the initial 
formation of 5023, which is poised to undergo an intramolecular proton transfer to yield 
the more stable zwitterion 5024. The following proton transfer events finally afford 
amide 5025 as the final product. Benzyne could even be intercepted by ethers in a polar 
addition fashion. Yoshida and coworkers86 described a multicomponent cascade reaction 
that was initiated by a polar addition of THF (5026) to benzyne 5001’. They found that 
the originally formed zwitterion 5027 could react with a bromoalkyne like 5028, 
producing bromoarene 5029 as the ultimate product in decent yield.  
Scheme 5.5| A polar addition to aryne in the synthesis of XPhos. 
 
The high reactivity of benzyne as an electrophile has enabled the formation of 
otherwise hard-to-construct bonds and finds wide applications in the preparation of many 
important aromatics. For example, Buchwald’s bulky electron-rich phosphine ligands 
have gained much attention because of their unique ability to effect difficult C-C, C-N, 
and C-O bond formations. The key step in the syntheses of these ligands [e.g., XPhos 
                                                
86  Yoshida, H; Asatsu, Y.; Mimura, Y.; Ito, Y.; Ohshita, J.; Takaki, K. Three-component coupling of 
arynes and organic bromides. Angew. Chem. Int. Ed. 2011, 50, 9676–9679. 
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(5032)] involves a polar addition of Grignard reagent 5030 to benzyne 5001’.87 The 
resulting organomagnesium species 5031 is smoothly transformed to phosphine 5032 
under the catalysis of Cu(I). The high reactivity of aryne is essential to the efficient 
construction of the congested aryl–aryl bond in 5032. This synthesis can be done at 
substantial scale and tolerates different substitution in either of the reactants, which 
speaks to the robust nature of this reaction. 
2. Pericyclic reactions. 
Arynes also function as 2π components in pericyclic reactions. Because of its low-
lying LUMO, arynes are also extremely good dienophiles. The first few examples of 
Diels–Alder reactions involving benzynes were reported by Wittig’s group. They found 
that benzyne could be trapped efficiently by a neutral diene in a [4+2] fashion. Later, 
Huisgen’s group reported that benzynes generated by different methods behave the same 
in this Diels–Alder reaction.  
Scheme 5.6| Diels–Alder reaction between benzyne and furan. 
 
In addition to furan, which is known to be a potent diene in Diels–Alder reactions, 
benzyne also reacts with other heterocycles traditionally deemed to be sluggish dienes. 
Zhang and coworkers88 described a remarkable cascade reaction between benzyne and N-
substituted imidazoles (Scheme 5.7). The Diels–Alder reaction between o-benzyne with 
                                                
87  Kaye, S.; Fox, J. M.; Hicks, F. A.; Buchwald, S. L. The use of catalytic amounts of CuCl and other 
improvements in the benzyne route to biphenyl-based phosphine ligands. Adv. Synth. Catal. 2001, 343, 
789–794. 
88 Xie, C.; Zhang, Y. A new tandem reaction of benzyne: One-pot synthesis of aryl amines containing 
anthracene. Org. Lett. 2007, 9, 781–784. 
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N-methyl imidazole initially gives a tricycle 5036. The cycloadduct 5036 is not stable 
under the reaction conditions and undergoes a retro Diels–Alder reaction to eject a 
molecule of HCN and yields isoindole 5037. The resulting 5037, which itself is a potent 
diene, reacts again in a Diels–Alder fashion with benzyne species that are continuously 
being generated, to furnish 5038. The final reaction between amine 5038 and a third 
molecule of benzyne ultimately provides anthracene 5039. 
Scheme 5.7| Diels–Alder reaction between benzyne and N-methyl imidazole. 
 
Arynes could similarly be trapped by acyclic dienes. Lautens et al.89 reported that the 
Diels–Alder reaction between benzyne (generated from Kobayashi’s method) and a diene 
could be used to synthesize functionalized 1,4-dihydronaphthalenes (Scheme 5.8). The 
high degree of stereoretention observed from diene 5040 to dihydronaphthalene 5041 
provides strong support for a concerted reaction mechanism.  More impressively, when a 
diene is endowed with a chiral auxiliary like Oppolzer’s sultam (cf. 5041), the Diels–
Alder reaction occurs in a highly diastereoselective fashion, giving 5043 in >19:1 dr.  
                                                
89 a) Dockendorff, C.; Sahli, S.; Olsen, M.; Milhau, L.; Lautens, M. Synthesis of dihydronaphthalenes via 
aryne Diels–Alder reactions: scope and diastereoselectivity. J. Am. Chem. Soc. 2005, 127, 15028–
15029. b) Webster, R.; Lautens, M. Conformational effects in diastereoselective aryne Diels–Alder 
reactions: synthesis of benzo-fused [2.2.1] heterobicycles. Org. Lett. 2009, 11, 4688–4691. 
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Scheme 5.8| Diels–Alder reaction between benzyne and acyclic dienes. 
 
Danheiser and coworkers90 reported that benzyne could engage a conjugated enyne in 
a Diels–Alder reaction. For instance, a benzyne derivative 5045, obtained by treating 
5044 with a fluoride source (n-Bu4NSiPh3F2, TBAT), reacts with the intramolecularly 
tethered enyne subunit to give strained allene 5046 at room temperature, which then 
rearomatizes smoothly to the more stable naphthalene 5047. Because high strain is built 
into the product as well as the corresponding transition structure, Diels–Alder reactions in 
which enynes function as the 4π component normally require high temperature. The 
facility under which 5045 cyclizes further attests to the potency of benzynes as 
dienophiles in Diels–Alder reactions.  
Scheme 5.9| Diels–Alder reaction between benzyne and enyne. 
 
As early as in 1960s, the reactivity of benzynes as potent dipolarophiles had been 
                                                
90  Hayes, M. E.; Shinokubo, H. Danheiser, R. L. Intramolecular [4+2] cycloadditions of benzynes with 
conjugated enynes, arenynes, and dienes. Org. Lett. 2005, 7, 3917–3920. 
Diels–Alder
5001' 5040 5041
O R OR
N
S
O
O
R
MeO
5042 5043
(dr > 19:1)
NTf
TfO
TMS
NTf NTf N
Tf
TBAT
THF, rt
Diels–Alder [1,5]-H
5044 5045 5046 5047
  Hexadehydro-Diels–Alder Reaction 
 66 
explored and established. As summarized in Scheme 5.10, benzyne undergoes efficient 
[3+2] cycloaddtion reactions with almost all dipoles known to the time.91,92,93 These 
reactions represent a useful strategy to prepare benzo-fused heterocycles. 
Scheme 5.10| [3+2] cycloaddtion between benzyne and various [1,3]-dipoles 
 
The [3+2] cycloadditions between benzyne and pyridine N-oxides are especially 
interesting (Scheme 5.11). In 2006, Larrock94 reported that the reaction between 5017 and 
pyridine N-oxide (5048) in acetonitrile in the presence of CsF gave 3-substituted pyridine 
5049 as the sole product (green). In 2012, Liu95 noticed that under slightly modified 
conditions (THF/DCM as solvent, TBAF as fluoride source), the same reactants (5017 
and 5048) yielded 2-substituted pyridine 5050 as the major product (orange). In fact, the 
mechanism for the formation of each product involves the same [3+2] cycloaddition 
                                                
91  Reaction with nitriloxides: Minisci, F.; Quilico, A. Chimica e l’Industria 1964, 46, 428. 
92  Reaction with azides: a) Reynolds, G. A. The reaction of organic azides with benzyne. J. Org. Chem. 
1964, 29, 3733–3734. b) Wittig, G.; Hoffmann, R. W. Dehydrobenzol aus 1.2.3-Benzothiadiazol-1.1-
dioxyd. Chem. Ber. 1962, 95, 2718–2728. 
93  Reaction with nitrones and diazocompounds: Huisgen, R.; Knorr, R. Benz-in als Dipolarophil. 
Naturwissenschaften, 1961, 48, 716–716. 
94  Raminelli, C.; Liu, Z.; Larock, R. C. Regioselective synthesis of 3-(2-hydroxyaryl)pyridines via arynes 
and pyridine N-oxides. J. Org. Chem. 2006, 71, 4689–4691. 
95  Regioselective synthesis of 2-(2-hydroxyaryl)pyridines from the reactions of benzynes with pyridine N-
oxides 
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between benzyne 5001’ and pyridine N-oxide 5048, which gives tricycle 5051 as the 
initial adduct. Under Larrock’s condition, 5051 undergoes an intramolecular bond 
reorganization that opens the weak N-O bond and affords intermediate 5052, which 
contains a three membered ring. In the presence of fluoride ions, intermediate 5052 then 
rearomatizes to form 5053. On the other hand, 5051 formed in Liu’s condition does not 
go through the same bond reorganization event as those in Larock’s condition, but instead 
gets rapidly deprotonated in the presence of the high concentration of fluoride ions. 
Deprotonated 5051 smoothly rearomatizes to deliver the 2-substituted pyridine 5054 
directly.  
Scheme 5.11| [3+2] cycloadditions between benzyne and pyridine N-oxide. 
 
Besides the above-mentioned pericyclic reactions, arynes also undergo Alder-ene 
reactions with alkenes and alkynes. A more detailed review on this topic is delayed to 
Section 7.4.  
TMS
OTf O
N
NOHNOH
CsF
MeCN, rt
TBAF
THF/DCM
rt
O
N
O
N
Larock's conditionLiu's condition
O
N O N
H
OH N
F-
H F-
NOH
50485017 50495050
5051
5052 5053
5054
5048
[3+2]
5001'
  Hexadehydro-Diels–Alder Reaction 
 68 
Benzynes are known to react with alkenes (especially the electron rich alkenes) in 
[2+2] fashion. However, whether this type of reaction occurs via a stepwise or a 
concerted mechanism is still under debate.  
3. Transition metal catalyzed reactions. 
The use of transition metals has enabled the discovery of numerous elegant and 
powerful transformations with linear alkynes. However, the effect of transition metals on 
the reactivity of benzynes has not been thoroughly investigated.96  
It has been known for long that interaction between transition metals and arynes 
releases a large portion of strain in the triple bonds of arynes and stabilizes these reactive 
species. In fact, most of the benzyne-transition metal complexes synthesized in the early 
days were primarily for the purpose of structural studies. On the basis of the work from 
Erker’s group,97 Buchwald and coworkers98 developed a protocol that enabled the 
isolation of a benzyne-zirconocene complex 5055 and its characterization by X-ray 
crystallography. Further investigation99 revealed that this zirconocene-benzyne complex 
5055 has umpolunged reactivity and behaves like a strong nucleophile. As summarized in 
Scheme 5.12, this complex reacts efficiently not only with various electrophiles like 
proton, carbonyls, or nitriles, but also with alkynes or alkenes to give the corresponding 
metallocycles. None of these types of reactivity is typically observed with free benzynes, 
                                                
96  Guitián, E.; Peréz, D.; Peña, D. Palladium-catalyzed cycloaddition reactions of arynes. Top. Organomet. 
Chem. 2005, 14, 109–146. 
97  a) Erker, G.; Kropp, K. Equilibrium between metallaindans and aryne olefin-metal complexes. J. Am. 
Chem. Soc. 1979, 101, 3659–3660. b) Erker, G. The reaction of intermediate zirconocene-aryne 
complexes with C–H bonds in the thermolysis of diarylzirconocenes. J. Organomet. Chem. 1977, 134, 
189–202. 
98  Buchwald, S. L.; Watson, B. T.; Huffman, J. C. Trimethylphosphine adduct of the zirconocene-benzyne 
complex: synthesis, reactions, and x-ray crystal structure. J. Am. Chem. Soc. 1986, 108, 7411–7413. 
99  a) Buchwald S.L.; Nielsen R. B. Group 4 metal complexes of benzynes, cycloalkynes, acyclic alkynes, 
and alkenes. Chem. Rev. 1988, 88,1047–1058. b) Broene, R. D. Buchwald, S. L. Zirconocene 
complexes of unsaturated organic molecules: New vehicles for organic synthesis. Science 1993, 261, 
1696–1701.  
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and therefore are results of coordination with zirconium.  
Scheme 5.12| Representative reactivities of benzyne-zirconocene complex. 
 
Almost contemporary with the development of aryne-zirconocene chemistry, the 
reactivity of arynes complexed with late transition metals was also being explored.96 
These late transition metal containing aryne complexes are even more versatile and show 
high reactivities toward both nucleophiles and electrophiles.  
However, until the late 1990s, the only metal-aryne complexes whose utility in 
organic synthesis had been explored were limited to a few metal-zirconium complexes. 
The requirement of using a stoichiometric amount of precious metals along with harsh 
conditions to generate these complexes significantly hampered serious exploration of 
their synthetic utilities. The advent of Kobayshi’s method,84 which allowed the 
generation of benzynes under mild conditions, fueled a rapid growth of transition metal 
mediated aryne chemistry. Several typical transformations developed since then are listed 
here to illustrate the power of these reactions.  
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Scheme 5.13| Pd0 catalyzed benzyne trimerization. 
 
In 1998, Peréz, Guitián and coworkers100 reported the first metal-catalyzed process 
that involved aryne substrates (Scheme 5.13). They established that when Kobayshi’s 
benzyne precursor84 5017 was treated with fluoride sources, the in situ generated benzyne 
(5001’) efficiently trimerized into triphenylene 5057 in the presence of a catalytic amount 
of Pd0. Notably, while the nature of the catalysts or ligands employed had only a 
negligible effect on the efficiency of this reaction, the use of a harsher aryne generating 
method (entry 5, 5056 + nBuLi) dramatically compromised its yield. Under the optimized 
conditions, more elaborated triphenylenes could be synthesized.  
Because of its high reactivity, aryne generated in a reaction flask will not accumulate 
and its concentration is always low. One very basic law in physical organic chemistry 
states that “a rate is a rate constant times a concentration101”. Therefore, in principal, the 
participation of benzyne in a certain reaction could be outcompeted by other less reactive 
                                                
100 Peña, D.; Escudero, S.; Pérez, D.; Guitián, E.; Castedo, L. Efficient palladium-catalyzed 
cyclotrimerization of arynes: Synthesis of triphenylenes. Angew. Chem. Int. Ed. 1998, 37, 2659–2661. 
101  Hoye, T. R.; Ryba, T. D. Divergent kinetic control of classical versus ozonolytic lactonization:   
mechanism-based diastereoselection. J. Am. Chem. Soc., 2005, 127, 8256–8257.  
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substrates,102 if the latter are used at high enough concentrations. For example,103 when 
an electron deficient alkyne 5058 (dimethyl acetylene-dicarboxylate, DMAD) was used 
in the above triphenylene synthesis reactions, phenanthracene 5059 or naphthalene 5060 
could be prepared as the major product depending on the catalyst choice. This 
cotrimerization of aryne and alkynes has demonstrated utility in the synthesis of 
important polyaromatic hydrocarbons104 and natural products.105  
Scheme 5.14| Cotrimerization of benzyne and DMAD. 
 
Besides trimerization reactions, transition metal enabled three-component coupling 
reactions involving an aryne is another type of powerful transformation.106 A  
                                                
102 For the cotrimerization of benzyne and alkenes, see: a) Qintana, I.; Boersma, A. J.; Peña, D.; Pérez, D.; 
Guitián, E. Metal-catalyzed cotrimerization of arynes and alkenes. Org. Lett. 2006, 8, 3347–3349. b) 
Saito, N. Shiotani, K. Kinbara, A.; Sato, Y. Nickel-catalyzed [2+2+2] cycloaddition of arynes and an 
unactivated alkene: synthesis of 9,10-dihydrophenanthrene derivatives. Chem. Commun. 2009, 4284–
4286.  
103 Peña, D.; Pérez, D.; Guitián, E.; Castedo, L. Palladium-catalyzed cocyclization of arynes with alkynes: 
Selective synthesis of phenanthrenes and naphthalenes. J. Am. Chem. Soc. 1999, 121, 5827–5828. 
104  Peña, D.; Pérez, D.; Guitián, E.; Castedo, L. Selective Palladium-catalyzed cocyclotrimerization of 
arynes with dimethyl acetylenedicarboxylate:   A versatile method for the synthesis of polycyclic 
aromatic hydrocarbons. J. Org. Chem. 2000, 65, 6944–6950. 
105  Sato, Y.; Tamura, T.; Mori, M. Arylnaphthalene lignans through Pd-catalyzed [2+2+2] cocyclization of 
arynes and diynes: Total synthesis of taiwanins C and E. Angew. Chem. Int. Ed., 2004, 43, 2436–2440. 
106  a) Henderson, J. L.; Edwards, A. S.; Greaney, M. F. Three-component coupling of benzyne:   Domino 
intermolecular carbopalladation. J. Am. Chem. Soc. 2006, 128, 7426–7427. b) Jayanth, T. T.; 
Jeganmohan, M.; Cheng, C.-H. Highly efficient route to o-allylbiaryls via palladium-catalyzed three-
component coupling of benzynes, allylic halides, and aryl organometallic reagents. Org. Lett. 2005, 7, 
2921–2924. c) Jeganmohan, M.; Bhuvaneswari, S.; Cheng, C.-H. A cooperative copper- and palladium-
catalyzed three-component coupling of benzynes, allylic epoxides, and terminal Alkynes. Angew. Chem. 
Int. Ed. 2009, 48, 391–394. d) Worlikar, S. A.; Larock, R. C. Synthesis of 9-fluorenylidenes and 9,10-
phenanthrenes through palladium-catalyzed aryne annulation by o-halostyrenes and o-halo allylic 
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Scheme 5.15| Three-component reaction catalyzed by Pd0. 
 
representative example106b of this reaction type is shown in Scheme 5.15. In the presence 
of proper Pd0 catalyst and ligand, 1,2-disubstituted arene like 5063 could be made 
directly from allyl chloride (5061), boronic acid 5062, and benzyne precursor 5017. The 
mechanism proposed for this transformation involves four individual steps: 1) oxidative 
insertion of Pd0 to allyl chloride to form the π-allyl species 5064; 2) carbopalladation of 
the resulting 5064 to the in situ generated benzyne intermediate 5001’ to make the 
arylpalladium species 5065; 3) transmetallation between 5065 and 5062 to afford biaryl 
palladium 5067; 4) reductive elimination of 5067 to provide the final product 5063 and 
                                                                                                                                            
benzenes. J. Org. Chem. 2009, 74, 9132–9139. e) Waldo, J. P.; Zhang, X.; Shi, F.; Larock, R. C. 
Efficient synthesis of fluoren-9-ones by the palladium-catalyzed annulation of arynes by 2-
haloarenecarboxaldehydes. J. Org. Chem. 2008, 73, 6679–6685.  
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regenerate the Pd0 catalyst. It is worth pointing out that the second step of this proposed 
catalytic cycle is a reaction between in situ generated 5064 and in situ generated 5001’, 
both of which are present in low concentrations. The success of this transformation can 
only be explained by the extremely high reactivity of benzyne toward organopalladium 
species. Given the complexity of this cycle, the functional group tolerance demonstrated 
by this reaction is very remarkable.  
As evident from the above discussion, o-arynes have already demonstrated 
tremendous potential in synthetic chemistry. Nonetheless, many lines of exploration in 
aryne chemistry are still undeveloped, and new aryne trapping reactions are continuously 
being discovered. Obviously, the freedom in reagent choice allowed by Kobayashi’s 
aryne generating protocol (see next section for an overview of conventional aryne 
generating methods) was a key for the recent resurgence of aryne trapping 
methodologies. It is foreseeable that the emergence of a fundamentally new aryne 
generating method with greater functional group compatibility will bring even more 
opportunities into this field.  
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5.3 A brief review of o-benzyne generating methods 
In contrast to the myriad benzyne trapping reactions, the methods for its generation 
are relatively limited. Most of these methods, which I have arbitrarily divided into four 
categories, are summarized in Figure 5.3.  
Figure 5.3| Conventional methods of generating arynes. 
 
The first generation methods discovered for making arynes involved the use of strong 
base (blue). These were used in, for example, Roberts’ study that proved the existence of 
arynes69 and Huisgen’s investigation on the Diels–Alder reactions between benzyne and 
furan.70 The usage of strong bases is obviously a drawback of this series of methods, 
which causes significant challenges in handling, and more importantly, functional group 
compatibility issues.  
The second category capitalize on the instability of substrates like benzene-
diazonium-2-carboxylate and benzo[d][1,2,3]thiadiazole 1,1-dioxide (green). Benzyne 
N2+
CO2- N
S
O2
N
N
N
N
NH2
TMS
OTf
TMS
IPhOTf
X
OTf
X1
X2
F
X
Li
F
MgBr heat
or
hυ
0 °C
-20 °C
0 °C
Pb(OA
c) 4
F-
F-
n-BuLi
strong base
Mg or
RMgX
  Hexadehydro-Diels–Alder Reaction 
 75 
can be generated from these two precursors simply by heating or irradiation in the 
absence of additional reagents. The light-induced degradation of benzene-diazonium-2-
carboxylate enabled low temperature generation of arynes in an argon matrix, which 
allowed several direct physical characterizations76,77 of this extremely reactive species. 
Although the conditions used in these types of methods are the mildest of all, their utility 
in synthetic chemistry is still limited, presumably for two reasons: 1) the preparation of 
elaborated aryne precursors of this type is often tedious; 2) the thermal instability of these 
compounds107 raises safety concerns. 
Third, benzyne can be generated by oxidation of 1-aminobenzotriazole with oxidants 
like Pb(OAc)4 (red).108 The power of this method is illustrated by the transformation 
shown in Scheme 5.16. Treating a benzoporphyrazine derivative 5068 with Pb(OAc)4 
initiated the generation of the corresponding benzyne intermediate, which was trapped in 
situ by benzene solvent to afford the barreleno-fused product 5069 in ca. 40% yield. The 
complexity of the starting material and product in the reaction are testaments to the 
mildness of this method. However, the preparation of benzyne precursors of this type is 
also laborious.  
  
                                                
107  Benzene-diazonium-2-carboxylate is known to be explosive.  
108  a) Campbell, C. D.; Rees, C. W. J. Chem. Soc. C 1969, 742–747. b) Vagin, S. I.; Frickenschmidt, A.; 
Kammerer, B.; Hanack, M. Reactivity of dehydrometallophthalocyanines and –porphyrazines. Chem. 
Eur. J. 2007, 13, 985–991. d) Birkett, M. A.; Knight, D. W.; Little, P. B.; Mitchell, M. B. A new 
approach to dihydrobenzofurans and dihydrobenzopyrans (chromans) based on the intramolecular 
trapping by alcohols of benzynes generated from 7-substituted-1-aminobenzotriazoles. Tetrahedron 
2000, 56, 1013–1023. d) Knight, D. W.; Qing, X. A synthesis of α-tocopherol featuring benzyne 
trapping by an alcohol. Tetrahedron Lett. 2009, 50, 3534–3537. 
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Scheme 5.16| Synthesis of zinc barreleno-fused benzoporphyrazine 5069 from 1-
aminobenzotriazole derivative 5068 
 
The most widely used benzyne generation method is the one invented by Kobayashi84 
in 1983 (pink109). As alluded to in the previous section, the introduction of this method, 
which avoided the use of strong bases, has permitted the use of many labile reagents to 
interrogate the innate reactivities of arynes, and resulted in a recent Renaissance in the 
study of aryne chemistry. One limitation of this strategy, again, lies in the synthesis of 
these aryne precursors themselves, which most often requires the use of strong bases.110  
  
                                                
109  Kitamura and coworkers introduced the strategically analogous method that uses o-silylphenyliodonium 
salts as the benzyne precursors. For references, see: a) Kitamura, T.; Yamane, M. (Phenyl)[o-
(trimethylsilyl)phenyl]iodonium triflate. A new and efficient precursor of benzyne. J. Chem. Soc. Chem. 
Commun. 1995, 983–984. b) Kitamura, T.; Yamane, M.; Inoue, K.; Todaka, M.; Fukatsu, N.; Meng, Z.; 
Fujiwara, Y. A new and efficient hypervalent iodine−benzyne precursor, (phenyl)[o-
(trimethylsilyl)phenyl]iodonium triflate:   Generation, trapping reaction, and nature of benzyne. J. Am. 
Chem. Soc. 1999, 121, 11674–11679.  
110  An improved strategy for the syntheses of Kobayashi’s benzyne precursors was described by Garg’s 
group. Bronner, S. M.; Garg. N. K.  J. Org. Chem. 2009, 74, 8842–8843. 
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Chapter 6. The HDDA Reaction: Its Discovery and 
Initial Explorations on Its Scope 
6.1 Discovery of HDDA reaction 
In an otherwise “unrelated” course of study, a postdoctoral associate in the laboratory 
at the time, Baire Beeraiah, was investigating the oxidation of a tetrayne alcohol 6001, 
with the purpose of preparing its corresponding ketone (6003, Scheme 6.1). To 
everyone’s surprise, however, the product resulting from this reaction was the tricyclic 
arene 6002. Two features of this conversion were especially intriguing: 1) an aromatic 
ring was formed from an acyclic precursor; 2) an O-Si bond, one of the strongest bonds 
in chemistry (191 kcal•mol-1), was cleaved at room temperate in the absence of any 
bases!  
These two distinctive features of this conversion hinted at the mechanism (Scheme 
6.1 A). Professor Hoye and Dr. Baire ascribed the facile and unprecedented cleavage of 
the O-Si bond during the reaction to the high reactivity of benzyne intermediate 6004’ 
and that the benzyne 6004’ had been in turn, produced from ynone 6003 (the anticipated 
product from oxidation of alcohol 6001). We now call this transformation the 
hexadehydro-Diels–Alder (HDDA) reaction.111  
The modest yield (53%) observed in this reaction was attributed to a competitive, 
nonproductive [4+2] cyclization mode that is available in structure 6003 as indicated by 
the gray box. Based on this reasoning, they designed and synthesized a new substrate–the 
ketotriyne 6006 (3 steps from 6005, Scheme 6.1 B)–that could only undergo HDDA 
                                                
111 Hoye, T. R.; Baire, B.; Niu, D.; Willoughby, P. H.; Woods, B. P. The hexadehydro-Diels–Alder 
reaction. Nature 2012, 490, 208–212. 
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reaction with a single regiochemical outcome. Their efforts were rewarded by its smooth 
transformation at room temperature to the hexasubstituted, tetracyclic indenone 
derivative 6007 in 93% yield after chromatographic purification.   
Scheme 6.1| A) Uncovering of hexadehydro-Diels–Alder (HDDA) reaction in the 
Hoye laboratory; B) Rationally designed HDDA substrate 6006 and its efficient 
conversion to 6007. 
 
It is proper to diverge at this point and discuss the etymology of “hexadehydro-Diels–
Alder”. The Diels–Alder [4+2] reaction112 is arguably the most revered of all chemical  
reactions25,113. The prototypical event, found in every organic chemistry textbook, is the 
combination of 1,3-butadiene (6009) as the 4π-component with ethylene (6008) as the 
dienophile to give cyclohexene (6010)–a product at the tetrahydrobenzene oxidation  
                                                
112 Diels, O.; Alder, K. Syntheses in the hydroaromatic series [in German]. J. Liebigs Ann. der Chem. 1928, 
460, 98–122. 
113 Onishchenko, A. S. Diene Synthesis (Israel Program for Scientific Translations Ltd., 1964). 
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Scheme 6.2| Etymology of hexadehydro-Diels–Alder reaction. 
 
state. If, instead, an alkyne like ethyne (6011) is the dienophile, a 1,4-cyclohexadiene 
[1,4-dihydrobenzene (6012)] results; we suggest this be viewed as a didehydro-Diels–
Alder reaction (Scheme 6.2B). Another well-known variant involves engagement of a 
(yet more highly oxidized) 1,3-enyne (6013) as the 4π-component with an alkyne (6011, 
Scheme 6.2C). The intermediate cyclic allene 6014 rapidly rearranges via a [1,5] 
hydrogen atom shift to benzene (6015). This process was known as the dehydro-Diels–
Alder (DDA) reaction.114,115 We suggest amending the moniker for this transformation to 
tetradehydro-Diels–Alder (TDDA) reaction. The most highly oxidized Diels-Alder 
variant like the one converting 6005 to 6007 in Baire’s study is the cycloaddition between 
a 1,3-diyne (e.g, 6016) and an alkyne (e.g., 6011)–here a diynophile, which generates o-
benzyne (cf. 6017, 6017’, Scheme 6.2D). This transformation is therefore termed as 
hexadehydro-Diels–Alder (HDDA) reaction. 
The HDDA reaction that converts tetrayne 6003 to benzyne 6004’ was unanticipated 
                                                
114 Wessig, P.; Müller, G. The dehydro-Diels–Alder reaction. Chem. Rev. 2008, 108, 2051–2063. 
115 Michael, A.; Bucher, J. E. Über die Einwirkung von Eissigsäureanhydrid auf Phenylpropiolsäure [in 
German]. Chem. Zentrblt. 1898, 731–733. 
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presumably for the following two major reasons. First, as discussed in section 5.1, the 
most widely accepted (and arguably the most accurate) representation of benzyne is 
6017’ (cf. 6004’). However, it is only through the less commonly encountered, cumulene-
like resonance structure 6017 (cf. 6004) that benzyne can be connected to the alkyne 
precursors 6011 and 6016 (cf. 6003) via a Diels–Alder-like reaction arrow pushing.  
Second, benzyne has left a dogmatic impression on the community as a highly reactive 
and “unstable” species. In contrast, linear alkynes, because of their easy availability and 
ubiquity, are usually recognized as “stable” functional groups. It is counterintuitive that 
conversion of a “stable” alkyne like 6003 to an “unstable” benzyne like 6004’ would be 
thermodynamically favorable/allowed (see Section 6.4 for more detailed discussion on 
some thermodynamic features of HDDA reactions). These two reasons might account for 
the dormancy116,117,118 of this transformation in the synthetic community until this study. 
As exemplified by the transformation from 6001 to 6002, the HDDA reaction 
converts poly-yne substrates to highly reactive benzyne intermediates in a metal-, 
reagent-, and catalyst-free fashion. The mild conditions and operational ease of the 
HDDA reaction provide obvious advantages over other aryne-generating methods known 
at the time, and its synthetic potential was immediately apparent to us. Dr. Beeraiah 
Baire, Patrick H. Willoughby, Brian P. Woods, and I then teamed up and started to 
explore the possibilities of this aryne-generating strategy. 
                                                
116 Bradley, A. Z.; Johnson, R. P. Thermolysis of 1,3,8-nonatriyne: Evidence for intramolecular [2+4] 
cycloaromatization to a benzyne intermediate. J. Am. Chem. Soc. 1997, 119, 9917–9918. 
117 a) Miyawaki, K.; Suzuki, R.; Kawano, T.; Ueda, I. Cycloaromatization of a non-conjugated polyenyne 
system: Synthesis of 5H-benzo[d]fluoreno[3,2-b]pyrans via diradicals generated from 1-[2-{4-(2-
alkoxymethylphenyl)butan-1,3-diynyl}]phenylpentan-2,4-diyn-l-ols and trapping evidence for the 1,2-
didehydrobenzene diradical. Tetrahedron Lett. 1997, 38, 3943–3946. b) Kimura, H., Torikai, K., 
Miyawaki, K.; Ueda, I. Scope of the thermal cyclization of nonconjugated ene-yne-nitrile system: a 
facile synthesis of cyanofluorenol derivatives. Chem. Lett. 2008, 37, 662–663 and references therein. 
118 Tsui, J. A.; Sterenberg, B. T. A metal-templated 4 + 2 cycloaddition reaction of an alkyne and a diyne to 
form a 1,2-aryne. Organometallics, 2009, 28, 4906–4908. 
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6.2 Initial explorations on the substrate scope of HDDA reaction  
We quickly established that the HDDA reaction is quite general with respect to both 
substrate scope and the types of intramolecular trapping events (see Scheme 6.3). During 
this course of study, we found: i] the presence of an electron withdrawing substituent on 
the diynophile enhances substrate reactivity [cf. conditions for 6006 to 6007 (Scheme 6.1 
B) vs. entry 1]; similarly, an alkyne substituent on the diynophile also accelerates the  
Scheme 6.3| Benzenoid (bold black bonds) synthesis via the HDDA cycloaddition 
has considerable substrate scope with respect to the nature of i) the poly-yne tether 
(red) and ii) the intramolecular trapping moiety (blue). My specific contributions to 
this Scheme are identified by the gray box. 
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HDDA reactions (entry 6-7); ii] the activating carbonyl group can be either a distal 
(entries 2 and 5) or a tethering substituent (entry 3-4, and 8-10); iii] carbonyl activation is 
not a necessity (entries 1, 6, and 7); iv] products having nitrogen-containing heterocycles 
annulated to the new arene ring can be prepared (entries 3, 5, and 6); v] an ester tether 
(entry 10) cyclizes more slowly than its N-phenyl amide analog (entry 3), consistent with 
the lower concentration60 of the s-cis conformer required for ring closure; vi] all of our 
observations are consistent with the absence of radical character during both the 
cycloaddition and trapping phases of the process; e.g., reactions performed in chloroform 
(an excellent hydrogen atom donor) solvent (entries 6 and 9) have shown no evidence of 
hydrogen atom transfer; vii] the previously unknown silyl ether trapping reaction (cf. 
Scheme 6.1) has considerable generality (entries 1-3, 5, 8, and 10); viii] other efficient 
internal benzyne traps include tethered alcohols (entries 6-7), aryl rings ([4+2] 
cycloaddition in entry 9), or alkenes (ene reaction in entry 4); ix] seven-membered ring 
formation is feasible (entry 8).  
Two limitations of the HDDA reaction we observed during the studies are worth 
mentioning. First, the terminal position of the diynophile in HDDA reactions does not 
tolerate primary or secondary alkyl substituents. For example, when substrate 6018 was 
subjected to the same conditions used for otherwise similar benzyne precursors (cf. entry 
4 and 9 in Scheme 6.3), no product resulting from HDDA reaction could be isolated 
(Scheme 6.4). Based on the study from Danheiser’s group,119 we hypothesize that 
substrates like 6018 preferentially undergo an intramolecular propargylic ene reaction to 
form intermediates like 6019, which ultimately decompose to intractable products.  
                                                
119 Robinson, J. M.; Sakai, T.; Okano, K; Kitawaki, T.; Danheiser, R. L. Formal [2+2+2] cycloaddition 
strategy based on an intramolecular propargylic ene reaction/Diels−Alder cycloaddition cascade. J. Am. 
Chem. Soc. 2010, 132, 11039–11041. 
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Scheme 6.4| Some limitations of HDDA reaction. 
 
The second limitation of HDDA reaction concerns the tether used in the benzyne-
forming event. To date, we have only been able to effect intramolecular HDDA reactions 
productively. A tether is required for the cyclization event to 1) lower the activation 
barrier, and 2) address the selectivity issue (e.g., suppress diyne reacting with diyne). 
Moreover, unlike in normal Diels–Alder reactions, 4-atom tethers between diyne and 
diynophile are rather ineffective in promoting HDDA reactions. HDDA reaction of 
substrates with 4-atom linker either demanded very high temperature (>180 °C) or 
proceeded in very low yield. For example, cyclization of triynone 6020 gave only trace 
amount of desired anthraquinone product 6021. Such unexpected outcome may reflect the 
difficulty these substrates had in achieving the required parallel arrangement between the 
diyne and the diynophile moieties for concerted HDDA reactions. 
In spite of the above listed limitations, the HDDA reaction have many desirable 
features which include: i] each substrate shown in Scheme 6.3 is readily accessible (2-7 
steps) by a convergent coupling strategy; ii] both the substrates and products of HDDA 
reaction are otherwise robust at temperatures required for HDDA cyclization; iii] 
stringent exclusion of air or water is not necessary for conducting HDDA reactions; iv] 
arynes generated under these conditions are free of any reagents or by-products, and 
could be considered “pristine”. These features granted significant scalability and 
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operational ease to this aryne-making method, and enabled us to uncover many 
unprecedented modes of aryne trapping reaction in a short period of time. 
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6.3 Initial explorations on the intermolecular trapping reactions of HDDA-born 
arynes 
We were eager to validate the feasibility of intermolecular trapping of these thermally 
generated benzynes. Clearly, this would add considerable versatility and power to a 
HDDA-initiated transformation.  
Anecdotally, my investigation on intermolecular trapping of HDDA-born benzyne 
was initiated by an “unsuccessful” experiment (Scheme 6.5). Having recognized the 
power of HDDA reaction, I designed substrate 6022, which has a properly positioned 
acetoxy group, to study if this moiety could also efficiently trap the in situ generated 
benzyne 6023. Importantly, the reaction of esters with benzynes had not been studied 
before, probably because of the lability of ester groups to the conventional, basic aryne-
generating conditions. Treating 6022 with conditions that successfully promoted HDDA 
cyclization of very similar substrates (cf. entry 4 and 9 in Scheme 6.3), however, yielded 
no isolable product. This result suggested that an acetoxy group is too non-nucleophilic to 
trap benzyne 6023. Fortunately, however, it also meant that the ca. one gram of 6022 that 
I prepared could be instead used for exploring the bimolecular trapping reactions of 
HDDA-born benzynes. 
Scheme 6.5| Design of substrate 6022 and its “unsuccessful” intramolecular trapping 
reaction. 
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The efforts on intermolecular trapping study turned out to be very fruitful. I quickly 
established that benzyne 6023 could be captured by a variety of external reagents to give 
adducts like 6025 (Scheme 6.6). Highlights include: i] benzene as solvent forms the 
Diels–Alder adduct 25a; although a precedented process,120 because of the low reactivity 
of simple aromatics, rarely have they been trapped by benzynes in high yield; this result 
also indicates that many intramolecular trapping events are faster than capture by the 
aromatic solvents used in earlier examples (entries 1-3, 5, 7-8 and 10 of Scheme 6.3);  
Scheme 6.6| Bimolecular trapping reactions of benzyne 6023 to give adducts 25a-f.  
 
  
                                                
120 Stiles, M.; Miller, R. G.; Burckhardt, U. Reactions of benzyne intermediates in non-basic media. J. Am. 
Chem. Soc. 1963, 85, 1792–1797. 
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Hoffman and Suzuki121 commented that the abnormally high yield of 6025a could be 
ascribed to the higher reactivity of arynes generated by HDDA reaction than those made 
conventionally; ii] the [2+2] cycloaddition of norbornene gives 6025b; this reaction also 
occur in higher yield than has been observed for trapping of arynes formed by 
conventional methods;83 iii] N-phenylacetamide gives 6025c, demonstrating that a 
nitrogenous substituent can be conveniently installed; iv] acetic acid and phenol each 
traps 6023 to cleanly provide adducts 6025d and 6025e, respectively, in processes that 
may share the mechanistic feature of transfer of a hydroxyl proton coincident with 
nucleophilic attack (i.e., concerted oxa-ene reaction mechanism, see Section 7.2 for 
further discussion); v] this mode of reaction with acetic acid or phenol is unique and 
complementary to that seen with benzynes generated by non-reagent-free 
methods;122,123,124 vi] the first efficient trapping of aryne by halogen ions was achieved 
using Br(CH2)2NH2•HBr in THF/H2O (20:1) as an HBr source to give 6025f (6:1 mixture 
of regioisomers).  
The high degree of regioselectivity observed for formation of products 6025c-f is 
worth special attention. In fact, the synthetic utility of arynes trapping reactions has in 
many cases been complicated by their low degree of regioselectivities. In 2010, Buszek 
                                                
121 Hoffman, R. W.; Suzuku, K. A “hot, energized” benzyne. Angew. Chem. Int. Ed. 2013, 52, 2655–2656. 
122 Liu, Z.; Larock, R. C. Facile O-arylation of phenols and carboxylic acids. Org. Lett. 2004, 6, 99–102. 
123 a) Cheong, P. H.-Y.; Paton, R. S.; Bronner, S. M.; Im, G. J.; Garg, N. K.; Houk, K. N. Indolyne and 
aryne distortions and nucleophilic regioselectivities. J. Am. Chem. Soc. 2010, 132, 1267–1269. b) Im G. 
J.; Bronner, S. M.; Goetz, A. E.; Paton, R. S.; Cheong, P. H.-Y.; Garg, N. K.; Houk, K. N. Indolyne 
experimental and computational studies: synthetic applications and origins of selectivities of 
nucleophilic additions. J. Am. Chem. Soc. 2010, 132, 17933–17944. 
124 After our initial study was published, Daugulis group reported an efficient phenol-ene reaction with 
benzynes generated under non-reagent free conditions under the catalysis of Ag+. Truong, T.; Daugulis, 
O. Divergent reaction pathways for phenol arylation by arynes: Synthesis of helicenes and 2-
arylphenols. Chem. Sci. 2013, 4, 531-535. 
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and Cramer125 and Houk and Garg123,126 have independently developed computational 
approaches to predict the regioselectivity of reactions that involve the aryne 
intermediates. All these studies correlated the relative magnitude of the computed internal 
bond angles of an unsymmetrical (distorted) arynes with the site of nucleophilic attack. 
Namely, the more obtuse angle corresponds to the more electron deficient (δ+) of the two 
benzyne carbon atoms. We computed the geometry for 6023 [R = CH3; M06-2X62/6-
31+G(d,p)] to have internal angles of 135º and 119º at atoms “a” and “b”, respectively. 
Therefore, it is consistent with the established models that the more electrophilic site 
observed experimentally is also atom “a”. 
  
                                                
125 Buszek, K. R.; Garr, A. N.; Luo, D.; Brown, N.; Cramer, C. J.; VanderVelde, D. Experimental and 
theoretical investigations into the unusual regioselectivity of 4,5-, 5,6-, and 6,7-indole aryne 
cycloadditions. Org. Lett. 2010, 12, 96–99. 
126 Goetz, A. E.; Bronner, S. M.; Cisneros, J. D.; Melamed, J. M.; Paton, R. S.; Houk, K. N.; Garg, N. K. 
An efficient computational model to predict the synthetic utility of heterocyclic arynes.  Angew. Chem. 
Int. Ed. 2012, 51, 2758–2762. 
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6.4. Thermodynamics of HDDA reaction 
As was mentioned in Section 6.1, the thermodynamic feasibility of HDDA reactions 
that convert “stable alkynes” to “unstable” arynes is very counterintuitive, and therefore 
warrants a more detailed discussion.  
In fact, Johnson and coworkers127 have recently investigated the HDDA reaction 
between 1,3-butadiyne (6016) and acetylene (6011) to generate benzyne (6017’) with 
computational tools. Their calculation suggested this hypothetical reaction is exothermic 
by 51.4 kcal•mol-1! In other words, in spite of its high strain (which, coincidentally, is 
also ca. 50 kcal•mol-1), o-benzyne is thermodynamically more stable than its alkyne 
precursors by ca. 50 kcal•mol-1. This computational outcome, although surprising, can be 
rationalized by 1) the aromatic stabilizing energy of benzyne (ca. 30 kcal•mol-1, see 
section 5.1), and 2) the higher stability of σ-bonds (ca. 81 kcal•mol-1) in product 
compared with alkynyl π-bonds (ca. 53 kcal•mol-1) in starting materials. This result once 
again emphasize that thermodynamic stability and kinetic stability are not necessarily 
correlated. 
Scheme 6.7| Computed energetics of hypothetical transformation from butadiyne and 
acetylene to o-benzyne.  
 
  
                                                
127 Ajaz, A.; Bradley, A. Z.; Burrell, R. C.; Li, W. H. H.; Daoust, K. J.; Bovee, L. B.; DiRico, K. J.; 
Johnson, R. P. Concerted vs. stepwise mechanisms in dehydro-Diels−Alder reactions. J. Org. Chem. 
2011, 76, 9320–9328. 
+
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In order to gain additional understanding of some of the key thermodynamic features 
associated with the HDDA reactions, I prepared ester 6026 and studied its HDDA 
reaction: this simple triyne was cycloisomerized, and the resulting aryne 6027 trapped in 
t-butanol (120  °C, closed tube) to produce 5-t-butoxyphthalide (6028) in 68% yield. 
Using DFT methodology, we have computed the free energy of reaction for the 
conversion of triyne 6026 to the aryne 6027 and found it to be −51  kcal  mol−1. These very 
favorable reaction energetics corroborate the conclusions of Johnson,127 and reflect the 
large amount of potential energy inherent in the alkyne functional group. Additionally, 
the free energy of reaction for the trapping by t-butanol of the strained alkyne in 6027 
was computed to be −73  kcal  mol−1. Thus, the overall transformation of 6026 to 6028 is 
exothermic by >120  kcal  mol−1. 
Scheme 6.8| Computed free energy changes for a representative (real) HDDA-
initiated cascade. 
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To summarize this chapter, an accidental and serendipitous discovery made by Dr. 
Baire led us to identify and establish the scope of the previously unexploited HDDA 
reaction, a powerful method for making benzynes under purely thermal conditions. This 
HDDA reaction demonstrated an unparalleled level of functional group tolerance. 
Benzynes generated using this method are on average much more sophisticated than 
those made conventionally. The subsequent aryne trapping events, which could occur 
either intra- or intermolecularly, add considerable complexity to the ultimate products. 
This powerful HDDA/aryne trapping cascade comprises a fundamentally new, arguably 
revolutionary, way to synthesize benzenoid compounds–especially those highly 
substituted ones. Equally importantly, because HDDA-derived benzynes are born in the 
absence of byproducts and external reagents, this reaction constitutes an excellent 
platform to explore the intrinsic and inherent reactivities of benzynes. Myriad additional 
unprecedented reactivities have manifested since then and some will be discussed in the 
next chapter.  
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Chapter 7. Some additional reactions of benzynes 
generated by HDDA reactions 
7.1 A HDDA approach to prepare substituted indolines and carbazoles 
Nitrogen-containing benzofused heterocycles128,129,130 like indolines, indoles, and 
carbazoles are very important moieties present in many biologically active natural 
products, pharmaceutical agents, and modern functional materials (see Figure 7.1 for 
some representative examples). Not surprisingly, synthesis of these heterocycles has 
attracted tremendous amount of interest from synthetic communities. Numerous methods 
toward these hetereocycles have been developed to date, and new strategies continue to 
emerge.  
Figure 7.1| Some selected examples of natural products and functional materials that 
contain indole, indoline, or carbazole units. 
 
  
                                                
128 a) Joule, J. A. In Science of Synthesis; Thomas, E. J., Ed.; Thieme:   Stuttgart, 2000; Vol. 10, 361−652. b) 
Sundberg, R. J. Indoles; Academic Press:   London, 1996. 
129 a) Schmidt, A. W.; Reddy, K. R.; Knölker, H.-J. Occurrence, biogenesis, and synthesis of biologically 
active carbazole alkaloids. Chem. Rev. 2012, 112, 3193−3328. b) Knölker, H.-J.; Reddy, K. R. In The 
Alkaloids; Cordell, G. A., Ed.; Academic Press: Amsterdam, 2008; Vol. 65, p 1. 
130 Lemasson, F. A.; Strunk, T.; Gerstel, P.; Hennrich, F.; Lebedkin, S.; Barner-Kowollik, C.; Wenzel, W.; 
Kappes, M. M.; Mayor, M. Selective dispersion of single-walled carbon nanotubes with specific chiral 
indices by poly(N-decyl-2,7-carbazole). J. Am. Chem. Soc. 2011, 133, 652−655. b) Li, P.-P.; Chen, Y.; 
Zhu, J.; Feng, M.; Zhuang, X.; Lin, Y.; Zhan, H. Charm-bracelet-type poly(N-vinylcarbazole) 
functionalized with reduced graphene oxide for broadband optical limiting. Chem. Eur. J. 2011, 17, 
780−785. c) Li, J.; Grimsdale, A. C. Carbazole-based polymers for organic photovoltaic devices. Chem. 
Soc. Rev. 2010, 39, 2399−2410. 
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Nowadays, most strategies128 developed for preparing indoles and indolines focus on 
the construction of the 5-membered heterocyclic ring, with the benzenoid ring inherited 
from the corresponding benzene containing starting materials. One limitation of these 
methods is that the substitution patterns on the benzenoid ring of these heterocycles are 
limited by those available in the starting materials. One exception is a tetradehydro-
Diels–Alder (TDDA) reaction based approach developed by the Danheiser’s group131 
(Scheme 7.1). In this reaction, the intramolecular [4+2] cycloaddition between an alkyne 
unit and an enyne unit within 7001 initially generates strained isoaromatic cyclic allene 
7002, which under the reaction conditions rearranges via a [1,5] proton or hydrogen atom 
transfer to afford indoline 7002 as the final product. Later, Saá et al.132 established that 
this TDDA reaction could also be applied to the synthesis of carbazoles. This strategy is 
distinctive from the other established ones in that it has enabled the synthesis of those 
heterocycles that are heavily substituted on (one of) the benzenoid ring(s).  
Scheme 7.1| Tetradehydro-Diels–Alder (TDDA) approach to make indolines and 
carbazoles. 
 
  
                                                
131 Dunetz, J. R.; Danheiser, R. L. Synthesis of highly substituted indolines and indoles via intramolecular 
[4+2] cycloaddition of ynamides and conjugated enynes. J. Am. Chem. Soc. 2005, 127, 5776–5777. 
132 a) Martínez-Esperón, M. F.; Rodríguez, D.; Castedo, L.; Saá, C. Coupling and cycloaddition of 
ynamides: homo- and Negishi coupling of tosylynamides and intramolecular [4+2] cycloaddition of N-
(o-ethynyl)phenyl ynamides and arylynamides. Tetrahedron, 2006, 62, 3843–3855. b) Martínez-
Esperón, M. F.; Rodríguez, D.; Castedo, L.; Saá, C. Synthesis of carbazoles by dehydro Diels–Alder 
reactions of ynamides. Tetrahedron, 2008, 64, 3674–3686. 
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Here a HDDA approach to prepare substituted indoline and carbazoles will be 
described. As generalized in Scheme 7.2, this strategy is to use HDDA reaction of 
ynamide like 7004 to make intermediate aryne 7005, which could be trapped in situ to 
give heterocycle 7006. As can be inferred from the general structure of 7006, this method 
should also be capable of preparing indolines or carbazoles with highly decorated 
benzenoid rings. Compared with Danheiser’s strategy, which is in essence an 
isomerization reaction, this method has two additional advantages: 1) it enables the 
construction of those fused benzenoid rings that are fully substituted; 2) it permits the use 
of external aryne trapping agents, amounting to a two-component or sometimes, even 
multi-component reaction, thereby adding tremendous flexibility into the choice of 
functional groups that can be incorporated. 
Scheme 7.2| HDDA approach to make indolines and carbazoles 
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easily removable methoxycarbonyl group131 (7010d), and this new protecting group had 
little effect on the rate of cyclization. 5) An alkynyl group on diynophile speed up HDDA 
event significantly (7010e). 6) The regioselectivity in the formation of 7010e is notable. 
Scheme 7.3| Preparation of indolines and carbazoles using HDDA reaction. 
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electronic activation of the diynophile by the benzene ring.  
More importantly, aryne intermediates can react with external trapping agents.111 The 
reagent-free nature of HDDA reaction has allowed the use of a wide variety of trapping 
agents and the discovery of many previously unknown trapping modes of arynes. This 
feature lends tremendous potential of using HDDA strategy in this setting. As shown in 
Scheme 7.3, a series of indolines and carbazoles (7011a-f) have been efficiently made 
with this method. Highlights include: i) cycloaddition with cyclopentadiene or benzene 
are efficient; ii) halogen atoms can be attached to the fleeting benzyne, providing handles 
for further manipulations; iii) heteroatoms such as O and N can be introduced.  
Scheme 7.4| Reaction of arynes with isocyanide. 
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The reaction of between carbazolyne and isocyanide133 warrants some special 
attention (Scheme 7.4). When a solution of triyne 7012a in CDCl3 was heated in the 
presence of admantyl isocyanide (7013), carbazole 7014a, which incorporated a molecule 
of CDCl3, was made in >80% yield. I propose that zwitterion 7015 is capable of 
deprotonating CDCl3 to generate carbanion CCl3-, which then quenches the nitrilium 
group to give 7014a (path b). In contrast, when the analogous triyne 7012b, which bears 
a free hydroxyl group, was subjected to the same conditions, the tetracycle 7014b was 
formed instead. Presumably, tetracycle 7014b arises from direct trapping of the nascent 
nitrilium in 7105 with its free hydroxy group (path a). 
The question whether HDDA reaction occurs in a concerted or a stepwise mechanism 
is still not answered. Johnson’s group127 have computed the energetics of each 
mechanism on the parent butadiyne+acetylene system and found the computed barrier for 
each pathway to be different only by 0.5 kcal/mol (36.5 kcal/mol for concerted vs. 37 
kcal/mol for stepwise mechanism respectively). The authors are inclined toward a 
stepwise mechanism for this reaction. However, the experimental observations we made 
are more consistent with a concerted reaction mechanism. For example, we found BHT 
and hydroquinone, which are deemed to be excellent radical scavengers, can be used in 
HDDA reactions either as an additive or as an external trapping agent; chloroform is 
routinely used as solvents; the HDDA reactions showed no sensitivity to oxygen. During 
the course of indoline synthesis project, Tao Wang and I gained some additional evidence 
supporting the concerted reaction mechanism. 
As shown in Scheme 7.5, we have prepared a series of triyne precursors that differ 
                                                
133 a) Rigby, J. H.; Laurent, S. Addition of alkyl and aryl isocyanides to benzyne. J. Org. Chem. 1998, 63, 
6742–6744. b) Allan, K. M.; Gilmore, C. D.; Stoltz, B. M. Benzannulated bicycles by three-component 
aryne reactions. Angew. Chem. Int. Ed. 2011, 50, 4488–4491. 
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only by the electron-withdrawing groups on the diynophile part, and obtained the half-
lives of each substrate under identical conditions. We found that the rate of the HDDA 
reaction of substrate 7016 increases as the substituent on the diynophile becomes more 
electron-withdrawing. The observed difference in half-lives was converted into the 
activation energy difference [ΔΔG‡(exp)] among each reaction using Arrhenius equation.  
We next investigated the hypothetical HDDA reactions of 7018, model substrates that 
resemble 7016, using DFT methods. The calculated activation energy difference 
[ΔΔG‡(calc.)] of these reactions based on a concerted mechanism (cf. 7019) agrees well 
with the experimental ones associated with substrates 7016. Such agreement provides 
additional support for a concerted reaction pathway. 
Scheme 7.5| Electron withdrawing groups on diynophiles accelerate HDDA reaction: 
experimental observation and computational prediction. 
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In conclusion, we have demonstrated a general strategy that is based on the HDDA 
reaction to prepare indolines and carbazoles. Complementary to most available ones 
toward these moieties, this strategy constructs the benzenoid ring de novo. Compared 
with the TDDA based method developed by Danheiser, this strategy, in which aryne is 
generated as the primary intermediate, allows more flexibility to introduce functional 
groups on the newly formed benzene ring, and therefore, is more suitable for library 
synthesis. Finally, an investigation that combines computational study with kinetic study 
provides evidence for a concerted mechanism in these HDDA reactions.  
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7.2 The ene reaction between phenols124 and HDDA-born benzynes 
Phenols, like p-cresol (7020), are known to be ambiphilic nucleophiles (Scheme 7.6). 
Their reactions with arynes made under conventional conditions normally occur at the O-
site. For instance, the aryne 7022 generated by treating 7021 with CsF reacts with p-
cresol to give two regioisomeric aryl ethers 7023 and 7024 in 1:3 ratio.123 However, we 
found that the reaction between p-cresol and aryne 7026, which is derived from 7025 via 
HDDA reaction, yields biaryl 7027, the product arising from phenol C-site attack to the 
exclusion of any observable aryl ether products.  
Scheme 7.6| Reactions between p-cresol and arynes that are generated in different 
ways.  
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7026 (cf. 7027 and 7030a-d), although their trapping efficiency decreases as phenols 
become more electron-deficient, consistent with the notion that aryne functions as the 
electrophile in these reactions. Besides, the synthetically versatile aldehyde group (cf. 
7030b) and halogen atoms (cf. 7030f) are also tolerated.  
Scheme 7.7| Hetera-ene reaction between aryne and phenol: Scope of phenols and 
rationale for regioselectivity. 
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Phenols with a fused arene origin were found to be considerably better ene donors (cf. 
7030g-h). The enhanced reactivity of these substrates is most likely a result of intrinsic 
lower aromatic stabilizing energy in each ring of these systems. For these phenols with 
two potential C-attacking sites, the high degree of regioselectivity observed (cf. 7030i-j) 
is notable. The formation of these regioisomers could be best explained by the minimized 
breakage of aromaticity in the corresponding transition structures. That is, transition 
structure like 7031a is more stable than 7031b because the aromaticity of one ring is still 
fully retained in the former. Regardless, the chemoselectivity for reaction between aryne 
and 5-hydroxy indole is remarkable, and serves as another testament to the mildness of 
HDDA reactions. 
Not surprisingly, this ene reaction tolerates arynes with various substitution patterns 
and electronic properties. Besides triyne 7025 (Scheme 7.6), tetraynes are also viable 
aryne precursors, as represented by the decent yields for the formation of 7032a-c. In all 
these cases, it is the regioisomer arising from attack at α-C position (cf. 7032c) was 
formed predominantly, consistent with the notion that the carbon atom with the more 
obtuse angle is more electrophilic. One exception to this rule was noticed when 2-
naphthol was used as the ene donor. In this case, the major product was 7032e, the 
compound resulting from phenol attack at β-C position. Product 7032d was formed only 
as a minor component presumably due to the highly unfavorable steric repulsion between 
the aryl ring and the butyl group present in transition structure 7033.  
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Scheme 7.8| Hetera-ene reaction between aryne and phenol: Scope of arynes and 
unexpected regioselectivity. 
 
ortho-Arylated phenols are important moieties that are frequently encountered in 
organo-catalysts, functional materials, and biologically active agents. Direct ortho-
arylation of unprotected phenols represents the most straightforward method toward these 
compounds. The hetera-ene reaction between HDDA-born aryne and substituted phenols 
is one such method. In this section of study, I have investigated the scope and limitations 
of this reaction. This reaction displays good functional group compatibility with respect 
to both the aryne and the phenol partner, and represents a general method to prepare these 
compounds. 
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7.3. Dichlorination of arynes  
Aryl chlorides are commonly encountered in, for example, agrochemicals, 
pharmaceuticals, natural products, and photonic materials. Aryl chlorides have also 
grown in importance as synthetic intermediates in light of improved methodologies 
capable of activating the relatively inert Csp2-Cl bonds.134 Classically, 
monochlorobenzenes are made from Sandmeyer reaction or electrophilic aromatic 
halogenation. We have reported that HDDA-born aryne could be efficiently trapped by a 
suitable HBr source111 to produce the monobromoarenes 7034a and 7034b (Scheme 7.9). 
Since then, we have observed that treatment with various ammonium chlorides gives a 
similar outcome, namely the formation of chlorides 7035a and 7035b. 
Scheme 7.9|  Monohalo arene formation (7034 or 7035; 70-80% yield) through 
hydrogen halide addition to the benzyne 7026 formed via the thermal 4+2 
cycloisomerization of the triyne 7025. 
 
1,2-Dichlorobenzene derivatives, the principal subject of this section, are seen in 
target compounds of interest, as represented by the structures 7034a-d (Scheme 7.10). 
The preparation of ortho-dichlorinated arenes is more challenging than that of 
monochloroarenes. There are only a few reports of direct 1,2-dihalogenation of arynes. 
                                                
134  Noyori, S.; Nishihara, Y. Recent advances in cross–coupling reactions with aryl chloride, tosylates, and 
mesylates. In Applied Cross Coupling Reactions. (Springer, 2013). 
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These are limited to (i) diiodination135,136 (with I2) or dibromination135a(with Br2), in 
which the reactions tend to proceed less effectively for arynes more elaborate than those 
of benzyne itself (from anthranilic acid or ortho-TMSPhOTf)135c and (ii) vicinal, mixed 
fluorohalogenation via silver(I)-promoted, net addition of FCl, FBr, or FI to HDDA-
generated benzynes.137 We are not aware of any examples of aryne dichlorination prior to 
this study. Here we describe a strategy to make 1,2-dichlorinated arenes from triynes via 
the intermediate benzynes.  
Scheme 7.10|  Examples of 1,2-dichlorinated target compounds (7036a, Agrylin®, 
platelet reducing agent for treatment of thrombocytosis; 7036b, indacrinone, diuretic 
developed for treatment of gout and hypertension; 7036c, kutznerides, antimicrobial 
cyclic peptides; and 7036d, for organoelectronic applications). 
 
We initially explored the possibility of trapping the HDDA-generated benzyne 7026 
with either I2 or Br2. We were not surprised that this experiment did not produce 
observable amounts of the desired dihalobenzenes (i.e., 7034/7035 where X = Y = I or 
Br). In general, one practical feature of HDDA chemistry is that the alkynes in the triyne 
                                                
135  a) Friedman, L.; Logullo, F. M. Synthesis of o-Dihalogenobenzenes from Benzenediazonium-2-
carboxylate. Angew. Chem., Int. Ed. 1965, 4, 239–240. b) Birkett, M. A.; Knight, D. W.; Little, P. B.; 
Mitchell, M. B. Tetrahedron 2000, 56, 1013. c) Perry, R. J.; Turner, S. R. J. Org. Chem. 1991, 56, 6573. 
d) Rodríguez-Lojo, D.; Cobas, A.; Peña, D.; Pérez, D.; Guitián, E. Aryne Insertion into I–I σ-Bonds. 
Org. Lett. 2012, 14, 1363–1365. 
136  Buchwald, S. L.; Lucas, E. A.; Davis, W. M. J. Am. Chem. Soc. 1989, 111, 397. 
137  Wang, K.-P., Yun, S. Y., Mamidipalli, P. & Lee, D. Unified approaches for fluorination, 
trifluoromethylation, and trifluoromethylthiolation of arynes. Chem. Sci. 2013, 4, 3205–3211. 
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reactant need to be compatible with the agents intended to trap the intermediate benzynes 
under the conditions required to generate the benzyne. For example, addition of Cl2 (and 
Br2) to alkynes is relatively fast and is not expected to be compatible with most HDDA 
substrates.  However, various metal halides are known to act as milder dihalogen 
surrogates for some dihalogen addition reactions.138 We have learned that dilithium 
tetrachlorocuprate (Li2CuCl4) functions as an effective dichlorinating agent of HDDA-
generated benzynes and report those observations here.   
We used the symmetrical tetrayne 6 for our initial explorations; it is both quite easy to 
prepare and has relatively high reactivity as a HDDA substrate. When a solution of 6 in 
CH3CN was heated in the presence of either FeCl3, no desired dichlorination product 7 
was formed, as judged by GC or TLC analysis (entry 1, Scheme 7.11a). The first 
indication of a successful outcome was seen with the use of CuCl2 in acetonitrile. 
Addition of 6 and warming the resulting solution to 68 °C led to the formation of 7 in 
67% yield following purification. Using Li2CuCl4 in acetonitrile gave similar results. The 
efficiency of the reaction was increased when the solvent was changed to THF; 7 was 
isolated in 85% yield. Under these conditions, no noticeable amount of dihydrogenation 
(by THF, see section 7.5) or HCl addition products derived from competitive trapping of 
the intermediate benzyne was observed. Notably, dioxane was an ineffective solvent for 
this transformation, presumably due to the low solubility of Li2CuCl4, which stands in 
contrast to its high solubility in THF. 
                                                
138  a) Rodebaugh, R.; Debenham, J. S.; Fraser-Reid, B.; Snyder, J. P. Bromination of alkenyl glycosides 
with copper(II) bromide and lithium bromide:   Synthesis, mechanism, and DFT calculations. J. Org. 
Chem. 1999, 64, 1758–1761. b) Uemura, S.; Sasaki, O.; Okano, M. Selective cis-chlorination of olefins 
by antimony(V) chloride. J. Chem. Soc. D, 1971, 1064–1065. c) Kovacic, P.; Brace, N. O. Chlorination 
of aromatic compounds with metal chlorides. J. Am. Chem. Soc. 1954, 76, 5491–5494. d) Uemura, S.; 
Onoe, A.; Okano, M. The chlorination of olefins with antimony(V) chloride. Bull. Chem. Soc. 
Jap. 1974, 47, 692–697. e) Yang, L.; Lu, Z.; Stahl, S. S. Regioselective copper-catalyzed chlorination 
and bromination of arenes with O2 as the oxidant. Chem. Commun. 2009, 6460–6462. 
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Scheme 7.11| a. Identification of Li2CuCl4 as an effective reagent for vic-
dichlorination of the benzyne derived from tetrayne 6. b. 1H NMR spectrum of the 
crude product mixture arising from the entry 4 experiment. 
 
We next probed some of the scope of this Li2CuCl4-mediated dichlorination reaction. 
Products 7039a-j (Scheme 7.12) encompass dichlorinated isoindoline, isoindolone, 
isobenzofuran, indane, and fluorenone skeletons. These results show that a variety of 
functional groups, present in the triyne precursors and/or the benzenoid products, are 
tolerated. They include toluenesulfonamide, ketone, ester, amide, carbonate, alkyl or aryl 
chloride, silyl ether, silyl alkyne, alkene, and (electron rich) aromatic ring. However, we 
have observed that triyne substrates containing a free alcohol or terminal alkyne are not 
compatible.  
Notably, each of the benzyne precursors to 7039i-j bears an intramolecular trap. In 
the absence of an external trapping agent, efficient aromatic Diels-Alder111 or aromatic 
ene (see Section 7.4) reaction within the intermediate benzyne occurs. However, in the 
presence of Li2CuCl4 these intramolecular trapping modes were largely if not completely 
superseded by chlorination to instead produce 7039i-j. 
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Scheme 7.12| Products (7039a-j) of dichlorination (10 equiv of Li2CuCl4, 
[substrate]0 = 0.03 M in THF) of various HDDA-derived benzynes [55-89% isolated 
yields].  
  
In conclusion, we have developed a new and efficient benzyne dichlorination reaction 
using the mild oxidizing agent, dilithium tetrachlorocuprate. We have shown that various 
types of 1,2-dichlorinated products can be accessed. The conditions are compatible with a 
considerable variety of functional groups in the benzyne precursor and resultant 
benzenoid product.  
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7.4 The aromatic ene reaction 
Ene reactions,139 which involve the attack of an alkene (the ene donor) by an 
unsaturated enophile (A=B or A≡B), are well known in organic chemistry.140 In the 
process an allylic hydrogen atom is transferred to the enophile and the alkene π-bond is 
transposed (i.e., C1=C2–C3–H + A=B to H–B–A–C1–C2=C3).  
Scheme 7.13| a) Structural delineation of an aromatic ene reaction. b) Previous 
examples of aromatic ene reaction.  
 
Aromatic ene reactions–those in which an arene bearing a benzylic C–H bond serves 
as the ene donor (cf. 7040 to 7041, Scheme 7.13)–are extremely rare. The only (four) 
reported examples involve o-benzyne (7042) itself as the enophile. Each proceeds in low 
yield (≤6%) and is presumed to follow the pathway shown in Fig. 1b (7042 to 7044 via 
                                                
139  Alder, K.; Pascher, F.; Schmitz, A. Über die Anlagerung von Maleinsäure-anhydrid und 
Azodicarbonsäure-ester an einfach ungesättigte Koh an einfach ungesättigte Kohlenwasserstoffe. Zur 
Kenntnis von Substitutionsvorgängen in der Allyl-Stellung. Ber. Dtsch. Chem. Ges. 1943, 76, 27. 
140  Hoffman, H. M. R. The ene reaction. Angew. Chem. Int. Ed. 1969, 8, 556–577. 
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7043);141 the competing formation of bimolecular [4+2] Diels–Alder reaction products 
between o-benzyne (7042, now acting as a dienophile) and toluene (the diene) perhaps 
has contributed to the fact that this fundamentally intriguing and rare type of ene reaction 
has since remained unexplored and unexploited. 
Arynes are known to function as enophiles.83 The earliest examples of this were 
sporadic and isolated in their nature, but recent studies have established synthetically 
useful ene reaction protocols involving arynes as the enophile (Scheme 7.14). Lautens et 
al. has reported the wide scope of intramolecular ene reactions of (classically generated) 
benzyne derivatives like 7046 (from 7045) in which pendant alkenes cyclize efficiently to 
provide annelated products like 7047.142 We recently described the intramolecular ene 
reaction of the aryne 7049 to give 7050.111 Cheng and coworkers have demonstrated the 
generality of a bimolecular propargylic ene reaction between o-benzyne (7042, generated 
from 7051 by the method of Kobayashi84) and an alkyne (cf. 7052) to give an allene (cf. 
7053).143 Lee et al. have recently described the considerable scope of reactions like 7048 
to 7050 as well as an intramolecular propargylic ene reaction (7054 to 7056 via 7055).144 
Arynes are also known to participate in hetera-ene reactions with a phenol111,124 (see 
Section 7.2) or aniline145 derivative serving as the ene donor.  
                                                
141  a) Brinkley, Y. J.; Friedman, L. Novel ene and insertion reactions of benzyne and alkylbenzenes. 
Tetrahedron Lett. 1972, 13, 4141–4142. b) Tabushi, I.; Yamada, H.; Yoshida, Z.; Oda, R. Reactions of 
benzyne with substituted benzenes. Bull. Chem. Soc. Jpn. 1977, 50, 285–290. 
142  a) Candito, D. A.; Panteleev, J.; Lautens, M. Intramolecular aryne–ene reaction: synthetic and 
mechanistic studies. J. Am. Chem. Soc. 2011, 133, 14200–14203. b) Candito, D. A.; Dobrovolsky, D.; 
Lautens, M. Development of an intramolecular aryne ene reaction and application to the formal 
synthesis of (±)-crinine. J. Am. Chem. Soc. 2012, 134, 15572–15580. 
143  Jayanth, T. T.; Jeganmohan, M.; Cheng, M.; Chu, S.; Cheng, C. Ene reaction of arynes with alkynes. J. 
Am. Chem. Soc. 2006, 128, 2232–2233. 
144  Karmakar, R.; Mamidipalli, P.; Yun, S. Y.; Lee, D. Alder-ene reactions of arynes. Org. Lett. 2013, 15, 
1938–1941. 
145 Pirali, T.; Zhang, F.; Miller, A. H.; Head, J. L.; McAusland, D.; Greaney, M. F. Transition-metal-free 
direct arylation of anilines. Angew. Chem. Int. Ed. 2012, 51, 1006–1009. 
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Scheme 7.14| Arynes as enophiles reacting with a, an alkene, b, an alkyne donor 
bearing an allylic or propargylic hydrogen atom, respectively.  
 
Here we show the first examples of efficient aromatic ene reactions. They were 
developed in the context of arynes like 7058 (Scheme 7.15), which bear suitably disposed 
aromatic substituents, and pass through isotoluene species like 7059, reactive 
intermediates in their own right for which we also report here some unprecedented 
transformations. 
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Scheme 7.15| This work: aryne as enophile reacting with arene bearing a benzylic 
hydrogen atom.  
 
In fact, the “discovery” of aromatic ene reaction in this lab was an accident (Scheme 
7.16). Having recognized the ability of aryne to cleave Si-O bonds,111 I designed and 
synthesized triyne 7060, to explore the possibility of a hetera-ene like reaction between 
aryne and the tethered silyl phenol ether moiety within intermediate 7061a, expecting the 
formation of pentacyclic compound 7062. In reality, however, the isomerization of 7060 
gave 7063 as the only isolated product. Not the expected pathway, the conversion from 
7060 to 7063 was puzzling and interesting. 
Scheme 7.16| Serendipitous discovery of aromatic ene reaction. 
 
  
aromatic
ene
H H H
7058 7059
HDDA
Me
7057
This work:
85 ºC
22 h
CDCl3
(HDDA)
O
TMS
O
O
TBS
O
O TMS
O*Si
7061a
"Expected"
hetera-ene
reaction
Si*
HO
TMSO
O
7062 not formed7060
O
O TMS
7061b
OTBS OTBS
TMSO
O
7063  ca. 80%
24 24α α
  Hexadehydro-Diels–Alder Reaction 
 113 
Scheme 7.17| Deuterium-labeling experiments to probe the mechanism for the 
conversion of 7060 to 7063. 
 
I then performed studies to probe the mechanism of this transformation. The 
exclusive formation of Cα-C4 bond over Cβ-C2 bond speaks against a Friedel–Crafts 
type of mechanism. In order to gain additional mechanistic insights, I then conducted two 
complementary deuterium-labeling experiments. In the first, triyne 7060 was heated in 
the presence of D2O (specifically, D2O-saturated chloroform). The dominant product, 
7062-d1 (Scheme 7.17), was monodeuterated (ca. 93% deuterium incorporation, 1H NMR 
analysis). In the second, trideuterated substrate 7060-d3 was heated, this time in the 
presence of H2O. In this case, the dominant product was 7062e-d2, in which one of the 
three aromatic deuterium atoms in 7060-d3 had been lost. The results of these two 
experiments suggested: 1) a benzylic C-H was cleaved under the reaction conditions; 2) 
the hydrogen atom on Cβ of 7063 originates from the broken benzylic C-H bond. With 
this information, we propose the conversion of 7060 to 7063 comprises a three-step 
sequence: 1) the HDDA cyclization to make benzyne 7061; 2) the aromatic ene reaction 
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to make isotoluene 7064; and 3) the rearomatization of 7064 assisted by external H2O. 
This transformation represents the first efficient aromatic ene reaction. 
In retrospect, the “discovery” of the aromatic ene reaction was a fortunate outcome. 
Realization of the aromatic ene reaction has heretofore been elusive for at least two 
fundamental reasons. First, the energetics of dearomatization associated with the primary 
ene event (cf. 7061 to 7064 in Scheme 7.17) require that the enophile be of inherently 
high reactivity. Second, o-benzyne, the only known enophile capable of overcoming this 
barrier, displays competitive [4+2] (Diels–Alder) reactivity toward the dienic character 
that is necessarily present in the requisite aromatic ring of the ene donor.141 These two 
issues were fortuitously addressed at the same time by using triyne 7060 that had been 
designed for a different purpose: 1) the reagent- and byproduct-free nature of the HDDA 
reaction (of 7060) in effect rendered the resulting benzyne longer lifetime, and therefore 
allowed the efficient trapping of benzyne with the tethered tolyl substituent, a process 
with relatively high activation energy; 2) the skeletal feature of 7060 played a critical role 
in biasing the reaction outcome against intramolecular Diels–Alder event and toward 
aromatic ene event. This latter point had not been evident until computational 
investigation on this reaction was performed. 
We used density functional theory [DFT, M062X62/6-31G(d)] to study three benzyne 
derivatives 7064 (n = 1, 2, and 3), each differing only in the length of the methylene 
chain joining the tolyl to benzyne moieties (Scheme 7.18). The computed relative TS 
energies for 7064 (n = 3) in fact favor the intramolecular Diels–Alder pathway. This 
result is consistent with an experimental outcome we observed before: reaction of 
substrate 7068a gave 7070a to the exclusion of any observable amount of ene product  
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Scheme 7.18| Competition between aromatic ene and aromatic Diels-Alder pathways 
(n is the total number of atoms that link the aryne to the trapping aryl component for 
each structure in this scheme). 
 
7069a111 (Scheme 7.18). Computation of either of the other substrates 7064 (n = 1 or 2) 
showed a decided preference for the ene rather than the Diels–Alder event. But the 
computed activation barrier for the aromatic ene reaction was considerably higher for the 
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substrate having the similar two-atom link as those in 7060 and 7064 (n = 2), produced 
only the aromatic ene-type product 7069b (88% yield). Substrates with one-atom link 
between the aryne and the tolyl moiety as in 7064 (n = 1) failed to give any isolable 
product (vide infra). The two-atom linker between the aryne and trapping arene rings 
therefore is a key structural element that permitted an efficient aromatic ene reaction.  
Scheme 7.19| The HDDA-initiated aromatic ene reaction. a, the generic 
transformation, in which three new rings are generated. b, scope, demonstrating 
functional group tolerance and variations in the polycyclic skeletons of the products. 
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To recapitulate, this unique HDDA//aromatic ene process (Scheme 7.19) converts a 
triyne substrate like 7071 [bearing a (meta-alkyl)aryl substituent, connected through a 
two atom linker] via an aryne like 7072 to an isotoluene intermediate like 7073, which 
aromatizes to a final tricyclic product like 7074. As with all HDDA-initiated reactions, 
this transformation is simply thermally induced, can be performed in a variety of non-
participating solvents, and does not require particularly stringent reaction conditions (e.g., 
oxygen- or water-free). The broad scope of the process is demonstrated by the results 
summarized in Scheme 7.19b. Highlights include: (i) Arynes having a variety of different 
electronic properties, as governed by the functional groups within the triyne tether (red), 
are effective enophiles (cf. 7063, 7070b and 7074a-e and j); (ii) the linker (blue) between 
the aryne enophile and arene ene donor can incorporate carbon, nitrogen, or oxygen 
atoms and can bear substitution (7074h); (iii) substituents on the arene donor [e.g., 
alkoxy (7074k), silyloxy (7063 and 7074f), or halide (7074g)] are well-tolerated; (iv) on 
the other hand, minimally substituted arenes are also effective (cf. 7074i); (v) the arene 
donor is not restricted to benzenoid derivatives; efficient formation of the pyridine-
containing product 7074j bodes well for the potential ene trapping by other 
heteroaromatics; (vi) secondary benzylic C–H bonds will participate in the ene transfer 
event, although at a slightly slower rate than that of a primary (cf. 1:2 ratio of products 
7074n:7074o). 
Some limitations of this reaction are worth mentioning here (Scheme 7.20). The 
ability to generate the reactive aryne intermediate in the absence of other reagents (i.e., 
by thermal activation only) was essential for realizing an efficient aromatic ene reaction. 
This point was illustrated by the outcome of our attempt to use the Lautens strategy (cf. 
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7045 to 7047 in Scheme 7.14) to effect the aromatic ene trapping of the aryne 7076 
generated by base-induced elimination of HBr from bromoarene 7075 (Scheme 7.20). 
The biaryl 7077 was formed, but in only ca. 2% yield. Products resulting from amine 
trapping (7079) and reduction (7078)146 of the intermediate aryne were formed 
predominantly. Additionally, high yielding aromatic ene reactions were observed only 
with substrates that have two atom linker between aryne and tolyl substituent: those with 
three atom linker gave Diels–Alder adduct predominantly; those with one atom linker 
like 7081 (from 7080) failed to give 7082 presumably because of the high activation 
energy for the process as predicted by computational study. 
Scheme 7.20| Some limitations of aromatic ene reaction. 
 
Despite these limitations, we still deem the aromatic ene reaction a useful 
transformation. We further reasoned that because the isotoluene intermediate 7073 
formed via the initial aromatic ene reaction was sufficiently long-lived to encounter 
water, it might be possible to trap this species in an even more productive manner by an 
added external enophile (cf. A=B, 7073 to 7083 in Scheme 7.21). Indeed, when a 1,2- 
                                                
146  Niu, D; Willoughby, P. H.; Woods, B. P.; Baire, B.; Hoye, T. R. Alkane desaturation by concerted 
double hydrogen atom transfer to benzyne. Nature 2013, 501, 531–534. 
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Scheme 7.21| HDDA//aromatic ene//Alder ene cascade. 
 
dichloroethane solution of the trideuterated substrate 7084-d3 was heated in the presence 
of maleic anhydride147 (Scheme 7.21), the adduct 7086-d3 was formed. The observed net 
cis-addition of carbon and deuterium across the enophile π-bond was stereospecific 
(coupling constant and chemical shift analysis of the 1H NMR spectrum), providing 
evidence for a concerted ene reaction between maleic anhydride and 7084-d3.  
This successful transformation of 7084-d3 to 7086-d3 via 7085 showed that it was 
possible to unite an additional (bimolecular) ene trapping reaction with the initial 
(unimolecular) aromatic ene reaction. This amounts to a HDDA//aromatic ene//Alder ene 
cascade. The sequence is enabled because the isotoluene intermediate 7085 is still 
endowed with a considerable portion of the potential energy embodied by the three 
alkyne units in the initial HDDA substrate 7084-d3. The scope of this three-stage cascade 
process can be seen from the examples shown in Scheme 7.22.  Highlights include: 
                                                
147 Alder, V. K.; Schmitz-Josten, R. Über die Addition von Maleinsäure-anhydrid an Styrol. Liebigs Ann. 
Chem. 1955, 595, 1–37. 
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Scheme 7.22| Scope of HDDA//aromatic ene//Alder ene cascade. 
 
(i) a variety of types of external enophiles can be used to trap the isotoluene intermediate; 
these include electron-deficient alkenes (maleic anhydride and maleimides), α-dicarbonyl 
compounds (pyruvates, glyoxalate, and N-methylisatin), and an N-sulfonylimine;  (ii) the 
overall cascade process is tolerant of a large number of inherently reactive functional 
groups including imide, anhydride, ketone, ester, halogen, alcohol, aldehyde, and 
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sulfonamide that are present in the trapping enophiles and the newly formed products, 
demonstrating a considerable degree of chemoselectivity; (iii) the process is also 
compatible with a broad array of functionality in the aryne precursor–derivatives of 
isoindolone, phthalide, fluorenone, and indane can all be produced in high yields; (iv) the 
reaction can be conducted at relatively high substrate (triyne) concentration (0.2 to 0.3 
M), which speaks to the inherently fast nature of the aromatic ene trapping step; (v) only 
1.2 to 2 equivalents of external trapping enophiles were used, which suggests that the 
isotoluene intermediate has a relatively long lifetime and bodes well for application to 
convergent coupling synthesis strategies using complex triyne substrates and complex 
trapping enophiles; (vi) various steps in the cascade are stereoselective, as indicated by 
the production of a 4:1 ratio of diastereomers 7087i and its epimer from the 
corresponding (chiral) triyne. Although we do not yet know the exact origin of this 
selectivity, relative asymmetric induction in this case can occur at either (or both) of two 
stages. The aromatic ene substrate 7088 has diastereotopic re and si faces at its (two 
equivalent) ortho-carbon atoms, as does the isotoluene intermediate 7089 at its exo-
methylene carbon atom. 
Isotoluene intermediate from aromatic ene reaction could also be trapped by other 
reagents. For example, when aryne precursor 7090 was heated in o-dichlorobenzene, a 
significant byproduct 7093 was formed, along with conventional HDDA//aromatic 
ene//aromatization products 7091 and 7092 (Scheme 7.23a). Notably, 7093 has a higher 
oxidation state than 7091 or 7092, suggesting the participation of some oxidants in the 
process of its formation. Presumably, oxygen dissolved in the reaction solvent and 
present in the head space of the reaction flask is responsible for the production of 7093. A 
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mechanism shown in Scheme 7.23b was proposed, the key step of which involves the 
oxidation of isotoluene intermediate 7094 by O2 to give peroxide intermediate 7095. 
However, dehydration of 7095 to form 7093 represents another unprecedented 
transformation,148 and its mechanism is still unclear.  
Scheme 7.23| a) Formation of 7093 was observed as a byproduct in the reaction with 
substrate 7090. b) Proposed mechanism for the formation of 7093 from 7090. 
 
In conclusion, the transformations shown in this section revealed the generality of a 
heretofore rare and elusive type of ene reaction in which an arene bearing a benzylic C–H 
bond functions as the ene donor. I have shown that the isotoluenes generated by this 
HDDA-enabled "aromatic ene" reaction can rearomatize either by net rearrangement or 
through interception by an external enophiles. Thus, two complementary processes have 
emerged. In the first, the isotoluene rearomatizes to provide polycyclic products like 
7074a-o (Scheme 7.19) in a process explained by water-mediated proton shuttling. In the 
second, the reactive isotoluene is further engaged by an external enophile to give 
products of yet greater structural complexity (cf. 7087a-i, Scheme 7.22). This ene-upon-
                                                
148  For precedented metal-free Csp2-H bond activation by peroxides, see: Yuan, C.; Liang, Y.; Hernandez, 
T.; Berriochoa, A.; Houk, K. N.; Siegel, D. Metal-free oxidation of aromatic carbon-hydrogen bonds 
through a reverse-rebound mechanism. Nature, 2013, 499, 192–196.  
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ene cascade reaction involves the overall formation of four carbon-carbon bonds and 
three rings, requires no external reagents, and generates no byproducts. The discovery of 
this efficient aromatic ene reaction further attests to the importance of a key feature of the 
HDDA cycloisomerization—namely, its ability to deliver aryne intermediates in the 
absence of the potentially interfering reagents that typically accompany aryne formation 
by classical methods.149 
  
                                                
149 Kitamura, T. Synthetic methods for the generation and preparative application of benzyne. Aust. J. 
Chem. 2010, 63, 987–1001. 
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7.5. Double hydrogen transfer between saturated alkanes and benzynes 
As can be seen from the discussion in the previous sections, chemists have developed 
numerous ways to introduce substituents into aryne intermediates, thereby making 
decorated benzenoid rings. In contrast, the reduction of aryne, i.e., introducing two 
hydrogen atoms to the strained bond of aryne (Scheme 7.24a) received very little 
attention from the synthetic community. Two reasons may account for this situation: 1) o-
aryne like 7042 is highly prone to nucleophilic attack, which may have obscured its 
ability to react with potential H2 donors; 2) this reduction method is of little preparative 
value if aryne is produced by a conventional 1,2-elimination method, since the starting 
material (7096) will be more difficult to access than the product (7097).  
Scheme 7.24| Reduction of aryne by “H2”. 
 
On the other hand, the dihydrogenation of aryne like 7099 that is originated from 
HDDA reaction is of significant synthetic interest because this method would provide 
direct access to 1,2,3,4-tetrasubstituted arenes like 7100 from suitable triynes like 7098. 
The focus of this section will be such a transformation and some additional discoveries 
made during the course of study. 
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Initial attempts of effecting dihydrogenation of HDDA-born arynes using 
conventional hydrogen atom donors like Et3SiH, Bu3SnH, or 1,4-cyclohexadiene were 
not successful. An extensive survey into literature revealed an intriguing observation 
made by Sterenberg and coworkers: when attempting to recrystallize the bis-diyne-
bridged, dinuclear metal complex 7101 from THF, they isolated the reduced arene 7103 
in >90%150 (Scheme 7.25). They later confirmed that the solvent (THF) was the source of 
the hydrogen (and, in the case of THF-d8, deuterium) atoms that appeared in the reduced 
benzenoid product. To gain some further insights into this unusual reduction of 7101, the 
authors incubated 7101 with furan, and observed the clean formation of a product 
apparently arising from the Diels–Alder reaction between aryne 7102 and furan, thereby 
confirming that in these reactions, tetrayne 7101 initially isomerizes to aryne 7102. 
Therefore, they proposed that the formation of arene 7103 is the result of aryne (7102) 
reduction by THF. 
Scheme 7.25| Sterenberg’s observation: HDDA-born benzyne 7102 could be 
dihydrogenated by THF.  
 
Inspired and encouraged by Sterenberg’s observation, I heated substrate 7025 in 
THF-h8, to see if the corresponding aryne intermediate could be reduced under such 
conditions. To my delight, arene 7104 was isolated as the major product (55-60%) when 
                                                
150  Tsui, J. A.; Sterenberg, B. T. A metal-templated 4 + 2 cycloaddition reaction of an alkyne and a diyne to 
form a 1,2-aryne. Organometallics 2009, 28, 4906–4908. 
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the reaction was completed. This result verified that THF is indeed an effective reductant 
for aryne. However, peroxide 7105 was also isolated from the reaction mixture and 
characterized by 1H NMR and HR ESI-MS, albeit as a minor component (ca. 20%). To 
rationalize the formation of this peroxide, I proposed the mechanism shown in Scheme  
Scheme 7.26| Reaction of aryne with THF: formation of reduced arene and peroxide 
byproduct. 
 
7.26b, which involves: 1) (reversible) nucleophilic attack of THF to aryne 7026, 
generating zwitterion 7106; and 2) zwitterion quenching by peroxide 7107 originated 
from THF auto-oxidation. To validate this mechanism, 7025 was heated in air-free THF 
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in the presence of intentionally added tBuOOH. Under these conditions, peroxide 7108 
was isolated as the minor product instead. Having established the source of the byproduct 
7105, I then conducted the reduction 7025 using carefully deoxygenated THF. Under 
these new conditions, the formation of peroxide was almost completely suppressed, and 
the yield for the desired reduced arene was improved to >75%. 
Although a condition for aryne reduction was identified, the mechanism for this 
transformation was still unclear. In fact, it was very surprising to see THF be an efficient 
reducing agent for arynes for two reasons. First, THF was one of the most frequently 
used solvents for reactions involving arynes, yet the only report that documented its 
ability to reduce aryne was the one from Sterenberg’s group. Second, the reported 
reactions between THF and aryne in most cases occur in a polar addition pathway86,151 
(cf. 7026 to 7106 in Scheme 7.26b).  
To gain additional mechanistic insights into this reaction, I repeated the generation 
and trapping of aryne 7026, this time in the presence of an equimolar mixture of THF-h8 
and THF-d8 (Scheme 7.27a). Intriguingly, only the diprotio- and dideuterio-benzenoid 
products 7104-h2 and 7104-d2 were produced; none of the mono-H/mono-D analog 
(7104-hd) was detected. The observed 7104-h2:7104-d2 product ratio was 6:1, indicating 
a significant H/D kinetic isotope effect for the 2H-transfer. The complementary 
experiment of using a 1:6 molar ratio of THF-h8:THF-d8 resulted in a nearly 1:1 ratio of 
products 7104-h2:7104-d2. The lack of an observable level of monodeuterated product in 
any of these experiments is evidence that both of the two added hydrogen atoms in 7104 
originate from a single molecule of THF. Moreover, when the reduction of 7025 was 
                                                
151 Feltenberger, J. B.; Hayashi, R.; Tang, Y.; Babash, E. S. C.; Hsung, R. P. Enamide-benzyne-[2+2] 
cycloaddition: stereoselective tandem [2+2]-pericyclic ring-opening-intramolecular N-tethered [4+2] 
cycloadditions. Org. Lett. 2009, 11, 3666–3669.  
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performed in CDCl3 using 20 equiv of THF, I was able to observe the formation of 2,3-
dihydrofuran as a byproduct (Scheme 7.27b). This outcome further suggests that the two 
transferred hydrogen atoms derive from the vicinal C-H bonds in THF. 
Scheme 7.27| a) Deuterium-labeling experiments for the reduction of aryne by THF. 
b) A crude 1H NMR spectrum for reduction of 7025 (0.01 M) in CDCl3 using ca. 20 
equiv THF.  
 
Additional insights were gained from the reaction between aryne and 1,4-dioxane. It 
was initially astounding to see that 1,4-dioxane, a molecule structurally very close to 
THF, is totally ineffective to reduce aryne 7026 (Scheme 7.28a). To rationalize this 
dichotomy and the observations discussed in the previous paragraph, I proposed that this 
double hydrogen transfer process occurs in a concerted fashion, the transition structure of 
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which contains 6 coplanar atoms, as depicted by structure 7109-A and 7109-B in Scheme 
7.28b.  
Scheme 7.28| a. Drastic reactivity difference between THF and 1,4-dioxane in 
reducing arynes. b. Proposed mechanism for double hydrogen transfer between aryne 
and THF/1,4-dioxane. 
 
Although such a description might seem unusual, the generally accepted mechanism 
for (i) the reduction of alkenes by diimide (HN=NH)152 and (ii) type II dyotropic 
reactions153 involves a similar simultaneous, co-planar double hydrogen atom transfer. 
Importantly, this mechanism explains the reactivity difference between THF and 1,4-
dioxane in reducing arynes: the reactive conformer of THF is envelop-shaped, low-lying 
in energy, and therefore highly populated; whereas the reactive conformer of 1,4-dioxane 
is boat-shaped, ca. 8 kcal•mol-1 less stable than the chair conformer, and therefore only 
present in solution at low concentration.  
                                                
152  a) Hünig, S.; Müller, H.; Thier, W. Reduktionen mit diimid. Tetrahedron Lett. 1961, 2, 353–357. b) 
Corey, E. J.; Pasto, D. J.; Mock, W. L. Chemistry of diimide. II. Stereochemistry of hydrogen transfer to 
carbon-carbon multiple bonds. J. Am. Chem. Soc. 1961, 83, 2957–2958. 
153  a) Fernández, I.; Cossío, F. P.; Sierra, M. A. Dyotropic reactions: Mechanisms and synthetic 
applications. Chem. Rev. 2009, 109, 6687–6711. b) Fernández, I.; Sierra, M. A.; Cossío, F. P. In-plane 
aromaticity in double-group transfer reactions. J. Org. Chem. 2007, 72, 1488–1491. 
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Somewhat satisfied with the above mechanism, I became curious if the propensity to 
attain conformers with eclipsing vicinal C-H bonds is the most important factor that 
dictates the ability of a certain molecule to simultaneously transfer two hydrogen atoms 
to aryne. If so, one should predict aryne to be efficiently reduced by cyclopentane but not 
by cyclohexane. This prediction initially sounded rather absurd, but turned out to have 
merit. Reduction of 7025 in cyclopentane afforded the reduced arene 7104 in ca. 80%  
Scheme 7.29| a. Relative efficiency of various cyclic alkanes in reducing aryne. b. 
Computed transition structures of double hydrogen transfer process between benzyne 
and cyclopentane/cyclohexane. c. A crude 1H NMR spectrum for reduction of 7025 
(0.01 M) in CDCl3 using ca. 20 equiv cyclooctane.  
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yield. On the other hand, the reduction attempted in cyclohexane produced only trace 
amount of 7104 (Scheme 7.29a, entry 1 and 2). As predicted, cyclopentane is a much 
more effective 2H-donor than is cyclohexane. In fact, all cyclic alkanes with ring sizes 
between five and eight (entry 1-4 in the tablet inset of Scheme 7.29a) except cyclohexane 
are potent 2H-donors. The potency of cyclooctane, for example, can be illustrated by the 
fairly clean crude 1H NMR spectrum (Scheme 7.29c) of a reaction mixture obtained by 
heating a CDCl3 solution of 7025 (0.01 M) in the presence of only 20 equiv of 
cyclooctane.  
Using computational tools, Dr. Willoughby located the transition structures for the 
reactions between benzyne and cyclopentane vs. cyclohexane. He found the activation 
energy (ΔG‡) for the reaction with cyclohexane is ca. 5.4 kcal•mol-1 higher than that for 
cyclopentane. Not coincidentally, the energetic penalty for cyclohexane to adopt the boat 
(reactive) conformation is ca. 6 kcal•mol-1. All these observations are consistent with the 
hypothesis that there is a preference for an eclipsed geometry for the relevant HCsp3Csp3H 
subunit within the 2H-donor molecule. Cyclohexane, dominated by its chair 
conformation, is least disposed toward transfer of two of its hydrogen atoms, whereas the 
other hydrocarbons all have low-lying conformers with HCsp3Csp3H dihedral angles much 
smaller than 60°. That is, those cyclic hydrocarbons populated to a significant extent by 
conformers having less highly staggered vicinal C–H bonds are the more reactive 2H-
donors.  
Dr. Willoughby then performed a systematic study that relates to the kinetics of this 
reaction. With the assistance of No-D NMR154 and qNMR,155 He first quantified the 
                                                
154 a) Hoye, T. R.; Eklov, B. M.; Ryba, T. D.; Voloshin, M.; Yao, L. J. No-D NMR (No-deuterium proton 
NMR) spectroscopy: a simple yet powerful method for analyzing reaction and reagent solutions. Org. 
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relative rate (krel) of each hydrocarbon in reducing a structurally related aryne 7111 
(generated from triyne 7110) by measuring the ratio of the alkene resonances formed 
(Scheme 7.30). He noticed that cyclohexane is ca. 100 times less potent than 
cyclopentane as a 2H-donor. On the contrary, norbornane, having a boat-like cyclohexane 
embedded in its framework (and an associated HCsp3Csp3H moiety with a 0° dihedral 
angle) is a kinetically competent donor (entry 4 in Scheme 7.30) even though the product 
norbornene comprises a strained alkene. He then computed the activation energy for the 
reaction between the parent o-benzyne with each hydrocarbon. He found there is a 
remarkably good correlation between the computed ΔG‡ values and the observed krel 
values. These observations provide additional support for the idea of substantial 
dependence on dihedral angle for the process, which can only be true if the double 
hydrogen atom transfer event is concerted. 
Scheme 7.30| Relative efficiency of various cyclic alkanes in reducing aryne.  
 
                                                                                                                                            
Lett. 2004, 6, 953–956. b) Hoye, T. R.; Eklov, B. M.; Voloshin, M. No-D NMR spectroscopy as a 
convenient method for titering organolithium (RLi), RMgX, and LDA solutions. Org. Lett. 2004, 6, 
2567–2570.  
155 Pauli, G. F.; Jaki, B. U.; Lankin D. A., Routine experimental protocol for qHNMR illustrated with taxol. 
J. Nat. Prod. 2007, 70, 589–595.  
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It is relevant to emphasize here that the alkane-to-alkene conversion almost always 
involves one or more chemical intermediates in a multistep reaction pathway; these may 
be either isolable species (such as alcohols or alkyl halides) or reactive intermediates 
(such as carbocations, alkyl radicals, or σ-alkyl-metal species). The one step desaturation 
of simple, unactivated alkanes by aryne described here is, therefore, mechanistically 
unique.  
Scheme 7.31| Reduced benzenoid products 7113a–g generated by heating the triyne 
precursor in cyclooctane under the indicated conditions (starting substrate 
concentration 10 mM). 
 
Following these mechanistic investigations, we also probed the scope of this aryne 
reducing methodology. We prepared products 7113a-g (Scheme 7.31) by incubating the 
corresponding triyne precursor [inferred from the dashed line in each structure] in 
cyclooctane under the indicated conditions. Notable features include: (i) a variety of 
functional groups, present in both the triyne precursor and benzenoid product, are readily 
tolerant of these benign reducing conditions; (ii) benzynes representing a breadth of 
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electronic activation and/or perturbation engage in the reaction; (iii) most of the products 
7113 have a 1,2,3,4-tetrasubstituted motif, a substitution pattern that can be challenging 
to access by classical aromatic synthesis strategies; (iv) the double hydrogen atom 
transfer process occurs readily even at ambient temperature (cf. 7113a); and (v) the 
reaction is not limited by scale (cf. 7113g). 
Finally, an ancillary but important practical consideration is worth mentioning. The 
most common method for generating simple benzyne derivatives, including the parent o-
benzyne, is that of Kobayashi84 in which 2-trimethylsilylphenyl triflate [1,2-
TMS(OTf)C6H4] is exposed to a fluoride ion source (commonly CsF) in, most often, THF 
as the solvent. We speculated that some known trapping reactions of benzynes generated 
in THF are compromised in their efficiency due to competitive reduction by that solvent. 
Indeed, when we exposed o-TMSPhOTf to CsF in THF-d8 in the absence of any other 
trapping agent, we observed the production of benzene (C6H4D2, by 1H NMR analysis). 
Similarly, benzene (and cyclopentene) was seen when CsF and o-TMSPhOTf were 
reacted in CD3CN that contained cyclopentane (ca. 25 equiv). We suggest that all 
traditional benzyne generation methods performed in the presence of a potential 2H-
donor (most typically, THF) are at risk to the unwanted, benzyne-depleting, 2H-transfer 
process, especially when the benzyne trapping event is inherently slow. Indeed, we can 
infer that this has already been encountered. For example, recent reports show THF to be 
an inferior medium (vs. 1,4-dioxane156 or diethyl ether157) for some benzyne trapping 
reactions. This is consistent with (i) the relative efficiency of THF vs. 1,4-dioxane as a 
                                                
156  Ma, Z.-X.; Feltenberger, J. B.; Hsung, R. P. Total syntheses of chelidonine and norchelidonine via an 
enamide–benzyne–[2+2] cycloaddition cascade. Org. Lett. 2012, 14, 2742–2745. 
157  Sumida, Y.; Kato, T.; Hosoya, T. Generation of arynes via ate complexes of arylboronic esters with an 
ortho-leaving group. Org. Lett. 2013, 15, 2806–2809. 
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2H-donor and (ii) our arguments for angle-dependency during the 2H-transfer. 
In summary, described in this section is the discovery of an unprecedented 
bimolecular double hydrogen atom transfer process. The reaction is important from the 
perspective of both reactants: the saturated alkane donor and the benzyne acceptor. Both 
(vicinal) hydrogen atoms come from the same donor molecule. There is substantial 
dihedral angle dependence because donors having a greater degree of eclipsing among 
their low-energy conformers are more reactive. This finding is reinforced by the 
geometry of computed transition structures, which show near planarity of the six reacting 
atoms. Our observations support a pathway in which both hydrogen atoms are transferred 
simultaneously from the saturated alkane to the benzyne carbon atoms—a process that 
could be viewed as a metal-free, double C–H activation event. 
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Chapter 8. A Protocol to Investigate Kinetics of 
Benzyne-Trapping Reactions 
8.1 Mathematical background  
Hundreds of aryne trapping reactions have been developed since the initial discovery 
of this fascinating synthetic intermediate. The myriad trapping modes attest to the 
synthetic versatility of arynes. Last year, we disclosed hexadehydro-Diels–Alder 
(HDDA) reaction as a general method to prepare arynes. This method, which converts a 
triyne substrate to aryne intermediate in a reagent- and byproduct-free fashion, enabled us 
and others to explore aspects of intrinsic aryne reactivity, including the discovery of some 
entirely new modes of trapping reactions.111,146,158,159 However, despite the numerous 
(and multifaceted) aryne trapping reactions that have been developed to date, rarely has it 
been possible to probe kinetic aspects of these powerful transformations. This is not a 
trivial problem because the benzyne forming reaction rather than its subsequent trapping 
is nearly always the rate-limiting event. Certainly there is no report of a general strategy 
for studying the kinetics of aryne trapping [e.g., for deducing the kinetic order of the 
trapping reactant(s)]. 
When investigating the scope of aryne dichlorination methodology (cf. Section 7.3), I 
found the trapping of aryne 8002 (generated from 8001, Scheme 8.1) with Li2CuCl4 to be 
interesting: the production of dichlorinated arene 8003 is accompanied by benzobarrelene 
8004 under conventional conditions. However, formation of 8004 was suppressed when a 
                                                
158  Niu, D.; Hoye, T. R. The aromatic ene reaction. Nat. Chem. 2014, 6, 34–40. 
159  a) Yun, S. Y.; Wang, K.-P.; Lee, N.-K.; Mamidipalli, P.; Lee, D. Alkane C–H activation by aryne 
intermediates with a silver catalyst. J. Am. Chem. Soc. 2013, 135, 4668–4671. b) Wang, K.-P.; Yun, S. 
Y.; Mamidipalli, P.; Lee, D. Unified approaches for fluorination, trifluoromethylation, and 
trifluoromethylthiolation of arynes. Chem. Sci. 2013, 4, 3205–3211.  
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more concentrated solution of Li2CuCl4 was used. The observation that the ratio of 8003 
to 8004 is dependent on the concentration of Li2CuCl4 used has inspired me to consider 
whether substrate like 8002, which has an intramolecular trapping group, could be used 
as a probe for studying kinetics of intermolecular aryne trapping events. 
This thinking is supported by mathematical considerations. Assuming 1) the rate 
constant for the formation of 8003 is k1, and 2) the formation of 8003 has nth order of 
dependence on the concentration of Li2CuCl4, then the rate law for the formation of 8003 
can be expressed in the following equation: 
 
Benzobarrelene 8004 arises via an intramolecular process, and consequently, the rate of 
its formation can be expressed by equation 2 
 
The relative rate for the formation of 8003 and 8004 can be expressed as shown in eq 3 
and transformed to eq 3'.  
 
When a large excess of Li2CuCl4 is used, equation 3' can be approximated as eq 4, which 
can also be expressed in logarithmic form as eq 4'. 
 
According to these equations, the order of dependence on a certain external trapping 
reagent (in this case, Li2CuCl4) can be deduced by plotting its concentration against the 
ratio of the products arising from intramolecular trapping (like 8004) and intermolecular 
trapping (like 8003).  
d[8003] = k2 •[8002]1•[Li2CuCl4]n•dt (eq 1)
k1•[8002]1•dtd[8004] = (eq 2)
k1•[8002]1•dt
d[8003]
d[8004]
=
k2 •[8002]1•[Li2CuCl4]n•dt [8003]
[8004]
=
k1•[8002]1•dt
k2 •[8002]1•[Li2CuCl4]n•dt
∫
∫
(eq 3, 3')
≈
k2 •[Li2CuCl4]nk1
[8003]
[8004]
[8003]
[8004]
ln ≈ n•ln [Li2CuCl4] + ln
k2
k1
(eq 4, 4')
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Scheme 8.1| The competitive formation of dichlorobenzene derivative 8003 and 
benzobarrelene 8004 under conventional benzyne dichlorination conditions.  
 
In practice, the product ratio of 8003 to 8004 was measured at a series of 
concentrations of Li2CuCl4 and the results are given in Scheme 8.1. From the slope of the 
plot of ln[8003]/[8004] vs. ln[Li2CuCl4], we determined that formation of 8003 showed a 
first-order dependence on [Li2CuCl4]. Since aryne precursors with various intramolecular 
trapping groups can be easily prepared, this protocol should be applicable for studying 
the molecularity of many intermolecular aryne trapping reactions. 
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8.2. Kinetics of aryne trapping by alcohols 
The reaction between aryne like 8005 and alcohol like 8006 has been known for over 
100 years. To the best of our knowledge, all the reactions between arynes and alcohols 
reported resulted in the formation of aryl ethers like 8008. It is usually proposed123 that 
these reactions occur via transition structures like 8007, which implies a direct insertion 
into OH bond of alcohol by aryne.  
Scheme 8.2| A typical reaction between aryne and alcohol and the widely accepted 
mechanism of this reaction.  
 
Dr. Willoughby noticed, however, the reaction outcome between HDDA-born aryne 
like 8010 and alcohol (e.g., isopropanol) is dependent on the concentration of alcohol 
used: at high concentrations of iPrOH, the ethereal product 8012 was formed 
predominantly (Scheme 8.2, Path A); at low concentrations of iPrOH, on the other hand, 
reduced arene 8014 was produced as the major product (Path B). Following a series of 
deuterium-labeling experiments and computational study, he hypothesized the hydrogen 
transfer from alcohol to aryne 8010 occur via a Cannizzaro type of mechanism as 
indicated by the transition structure 8013. At the same time, he challenged the generally 
accepted mechanism for the addition reaction between aryne and alcohol (cf. Scheme 
8.2), and proposed a pathway that involves the participation of alcohol dimer in the 
transition structure (8011). 
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Scheme 8.3| The preferred reaction pathway of HDDA-born aryne with alcohol is 
dependent on the concentration of alcohol used. 
 
Undoubtedly, knowledge about the kinetic order of alcohol in each trapping mode is 
valuable to verify Dr. Willoughby’s hypotheses. To my fortune, I just developed a 
protocol that can be used for tapping such information (see Section 8.1). 
In order to accurately measure the ratio of products arising from intermolecular 
trapping to those from intramolecular trapping, the reaction rate for each process should 
be close. In other words, to probe the kinetic orders of different external trapping agents, 
aryne precursors with different intramolecular trapping groups may be required. For 
example, when studying the reaction between aryne and Li2CuCl4, aryne 8002 (Scheme 
8.1), which bears a 4-methoxybenzyl group, was employed. Since alcohols are less 
competent trapping reagents for arynes than Li2CuCl4, I found the use of aryne 8016, 
which has a correspondingly less potent benzyl trapping group, to be most appropriate for 
this purpose.  
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Scheme 8.4| Kinetic study for the reactions between aryne 8016 and isopropanol. 
 
To my surprise, no product arising from aryne hydrogenation was formed even when 
very low concentration of iPrOH was used: the reaction between aryne 8016 and 
isopropanol gave only aryl ether 8017/8018 and benzobarrelene product 8019. Moreover, 
the isomeric 8017 and 8018 were formed by different mechanisms! This was first seen 
from the changing regioselectivity of alcohol addition at different alcohol concentrations: 
the ratio of 8017 to 8018 ranges from 30:1 to 6:1. Later, the product ratio of each ether 
adduct (8017 or 8018) to 8019 was measured at a series of concentrations of isopropanol 
(results are given in Scheme 8.3). From the regression equations derived from these data, 
it can be concluded that formation of 8018 has a second-order but formation of 8017 has 
a first-order dependence on [isopropanol]. No reduction of 8015 was observed even at 
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low concentrations of isopropanol because the formation of 8017 has a much larger rate 
constant. 
I attributed the “abnormal” mechanism for the formation of 8017 to the presence of a 
heteroatom (oxygen atom) with the side chain of 8015, which may assist the rate-limiting 
proton transfer event as depicted in Scheme 8.5a, or function as a directing group as 
indicated in Scheme 8.5b.  
Scheme 8.5| Plausible mechanisms for the formation of 8017. 
 
Based on the above rationale, I designed and synthesized substrate 8023, an analogue 
of 8015 that is devoid of heteroatoms on the side chains (Scheme 8.6), to study the aryne 
reduction mechanism. Gratifyingly, heating 8023 in the presence of isopropanol indeed 
gave the reduced arene 8025 as a byproduct. Additionally, the ratio of two isomeric 
alcohol adducts (8026 and 8027) was not affected by the different concentrations of 
isopropanol used. Finally, plotting the ratio of each product to benzobarrelene 8028 
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against [isopropanol] revealed that indeed, the formation of reduced arene 8025 and 
alcohol adduct 8026 has a first-order and second-order dependence on [isopropanol], 
respectively.   
Scheme 8.6| Kinetic study for the reactions between aryne 8024 and isopropanol 
conducted in CDCl3. 
 
In conclusion, by using a protocol that we established for probing kinetic aspects of 
aryne trapping events, I gained some insights into the mechanisms of reactions between 
HDDA-born aryne and alcohols. I found that: 1) the previously unprecedented double 
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hydrogen atom transfer event between alcohol and aryne demonstrated a first-order 
dependence on the concentration of alcohol, supporting a Cannizzaro type of pathway for 
this transformation; and 2) as opposed to what was implied by the conventionally 
proposed mechanism, the alcohol addition to aryne actually showed a second-order 
dependence on the concentration of alcohol, suggesting the involvement of two alcohol 
molecules in the rate-limiting step of this transformation. The information obtained in 
this section of study further attest to the utility of substrates like 8023 in studying 
mechanism of aryne trapping reactions. 
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General Experimental Protocols 
1H and 13C NMR spectra were recorded on Varian Inova 500 (500 MHz) and Varian 
Inova 300 (300 MHz) spectrometers. Chemical shifts for proton spectra are referenced to 
TMS (δ 0.00 ppm) for spectra recorded in CDCl3; to CD3SOCHD2 (δ 2.50 ppm) for 
DMSO-d6; and to CHD2OD (δ 3.31 ppm) for MeOH-d4. Non-first order multiplets are 
identified as "nfom". Chemical shifts for carbon spectra are referenced to CHCl3 (δ 77.23 
ppm) for spectra recorded in CDCl3; to (CD3)2SO (δ 39.50 ppm) for DMSO-d6; and to 
CD3OD (δ 49.00 ppm) for MeOH-d4. TMS is present in some of the 13C NMR samples 
(δ ca. 0.0 ppm). HSQC refers to heteronuclear single quantum correlation. The following 
format was used to report resonances: chemical shift in ppm (multiplicity, coupling 
constant(s) in Hz, integral value, and assignment). Coupling constant analysis was guided 
by methods we have described elsewhere.160 Some complex structures are numbered in 
order to simplify identification of the proton assignment. 
Infrared (IR) spectra were recorded on a Prospect MIDAC FT-IR spectrometer using 
a NaCl plate (thin film) or ZnSe plate (ATR). Absorptions are reported in cm-1.  
MPLC refers to medium pressure liquid chromatography (25-200 psi) using hand-
packed columns of silica gel (18-32 µm, 60 Å pore size), a Waters HPLC pump, and a 
Waters R401 differential refractive index detector. Flash chromatography was performed 
using E. Merck silica gel (40-63 µm).  
GCMS data were recorded on an Agilent 5975 MSD at 70 eV. The methods used are 
noted parenthetically: e.g., 5025015 refers to 2 min initial hold time at 50 °C, a ramp to 
250 °C at a rate of 20 °C min-1, and a final hold time of 3 min (for a total run time of 15 
min). The column was 30 m HP-5 × 0.32 mm × 0.25 µm film thickness.  
Reactions requiring anhydrous conditions were performed under an atmosphere of 
nitrogen or argon in flame or oven dried glassware. Reported (external) reaction 
temperatures are the temperature of the heating bath. HDDA initiated cascade reactions, 
including those that were carried out at temperatures above the boiling point of the 
solvent, were typically carried out in a screw-capped vial or culture tube fitted with an 
inert, Teflon®-lined cap. Those carried out in deuterated solvents were typically 
                                                
160 a) T. R. Hoye, P. R. Hanson, J. R. Vyvyan, J. Org. Chem. 1994, 59, 4096-4103. b) T. R. Hoye, H. Zhao, 
J. Org. Chem. 2002, 67, 4014-4016. 
  Experimental 
 147 
performed in a capped NMR sample tube (5 mm diameter). Anhydrous THF, diethyl 
ether, toluene, and methylene chloride were tapped immediately prior to use after being 
passed through a column of activated alumina. Triethylamine and pyridine were distilled 
from KOH. Diisopropylamine was distilled from CaH2. DMF and DMSO were stored 
over 4Å molecular sieves. 
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General Procedures A-C. 
A. General Procedure A: Terminal Alkyne Bromination 
Solid AgNO3 (0.1 equiv) was added to a solution of N-bromosuccinimide (NBS, 
1.05–1.1 equiv) and the terminal alkyne substrate (1.0 equiv) and in acetone (0.1 M) at rt. 
The resulting slurry was stirred for one hour and then either i) partitioned between water 
and Et2O, and washed with brine, dried (Na2SO4) or ii) filtered (Celite® using acetone 
eluent) and then concentrated. The crude material was used either directly or after being 
purified by flash chromatography. 
B. General Procedure B: Alkyne Cross-Coupling using Cadiot–Chodkiewicz in 
piperidine 
A solution of a terminal alkyne (1.0 equiv) and a 1-bromoalkyne (1.2–1.5 equiv) in 
piperidine (0.3-0.8 M) was deoxygenated (three freeze-pump-thaw cycles). The solution 
was cooled to 0 °C and CuCl was added. After 1 h saturated aqueous NH4Cl was added 
and the resulting mixture was extracted with EtOAc or Et2O. The combined extracts were 
washed (brine), dried (Na2SO4), and concentrated. The crude material was then purified 
using flash chromatography. 
C. General Procedure C: Alkyne Cross-Coupling using Cadiot–Chodkiewicz in 
Et2O/n-BuNH2/water. 
To a solution of CuCl (0.05 equiv) in 30:70 (v:v) n-BuNH2:H2O (0.01 M) in a capped 
reaction vessel was added an excess of NH2OH•HCl (typically a few crystals on a 
reaction scale ≤1 mmol). The color of the solution turned from deep blue to colorless 
within seconds, indicating full consumption of Cu(II). The resulting solution was then 
cooled at 0 °C. A solution of the terminal alkyne (1.0 equiv) and the 1-bromoalkyne (1.2–
1.5 equiv) in Et2O (0.25 M) was added dropwise. The reaction mixture was stirred for 1 
h, during which time a few crystals of NH2OH•HCl were periodically added whenever 
the solution became blue. The reaction mixture was diluted with saturated aqueous 
NH4Cl and extracted with EtOAc or Et2O. The combined organic extracts were washed 
with brine, dried (Na2SO4), and concentrated. The crude material was typically purified 
by flash chromatography. 
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(±)–(5R,7R)-8-((tert-Butyldimethylsilyl)oxy)-5,7-dimethyloctanenitrile (3015): 
 
To a solution of iodide (±)-3005 (406 mg, 1.14 mmol, 1 equiv), acrylonitrile (301 mg, 
5.69 mmol, 5 equiv), AIBN (5 mg, 28.5 µmol, 2.5% equiv) in benzene (6 mL) heated at 
75 oC was added a benzene (3 mL) solution of nBu3SnH (487.2 mg, 1.68 mmol, 1.5 
equiv) and AIBN (5 mg, 28.5 µmol, 2.5% equiv) via syringe pump over 30 min. The 
reaction mixture was maintained at 75 oC for an additional 20 min. The reaction mixture 
was allowed to cool to room temperature and concentrated in vacuo. The residue was 
subjected directly to flash chromatography (silica gel, Hexane/EtOAc, 10:1) to give, in 
elution order, (±)-3015 (254 mg, 78%) and (±)-3016.  
Characterization data for (±)-3015:  
1H NMR (500 MHz, CDCl3): δ = 3.42 (dd, J = 9.7, 5.5 Hz, 1H, CHaHbOSi) 3.51 (dd, J = 
9.7, 6.3 Hz, 1H, CHaHbOSi), 2.32 (app t, J = 7.2 Hz, 2H, CH2CN), 1.74-1.54 (m, 3H, 
CH3CHCH2OSi and CH2CH2CN), 1.47-1.42 (m, 1H, CH3CH(CH2)CH2CH2CH2), 
1.38-1.32 (m, 2H), 1.26-1.16 (m, 2H), 0.91 (d, J = 7 Hz, 3H, CH3CH), 0.90 (s, 9H, 
(CH3)3C), 0.88 (d, J = 5.6 Hz, 3H, CH3CH), and 0.03 (s, 6H, (CH3)2Si).  
13C NMR (500 MHz, CDCl3): δ = 68.1, 40.7, 36.7, 33.1, 29.6, 26.0, 22.9, 20.2, 17.6, 
17.5, and -5.4.  
IR (neat): 2955, 2927, 2871, 2855, 2244, 1471, 1463, 1255, 1251, 1094, and 837.  
HR ESI-MS calcd for C16H33NOSi [M + Na]+ 309.2226, found 309.2275. 
(±)–(5R,7R)-8-((tert-Butyldimethylsilyl)oxy)-5,7-dimethyloctanal (3020): 
 
To a solution containing nitrile (±)-3015 (27 mg, 0.096 mmol, 1 equiv) in toluene (1 
mL) at -78 oC was added Dibal-H (0.1 mL, 1.5 M in toluene, 0.15 mmol, 1.5 equiv) 
ITBSO
(±)-3005
CN TBSO CN TBSO CN
NC
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 nBu3SnH (1.5 equiv)
AIBN
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TBSO CHO
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dropwise. After addition, the reaction mixture was stirred at the same temperature for 3 h. 
A 0.5 mL portion of a solution containing acetic acid (2.5 g, 41.7 mmol, 2.4 mL), sodium 
acetate (2.4 g, 29.1 mmol), and THF (9.5 mL) in water (40 mL) was added dropwise at -
78 oC. The flask was warmed to room temperature and kept for 20 min, at which time 
Celite was added and stirring was continued for an additional 5 min. The slurry was 
filtered through a Celite bed. The filtrate was washed with brine, dried (Na2SO4), and 
concentrated in vacuo. The residue was subjected to flash chromatography (silica gel, 
Hexane/EtOAc, 19:1) to give (±)-3020 (22 mg, 82%) as a colorless oil.  
1H NMR (500 MHz, CDCl3): δ = 9.77 (t, J = 2 Hz, 1H, CHO), 3.44 (dd, J = 10 Hz, 5.5 
Hz, 1H, CHaHOSi), 3.32 (dd, J = 10 Hz, 6.5 Hz, 1H, CHHbOSi), 2.41 (dddd, J = 17.8 
Hz, 7.7 Hz, 6.9 Hz, 1.9 Hz, 1H, CHHCHO, overlapping with CHHCHO), 2.41 (dddd, 
J = 18 Hz, 7.9 Hz, 6.9 Hz, 1.8 Hz, 1H, CHHCHO, overlapping with CHHCHO), 
1.69-1.64 (m, 2H), 1.62-1.52 (m, 3H), 1.35-1.26 (m, 3H), 1.08-1.03 (m, 1H), 0.90 (s, 
9H, (CH3)3C), 0.89 (d, J = 7Hz, 3H, CHa3CH), 0.87 (d, J = 6.5Hz, 3H, CHb3CH), 
0.03 (s, 6H, (CH3)2Si).  
13C NMR (500 MHz, CDCl3): δ = 202.8, 68.2, 44.2, 40.9, 36.2, 33.1, 30.0, 29.1, 26.0, 
20.2, 19.4, 17.6, and -5.3.  
IR (neat): 2927, 2857, 2711, 1735, 1462, 1256, 1251, 1097, and 837.  
HR ESI-MS calcd for C16H34O2Si [M + Na]+ 306.2220, found 306.2183. 
(E)-1-Methyl-4-((2-methylbut-2-en-1-yl)sulfonyl)benzene (3022): 
 
To a solution of tiglic alcohol (3021, 0.5 g, 5.8 mmol) in dichloromethane (30 mL) 
cooled at 0 °C was added PPh3 (1.52 g, 5.8 mmol), imidazole (0.69 g, 10.2 mmol), and I2 
(1.47 g, 5.8 mmol) in sequence. The resulting solution was stirred at this temperature for 
an additional 2 h, at which time TolSO2Na (2.68 g, 15 mmol) was added. The reaction 
was warmed up to rt overnight with stirring in the absence of light. The resulting mixture 
was partitioned between dichloromethane and water. The aqueous layer was washed with 
OH SO2Tol
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additional portions of dichloromethane. The combined organic phase was washed with 
brine, dried (Na2SO4), and concentrated in vacuo. The residue was subjected to MPLC 
(silica gel, Hexane/EtOAc, 3:1) to give (E)-3022 (0.6 g, 2.7 mmol, 45%) as a colorless 
solid.  
1H NMR (500 MHz, CDCl3): δ = 7.70 (d, J = 8.2 Hz, 2H, ArHoSO2), 7.30 (d, J = 8.1 Hz, 
2H, ArHmSO2), 5.18 (br q, J = 6.8 Hz, 1H, C=CH), 3.68 (s, 2H, ArSO2CH2), 2.43 (s, 
3H, ArCH3), 1.72 [s, 3H, CH3CH=C(CH3)-], and 1.53 (d, J = 6.8 Hz, 3H, 
CH3CH=C). 
(±)–tert-Butyldimethyl(((2R,4R)-2,4,10-trimethyldodeca-8,10-dien-1-yl)oxy)silane 
(3023)  
 
To a solution of E-3022 (185 mg, 0.83 mmol) in THF (6 mL) cooled at -78 °C was 
added nBuLi (2.5 M, 0.33 mL, 0.83 mmol). The resulting solution was kept at this 
temperature for 0.5 h, at which time (±)-3020 (182 mg, 0.64 mmol) in THF (7 mL) was 
added. The reaction was allowed to proceed for 1 h, when excess Ac2O was added. The 
mixture was warmed up to room temperature overnight. The reaction solution was 
partitioned between EtOAc and water. The aqueous layer was washed with additional 
portions of dichloromethane. The combined organic phase was washed with brine, dried 
(Na2SO4), and concentrated in vacuo. The residue was subjected to flash chromatography 
(silica gel, Hexane/EtOAc, 8:1) to give intermediate acetate as a mixture of 
diastereoisomers and epimers (280 mg). 
To a solution of the acetate obtained from the previous step in a mixture solvent of 
THF (18 mL) and MeOH (6 mL) was cooled at -24 °C was added Na-Hg (280 mg, 0.5 
mmol). The reaction was stirred at this temperature for 14 h. The resulting organic layer 
was concentrated and subjected to flash chromatography (silica gel, Hexane/EtOAc, 
TBSO CHO
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20:1) to yield 3023 as a mixture of diastereoisomers and epimers (120 mg, 65% overall). 
Characterization data of the major epimer: 
1H NMR (500 MHz, CDCl3): δ 6.05 (d, J = 16.0 Hz, 1H, CH=CHCH2), 5.55 (dt, J = 16.0 
and 7.0 Hz, 1H, CH=CHCH2), 5.44 (q, J = 7.0 Hz, 1H, CH3CH=), 3.45 (dd, J = 5.3, 
9.7 Hz, 1H, CHaHbOH), 3.31 (dd, J = 6.8, 9.8 Hz, 1H, CHaHbOH), 2.06 (m, 1H, 
CH=CHCHaHb-), 1.72 (br s, 3H, CH3C=CH), 1.71 (d, J = 7.5 Hz, 3H, CH3CH=), 1.69 
(m, 1H, HOCH2CH-), 1.5-1.2 (m, 5H), 1.06 (m, 1H), 0.94 (m, 1H), 0.90 [s, 9H, 
SiC(CH3)3], 0.87 [d, J = 7.5 Hz, 3H, HOCH2CH(CH3)-], and 0.87 [d, J = 7.5 Hz, 3H, 
HOCH2CH(CH3)CH2CH(CH3)-], and 0.04 [s, 6H, Si(CH3)2]. 
(±)-(2R,4R,8E,10E)-2,4,10-Trimethyldodeca-8,10-dienal (3024) 
 
(±)-(2R,4R,8E,10E)-2,4,10-Trimethyldodeca-8,10-dien-1-ol (S1)   
 
A solution of 3023 (ca. 120 mg, 0.4 mmol) was dissolved in THF (2 mL) and cooled 
to 0 oC. TBAF (1.0 M in THF, 0.6 mL) was added dropwise over 10 min. The resulting 
solution was stirred overnight. The reaction mixture was quenched by addition of 
saturated NH4Cl (30 mL). The aqueous layer was extracted with EtOAc (50 mL x 2). The 
combined organic layers were washed with brine, dried over Na2SO4, and concentrated. 
Flash chromatography (silica gel, hexanes:EtOAc = 8:1) gave purified S1 (90 mg, 0.4 
mmol, quantitative) as a colorless oil.  
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1H NMR (CDCl3, 500 MHz): δ 6.04 (d, J = 16.0 Hz, 1H, CH=CHCH2), 5.53 (dt, J = 16.5 
and 7.0 Hz, 1H, CH=CHCH2), 5.43 (q, J = 7.0 Hz, 1H, CH3CH=), 3.50 (dd, J = 5.0 
and 10.0 Hz, 1H, CHaHbOH), 3.36 (dd, J = 7.5 and 10.0 Hz, 1H, CHaHbOH), 2.08 
(ddt, J = 14.0, 7.0 and 7.0 Hz, 1H, CH=CHCHaHb-), 2.03 (ddt, J = 14.0, 7.0, and 7.0 
Hz, 1H, CH=CHCHaHb-), 1.71 (br s, 3H, CH3C=CH), 1.69 (d, J = 7.5 Hz, 3H, 
CH3CH=), 1.69 (m, 1H, HOCH2CH-), 1.46-1.55 [m, 1H, 
HOCH2CH(CH3)CH2CH(CH3)-], 1.38-1.46 (m, 1H), 1.27-1.38 (m, 3H), 1.06 (m, 
1H), 0.94 (m, 1H), 0.91 [d, J = 7.5 Hz, 3H, HOCH2CH(CH3)-], and 0.88 [d, J = 7.5 
Hz, 3H, HOCH2CH(CH3)CH2CH(CH3)-]. 
13C NMR (CDCl3, 125 MHz): 134.6, 134.4, 127.2, 124.4, 68.3, 41.0, 36.2, 33.2, 33.1, 
29.9, 27.0, 20.3, 17.3, 13.7, and 12.1 ppm. 
IR (neat): 3338, 2924, 2871, 2858, 1652, 1628, 1459, 1377, 1036, and 962 cm-1. 
GC-LRMS: tR = 9.07 min. m/z: 224 (M+), 209 (M+-Me), 193 (M+-CH2OH), 151 (M+-
C4H8OH), 123, 109, 99, 95, 93, 81, 67, and 55 (C4H7+). 
(±)-(2R,4R,8E,10E)-2,4,10-Trimethyldodeca-8,10-dienal (3024) 
 
To a stirred solution of oxalyl chloride (2.02 mL, 23.2 mmol) in CH2Cl2 (55 mL) 
cooled at -78 °C was added dropwise a solution of DMSO (3.08 mL, 46.4 mmol) in 
CH2Cl2 (8 mL). The resulting mixture was stirred at this temperature for 3 min, when a 
solution of diene alcohol S1 (2.6 g, 12 mmol) in CH2Cl2 (35 mL) was added. The 
resulting solution was stirred at this temperature for an additional 20 min, and 
triethylamine (9.7 mL, 69.6 mmol) was added. The resulting mixture was allowed to 
warm to 0 °C over 1 h with stirring. The mixture was quenched by addition of water (40 
mL). The aqueous layer was extracted with CH2Cl2 (50 mL x 2). The combined organic 
layers were washed with brine, dried over Na2SO4, and concentrated. The resulting crude 
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aldehyde was subjected to flash chromatography (silica gel, hexanes:EtOAc = 15:1) to 
give purified aldehyde 3024 (2.2 g, 85%) as a colorless oil.  
1H NMR (CDCl3, 500 MHz): δ 9.58 (d, J = 2.5 Hz, 1H, -CHO), 6.05 (d, J = 15.5 Hz, 1H, 
CH3CH=C(CH3)CH=), 5.53 (dt, J = 15.0 and 7.0 Hz, 1H, CH3CH=C(CH3)CH=CH-), 
5.43 (q, J = 6.5 Hz, 1H, CH3CH=), 2.43 (dqd, J = 14.0, 7.0 and 2.6 Hz, 1H, -
CHCHO), 2.07 (ddt, J = 14.0, 6.5, and 6.5 Hz, 1H, -CH=CH-CHaHb-), 2.05 (ddt, J = 
14.0, 6.5, and 6.5 Hz, 1H, -CH=CH-CHaHb-), 1.73 (m, 1H, CHOCH(CH3)CHaHb-), 
1.72 (br s, 3H, CH3CH=C(CH3)-), 1.70 (d, J = 7.5 Hz, 3H, CH3CH=), 1.50 [m, 1H, 
CHOCH(CH3)CH2CH(CH3)-], 1.28-1.49 [m, 4H, 
CHOCH(CH3)CH2CH(CH3)CH2CH2-], 1.10-1.16 [m, 1H, CHOCH(CH3)CHaHb-], 
1.08 [d, J = 7.0 Hz, 3H, CHOCH(CH3)-], and 0.90 [d, J = 7.5 Hz, 3H, 
CHOCH(CH3)CH2CH(CH3)-]. 
13C NMR (CDCl3, 125 MHz): δ 205.5, 134.9, 134.4, 127.0, 124.5, 44.2, 38.2, 36.3, 33.0, 
30.3, 26.9, 19.8, 14.2, 13.7, and 12.1 ppm. 
IR (neat): 2961, 2928, 2837, 2857, 2706, 1727, 1458, 1378, 1239, and 963 cm-1. 
HRMS (ESI-TOF): Calcd for (C15H26NaO)+: 245.1876. Found: 245.1876. 
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(±)-(2E,4R,6R,10E,12E)-2,4,6,12-Tetramethyltetradeca-2,10,12-trienal (3025) 
 
(±)-(2E,4R,6R,10E,12E)-Methyl 2,4,6,12-Tetramethyltetradeca-2,10,12-trienoate 
(S2) 
 
To a solution of aldehyde 3024 (2.2 g, 9.9 mmol) in CH2Cl2 (82.5 mL) was added 
carbomethoxyethylidene triphenylphosphorane (3004, 13.7 g, 39.6 mmol). The resulting 
solution was heated at 55 °C for 48 h in two capped culture tubes, at which time GC 
analysis showed full consumption of starting material. The resulting solution was 
concentrated in vacuo. The resulting yellow solid was triturated with hexanes and 
filtered. The solid cake was washed with additional hexanes (100 mL x 2). The combined 
filtrates were then concentrated and purified by flash chromatography (silica gel, 
hexanes:EtOAc = 15:1) to give triene ester S2 (2.9 g, 99%) as a colorless oil.  
1H NMR (CDCl3, 500 MHz): δ 6.50 (dq, J = 10.0 and 1.5 Hz, 1H, MeO2CC(CH3)=CH-), 
6.04 (d, J = 15.5 Hz, 1H, CH3CH=CH(CH3)CH=), 5.53 (dt, J = 15.0 and 7.0 Hz, 1H, 
CH3CH=CH(CH3)CH=CH-), 5.43 (q, J = 6.5 Hz, 1H, CH3CH=), 3.73 (s, 3H, -
COOCH3), 2.60 (m, 1H, MeO2CC(CH3)=CHCH(CH3)CH2-), 2.04 (dt, J = 7.0 and 7.0 
Hz, 2H, -CH=CH-CH2-), 1.84 (d, J = 1.5 Hz, 3H, MeO2CC(CH3)=CHCH(CH3)CH2-), 
1.72 (br s, 3H, CH3CH=C(CH3)CH=), 1.70 (d, J = 7.0 Hz, 3H, CH3CH=), 1.22-1.45 
(m, 5H), 1.05-1.18 (m, 2H), 0.97 (d, J = 6.5 Hz, 3H, 
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MeO2CC(CH3)=CHCH(CH3)CH2-), and 0.82 [d, J = 6.0 Hz, 3H, 
MeO2CC(CH3)=CHCH(CH3)CH2CH(CH3)-]. 
13C NMR (CDCl3, 125 MHz): δ 168.9, 148.5, 134.7, 134.4, 127.2, 125.9, 124.4, 51.7, 
44.5, 37.2, 33.1, 30.9, 30.7, 27.0, 20.6, 19.5, 13.7, 12.5, and 12.1 ppm. 
IR (neat): 2954, 2926, 2869, 1717, 1649, 1454, 1435, 1377, 1312, 1274, 1225, 1191, 
1155, 1098, 963, and 760 cm-1. 
HRMS (ESI-TOF): Calcd for (C19H32NaO2)+ 315.2295. Found: 315.2292. 
(±)-(2E,4R,6R,10E,12E)-2,4,6,12-Tetramethyltetradeca-2,10,12-trien-1-ol (S3) 
 
To a solution of triene ester S2 (2.9 g, 9.9 mmol) in toluene (100 mL) cooled at -78 
oC was added dropwise a Dibal-H solution (20 mL, 1.5 M in toluene, 3.1 equiv). The 
reaction mixture was stirred at this temperature for 2 h, at which time TLC showed full 
consumption of starting material. The mixture was quenched at -78 °C by slow addition 
of a solution containing AcOH (2.5 g, 41.7 mmol), NaOAc (2.4 g, 29.1 mmol), THF (9.5 
mL), and water (40 mL). The mixture was allowed to warm to room temperature, Celite 
was added, and stirring was continued for 30 min. The mixture was filtered through a 
Celite bed. The aqueous layer was extracted with EtOAc (50 mL x 3). The combined 
organic layers were washed with brine, dried over Na2SO4, and concentrated. The 
resulting crude mixture was purified with flash chromatography (silica gel, 
hexanes:EtOAc = 10:1) to give triene alcohol S3 (2.46 g, 9.4 mmol, 94%) as a colorless 
oil.  
1H NMR (CDCl3, 500 MHz): δ 6.04 [d, J = 15.5 Hz, 1H, CH3CH=CH(CH3)CH=], 5.53 
(dt, J = 15.0 and 7.0 Hz, 1H, =CHCH2), 5.44 (q, J = 6.5 Hz, 1H, CH3CH=), 5.10 [dtq, 
J = 10.0, 1.5, and 1.5 Hz, 1H, -CH=C(CH3)CH2OH], 3.98 (br s, 2H, -CH2OH), 2.48 
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[m, 1H, -CH(CH3)CH=], 2.04 (dt, J = 7.5 Hz, 7.5 Hz, 2H, =CH-CH2-), 1.72 [dt, J = 
1.5 and 1.5 Hz, 3H, -CH=C(CH3)CH2OH], 1.70 (d, J = 7.0 Hz, 3H, CH3CH=), 1.67 
[d, J = 1.5 Hz, 3H, CH3CH=C(CH3)=], 1.30-1.42 (m, 3H), 1.21-1.30 (m, 2H), 1.02-
1.15 (m, 2H), 0.91 [d, J = 6.5 Hz, 3H, =CHCH(CH3)-], and 0.82 [d, J = 6.5 Hz, 3H, 
=CHCH(CH3)CH2CH(CH3)-]. 
13C NMR (CDCl3, 125 MHz): δ 134.6, 134.4, 133.1, 133.0, 127.3, 124.4, 69.1, 45.1, 
37.2, 33.2, 30.4, 29.6, 27.1, 21.6, 19.6, 13.8, 13.7, and 12.1 ppm.  
IR (neat): 3200-3600, 2953, 2924, 2866, 1651, 1628, 1455, 1377, 1069, 1009, 962, 848, 
and 798 cm-1. 
HRMS (ESI-TOF): Calcd for (C18H32NaO)+ 287.2346. Found: 287.2345. 
(±)-(2E,4R,6R,10E,12E)-2,4,6,12-Tetramethyltetradeca-2,10,12-trienal (3025) 
 
To a solution of triene alcohol S3 (2.46 g, 9.4 mmol) in CH2Cl2 (250 mL) was added 
activated MnO2 (16.3 g, 188 mmol, <5 mm) in three batches at 1 hour intervals at room 
temperature. The resulting mixture was stirred at room temperature overnight. The 
mixture was filtered through a pad of silica gel and Celite, and the filter pad was 
thoroughly washed with additional CH2Cl2 (100 mL x 2). The combined filtrate was 
concentrated in vacuo. The crude aldehyde was purified by flash chromatography (silica 
gel, hexanes:EtOAc = 20:1) to give aldehyde 3025 (2.34 g, 9.0 mmol, 96%) as a clear 
colorless oil.   
1H NMR (CDCl3, 500 MHz): δ 9.38 (s, 1H, -CHO), 6.21 [dq, J = 10.0 and 1.5 Hz, 1H, 
OHCC(CH3)=CH-], 6.03 [d, J = 15.5 Hz, 1H, CH=CH(CH3)CH=], 5.51 [dt, J = 15.0, 
and 7.0 Hz, 1H, CH3CH=CH(CH3)CH=CH-], 5.43 (q, J = 6.5 Hz, 1H, CH3CH=), 
2.80 [m, 1H, OHCC(CH3)=CHCH(CH3)CH2-], 2.04 (dt, J = 7.5 and 7.5 Hz, 2H, -
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CH=CH-CH2-), 1.75 [d, J = 1.0 Hz, 3H, OHCC(CH3)=CH-], 1.71 [dd, J = 1.5 and 1.5 
Hz, 3H, CH3CH=C(CH3)CH=], 1.69 (d, J = 7.5 Hz, 3H, CH3CH=), 1.33-1.44 (m, 
2H), 1.17-1.32 (m, 4H), 1.10-1.17 (m, 1H), 1.03 [d, J = 6.5 Hz, 3H, 
OHCC(CH3)=CHCH(CH3)CH2-], 0.83 [d, J = 6.0 Hz, 3H, CH2CH(CH3)CH2]. 
13C NMR (CDCl3, 125 MHz): δ 195.6, 160.8, 137.9, 134.8, 134.4, 127.0, 124.5, 44.4, 
37.1, 33.1, 31.2, 30.8, 27.0, 20.4, 19.5, 13.7, 12.1, and 9.4.  
IR (neat): 2960, 2926, 2870, 2857, 2706, 1690, 1644, 1456, 1378, 1312, 1013, and 963 
cm-1. 
HRMS (ESI-TOF): Calcd for (C18H30NaO)+ 285.2189. Found: 285.2194. 
(±)-4-Methoxy-5-methylene-3-((2E,4R,6R,10E,12E)-2,4,6,12-tetramethyltetradeca-
2,10,12-trienoyl)furan-2(5H)-one (3026) 
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(±)-3-((2E,4R,6R,10E,12E)-1-Hydroxy-2,4,6,12-tetramethyltetradeca-2,10,12-trien-1-
yl)-4-methoxy-5-methylenefuran-2(5H)-one (S4) 
 
Diisopropylamine (2.78 mL, 19.8 mmol) was dissolved in toluene (120 mL) in a 500 
mL round bottom flask cooled at -78 °C. To this solution was added nBuLi (7.8 mL, 2.5 
M in hexanes, 19.5 mmol) dropwise over 10 min. The resulting mixture was stirred at this 
temperature for 1 h. A solution of the methyl tetronate 3003 (2.26 g, 18 mmol) in a 
mixture of toluene (21 mL) and THF (18 mL) was added dropwise to the LDA solution 
over 10 min. The reaction mixture was stirred for an additional 5 min, during which the 
color of the reaction turned to dark brown. Aldehyde 3025 (2.34 g, 9.0 mmol) was 
dissolved in toluene (35 mL) and added dropwise to the flask over 15 min, and the 
resulting solution was stirred for 1.5 h. When TLC showed full conversion of starting 
material, the saturated NH4Cl (50 mL) was added, and the resulting mixture was warmed 
to room temperature. Water (50 mL) was added to dissolve all inorganic salts. The 
aqueous layer was extracted with EtOAc (50 mL x 3). The combined organic layers were 
washed with brine, dried over Na2SO4, and concentrated. The crude mixture was 
subjected to flash chromatography (silica gel, hexanes:EtOAc = 12:1 then 4:1) to give, in 
order of elution, an epimeric mixture of the alcohols S4 (3.15 g, 8.12 mmol, 91%, ca. 1:1 
dr as determined by 1H NMR) as a pale yellow oil and unreacted 3003 (1.05 g) as white 
solid.  
1H NMR (CDCl3, 500 MHz, for the mixture of diastereomers): δ 6.03+ (d, J = 15.5 Hz, 
0.5H, CH3CH=CH(CH3)CH=), 6.03– (d, J = 15.5 Hz, 0.5H, CH3CH=CH(CH3)CH=), 
5.52 (dt, J = 15.5 and 7.0 Hz, 0.5H, CH3CH=CH(CH3)CH=CH-), 5.51 (dt, J = 15.5 
and 7.0 Hz, 0.5H, CH3CH=CH(CH3)CH=CH-), 5.43 (q, J = 6.5 Hz, 1H, CH3CH=), 
5.20 (d, J = 8.5 Hz, 2H, -OH), 5.13 (br d, J = 9.5 Hz, 2H, -CH=C(CH3)CHOH-), 5.06 
(m, 2H, CH2=), 4.11 (s, 1.5H, MeO-), 4.10 (s, 1.5H, MeO-), 3.63 (d, J = 8.5 Hz, 
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0.5H, HOCH=), 3.61 (d, J = 8.5 Hz, 0.5H, HOCH=), 2.50 (m, 1H, -
CH(CH3)CH=C(CH3)CHOH-), 2.02 (m, 2H, CH3CH=C(CH3)CH=CH-CH2-), 1.70 
(m, 3H, -CH=C(CH3)CH2OH), 1.69 (m, 6H, CH3CH=CCH3), 1.17-1.42 (m, 5H), 
1.00-1.15 (m, 2H), 0.90 (d, J = 6.5 Hz, 1.5H, -HOCHC(CH3)=CHCH(CH3)-), 0.88 (d, 
J = 7.0 Hz, 1.5H, -HOCHC(CH3)=CHCH(CH3)-), 0.81 (d, J = 6.5 Hz, 1.5H, -
HOCHC(CH3)=CHCH(CH3)CH2CH(CH3)-), and 0.80 (d, J = 6.5 Hz, 1.5H, -
HOCHC(CH3)=CHCH(CH3)CH2CH(CH3)-). 
13C NMR (CDCl3, 500 MHz, for the mixture of diastereomers): δ 169.95, 169.90, 
162.27, 162.20, 149.41, 149.36, 134.69, 134.66, 134.45, 134.42, 134.08, 134.03, 
133.14+, 133.14–, 127.27, 127.21, 124.36, 124.32, 105.17, 105.05, 99.22, 99.21, 
69.91, 69.88, 60.71, 60.56, 45.00, 44.97, 37.17, 37.13, 33.12, 33.10, 30.54, 30.49, 
29.79, 29.77, 27.14, 27.12, 21.35, 21.28, 19.66, 19.63, 13.71, 13.68+, 13.68–, 13.58, 
12.09+, and 12.09– ppm.  
IR (neat): 3150-3650, 2955, 2925, 2866, 1748, 1667, 1621, 1615, 1462, 1455, 1354, 
1277, 1142, 1084, 1031, 978, 866, and 781 cm-1. 
HRMS (ESI-TOF): Calcd for (C24H36NaO4)+ 411.2506. Found: 411.2511.  
(±)-4-Methoxy-5-methylene-3-((2E,4R,6R,10E,12E)-2,4,6,12-tetramethyltetradeca-
2,10,12-trienoyl)furan-2(5H)-one (3026) 
 
To a solution of alcohol S4 (3.15 g, 8.12 mmol) dissolved in CH2Cl2 (400 mL) was 
added activated MnO2 (13.9 g, 160 mmol, <5 mm) in three batches at 1 hour intervals at 
room temperature. The resulting mixture was stirred at room temperature overnight. The 
mixture was then filtered through a pad of silica gel and Celite, and the pad was 
thoroughly washed with additional CH2Cl2 (100 mL x 3). The combined filtrates were 
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concentrated in vacuo. The crude mixture was purified by flash chromatography (silica 
gel, hexanes:EtOAc = 12:1) to give, in order of elution, ketone 3026 (1.88 g, 4.88 mmol, 
60%; 66% borsm) as a clear colorless oil and unreacted S4 (0.29 g, 0.7 mmol).  
1H NMR (CDCl3, 500 MHz): δ 6.31 [dq, J = 10.5 and 0.5 Hz, 1H, -COC(CH3)CH-], 6.04 
[d, J = 15.5 Hz, 1H, =C(CH3)CH=CH-], 5.52 [dt, J = 14.5 and 6.5 Hz, 1H, 
=C(CH3)CH=CHCH2], 5.44 (q, J = 6.5 Hz, 1H, CH3CH=), 5.17 (d, J = 2.5 Hz, 1H, 
CHaHb=C), 5.15 (d, J = 2.5 Hz, 1H, CHaHb=C), 3.91 (s, 3H, CH3O-), 2.77 [m, 1H, 
=CHCH(CH3)-], 2.05 (dt, J = 7.0 and 7.0 Hz, 2H, =CH-CH2), 1.90 [d, J = 0.5 Hz, 3H, 
-COC(CH3)=], 1.72 [br s, 3H, CH3CH=C(CH3)-], 1.70 (d, J = ca. 7 Hz, 3H, 
CH3CH=), 1.24-1.41 (m, 5H), 1.08-1.24 (m, 2H), 1.02 [d, J = 7.0 Hz, 3H, 
=CHCH(CH3)-], and 0.85 [d, J = 6.0 Hz, 3H, -CH2CH(CH3)CH2]. 
13C NMR (CDCl3, 125 MHz): δ 191.4, 166.0, 165.3, 157.1, 148.9, 136.6, 134.8, 134.4, 
127.1, 124.4, 104.8, 94.1, 60.9, 44.2, 37.0, 33.0, 31.8, 30.7, 27.0, 20.1, 19.7, 13.7, 
12.1, and 11.3 ppm. 
IR (neat): 3029, 2959, 2928, 2870, 1939, 1780, 1660, 1461, 1388, 1289, 1257, 1206, 
1150, 992, and 876 cm-1. 
HRMS (ESI-TOF): Calcd for (C24H34NaO4)+ 409.2350. Found: 409.2349. 
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(±)-(E)-1-Cyclopropyl-2-methylbut-2-en-1-ol (3031)  
 
A solution of cyclopropyl bromide (3030, 18 g, 150 mmol) in THF (60 mL) was 
added dropwise to magnesium (3.6 g, 150 mmol) in THF (15 mL) under a nitrogen 
atmosphere at a rate to maintain a gentle reflux. The resulting mixture was stirred at room 
temperature for an additional 30 min and then cooled in an ice bath. Tiglic aldehyde (11.2 
g, 133 mmol) in THF (25 mL) was then added over 15 min. The mixture was stirred at 
this temperature for 1 hour before saturated aqueous NH4Cl was added. This mixture was 
extracted with diethyl ether (50 mL x 3). The combined organic layers were washed with 
brine, dried over Na2SO4, and concentrated to give 18 g of crude alcohol. A portion of 
this crude alcohol was purified by flash chromatography (silica gel, hexanes:ether = 5:1) 
to give compound 3031 as a colorless oil.  
1H NMR (CDCl3, 500 MHz): δ 5.47 (qq, J = 6.7 and 1.2 Hz, 1H, CH3CH=), 3.21 (d, J = 
8.6 Hz, 1H, CHOH), 1.71 (dq, J = 1.2 and 1.2 Hz, 3H, CH3C=), 1.62 (qd, J = 6.7 and 
1.2 Hz, 3H, CH3CH=), 1.04 (ddddd, J = 8.6, 8.3, 8.3, 4.8 and 4.8 Hz, 1H, CHCHOH), 
0.56 (dddd, J = 4.8, 4.8, 8.8, and 8.8 Hz, 1H), 0.50 (dddd, J = 4.8, 4.8, 8.8, and 8.8 
Hz, 1H), 0.35 (dddd, J = 4.8, 4.8, 4.8, and 8.8 Hz, 1H), and 0.19 (dddd, J = 4.8, 4.8, 
4.8, and 8.8 Hz, 1H). 
13C NMR (CDCl3, 125 MHz): δ 137.8, 120.6, 82.8, 16.4, 13.3, 11.9, 3.7, and 3.0 ppm.  
IR (neat): 3400, 3080, 3005, 2919, 2862, 1671, 1433, 1380, 1022, and 1004 cm-1. 
GC-LRMS: tR = 4.33 min; m/z: 126 (M+), 111 (M+ -Me), 98 (M+ -CH2=CH2), 91, 83, 69, 
and 55 (C4H7+). 
  
3029
O MgBr
OH
3030 3031
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(2E,4E)-7-Bromo-3-methylhepta-2,4-diene (3028)  
 
A neat sample of the crude alcohol 3031 was cooled to 0 °C in an ice bath. 
Concentrated aqueous hydrobromic acid (48%, 22 mL) was added dropwise with 
vigorous stirring over 5 min. The mixture was stirred for an additional 8 min, at which 
time TLC showed full conversion. The resulting mixture was diluted with water and 
extracted with diethyl ether (50 mL x 3). The combined organic layers were washed 
sequentially with saturated NaHCO3 (50 mL x 3) and brine (50 mL), dried over Na2SO4, 
and concentrated to give crude bromide 3028, which was vacuum distilled from CaH2 to 
give 3028 as a colorless liquid (18 g, 95 mmol, 71% overall). bp ca. 56 oC/2 mm Hg.  
1H NMR (CDCl3, 500 MHz): δ 6.15 (dq, J = 16.0 and 1.1 Hz, 1H, =CCH=CH), 5.52 (qq, 
J = 7.0 and 1.1 Hz, 1H, CH3CH=), 5.48 (dt, J = 16.0 and 7.0 Hz, 1H, CH=CH-CH2), 
3.40 (t, J = 7.0 Hz, 2H, CH2Br), 2.65 (dt, J = 7.0 and 7.0 Hz, 2H, CH2CH2Br), 1.74 
(dd, J = 1.0 and 1.0 Hz, 3H, CH3C), and 1.72 (br d, J = 7.5 Hz, 3H, CH3CH=).  
13C NMR (CDCl3, 125 MHz): δ 137.6, 134.0, 126.4, 122.8, 36.2, 32.8, 13.8, and 12.0 
ppm.  
IR (neat): 3032, 2962, 2918, 2858, 1650, 1445, 1379, 1260, 1206, 1034, 963, and 794 
cm-1. 
GC-LRMS: tR = 5.72 min. m/z: 190 (M+), 188 (M+), 109 (M+ -Br), 95 (M+ -CH2Br), 81 
(M+ -CH2CH2Br), 67, and 55 (C4H7+).  
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2
3
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(±)-(2R,4R,8E,10E)-2,4,10-Trimethyldodeca-8,10-dien-1-ol (S1)   
 
A solution of bromodiene 3028 (9.45 g, 50 mmol) in THF (27 mL) was added to 
crushed magnesium turnings (1.32 g, 55 mL) in THF (6 mL) under a nitrogen atmosphere 
at a rate to maintain a gentle reflux over 20 min. The Grignard reagent prepared was then 
transferred into a 100 mL round bottom flask cooled to 0 °C in an ice bath, to which a 
solution of Li2CuCl4 (5 mL, 0.1 M; made from a 2:1 mole ratio of anhydrous LiCl and 
CuCl2) in THF was then added. The mixture was stirred at this temperature for 10 min, 
by which time the color of the solution had turned purple. Alkyl iodide 3005161 (4.5 g, 
12.6 mmol) in THF (12 mL) was added. The resulting mixture was stirred at 0 °C for 2 h, 
at which time the solution had become grayish red. Aqueous saturated NH4Cl (30 mL) 
was added. The aqueous layer was extracted with diethyl ether (50 mL x 2). The 
combined organic layers were washed with brine, dried over Na2SO4, and concentrated to 
give crude diene silyl ether 3023 (along with hydrocarbon by-products). Without further 
purification, this crude sample of 3023 was dissolved in THF (75 mL) and cooled to 0 oC. 
TBAF (1.0 M in THF, 18 mL) was added dropwise over 10 min. The resulting solution 
was stirred overnight. The reaction mixture was quenched by addition of saturated NH4Cl 
(30 mL). The aqueous layer was extracted with EtOAc (50 mL x 2). The combined 
organic layers were washed with brine, dried over Na2SO4, and concentrated. Flash 
chromatography (silica gel, hexanes:EtOAc = 8:1) gave purified S1 (2.6 g, 12 mmol, 
92% overall) as a colorless oil.  
1H NMR (CDCl3, 500 MHz): δ 6.04 (d, J = 16.0 Hz, 1H, CH=CHCH2), 5.53 (dt, J = 16.5 
and 7.0 Hz, 1H, CH=CHCH2), 5.43 (q, J = 7.0 Hz, 1H, CH3CH=), 3.50 (dd, J = 5.0 
and 10.0 Hz, 1H, CHaHbOH), 3.36 (dd, J = 7.5 and 10.0 Hz, 1H, CHaHbOH), 2.08 
(ddt, J = 14.0, 7.0 and 7.0 Hz, 1H, CH=CHCHaHb-), 2.03 (ddt, J = 14.0, 7.0, and 7.0 
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Hz, 1H, CH=CHCHaHb-), 1.71 (br s, 3H, CH3C=CH), 1.69 (d, J = 7.5 Hz, 3H, 
CH3CH=), 1.69 (m, 1H, HOCH2CH-), 1.46-1.55 [m, 1H, 
HOCH2CH(CH3)CH2CH(CH3)-], 1.38-1.46 (m, 1H), 1.27-1.38 (m, 3H), 1.06 (m, 
1H), 0.94 (m, 1H), 0.91 [d, J = 7.5 Hz, 3H, HOCH2CH(CH3)-], and 0.88 [d, J = 7.5 
Hz, 3H, HOCH2CH(CH3)CH2CH(CH3)-]. 
13C NMR (CDCl3, 125 MHz): 134.6, 134.4, 127.2, 124.4, 68.3, 41.0, 36.2, 33.2, 33.1, 
29.9, 27.0, 20.3, 17.3, 13.7, and 12.1 ppm. 
IR (neat): 3338, 2924, 2871, 2858, 1652, 1628, 1459, 1377, 1036, and 962 cm-1. 
GC-LRMS: tR = 9.07 min. m/z: 224 (M+), 209 (M+-Me), 193 (M+-CH2OH), 151 (M+-
C4H8OH), 123, 109, 99, 95, 93, 81, 67, and 55 (C4H7+). 
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(±)-4-Methoxy-5-methylene-3-((2E,4R,6R,10E,12Z)-2,4,6,12-tetramethyltetradeca-
2,10,12-trienoyl)furan-2(5H)-one (3026-Z);  
(±)-(5E,7R,9R,12aS,15S,16aS)-8,9,10,11,12,12a,15,16-Octahydro-17-methoxy-
5,7,9,14,15-pentamethyl-16a,3-metheno-2H-1-benzoxacyclotetradecin-2,4(7H)-dione 
[(±)-O-Methyl Okilactomycin D (3022)];  
(±)-(5E,7R,9R,12aR,15R,16aS)-8,9,10,11,12,12a,15,16-Octahydro-17-methoxy-
5,7,9,14,15-pentamethyl-16a,3-metheno-2H-1-benzoxacyclotetradecin-2,4(7H)-dione 
[(±)-O-Methyl 12a,15-bisepi-Okilactomycin D (3033)]; 
(±)-(5E,7R,9R,12aR,15R,16aR)-8,9,10,11,12,12a,15,16-Octahydro-17-methoxy-
5,7,9,14,15-pentamethyl-16a,3-metheno-2H-1-benzoxacyclotetradecin-2,4(7H)-dione 
[(±)-O-Methyl 12a, 15,16a-trisepi-Okilactomycin D (3034)  
 
Ketone 3026 (1.75 g, 4.53 mmol), which contained ca. 8% of the C2-Z isomer (3026-
Z), and hydroquinone (50 mg, 0.453 mmol) were dissolved in toluene (450 mL), and the 
resulting solution was heated in an oil bath at 110 oC in a pressure vessel sealed with a 
threaded cap for 4 d, at which time 1H NMR analysis showed full consumption of 3026-
E. The solution was concentrated in vacuo, and the resulting mixture was subjected to 
flash chromatography (silica gel, hexanes:EtOAc = 12:1 then 5:1). The fractions 
containing mixtures were further purified using MPLC to yield, in order of elution, 
unreacted 3026-Z as pale yellow oil (110 mg), co-eluting 3033-3035 as foamy solid (123 
mg, 7% as a mixture), and 3032 (0.98 g, 61%) as a white solid. Recrystallization (EtOAc) 
gave a sample of 3032 suitable for single crystal x-ray analysis. Compound 3033 could 
be selectively crystallized from the mixture of 3033-3035 using a vial-in-a-vial vapor 
diffusion crystallization. The mixture was dissolved in EtOAc in an open inner vial and 
cyclohexane was placed in the outer vial, which was then capped. After standing 
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overnight at room temperature, 3033 was obtained as colorless crystals, suitable for 
single crystal x-ray analysis. 
Under Lewis acidic conditions, cycloadduct 3034 and 3035 were formed 
predominantly. A pure sample of 3034 was obtained using the following method: 
Ketone 3026 (60 mg, 0.16 mmol), which contained ca. 8% of the C2-Z isomer (3026-
Z), was dissolved in a solution of LiClO4 in Et2O (5M, 10 mL). The resulting solution 
was kept at room temperature under a nitrogen atmosphere for 24 h. The resulting 
mixture was partitioned between Et2O and water. The combined organic layers were 
washed with brine, dried over Na2SO4, and concentrated. The residue was subjected to 
MPLC to give a co-eluting mixture of 3033-3035 as foamy solid (21 mg, 0.054 mmol, 
39% as a mixture), followed by 3032 (ca. 3 mg). Compound 3034, the major component 
in the mixture produced in this experiment, could be selectively crystallized using a vial-
in-a-vial vapor diffusion crystallization method. The mixture of 3033-3035 was dissolved 
in EtOAc (ca. 0.5 mL) in an open inner vial and cyclohexane (ca. 2 mL) was placed in 
the outer vial, which was then capped. After standing 2 days at room temperature, 3034 
was obtained as colorless crystals, suitable for single crystal x-ray analysis. 
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Compound 3026-Z 
1H NMR (CDCl3, 500 MHz): δ 6.44 [d, J = 15.5 Hz, 1H, =C(CH3)CH=CH], 6.31 [dq, J 
= 10.0 Hz, 1.5 Hz, 1H, -COC(CH3)CH-], 5.65 [dt, J = 15.5 Hz, 7.5 Hz, 1H, 
=C(CH3)CH=CHCH2], 5.32 (q, J = 6.5 Hz, 1H, CH3CH=), 5.17 (d, J = 2.5 Hz, 1H, 
CHaHb=C), 5.15 (d, J = 2.5 Hz, 1H, CHaHb=C), 3.91 (s, 3H, CH3O-), 2.79 [m, 1H, 
=CHCH(CH3)-], 2.11 (dt, J = 7.0 and 7.0 Hz, 2H, =CH-CH2), 1.92 (d, J = 1.0 Hz, 3H, 
-COC(CH3)=), 1.78 [br s, 3H, CH3CH=C(CH3)-], 1.71 (app d, J = 6.0 Hz, 3H, 
CH3CH=), 1.24-1.45 (m, 5H), 1.08-1.24 (m, 2H), 1.03 [d, J = 6.5 Hz, 3H, 
=CHCH(CH3)-], and 0.86 [d, J = 6.5 Hz, 3H, -CH2CH(CH3)CH2]. 
13C NMR (CDCl3, 125 MHz, DEPT): 157.1 (CH), 130.3 (CH), 126.9 (CH), 122.6 (CH), 
94.1 (CH2), 60.9 (CH3), 44.2 (CH2), 37.0 (CH2), 33.5 (CH2), 31.8 (CH), 30.7 (CH), 
27.0 (CH2), 20.6 (CH3), 20.1 (CH3), 19.7 (CH3), 13.0 (CH3), and 11.2 (CH3) ppm. 
IR (neat): 2957, 2926, 2870, 1773, 1636, 1454, 1388, 1287, 1257, 990, 973, and 874 cm-
1. 
HRMS (ESI-TOF): Calcd for (C24H34NaO4)+ 409.2350. Found: 409.2354. 
Compound 3032 
1H NMR (CDCl3, 500 MHz): δ 6.44 [dq, J = 7.7 and 1.4 Hz, 1H, -COC(CH3)=CH], 5.45 
(ddq, J = 4.5, 1.6, and 1.6 Hz, 1H, CH3C=CH-), 3.82 (s, 3H, CH3O), 2.61 [ddqd, J = 
10.9, 7.2, 7.2, and 3.8 Hz, 1H, -COC(CH3)=CHCH], 2.43 [ddqddq, J = 10.5, 6.5, 6.5, 
1.5, 1.5, and 1.5 Hz, 1H, CH3CH(CH2-)C=], 2.11 [dddq, J = 10, 4.5, 3.2, and 1.6 Hz, 
1H, CH3C(CH-)=CHCH-], 1.87 [d, J = 1.3 Hz, 3H, O=CC(CH3)=], 1.88-1.82 [m, 2H, 
CH3C(CHCHaHb)=CH and CH3C(CH-)=CHCHCHaHb], 1.70 [ddd, J = 1.4, 1.4, and 
1.4 Hz, 3H, CH3C(CH-)=CH], 1.67-1.58 (m, 1H), 1.64 [dd, J = 13.5, and 10.5 Hz, 
1H, CH3C(CHCHaHb)=CH], 1.44 (ddddd, J = 14.5, 7.4, 7.4, 7.4, and 4.8 Hz, 1H, 
CH2CHaHbCH2),1.42-1.35 (m, 1H), 1.35-1.19 (m, 4H), 1.14 [dddd, J = 14.0, 10.0, 
6.5, and 6.5 Hz, 1H, CH3C(CH-)=CHCHCHaHb], 1.07 [d, J = 7.0 Hz, 3H, 
CH3CH(CH3)CH2C], 1.02 (d, J = 7.0 Hz, 3H, CH3CHCH=C), and 0.89 (d, J = 6.0 Hz, 
3H, CH2CH3CHCH2).  
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13C NMR (CDCl3, 75 MHz): 192.2, 179.8, 168.4, 157.2, 140.7, 136.4, 122.3, 103.2, 86.0, 
59.7, 46.2, 45.0, 35.2, 34.0, 32.0, 30.6, 28.6, 28.4, 23.1, 20.9, 19.8, 19.5, 18.7, and 
10.9 ppm. 
IR (neat): 2963, 2922, 2860, 1745, 1644, 1635, 1455, 1371, 1355, 1260, 1002, and 945 
cm-1. 
HRMS (ESI-TOF): Calcd for (C24H34NaO4)+ 409.2350. Found: 409.2358. 
mp: 215-216 °C. 
ORTEP rendering for 3032: 
 
 
 
Compound 3033  
1H NMR (CDCl3, 500 MHz): δ 6.65 (dq, J = 8.0 and 1.1 Hz, 1H, -COC(CH3)=CH), 5.24 
[br q, J = 1.7 Hz, 1H, HC(CH3)C=CH-], 3.79 (s, 3H, CH3O), 2.61 [ddqd, J = 12, 8, 7, 
and 2.5 Hz, 1H, -COC(CH3)=CHCH], 2.44 (ddddd, J = 8.6, 2.2, 2.2, 2.2, and 2.2 Hz, 
1H, CH2CHCH=C), 2.27 (dqdq, J = 7, 7, 1.5 and 1.5 Hz), 2.20 (dd, J = 13.9 and 7.1 
Hz, 1H, CH3CH(C=)CHaHb), 1.86 (d, J = 1.2 Hz, 3H, O=CC(CH3)=), 1.74 [dd, J = 
1.8 and 1.8 Hz, 3H, CH3C(CH-)=CH], 1.69 (d, J = 13.8 Hz, 1H, CH3CH(C=)CHaHb), 
1.63-1.70 (m, 1H), 1.50-1.38 (m, 4H), 1.26-1.34 (nfom, 1H), 1.20 (d, J = 7.2 Hz, 3H, 
CH3CHCH2CO), 1.12-1.19 (m, 3H), 1.05 [d, J = 6.9 Hz, 3H, 
CH3CHCH=C(CH3)C=O], and 0.88 [br d, J = 5.9 Hz, 3H, CH3CHCH2CH(CH3)C=]. 
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13C NMR (CDCl3, 75 MHz): 194.1, 178.8, 169.7, 158.9, 139.7, 137.1, 120.7, 106.0, 84.9, 
60.3, 43.6, 38.0, 37.1, 34.6, 32.3, 32.1, 29.9, 26.8, 23.1, 22.1, 21.6, 20.2, 19.5, and 
11.3 ppm. 
IR (neat): 2957, 2923, 2868, 1754, 1638, 1448, 1350, 1260, 1230, 1096, 998, and 958 
cm-1. 
HRMS: Calcd for (C24H34NaO4)+ 409.2350. Found: 409.2352. 
mp: 171-172 °C. 
ORTEP rendering for 3033: 
 
 
Compound 3034  
1H NMR (CDCl3, 500 MHz): δ 6.73 [dq, J = 6.7 and 1.4 Hz, 1H, -COC(CH3)=CH], 5.27 
(ddq, J = 1.5, 1.5, and 1.5 Hz, 1H, CH3C=CH-), 3.86 (s, 3H, CH3O), 2.60 [ddqdq, J = 
10.3, 6.9, 6.9, 3.3, and 0.8 Hz, 1H, -COC(CH3)=CHCH], 2.41-2.47 (m, 2H, -
CHC=CHCH-), 2.12 [dd, J = 13.9 and 7.5 Hz, 1H, CH3C(CHCHaHb)=CH], 1.91 [dd, 
J = 1.0 and 1.0 Hz, 3H, O=CC(CH3)=], 1.79-1.70 (m, 1H, O-CCHCHaHb), 1.72 [dd, J 
= 14.0 and 6.9 Hz, 1H, CH3C(CHCHaHb)=CH], 1.71 [br s, 3H, CH3C(CH)=CHCH], 
1.55-1.38 (m, 6H), 1.29 (ddd, J = 14.3, 7.8, and 3.3 Hz), 1.25-1.17 (m, 1H), 1.11 [d, J 
= 7.0 Hz, 3H, CH3CH(CH=CC=O)CH2-], 1.08 [d, J = 7.2 Hz, 3H, CH3CHC(CH3)=], 
and 0.89 [d, J = 6.6 Hz, 3H, CH3CHCH2CH(CH3)CH2-].  
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13C NMR (DEPT) (CDCl3, 75 MHz): 156.0 (CH), 122.7 (CH), 60.3 (CH3), 44.4 (CH2), 
43.9 (CH), 37.2 (CH2), 35.4 (CH2), 32.7 (CH), 32.0 (CH), 31.7 (CH), 31.6 (CH2), 
24.2 (CH2), 22.5 (CH3), 21.2 (CH3), 20.1 (CH3), 19.2 (CH3), and 11.3 (CH3). 
IR (neat): 2953, 2922, 2868, 1755, 1644, 1450, 1344, 1255, 1050, and 957 cm-1. 
HRMS (ESI-TOF): Calcd for (C24H34NaO4)+ 409.2350. Found: 409.2356. 
mp: 152-153 °C.  
ORTEP rendering for 3034: 
 
 
(±)-(5E,7R,9R,12aS,15S,16aS)-8,9,10,11,12,12a,15,16-Octahydro-17-hydroxy-
5,7,9,14,15-pentamethyl-16a,3-metheno-2H-1-benzoxacyclotetradecin-2,4(7H)-dione 
[(±)-Okilactomycin D (3001)] and its Sodium Salt S5 
 
For S5: Compound 3032 (300 mg, 0.78 mmol) and LiCl (495 mg, 11.6 mmol) were 
dissolved in DMSO (30 mL). The solution was heated at 55 °C for 48 h. The reaction 
solution was partitioned between EtOAc and half-saturated aqueous NaCl solution. The 
organic layer was washed with half-saturated NaCl three more times, dried over Na2SO4, 
and concentrated to give S5 as a white amorphous solid (292 mg, 0.77 mmol, 95%). The 
NMR spectrum of this sample shows no evidence of anything other than S5. 
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2) brine
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For 3001: Compound 3032 (500 mg, 1.30 mmol) and LiCl (780 mg, 18.4 mmol) 
were dissolved in DMSO (75 mL).The reaction solution was cooled to room temperature 
and partitioned between EtOAc and 10% aqueous HCl solution. The organic layer was 
dried (Na2SO4) and carefully concentrated to provide okilactomcyin D (3001) (465 mg 
and 96%) as a white amorphous solid. The NMR spectrum of this sample indicates a 
purity level of ca. 95%. The material was passed through a bed of SiO2 using 90:9.9:0.1 
(DCM:EtOAc:TFA) as the eluant. This resulted in ca. 120% mass recovery of a slightly 
yellow solid, presumably due to retention of a portion of TFA. The purity level (1H 
NMR) was virtually the same as prior to this treatment. 
Compound S5  
1H NMR (CD3OD, 500 MHz): δ 5.86 [br d, J = 7.9 Hz, 1H, -COC(CH3)=CH], 5.51 (ddq, 
J = 5.2, 1.8, and 1.8 Hz, 1H, CH3C=CH-), 2.54-2.45 (m, 1H, O=CC=CHCH), 2.39-
2.28 (m, 2H, CH3CHCHaHbC-O), 1.83 [br s, 3H, O=CC(CH3)=], 1.83 (m, 1H, 
CH3C=CHCH), 1.68 (ddd, J = 1.2, 1.2, and 1.2 Hz, 3H, CH3C=CHCH), 1.71-1.56 (m, 
4H), 1.30-1.14 (m, 3H), 1.10 (ddd, J = 13.5, 8.0, and 2.8 Hz, 1H, 
CH3CHCHaHbCHCH3), 1.04 (d, J = 7.1 Hz, 3H, CH3CHCH2C-O), 1.05-0.97 (m, 
2H), 0.92 (d, J = 6.8 Hz, 3H, CH3CHCH=CC=O), and 0.86 [d, J = 6.6 Hz, 3H, 
CH3CHCH2CH(CH3)C=]. 
13C NMR (CD3OD, 75 MHz): 200.2, 199.5, 177.1, 145.4, 139.7, 136.1, 126.4, 97.1, 86.8, 
47.7, 46.8, 37.6, 36.0, 32.8, 32.2, 30.6, 30.2, 27.3, 22.2, 21.4, 21.1, 19.7, and 12.8 
ppm. 
HRMS: Calcd for (C23H31O4)— 371.2227. Found: 371.2221. 
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Okilactomycin D (7) 
1H NMR (CDCl3, 500 MHz): δ 5.94 [br d, J = 7.7 Hz, 1H, -COC(CH3)=CH], 5.51 (ddq, 
J = 5.5, 1.5, and 1.5 Hz, 1H, CH3C=CH-), 2.49 (dddq, J = 7.0, 7.0, 7.0 and 7.0 Hz, 
1H, O=CC=CHCH), 2.43-2.32 (m, 1H), 1.99 [br s, 3H, O=CC(CH3)=], 1.92-1.66 (m, 
4H), 1.61 (dddd, J = 13.4, 7.8, 2.6 and 2.6 Hz, 1H), 1.69 (ddd, J = 1.4, 1.4, and 1.4 
Hz, 3H, CH3C=CHCH), 1.42-1.12 (m, 7H), 1.04 (d, J = 7.1 Hz, 3H, CH3CHCH2C-
O), 0.92 (d, J = 6.8 Hz, 3H, CH3CHCH=CC=O), and 0.86 [d, J = 6.6 Hz, 3H, 
CH3CHCH2CH(CH3). 
1H NMR (CD3OD, 500 MHz): See table in next page. 
13C NMR (CD3OD, 75 MHz): See table in next page. 
IR (neat): 2954, 2920, 2870, 1698, 1621, 1558, 1455, 1360, 1307, 1259, 1082, 968, 886, 
and 846 cm-1. 
mp: 132-134 °C. 
  
  Experimental 
 174 
Comparison of the 1H and 13C NMR spectral data of 
natural (CD3OD, 500 and 125 MHz) and synthetic  
(CD3OD, 500 and 75 MHz, this work) okilactomycin D 
(3001).  
 
 
Position 
Natural 7  
d (multiplicity; J in 
Hz) 
Synthetic 7 
d (multiplicity; J in Hz) Dd 
Natural 7 
(d) 
Synthetic 7 
(d) Dd 
2 – – – 172.1 171.8 -0.3 
3 – – – 101.2 102.9 1.7 
4 – – – 194.3 194.0 -0.3 
5 – – – 140.1 140.3 0.2 
6 6.38 (dd; 7.5, 1.2) 6.42 (dq; 7.5, 1.4) 0.04 154.3 155.0 0.7 
7 2.64 (m) 2.65 (ddqd; 10.2, 7.1, 7.1, 3.3) 0.01 33.1 33.3 0.2 
8 1.22 (m) 
1.38 (m) 
1.22 (ddd; 13.6, 8.5, 3.3) 0.00 46.4 46.5 0.1 
9 1.45 (m) 
1.68-1.76 (m; 1H) 
1.33-1.48 (m; 4H) 
1.08-1.23 (m; 2H) 
N/A 
 
29.8 29.9 0.1 
10 1.18 (m) 
1.36 (m) 
36.8 37.0 0.2 
11 1.37 (m) 
1.73 (m) 
25.6 25.7 0.1 
12 1.12 (m) 
2.21 (m) 
 
2.20 (dddd; 14.0, 8.6, 6.0, 
2.8) 
-0.01 30.0 30.1 0.1 
12a 2.02 (m) 2.02-2.06 (m) 0.02 47.3 47.8 0.5 
13 5.57 (dt; 5.0, 1.5) 5.58 (ddq; 5.0, 1.8, 1.8) 0.01 125.0 124.9 -0.1 
14 – – – 136.9 137.1 0.2 
15 2.38 (dq; 10.7, 6.7) 2.38 (br dqd; 10.8, 7.1, 5.9) 0.00 32.1 32.3 0.2 
16 
1.73 (dd; 14.2, 10.4) 
1.80 (ddd; 13.8, 5.9, 1.6) 
1.73 (dd; 13.9, 10.9) 
1.82 (ddd; 13.8, 5.9, 1.6) 
0.00 
0.02 
35.3 35.4 0.1 
16a – – – 87.3 87.4 0.1 
17 1.86 (d; 1.1) 1.86 (d; 1.1) 0.00 11.8 11.8 0.0 
18 1.01 (d; 7.0) 1.01 (d; 7.0) 0.00 20.2 20.3 0.1 
19 0.89 (d; 6.8) 0.89 (d; 6.5) 0.00 20.9 21.0 0.1 
20 1.72 (d; 1.2) 1.72 (ddd; 1.4, 1.4, 1.4) 0.00 21.2 21.4 0.2 
21 1.10 (d; 7.0) 1.10 (d; 7.0) 0.00 19.4 19.5 0.1 
22 – – – 187.3 186.3 -1.0 
OH
O
OO
2
4
5
7
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21 16
16a
20
17
18
19
  Experimental 
 175 
C3-Methylated Okilactomycin D (4003) 
 
A solution of O-methyl okilactomycin D, Li2CO3, and MeI in DMF was heated at 70 
°C for 72 h. The resulting mixture was partitioned between EtOAc and H2O, with the 
aqueous layer being washed with additional portions of EtOAc. The combined organic 
layers were washed with brine, dried, and concentrated. The residue was subjected to 
flash chromatography (SiO2, Hexanes:EtOAc = 12:1) to give triketone 4003 as a 
colorless oil.  
1H NMR: δ 5.91 (dq, J = 9.7, 1.4 Hz, 1H, H6), 5.51 (ddq, J = 5.1, 1.6, 1.6 Hz, H13), 
2.72-2.62 (m, 1H), 2.45-2.40 (m, 1H), 2.28-2.23 (m, 1H), 1.90 (d, J = 1.2 Hz, 3H, 
H17), 1.90-1.85 (m, 1H), 1.80 (dd, J = 14.0, 11.0 Hz, 1H), 1.73 (ddd, J = 1.4, 1.4, and 
1.4 Hz, 3H, H20), 1.72 (s, 3H, C3CH3), 1.08 (d, J = 7.1 Hz, 3H), 0.99 (d, J = 6.7 Hz, 
3H), and 0.86 (d, J = 6.4 Hz, 3H). 
Diketonol 4004 
 
A solution of 4003 in MeOH and CHCl3 was cooled at -42 °C. NaBH4 was added to 
the solution in one portion. The resulting mixture was left at this temperature for 40 
seconds, and then quenched by addition of 1M HCl. The resulting mixture was 
partitioned between EtOAc and H2O, with the aqueous layer being washed with 
additional portions of EtOAc. The combined organic layers were washed with brine, 
OMe
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OO
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dried, and concentrated. The residue was subjected to flash chromatography (SiO2, 
Hexanes:EtOAc = 12:1, then 3:1) to give 4004 as a colorless solid following recovered 
4003. 
1H NMR: δ 6.42 (br d, J = 9.4 Hz, 1H, H6), 5.28 (br s, 1H, H13), 4.39 (d, J = 4.5 Hz, 1H, 
CHOH), 2.77 (d, J = 4.5 Hz, 1H, CHOH), 2.56-2.40 (m, 1H), 2.42-2.38 (m, 1H), 2.17 
(dd, J = 13.7, 8.2 Hz, 1H), 1.86 (br s, 3H, H17), 1.72 (dd, J = 13.7, 3.5 Hz, 1H), 1.68 
(br s, 3H, H20), 1.66 (s, 3H, C3CH3), 1.50–1.40 (m, 3H), 1.35–1.25 (m, 1H), 1.18 (d, 
J = 7.5 Hz, 3H), 1.01 (d, J = 6.7 Hz, 3H), and 0.91 (d, J = 6.5 Hz, 3H). 
13C NMR: δ 198.2, 177.5, 150.6, 137.1, 137.0, 125.4, 89.2, 84.1, 60.1, 44.4, 43.5, 42.8, 
36.5, 33.5, 33.4, 31.1, 28.7, 26.0, 24.8, 22.8, 21.2, 21.0, 20.8, and 13.8. 
Mp: 214-216 °C. 
IR: 3380, 2954, 2917, 2869, 2845, 1760, 1661, 1611, 1453, 1266, 1185, 1007, 974, and 
959.  
HRMS (ESI-TOF): Calcd for C24H36NaO4+ [M+Na]+ requires 411.2506; found 411.2531. 
(±)-(5Z,7R,9R,12aS,15S,16aS)-8,9,10,11,12,12a,15,16-Octahydro-17-hydroxy-
5,7,9,14,15-pentamethyl-16a,3-metheno-2H-1-benzoxacyclotetradecin-2,4(7H)-dione 
(4006) 
 
In an NMR tube, a sample of okilactomycin D obtained by acidification of the 
sodium salt (see above; 20 mg, 0.054 mmol) was dissolved in CDCl3 (0.7 mL) and heated 
to 60 °C for 20 min. The resulting solution was concentrated to give compound 4006 as a 
colorless oil. Approximately 7% of 7 remained in this equilibrated mixture.  
1H NMR (CDCl3, 500 MHz): δ 5.43 [dq, J = 11.0 and 1.6 Hz, 1H, -COC(CH3)=CH], 
5.06 [ddq, J = 1.5, 1.5 and 1.5 Hz, 1H, CH3C(CH-)=CH-], 2.65 [ddddq, J = 12.2, 2.3, 
OH
O
OO
Δ
O
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2.3, 2.3 and 2.3 Hz, 1H, CH3C(CH-)=CHCH], 2.43-2.37 [overlapping ms, 2H, 
CH3CH(CHaHb-)C=], 2.00 (d, J = 1.6 Hz, 3H, CH3CC=O), 1.88 [ddqd, J = 11.0, 
11.0, 6.5, and 2.0 Hz, 1H, CH3C(CO)=CHCH], 1.83 [d, J = 12.1 Hz, 1H, 
CH3CH(CHaHb-)C=], 1.76 [ddd, J = 2.5, 1.5 and 0.5 Hz, 3H, CH3C(CH-)=CH], 1.75-
1.69 (m, 1H, CH3CHCHaHbCHCH3), 1.53 (dddd, J = 14, 14, 4, and 2.5 Hz, 1H, 
CH3C=CHCHCHaHb), 1.32-1.11 (m, 5H), 1.22 [d, J = 7.3 Hz, 3H, CH3CHC(CH3)=], 
1.06-0.97 (m, 1H), 1.00 (ddd, J = 14.0, 11.7, and 4.4 Hz, 1H, CH3CHCHaHbCHCH3), 
0.91 (d, J = 6.4 Hz, 3H, O=CCCHCHCH3), and 0.83 [d, J = 6.9 Hz, 3H, 
CH3CHCH2CH(CH3)CH=]. 
13C NMR (CDCl3, 75 MHz): 202.8, 193.4, 166.6, 138.3, 137.9, 127.6, 123.9, 103.4, 88.2, 
42.5, 40.1, 39.5, 35.4, 33.4, 32.6, 32.4, 27.8, 21.5, 20.8, 20.5, 19.7, 19.2, and 18.8 
ppm. 
IR (neat): 2957, 2926, 2870, 1773, 1636, 1454, 1388, 1287, 1257, 990, and 874 cm-1. 
HRMS: Calcd for (C23H31O4)- 371.2227. Found: 371.2222. 
(±)-(5Z,7R,9R,12aS,15S,16aS)-8,9,10,11,12,12a,15,16-Octahydro-17-methoxy-
5,7,9,14,15-pentamethyl-16a,3-metheno-2H-1-benzoxacyclotetradecin-2,4(7H)-dione 
(4007) and its regioisomer 4008. 
 
Compound 4006 (20 mg) was dissolved in a mixed solvent of CHCl3 (1 mL) and 
CH3OH (1 mL), and a solution of TMSCHN2 [CAUTION: this reagent is potentially 
hazardous and should always be handled in a properly functioning fume hood] (0.25 mL, 
2.0 M in Et2O) was added at room temperature. The solution was kept at this temperature 
for an additional 30 min and then concentrated. The residue was subjected to flash 
chromatography (SiO2, hexanes:EtOAc = 8:1 then 4:1) to give 4007 as a white solid (ca. 
10 mg, 50%). A similar portion of a more slowly eluting isomer was tentatively assigned 
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to have the structure 4008 on the basis of analysis of its 1H NMR spectrum. The sample 
of 4007 was recrystallized by the technique described above for 3033 and 3034 to 
provide colorless crystals suitable for single crystal x-ray analysis. 
Compound 4007 
1H NMR (CDCl3, 500 MHz): δ 5.51 [dq, J = 11.5 and 1.4 Hz, 1H, -COC(CH3)=CH], 
5.05 (ddq, J = 1.8, 1.8, and 1.8 Hz, 1H, CH3C=CH-), 4.04 (s, 3H, CH3O), 2.64 
[ddddq, J = 12.2, 2.5, 2.5, 2.5, and 2.5 Hz, 1H, -CHC(CH3)=CHCHCH2], 2.51 [ddqd, 
J = 11.6, 11.6, 6.5, and 2.7 Hz, 1H, -COC(CH3)=CHCH-], 2.41-2.35 (m, 1H, 
CH3CHCH2C-O), 2.32 [dd, J = 13.9 and 7.2 Hz, 1H, CH3CH(C=)CHaHb], 1.97 [d, J 
= 1.5 Hz, 3H, O=CC(CH3)=], 1.72 [ddd, J = 2.5, 1.3, and 1.3 Hz, 3H, CH3C(CH-
)=CH], 1.68 [dd, J = 13.9 and 3.0 Hz, 1H, CH3CH(C=)CHaHb], ca. 1.67 (m, 1H), 
1.58-1.50 (m, 1H), 1.40 (ddd, J = 13.4, 10.4, and 2.7 Hz, 1H, CH3CHCHaHbCHCH3), 
1.37-1.15 (m, 5H, CHaHbCH2CH2CH), 1.10 (d, J = 7.3 Hz, 3H, CH3CHCH2CO), 1.01 
(ddd, J = 14.0, 11.6, and 4.3 Hz, 1H, CH3CHCHaHbCHCH3), 0.89 [d, J = 6.5 Hz, 3H, 
CH3CHCH=C(CH3)C=O], and 0.87 [d, J = 6.9 Hz, 3H, CH3CHCH2CH(CH3)C=].  
13C NMR (CDCl3, 75 MHz): 195.1, 183.8, 169.1, 139.5, 138.2, 134.3, 124.7, 108.2, 86.0, 
62.8, 42.0, 41.8, 40.3, 35.2, 34.4, 32.7, 32.3, 27.9, 21.8, 21.6, 21.4, 21.2, 19.13, and 
19.09 ppm. 
IR (neat): 2951, 2927, 2862, 1752, 1650, 1607, 1450, 1373, 1329, 1307, 1227, 1095, 
1055, 1021, and 946 cm-1. 
HRMS: Calcd for (C24H34NaO4)+ 409.2350. Found: 409.2352. 
mp: 176-177 °C. 
Compound 4008 
1H NMR (CDCl3, 500 MHz): d 5.59 [dq, J = 11.2 and 1.4 Hz, 1H, COC(CH3)=CH], 5.03 
[ddq, J = 1.8, 1.8, and 1.8 Hz, 1H, CH3C(CH)=CH], 4.03 (s, 3H, OCH3), 2.52 [ddddq, 
J = 11.6, 2.4, 2.4, 2.4, and 2.4 Hz, 1H, -CHCH3C(CH)=CHCHCH2], 2.40-2.33 [m, 
1H, CH3CHCH2C-O], 2.22 [dd, J = 14.0 and 7.5 Hz, 1H, CH3CH(C=)CHaHb], 2.01 
[d, J = 1.6 Hz, 3H, COC(CH3)=CH], 1.91 [ddqd, J = 11.6, 11.6, 6.3, and 1.9 Hz, 1H, 
COC(CH3)=CHCH], 1.78 [dd, J = 14.1 and 2.6 Hz, 1H, CH3CH(C=)CHaHb], 1.73 
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[ddd, J = 2.3, 1.1, and 1.1 Hz, 3H, CH3CH(C=)CHaHb], 1.81-1.65 (m, 2H), 1.47 (ddd, 
J = 13.8, 9.3, and 2.5 Hz, 1H, CH3CHCHaHbCHCH3), 1.3-1.1 (m, 5H), 1.19 (d, J =7.5 
Hz, 3H, CH3CHCH2CO), 0.99 (ddd, J = 13.9, 11.5, and 3.8 Hz, 1H, 
CH3CHCHaHbCHCH3), 0.92 [d, J = 6.4 Hz, 3H, CH3CHCH=C(CH3)C=O], and 0.84 
[d, J = 6.9 Hz, 3H, CH3CHCH2CH(CH3)C=].  
ORTEP rendering for 4008: 
 
Synthesis of chloroketone 4009. 
 
To a solution of neutral okilactomycin D (14 mg, 0.04 mmol) in CHCl3 (1.2 mL) was 
added tBuOCl (4.7 mg, 0.044 mmol, 1.1 equiv). The reaction was kept at room 
temperature for 30 min, and concentrated. Purification by flash chromatography (SiO2, 
hexanes:EtOAc = 4:1) gave 4009 as a yellow solid. 
1H NMR: δ 6.21 (dq, J = 10.4, 1.3 Hz, 1H, H6), 5.44 (ddq, J = 5.0, 1.6, 1.6 Hz, H13), 
2.65-2.56 (m, 1H), 2.45-2.38 (m, 1H), 2.10-2.06 (m, 1H), 2.06 (d, J = 1.3 Hz, 3H, 
H17), 2.00 (ddd, J = 14.1, 6.1, 2.1 Hz, 1H), 1.85 (dd, J = 14.2, 10.9 Hz, 1H), 1.71 
(ddd, J = 1.4, 1.4, and 1.4 Hz, 3H, H20), 1.65–1.56 (m, 1H), 1.54–1.47 (m, 1H), 
1.35–1.10 (m, 5H), 1.08 (d, J = 7.1 Hz, 3H), 1.00 (d, J = 6.7 Hz, 3H), and 0.80 (d, J = 
6.4 Hz, 3H). 
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13C NMR: δ 199.4, 184.1, 164.5, 154.2, 137.7, 134.0, 120.3, 93.3, 68.2, 44.3, 43.4, 35.8, 
35.6, 33.6, 30.5, 30.0, 28.3, 22.4, 22.0, 21.3, 20.6, 18.8, and 13.8. 
IR: 2957, 2919, 2869, 1817, 1764, 1689, 1604, 1456, 1223, 1182, 1032, and 989.  
HRMS (ESI-TOF): Calcd for C24H35ClNaO5+ [M+CH3OH+Na]+ requires 461.2065; 
found 461.2059. 
Mp: 152-155 °C. 
Synthesis of chloroalcohol 4010. 
 
A solution of 4009 (116 mg, 0.28 mmol) in MeOH (4.5 mL) and CHCl3 (6 mL) was 
cooled at -42 °C. NaBH4 (10 mg, 0.28 mmol) was added to the solution in one portion. 
The resulting mixture was left at this temperature for 120 seconds, and then quenched by 
addition of 1M HCl. The resulting mixture was partitioned between EtOAc and H2O, 
with the aqueous layer being washed with additional portions of EtOAc. The combined 
organic layers were washed with brine, dried, and concentrated. The residue was 
subjected to flash chromatography (SiO2, Hexanes:EtOAc = 12:1, then 3:1) to give 4010 
as a colorless solid (70 mg) following recovered 4009. 
1H NMR: δ 6.33 (br d, J = 10.3 Hz, 1H, H6), 5.34 (br d, J = 4.5 Hz, 1H, H13), 4.69 (d, J 
= 3.0 Hz, 1H, CHOH), 3.61 (br d, J = 4.0 Hz, 1H, CHOH), 2.59-2.42 (m, 3H), 2.14 
(s, 3H), 1.99 (dd, J = 13.9, 8.3 Hz, 1H), 1.99 (dd, J = 13.8, 7.1 Hz, 1H), 1.67 (br s, 
3H, H17), 1.58–1.48 (m, 1H), 1.40–1.35 (m, 1H), 1.30–1.22 (m, 5H), 1.10 (d, J = 7.2 
Hz, 3H), 1.01 (d, J = 6.6 Hz, 3H), and 0.94 (d, J = 5.8 Hz, 3H). 
13C NMR: δ 192.6, 169.1, 152.9, 136.6, 135.7, 123.7, 88.5, 86.4, 72.8, 44.2, 43.3, 40.3, 
36.7, 33.9, 32.5, 31.1, 29.1, 24.4, 23.5, 21.1, 20.8, 19.8, and 14.9.  
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IR: 3433, 2956, 2924, 2869, 1796, 1772, 1667, 1605, 1456, 1439, 1247, 1208, 1185, 
1091, and 968.  
HRMS (ESI-TOF): Calcd for C23H33ClNaO4+ [M+Na]+ requires 431.1960; found 
431.1973. 
ORTEP rendering for 4010: 
 
Synthesis of dienone 4012. 
 
To a solution of 4010 (25 mg, 0.07 mmol) in Et2O (0.7 mL) was added Zn dust (75 
mg, 1.15 mmol) and AcOH (0.6 mL). The resulting slurry was vigorously stirred for 2 h, 
and filtered through celite. Two procedures could be used to generate 4012.  
1) The filtrate (mostly 4011) is concentrated and the residue redissolved in CHCl3. 
The solution was heated at 60 °C to yield 4012 at a rate with t1/2 = 40 min. 
2) The filtrate was washed with satd. NaHCO3, brine, dried, and concentrated. The 
residue was purified by flash chromatography to give 4011. ZnI2 (7 mg, 0.02 mmol) was 
added to a solution of 4011 (40 mg, 0.12 mmol) in CHCl3 (4 mL) heated at 60 °C. The 
reaction was stirred at this temperature for 30 min, and concentrated. Purification by flash 
chromatography (SiO2, hexanes:EtOAc = 3:1) gave 4012 as a colorless solid (ca. 35 mg).  
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1H NMR: δ 7.61 (s, 1H, C22H), 6.32 (dq, J = 10.3, 1.3 Hz, 1H, H6), 5.40 (ddq, J = 4.5, 
1.5, 1.5 Hz, 1H, H13), 2.49 (dddq, J = 7.3, 7.3, 7.3 and 7.3 Hz, 1H, O=CC=CHCH), 
2.47-2.40 (m, 1H), 2.16-2.11 (m, 1H), 1.88 [d, J = 1.2 H, 3H, O=CC(CH3)=], 1.60 
(dd, J = 13.6, 9.4 Hz, 1H), 1.45-1.25 (m, 6H), 1.25-1.15 (m, 1H), 1.06 (d, J = 7.2 Hz, 
3H, CH3CHCH2C-O), 1.01 (d, J = 6.9 Hz, 3H, CH3CHCH=CC=O), and 0.91 [d, J = 
6.5 Hz, 3H, CH3CHCH2CH(CH3).  
13C NMR: δ 191.7, 168.3, 161.7, 156.6, 138.9, 136.8, 133.1, 123.7, 88.7, 45.9, 45.3, 
36.9, 36.3, 33.2, 32.8, 31.4, 31.0, 25.8, 21.6, 21.3, 19.9, 19.3, and 11.6.  
IR: 2955, 2925, 2870, 1763, 1659, 1635, 1455, 1336, 1217, 1090, and 1072. 
HRMS (ESI-TOF): Calcd for C23H32NaO3+ [M+Na]+ requires 379.2244; found 379.2270. 
 
To a solution of 4012 (32 mg, 0.1 mmol) in DCM (2.4 mL) cooled at 0 °C was added 
tBuOOH (3.96 M in toluene, 0.033 mL, 0.13 mmol, 1.3 equiv) and DBU (13 mg, 0.1 
mmol, 1 equiv). The reaction was kept at this temperature for 1 h and concentrated. 
Purification by flash chromatography (SiO2, hexanes:EtOAc = 3:1) gave 4013 as a 
colorless solid (30 mg). 
1H NMR: δ 6.49 (dq, J = 9.0, 1.2 Hz, 1H, H6), 5.27 (m, 1H, H13), 4.04 (s, 1H, C22H), 
2.73-2.63 (m, 1H), 2.36-2.29 (m, 2H), 2.10 (dd, J = 13.4, 6.7 Hz, 1H), 1.86 [br s, J = 
1.2 H, 3H, O=CC(CH3)=], 1.80 (dd, J = 13.5, 5.3 Hz, 1H), 1.72 (br s, 3H, C20CH3), 
1.65-1.50 (m, 2H), 1.40-1.30 (m, 3H), 1.25-1.20 (m, 2H), 1.15 (d, J = 7.3 Hz, 3H, 
CH3CHCH2C-O), 1.08 (d, J = 6.8 Hz, 3H, CH3CHCH=CC=O), and 0.89 [d, J = 5.8 
Hz, 3H, CH3CHCH2CH(CH3).  
13C NMR: δ 187.0, 168.9, 155.9, 138.6, 136.2, 121.2, 87.0, 65.2, 63.3, 43.5, 42.7, 35.6, 
35.1, 33.1, 32.7, 28.5, 28.2, 23.2, 21.5, 21.2, 20.0, 19.8, and 11.7.  
IR: 2948, 2919, 1762, 1683, and 1270. 
HRMS (ESI-TOF): Calcd for C23H32NaO4+ [M+Na]+ requires 395.2193; found 395.2204.  
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Synthesis of indoline S6 (Scheme 6.3, entry 5) 
 
N-(6-((tert-Butyldimethylsilyl)oxy)hexa-1,3-diyn-1-yl)-4-methyl-N-(4-
(trimethylsilyl)but-3-yn-1-yl)benzenesulfonamide (S6) 
 
A solution of 4-methyl-N-(4-(trimethylsilyl)but-3-yn-1-yl)benzenesulfonamide162 
(200 mg, 0.680 mmol), ((6-bromohexa-3,5-diyn-1-yl)oxy)(tert-butyl)dimethylsilane (230 
mg, 0.8 mmol), K2CO3 (190 mg, 1.4 mmol), CuSO4.5H2O (17 mg, 0.068 mmol), and 
1,10-phenanthroline (22 mg, 0.14 mmol) in anhydrous toluene (1 mL) was heated to 65 
ºC. After 16 h the reaction mixture was directly subjected to gradient flash 
chromatography (hexanes:EtOAc 12:1 to 5:1) to yield, in order of elution, the triynes S6 
(210 mg, 0.420 mmol, 62%) and S7 (19 mg, 6%, 0.0378), each as a pale yellow oil.  
1H NMR (500 MHz, CDCl3): δ 7.79 (d, J = 8.2 Hz, 2H, SO2ArHo), 7.36 (d, J = 8.2 Hz, 
2H, SO2ArHm), 3.74 (t, J = 7.1 Hz, 2H, OCH2), 3.49 (d, J = 7.7 Hz, 2H, NCH2), 2.54 
(t, J = 7.9 Hz, 2H, NCH2CH2), 2.52 (t, J = 7.1 Hz, 2H, OCH2CH2), 2.46 (s, 3H, 
ArCH3), 0.90 [s, 9H, SiC(CH3)3], 0.13 [s, 9H, Si(CH3)3], and 0.08 [s, 6H, Si(CH3)2C]. 
                                                
162  Trost, B. M.; Machacek, M.; Schnaderbeck, M. J. A regioselective Ru-catalyzed alkene−alkyne 
coupling. Org. Lett. 2000, 2, 1761–1764. 
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13C NMR (125 MHz, CDCl3): δ 145.2, 134.8, 130.1, 127.7, 101.7, 87.6, 81.4, 67.2, 65.6, 
61.6, 59.0, 50.4, 26.0, 24.1, 21.8, 20.0, 18.5, 0.1, and -5.2.  
IR (neat): 2955, 2930, 2857, 2253, 2228, 2179, 1598, 1469, 1376, 1252, 1172, 1105, and 
842 cm-1. 
HRMS (ESI-TOF): Calcd for C26H39NNaO3SSi2+ [M+Na+] requires 524.2081; found 
524.2088. 
N-(But-3-yn-1-yl)-N-(6-((tert-butyldimethylsilyl)oxy)hexa-1,3-diyn-1-yl)-4-
methylbenzenesulfonamide (S7) 
 
K2CO3 (62 mg, 0.44 mmol) was added to a stirred solution of S6 (112 mg, 0.22 mmol) 
in MeOH (8 mL) at room temperature. After 3 h the reaction mixture was concentrated 
and purified by flash chromatography (hexanes:EtOAc 5:1) to yield S7 (90 mg, 97%) as 
pale yellow oil. 
1H NMR (500 MHz, CDCl3): δ 7.79 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.36 (d, J = 8.1 Hz, 
2H, SO2ArHm), 3.74 (t, J = 7.1 Hz, 2H, OCH2), 3.50 (t, J = 7.5 Hz, 2H, NCH2), 2.52 
(t, J = 7.0 Hz, 2H, OCH2CH2), 2.51 (td, J = 7.4, 2.7 Hz, 2H, NCH2CH2), 2.46 (s, 3H, 
ArCH3), 1.97 (t, J = 2.6 Hz, 1H, C≡CH), 0.90 [s, 9H, SiC(CH3)3], and 0.08 [s, 6H, 
Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 145.3, 134.6, 130.1, 127.8, 81.5, 79.5, 70.9, 66.9, 65.5, 
61.6, 59.2, 50.2, 26.0, 24.1, 21.8, 18.54, 18.47, and -5.1. 
IR (neat): 3297, 2953, 2930, 2857, 2360, 2340, 2254, 2166, 1597, 1468, 1373, 1255, 
1171, 1092, 903, and 839 cm-1. 
HRMS (ESI-TOF): Calcd for C23H31NNaO3SSi+ [M+Na+] requires 452.1686; found 
452.1687. 
Methyl 5-(N-(6-((tert-Butyldimethylsilyl)oxy)hexa-1,3-diyn-1-yl)-4-
methylphenylsulfonamido)pent-2-ynoate (S8) 
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LiHMDS [0.15 mL, ca. 1.0 M in THF, 0.15 mmol, prepared by addition of n-BuLi 
(2.0 mL, 2.5 M in hexanes, 5.0 mmol) to a stirred solution of HMDS (1.0 mL, 4.8 mmol) 
in THF (2 mL) at -78 ºC] was added to a stirred solution of S7 (43 mg, 0.10 mmol) in 
THF (1 mL) at -78 ºC. After 1 h methyl chloroformate was added at the same temperature. 
After an additional 2 h the reaction mixture was quenched with satd. aq. NH4Cl, diluted 
with H2O, and washed with EtOAc. The combined organic extracts were washed with 
brine, dried (Na2SO4), and concentrated. Purification by flash chromatography 
(hexanes:EtOAc 5:1) gave the ynoate S8 (30 mg, 61%) as a pale yellow oil and recovered 
starting material S7 (11 mg, 26%). 
1H NMR (500 MHz, CDCl3): δ 7.79 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.37 (d, J = 8.1 Hz, 
2H, SO2ArHm), 3.76 (s, 3H, CO2Me), 3.74 (t, J = 7.1 Hz, 2H, OCH2), 3.55 (t, J = 7.5 
Hz, 2H, NCH2), 2.67 (t, J = 7.9 Hz, 2H, NCH2CH2), 2.53 (t, J = 7.0 Hz, 2H, 
OCH2CH2), 2.46 (s, 3H, ArCH3), 0.90 [s, 9H, SiC(CH3)3], and 0.08 [s, 6H, Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 153.8, 145.5, 134.4, 130.2, 127.8, 84.1, 81.8, 74.7, 66.5, 
65.4, 61.6, 59.6, 52.9, 49.2, 26.0, 24.1, 21.9, 18.8, 18.5, and -5.1. 
IR (neat): 2953, 2930, 2857, 2247, 2166, 1717, 1597, 1463, 1435, 1373, 1256, 1171, 
1090, and 839 cm-1. 
HRMS (ESI-TOF): Calcd for C25H33NNaO5SSi+ [M+Na+] requires 510.1741; found 
510.1779. 
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Methyl 8-(tert-Butyldimethylsilyl)-7-toluenesulfonyl -3,5,6,7-tetrahydro-2H-furo[3,2-
f]indole-4-carboxylate (S9, entry 5, Scheme 6.3) 
 
A solution of S8 (15 mg, 0.031 mmol) in toluene (3 mL) in a sealed vial was heated 
to 120 ºC (external bath temperature) in a sealed tube. After 18 h the reaction mixture 
was cooled and concentrated. Purification by flash chromatography (hexanes:EtOAc 5:1) 
gave the tricycle S9 (12 mg, 0.025, 80%) as a pale yellow solid.  
1H NMR (500 MHz, CDCl3): δ 7.22 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.12 (d, J = 8.6 Hz, 
2H, SO2ArHm), 4.64 (ddd, J = 8.9, 8.9, 7.9 Hz, 1H, OCHaHb), 4.53 (ddd, J = 9.7, 8.7, 
8.7 Hz, 1H, OCHaHb), 4.02 (ddd, J = 13.1, 8.0, 1.1 Hz, 1H, NCHaHb), 3.77 (s, 3H, 
CO2Me), 3.71 (ddd, J = 13.2, 11.8, 8.5 Hz, 1H, NCHaHb), 3.46 (br t, J = 9 Hz, 2H, 
OCH2CH2), 2.60 (ddd, J = 16.9, 8.5, 1.0 Hz, 1H, NCH2CHaHb), 2.37 (s, 3H, ArMe), 
1.74 (ddd, J = 16.9, 11.8, 8.0 Hz, 1H, NCH2CHaHb), 0.95 [s, 9H, SiC(CH3)3], 0.54 (s, 
3H, SiCH3), and 0.41 (s, 3H, SiCH3). 
13C NMR (125 MHz, CDCl3): δ 166.7, 166.1, 148.8, 144.1, 134.1, 131.0, 129.4, 128.2, 
126.5, 123.0, 120.5, 70.9, 51.8, 51.7, 31.3, 29.1, 28.6, 21.7, 18.1, -0.9, and -1.9. 
IR (neat): 2952, 2928, 2896, 2854, 1718, 1597, 1564, 1456, 1385, 1252, 1163, 1089, 
1065, 1049, 1011, and 739 cm-1. 
HRMS (ESI-TOF): Calcd for C25H33NO5SSi+ [M+H+] requires 488.1921; found 
488.1953. 
mp: 144-147 ºC. 
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Synthesis of fluorenone (Scheme 6.3, entry 9) 
 
1-(((3-Bromoprop-2-yn-1-yl)oxy)methyl)-3,5-dimethylbenzene (S10) 
 
Bromoalkyne S10 was prepared by treating 1,3-dimethyl-5-((prop-2-yn-1-
yloxy)methyl)benzene (150 mg, 0.86 mmol) with N-bromosuccinimide (NBS, 170 mg, 
0.96 mmol) and AgNO3 (17 mg, 0.10 mmol) in acetone (10 mL). Purification by flash 
chromatography (hexanes:EtOAc 12:1) gave bromoalkyne S29 (166 mg, 0.66 mmol, 
76%) as a pale yellow oil. 
1H NMR (500 MHz, CDCl3): δ 6.96 (br s, 2H, ArH2,H6), 6.94 (br s, 1H, ArH4), 4.52 (s, 
2H, OCH2C≡C), 4.19 (t, J = 0.8 Hz, 2H, ArCH2), and 2.31 [br s, 6H, Ar(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 138.2, 137.2, 129.7, 126.1, 76.5, 72.0, 58.2, 46.1, and 
21.4. 
IR (neat): 3015, 2918, 2854, 2213, 1608, 1463, 1380, 1351, 1160, 1088, 1036, and 844 
cm-1.  
HRMS (ESI-TOF): Calcd for C12H13NaOBr+ [M+Na+] requires 275.0042; found 
275.0066. 
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1-(2-(5-((3,5-Dimethylbenzyl)oxy)penta-1,3-diyn-1-yl)phenyl)-3-(trimethylsilyl)prop-
2-yn-1-ol (S11) 
 
Triyne S11 was prepared by stirring 1-(2-ethynylphenyl)-3-(trimethylsilyl)prop-2-yn-
1-ol163 (82 mg, 0.36 mmol), bromoalkyne S10 (95 mg, 0.38 mmol), and CuCl (4 mg, 0.04 
mmol) in dearated piperidine (1 mL) for 1 hour at 0 °C. Purification by gradient flash 
chromatography (hexanes:EtOAc 12:1 to 8:1) gave the triyne S11 (117 mg, 0.29 mmol, 
81%) as a clear yellow oil. 
1H NMR (500 MHz, CDCl3): δ 7.72 (dd, J = 7.8, 1.5 Hz, 1H, H3), 7.53 (dd, J = 7.7, 1.5 
Hz, 1H, H6), 7.42 (ddd, J = 7.6, 7.6, 1.4 Hz, 1H, H5), 7.30 (ddd, J = 7.6, 7.6, 1.3 Hz, 
1H, H4), 6.99 (br s, 2H, ArHa), 6.95 (br s, 1H, ArHb), 5.83 (d, J = 5.7 Hz, 1H, ArCH), 
4.57 (br s, 2H, OCH2C≡C), 4.33 (br s, 2H, ArCH2), 2.42 (d, J = 5.7 Hz, 1H, OH), 
2.33 [br s, 6H, Ar(CH3)2], and 0.20 (s, 9H, SiCH3). 
13C NMR (125 MHz, CDCl3): δ143.7, 138.2, 137.1, 133.9, 130.0, 129.8, 128.5, 127.1, 
126.2, 120.2, 104.1, 92.1, 80.6, 78.7, 75.3, 72.1, 71.0, 63.5, 57.9, 21.4, and 0.04. 
IR (neat): 3417, 3017, 2957, 2920, 2856, 2237, 2173, 1607, 1450, 1351, 1250, 1085, 
1056, 1040, 984, and 845 cm-1. 
HRMS (ESI-TOF): Calcd for C26H28NaO2Si+ [M+Na+] requires 423.1751; found 
423.1744. 
  
                                                
163  Suffert, J.; Abraham, E.; Raeppel, S.; Brückner, R. Synthesis of 5-/10-membered ring analogues of the 
dienediyne core of neocarzinostatine chromophore by palladium(0)-mediated ring-closure reaction. 
Liebigs Ann. 1996, 1996, 447–456. 
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1-(2-(5-((3,5-Dimethylbenzyl)oxy)penta-1,3-diyn-1-yl)phenyl)-3-(trimethylsilyl)prop-
2-yn-1-one (S12) 
 
MnO2 (380 mg, 4.37 mmol) was added to a stirred solution of alcohol S11 (117 mg, 
0.29 mmol) in CH2Cl2 (3 mL) at room temperature. After 1 h the reaction mixture was 
filtered through a plug of Celite® (CH2Cl2) and concentrated to give the triyne S12 (108 
mg, 0.27 mmol, 93%) as a pale yellow oil.  
1H NMR (500 MHz, CDCl3): δ 8.12 (dd, J = 7.6, 1.7 Hz, 1H, H6), 7.64 (dd, J = 7.7, 1.4 
Hz, 1H, H3), 7.52 (ddd, J = 7.5, 7.5, 1.5 Hz, 1H, H4), 7.48 (ddd, J = 7.6, 7.6,1.4 Hz, 
1H, H5), 6.99 (br s, 2H, ArHa), 6.94 (br s, 1H, ArHb), 4.56 (br s, 2H, OCH2C≡C), 
4.33 (br s, 2H, ArCH2O), 2.32 [br s, 6H, Ar(CH3)2], and 0.31 (s, 9H, SiCH3). 
13C NMR (125 MHz, CDCl3): δ 176.5, 139.2, 138.2, 137.1, 135.9, 132.7, 132.1, 129.8, 
129.0, 126.2, 121.5, 101.6, 101.4, 81.2, 79.4, 76.2, 72.1, 71.5, 57.9, 21.4, and 0.6. 
IR (neat): 2959, 2918, 2852, 2238, 2152, 1706, 1647, 1607, 1590, 1561, 1480, 1467, 
1351, 1236, 1096, 1076, 1014, and 848 cm-1. 
HRMS (ESI-TOF): Calcd for C26H26NaO2Si+ [M+Na+] requires 421.1594; found 
421.1599. 
(1r,3ar)-2,14-Dimethyl-7-(trimethylsilyl)-4,6-dihydro-1,3a-
ethenobenzo[de]indeno[1,2-g]isochromen-8(1H)-one (S13, Scheme 6.3, entry 9)  
 
A solution of ketone S12 (20 mg, 0.050 mmol) in CHCl3 (4 mL) was heated to 85 ºC 
(external bath temperature) in a sealed tube. After 16 h the reaction mixture was 
concentrated and purified by flash chromatography (hexanes:EtOAc 12:1) to give the 
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polycyclic ketone S13 (17 mg, 0.043, 85%) as a bright yellow oil.  
1H NMR (500 MHz, CDCl3): δ 7.90 (d, J = 7.5 Hz, 1H, H9), 7.63 (d, J = 7.0 Hz, 1H, 
H12), 7.51 (dd, J = 7.5, 7.5 Hz, 1H, H11), 7.28 (dd, J = 7.5, 7.5 Hz, 1H, H10), 6.16 
(br s, 2H, MeC=CH), 4.96 (s, 1H, HCR3), 4.79 (br s, 2H, OCH2CAr), 4.39 (br s, 2H, 
OCH2CR3), 1.99 (br s, 6H, CCH3), and 0.36 (s, 9H, SiCH3). 
13C NMR (125 MHz, CDCl3): δ 194.3, 149.8, 148.8, 144.6, 142.4, 136.3, 136.0, 135.5, 
135.1, 135.0, 134.4, 133.7, 128.3, 124.2, 121.8, 71.2, 70.4, 56.2, 51.2, 20.0, and 2.3. 
IR (neat): 2950, 2903, 2849, 1705, 1606, 1560, 1466, 1375, 1353, 1205, 1189, 1174, 
1122, 1097, 995, and 942 cm-1. 
HRMS (ESI-TOF): Calcd for C26H26NaO2Si+ [M+Na+] requires 421.1594; found 
421.1559. 
Synthesis of benzodifuranone (Scheme 6.3, entry 10) 
 
7-((tert-Butyldimethylsilyl)oxy)hepta-2,4-diyn-1-yl Propiolate (S14) 
  
DCC (110 mg, 0.55 mmol) was added to a stirred solution of propiolic acid (39 mg, 
0.55 mmol), alcohol S14 (119 mg, 0.50 mmol), and DMAP (6 mg, 0.05 mmol) in CH2Cl2 
(3 mL) at 0 ºC. After 2 h the mixture was passed through a plug of Celite® (EtOAc eluent) 
and concentrated. Purification by flash chromatography (hexanes:EtOAc 12:1) gave the 
ester S15 (71 mg, 0.24 mmol, 48%) as a pale yellow oil.  
1H NMR (500 MHz, CDCl3): δ 4.83 (t, J = 1.1 Hz, 2H, CO2CH2), 3.74 (t, J = 6.9 Hz, 2H, 
OCH2), 2.94 (s, 1H, C≡CH), 2.50 (tt, J = 1.1, 6.9 Hz, 2H, OCH2CH2), 0.90 [s, 9H, 
SiC(CH3)3] and 0.07 [s, 6H, Si(CH3)2]. 
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13C NMR (125 MHz, CDCl3): δ 151.9, 79.9, 76.1, 74.0, 72.7, 68.1, 65.3, 61.3, 54.2, 26.0, 
23.9, 18.4, and -5.2. 
IR (neat): 3289, 2953, 2931, 2836, 2857, 2262, 2123, 1724, 1470, 1367, 1257, 1206, 
1105, and 839cm-1. 
HRMS (CIMS): Calcd for C16H22NaO3Si+ [M+Na+] requires 313.1230; found 313.1252. 
8-(tert-Butyldimethylsilyl)-2,3-dihydrobenzo[1,2-b:4,5-c']difuran-5(7H)-one (S15, 
entry 10, Scheme 6.3) 
 
A solution of triyne S14 (29 mg, 0.10 mmol) in toluene (4 mL) was heated to 120 ºC 
(external bath temperature) in a sealed tube. After 48 h the reaction mixture was 
concentrated and purified by flash chromatography (hexanes:EtOAc 4:1) gave the 
tricycle S15 (25 mg, 0.086, 86%) as a white solid. 
1H NMR (500 MHz, CDCl3): δ 7.67 (t, J = 1.4 Hz, 1H, ArH), 5.20 (s, 2H, ArCH2O), 
4.64 (t, J = 8.7 Hz, 2H, ArCH2CH2), 3.25 (dt, J = 8.7, 1.2 Hz, 2H, ArCH2CH2), 0.89 
[s, 9H, SiC(CH3)3], and 0.33 [s, 6H, Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 171.5, 171.4, 155.3, 128.7, 123.2, 117.9, 111.4, 71.9, 
71.2, 28.7, 26.7, 18.6, and 3.8. 
IR (neat): 2949, 2927, 2902, 2855, 1747, 1589, 1459, 1400, 1360, 1325, 1259, 1099, 
1023, 1013, 881, and 839 cm-1. 
HRMS (CIMS): Calcd for C16H22NaO3Si+ [M+Na+] requires 313.1230; found 313.1237. 
mp: 167–169 ºC. 
Synthesis of triyne 6022 
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5-Bromopent-4-yn-1-yl Acetate (S16) 
 
5-Bromopent-4-yn-1-yl acetate was prepared by treating pent-4-yn-1-yl acetate164 
(780 mg, 6.19 mmol) with N-bromosuccinimide (NBS, 1.24 g, 6.97 mmol) and AgNO3 
(108 mg, 0.64 mmol) in acetone (40 mL) at rt for 2 hours. Purification by flash 
chromatography (hexanes:EtOAc 12:1) gave the bromoalkyne (1.30 g, 6.34 mmol, 91%) 
S16 as a pale yellow oil.  
1H NMR (500 MHz, CDCl3): δ 4.15 (t, J = 6.3 Hz, 2H, AcOCH2), 2.32 (t, J = 7.0 Hz, 
2H, C≡CCH2), 2.06 (s, 3H, CH3CO), and 1.85 (tt, J = 7.0, 6.3 Hz, 2H, CH2CH2O). 
13C NMR (125 MHz, CDCl3): δ 171.1, 79.0, 63.1, 38.8, 27.5, 21.0, and 16.7. 
IR (neat): 2961, 2340, 1738, 1434, 1367, 1240, and 1044 cm-1. 
HRMS (ESI-TOF): Calcd for C7H9AgBrO2+ [M+Ag+] requires 310.8831; found 
310.8811. 
7-(2-(1-Hydroxy-3-(trimethylsilyl)prop-2-yn-1-yl)phenyl)hepta-4,6-diyn-1-yl Acetate 
(S17) 
                                                
164  White, J. D.; Kim, T.-S.; Nambu, M. Absolute configuration and total synthesis of (+)-curacin A, an 
antiproliferative agent from the cyanobacterium Lyngbya majuscule. J. Am. Chem. Soc. 1997, 119, 103–
111. 
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Triyne S17 was prepared by stirring 1-(2-ethynylphenyl)-3-(trimethylsilyl)prop-2-yn-
1-ol163 (200 mg, 0.88 mmol), bromoalkyne S16 (200 mg, 0.98 mmol), and CuCl (8 mg, 
0.08 mmol), in dearated piperidine (2.5 mL) at 0 °C for 1 hour. Purification by flash 
chromatography (hexanes:EtOAc 5:1) gave the triyne S17 (255 mg, 0.72 mmol, 82%) as 
a pale yellow oil. This compound is contaminated with ca. 15% bromoalkyne S16 (1H 
NMR), which can be removed chromatographically in the subsequent step.  
1H NMR (500 MHz, CDCl3): δ 7.70 (dd, J = 7.8, 1.4 Hz, 1H, ArH6), 7.50 (dd, J = 7.7, 
1.0 Hz, 1H, ArH3), 7.40 (ddd, J = 7.7, 7.7, 1.3 Hz, 1H, ArH4/H5), 7.29 (ddd, J = 7.6, 
7.6, 1.3 Hz, 1H, ArH4/H5), 5.82 (d, J = 5.7 Hz, 1H, ArCH), 4.19 (t, J = 6.2 Hz, 2H, 
AcOCH2), 2.51 (d, J = 5.8 Hz, 1H, OH), 2.49 (t, J = 7.3 Hz, 2H, C≡CCH2), 2.08 (s, 
3H, CH3CO), 1.92 (tt, J = 7.0, 6.2 Hz, 2H, AcOCH2CH2), and 0.20 [s, 9H, Si(CH3)3]. 
13C NMR (125 MHz, CDCl3): δ 171.2, 143.5, 133.7, 129.6, 128.5, 127.1, 120.7, 104.2, 
91.9, 84.6, 79.4, 72.3, 65.8, 63.5, 63.0, 27.4, 21.0, 16.7, and 0.05. 
IR (neat): 3450, 2960, 2899, 2362, 2239, 2172, 1738, 1480, 1448, 1425, 1390, 1367, 
1247, 1041, 984, 955, and 848 cm-1. 
HRMS (ESI-TOF): Calcd for C21H24NaO3Si+ [M+Na+] requires 375.1392; found 
375.1389. 
7-(2-(3-(Trimethylsilyl)propioloyl)phenyl)hepta-4,6-diyn-1-yl Acetate (6022) 
  
MnO2 (400 mg, 4.60 mmol) was added to a stirred solution of triyne S17 (105 mg, 
0.298 mmol) in CH2Cl2 (3 mL) at room temperature. After 2 h the reaction mixture was 
filtered through a plug of Celite® (CH2Cl2 eluent) and concentrated. Purification by flash 
chromatography (hexanes:EtOAc 12:1) gave the ketone 6022 (90 mg, 0.26 mmol, 86%) 
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as a clear amber oil. 
1H NMR (500 MHz, CDCl3): δ 8.09 (d, J = 7.7 Hz, 1H, H6), 7.60 (d, J = 7.6 Hz, 1H, H3), 
7.50 (dd, J = 7.5, 7.5 Hz, H4), 7.44 (dd, J = 7.6, 7.6 Hz, 1H, H5), 4.18 (t, J = 6.2 Hz, 
2H, AcOCH2), 2.49 (t, J = 7.0 Hz, 2H, ArCH2), 2.07 (s, 3H, CH3CO), 1.91 (tt, J = 6.6, 
6.6 Hz, 2H, ArCH2CH2), and 0.30 (s, 9H, SiCH3).  
13C NMR (125 MHz, CDCl3): δ 176.6, 171.1, 139.1, 135.8, 132.6, 132.0, 128.6, 122.0, 
101.5, 101.4, 85.4, 80.4, 73.3, 66.4, 63.1, 27.5, 21.1, 16.8, and 0.6.  
IR (neat): 2961, 2900, 2240, 2152, 1739, 1648, 1589, 1560, 1479, 1366, 1235, 1044, 
1015, 955, and 850 cm-1.  
HRMS (ESI-TOF): Calcd for C21H22NaO3Si+ [M+Na+] requires 373.1230; found 
373.1206. 
3-(7-Oxo-6-(trimethylsilyl)-4,7-dihydro-1H-1,4-ethenobenzo[c]fluoren-5-yl)propyl 
Acetate (6025a) 
 
A solution of triyne 6022 (20 mg, 0.057 mmol) in benzene (5.5 mL) was heated at 85 
ºC (external bath temperature) in a sealed tube. After 14 h the reaction mixture was 
concentrated and purified by flash chromatography (12:1) to give fluorenone 6025a (17 
mg, 0.040 mmol, 70%) as a bright yellow oil.  
1H NMR (500 MHz, CDCl3): δ 7.93 (ddd, J = 7.7, 0.9, 0.9 Hz, 1H, H8), 7.60 (ddd, J = 
7.3, 1.3, 0.7 Hz, 1H, H11), 7.49 (ddd, J = 7.6, 7.6, 1.3 Hz, 1H, H10), 7.25 (ddd, J = 
7.4, 7.4, 0.9 Hz, 1H, H9), 6.94 (ddd, J = 6.5, 6.5, 1.6 Hz, 2H, CHa=CHb), 6.88 (ddd, J 
= 6.0, 6.0, 1.6 Hz, 2H, CHa=CHb), 5.71 (dddd, J = 5.9, 5.9, 1.7, 1.7 Hz, 1H, 
Csp3HCH=CHCsp3H), 5.24 (dddd, J = 5.9, 5.9, 1.6, 1.6 Hz, 1H, Csp3HCH=CHCsp3H), 
4.16 (t, J = 6.5 Hz, 2H, AcOCH2), 3.05-3.01 (br t, J = 8.2 Hz, 2H, ArCH2), 2.12 (s, 
3H, CH3CO), 1.83-1.76 (br tt, ΣJs = 29 Hz, 2H, ArCH2CH2), and 0.41 (s, 9H, SiCH3).  
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13C NMR (125 MHz, CDCl3): δ 194.5, 171.3, 152.1, 144.3, 143.0, 140.7, 139.1, 138.9, 
138.4, 136.8, 135.3, 135.1, 134.2, 128.2, 124.1, 122.3, 64.0, 46.0, 45.2, 32.0, 28.4, 
21.2, and 3.2.  
IR (neat): 3065, 2951, 2897, 1738, 1705, 1607, 1586, 1550, 1467, 1387, 1365, 1326, 
1301, 1244, 1043, and 857 cm-1. 
HRMS (ESI-TOF): Calcd for C27H28NaO3Si+ [M+Na+] requires 451.1700; found 
451.1724. 
3-((1R*,4S*,4aR*,11dS*)-7-Oxo-6-(trimethylsilyl)-2,3,4,4a,7,11d-hexahydro-1H-1,4-
methanobenzo[3,4]cyclobuta[1,2-c]fluoren-5-yl)propyl Acetate (6025b) 
 
A solution of triyne 6022 (20 mg, 0.057 mmol) and 2-norbornene (83 mg, 0.88 mmol) 
in ethanol-free CHCl3 (5 mL) was heated at 85 ºC (external bath temperature) in a sealed 
tube. After 18 h the reaction mixture was concentrated and purified by flash 
chromatography (12:1) to give fluorenone 6025b (16 mg, 0.036 mmol, 63%) as a bright 
yellow oil, which is assigned as the endo adduct on the basis of comparative spectral data 
for the known exo and endo adducts of o-benzyne and norbornene.165 No evidence was 
seen for the formation of a second diastereomer. 
1H NMR (500 MHz, CDCl3): δ 7.56 (ddd, J = 7.3, 1.0, 1.0 Hz, 1H, H8), 7.41 (ddd, J = 
7.4, 7.4, 1.1 Hz, 1H, H10), 7.32 (ddd, J = 7.4, 1.0, 1.0 Hz, 1H, H11), 7.22 (ddd, J = 
7.4, 7.4, 1.0 Hz, 1H, H9), 4.122 (dt, J = 11.0, 6.5 Hz, 1H, CHaHbOAc), 4.116 (dt, J = 
11.0, 6.6 Hz, 1H, CHaHbOAc) 3.31 [dd, J = 4.0, 1.0 Hz, 1H, H4a (or H11d)], 3.29 [dd, 
J = 4.0, 1.0 Hz, 1H, H11d (or H4a)], 2.71 (br t, J = 8.0 Hz, 2H, ArCH2), 2.47 (br s, 
1H, H1), 2.37 (br s, 1H, H4), 2.08 (s, 3H, CCH3), 1.88-1.72 (m, 2H, AcOCH2CH2), 
1.72-1.62 (m, 2H), 1.31-1.22 (m, 2H), 1.10 (br s, 2H), and 0.42 (s, 9H, SiCH3). 
                                                
165  Simmons, H. E. A cycloaddition reaction of benzyne. J. Am. Chem. Soc. 1961, 83, 1657–1662.  
2-norbornene, CHCl3
85 ºC, 18 h, 63%
O
TMS
OAc
6022 6025b
O TMS
H
H
OAc8
9
10 11
1
4
4a
11d
  Experimental 
 196 
13C NMR (125 MHz, CDCl3): δ 195.4, 171.2, 152.4, 143.1, 142.0, 140.7, 140.4, 140.3, 
137.5, 134.6, 134.3, 128.6, 124.0, 121.5, 64.2, 52.1, 48.6, 36.5, 35.9, 32.7, 32.0, 28.0, 
27.8, 27.7, 21.1, and 2.7. 
IR (neat): 2948, 2872, 1740, 1708, 1605, 1571, 1464, 1386, 1364, 1293, 1237, 1182, 
1173, 1079, 1042, 997, 998, 950, and 917 cm-1. 
HRMS (ESI-TOF): Calcd for C28H32NaO3Si+ [M+Na+] requires 467.2013; found 
467.2027. 
3-(9-Oxo-3-(N-phenylacetamido)-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl Acetate 
(6025c) 
 
A solution of triyne 6022 (20 mg, 0.057 mmol) and N-phenylacetamide (72 mg, 0.53 
mmol) in CHCl3 (5 mL) was heated at 85 ºC (external bath temperature) in a sealed tube. 
After 18 h the reaction mixture was concentrated and purified by flash chromatography 
(hexanes:EtOAc 5:1) to give the fluorenone 6025c (23 mg, 0.047 mmol, 82%) as a bright 
yellow oil. This sample contains ca. 5% of a second component to which we have 
tentatively assigned as the regioisomer based on resonances in the 1H NMR spectrum of 
the sample. The regioselectivity was substantiated by nOe analysis of the purified product 
mixture.  
Characterization data for 6025c 
1H NMR (500 MHz, CDCl3): δ 7.56 (ddd, J = 7.3, 1.2, 1.2 Hz, 1H, H8), 7.47−7.41 (m, 
2H, H5 and H6), 7.35 (s, 1H, H4), 7.31–7.21 (m, 3H, PhHm and H7), 7.05 (tt, J = 7.5, 
1.3 Hz, 1H, PhHp), 6.75 (dd, J = 8.4, 1.3 Hz, 2H, PhHo), 4.17 (t, J = 6.4 Hz, 2H, 
OCH2C), 2.86 (br t, J = 8.2 Hz, 2H, ArCH2), 2.13 (s, 3H, CH3CON), 2.08 (s, 3H, 
CH3CO2), 1.96–1.85 (m, ΣJs = 29.2 Hz, 2H, ArCH2CH2), and 0.46 (s, 9H, SiCH3).  
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13C NMR (125 MHz, CDCl3): δ 194.4, 171.2, 161.1, 155.5, 148.1, 145.0, 144.1, 143.4, 
140.4, 137.3, 134.5, 134.3, 129.2, 129.1, 123.9, 123.7, 120.8, 119.8, 116.6, 64.5, 31.1, 
26.5, 21.2, 16.1, and 2.8. 
IR (neat): 2950, 1738, 1711, 1685, 1591, 1487, 1467, 1368, 1295, 1224, 1164, 1120, 
1039, and 858 cm-1. 
HRMS (ESI-TOF): Calcd for C29H31NNaO4Si+ [M+Na+] requires 508.1915; found 
508.1882. 
3-(3-Acetoxy-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl Acetate (6025d) 
 
A solution of triyne 6022 (22 mg, 0.062 mmol) and acetic acid (0.2 mL, 3.5 mmol) in 
CHCl3 (5 mL) was heated at 85 ºC (external bath temperature) in a sealed tube. After 18 h 
the reaction mixture was concentrated and purified by flash chromatography 
(hexanes:EtOAc 5:1) to give fluorenone 6025d (23 mg, 0.056 mmol 89%) as a bright 
yellow oil. The regioselectivity was substantiated by nOe analysis of the purified product 
mixture. 
1H NMR (500 MHz, CDCl3): δ 7.58 (ddd, J = 7.2, 1.0, 1.0 Hz, 1H, H8), 7.46 (ddd, J = 
7.4, 7.4, 1.2 Hz, 1H, H6), 7.41 (ddd, J = 7.4, 1.0, 1.0 Hz, 1H, H5), 7.28 (ddd, J = 7.4, 
7.4, 1.1 Hz, 1H, H7), 7.22 (s, 1H, H4), 4.11 (t, J = 6.4 Hz, 2H), 2.78 (m, 2H, ArCH2), 
2.39 (s, 3H, CH3CO2Ar), 2.08 (s, 3H, CH3CO2CH2), 1.82-1.75 (br tt, ΣJs = 29 Hz, 2H, 
ArCH2CH2), and 0.46 (s, 9H, SiCH3).  
13C NMR (125 MHz, CDCl3): δ 194.3, 171.2, 169.4, 153.2, 145.2, 142.4, 143.1, 140.0, 
137.8, 134.7, 134.1, 129.3, 124.1, 119.9, 115.9, 64.2, 31.0, 26.3, 21.18, 21.12, and 2.7. 
IR (neat): 2949, 1759, 1739, 1713, 1605, 1591, 1467, 1387, 1366, 1295, 1243, 1201, 
1159, 1118, 1039, 995, and 854 cm-1. 
HRMS (ESI-TOF): Calcd for C23H26NaO5Si+ [M+Na+] requires 433.1441; found 
433,1436. 
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3-(3-(2-Hydroxyphenyl)-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl Acetate 
(6025e) 
 
A solution of triyne 6022 (21 mg, 0.06 mmol) and phenol (70 mg, 0.74 mmol) in 
CHCl3 (5 mL) was heated at 85 ºC (external bath temperature) in a sealed tube. After 14 h 
the reaction mixture was concentrated and purified by flash chromatography 
(hexanes:EtOAc 5:1) to give fluorenone 6025e (23 mg, 0.052, 86%) as a bright yellow 
oil. The regioselectivity was substantiated by nOe analysis of the purified product 
mixture. 
1H NMR (500 MHz, CDCl3): δ 7.61 (ddd, J = 7.4, 1.0, 1.0 Hz, 1H, H8), 7.46 (ddd, J = 
7.4, 7.4, 1.0 Hz, 1H, H6), 7.41 (ddd, J = 7.5, 1.0, 1.0 Hz, 1H, H5), 7.40 (s, 1H, H4), 
7.32 (ddd, J = 8.0, 7.3, 1.7 Hz, 1H, H4’), 7.28 (ddd, J = 7.3, 7.3, 1.2 Hz, 1H, H7), 
7.15 (dd, 7.5, 1.7 Hz, 1H, H6’), 7.03 (ddd, J = 7.4, 7.4, 1.3 Hz, 1H, H5’), 7.01 (dd, J 
= 7.0, 1.3 Hz, 1H, H3’), 4.84 (s, 1H, OH), 3.83 (dt, J = 6.1, 11.0 Hz, 1H, AcOCHaHb), 
3.82 (dt, J = 6.0, 10.9 Hz, 1H, AcOCHaHb), 2.87 (ddd, J = 13.7, 11.1, 5.4 Hz, 1H, 
ArCHaHb), 2.65 (ddd, J = 13.7, 11.0, 5.5 Hz, 1H, ArCHaHb), 1.87 (s, 3H, CH3CO2), 
1.70-1.54 (m, 2H, ArCH2CH2), and 0.49 (s, 9H, SiCH3).  
13C NMR (125 MHz, CDCl3): δ 195.1, 171.1, 152.2, 148.5, 143.60, 143.59, 143.4, 142.0, 
140.7, 134.8, 134.0, 130.2, 129.7, 129.2, 128.4, 124.2, 123.9, 121.0, 119.8, 115.9, 
63.8, 32.1, 29.4, 21.0, and 2.9.  
IR (neat): 3440, 2951, 1736, 1710, 1606, 1590, 1541, 1464, 1448, 1386, 1363, 1247, 
1185, 1040, and 979 cm-1. 
HRMS (ESI-TOF): Calcd for C27H28NaO4Si+ [M+Na+] requires 467.1649; found 
467.1647. 
3-(3-Bromo-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl acetate  and 3-(4-
Bromo-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl acetate (6025f) 
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A solution of triyne 6022 (18 mg, 0.051 mmol) and 2-bromoethylamine 
hydrobromide (the HBr source, 110 mg, 0.537 mmol) in THF:H2O (5 mL, 19:1) was 
heated at 85 ºC (external bath temperature) in a sealed vial. After 18 h the reaction 
mixture was diluted with H2O and extracted with EtOAc. The combined organic extracts 
were concentrated and purified by flash chromatography (hexanes: EtOAc 12:1) to give a 
mixture (6:1) of coeluting, regioisomeric fluorenones 6025f (16 mg, 0.037 mmol, 72%) 
as a bright yellow oil. These were spectroscopically characterized as a mixture. 
Characterization data of major component in 6025f 
1H NMR (500 MHz, CDCl3): δ 7.76 (s, 1H, H4), 7.60 (ddd, J = 7.4, 1.0, 1.0 Hz, 1H, H8), 
7.48 (dd, J = 7.4, 7.4, 1.1 Hz, 1H, H6), 7.44 (d, J = 7.3, 1.0, 1.0 Hz, 1H, H5), 7.30 
(ddd, J = 7.3, 7.3, 7.3, 1.1 Hz, H7), 4.17 (t, J = 6.5 Hz, 2H, AcOCH2), 3.09 (br t, J = 
8.3 Hz, 2H, ArCH2), 2.08 (s, 3H, CH3CO2), 1.90-1.80 (m, 2H, ArCH2CH2), and 0.46 
(s, 9H, SiCH3). 
13C NMR (125 MHz, CDCl3): δ 194.4, 171.19, 147.0, 144.6, 144.2, 142.8, 139.5, 134.8, 
134.0, 132.6, 129.5, 126.3, 124.3, 119.9, 64.1, 32.6, 30.6, 21.11, and 3.0 
Characterization data of minor component in 6025f 
1H NMR of S40 (500 MHz, CDCl3): δ 8.32 (ddd, J = 7.7, 0.9, 0.9 Hz, 1H, H5), 7.63 (d, J 
= 7.3, 1.2, 0.8 Hz, 1H, H8), 7.51 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H, H6), 7.39 (s, 1H, H3), 
7.32 (ddd, J = 7.5, 7.5, 0.8 Hz, 1H, H7), 4.12 (t, J = 6.4 Hz, 2H, AcOCH2), 2.83 (br t, 
J = 8.2 Hz, 2H, ArCH2), 2.08 (s, 3H, CH3CO2), 1.90-1.80 (m, 2H, ArCH2CH2), and 
0.43 (s, 9H, SiCH3). 
13C NMR of S40 (125 MHz, CDCl3): δ 194.2, 171.15, 150.5, 143.4, 143.3, 141.4, 140.3, 
134.7, 133.9, 129.2, 124.2, 123.2, 118.8, 63.7, 32.9, 32.1, 21.08, and 2.7 (one 
aromatic resonance is not detectable).  
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IR (neat): 2951, 1739, 1715, 1606, 1575, 1466, 1386, 1365, 1235, 1187, 1043, 974, 850, 
and 745 cm-1. 
HRMS (ESI-TOF): Calcd for C21H23BrNaO3Si+ [M+Na+] requires 453.0492; found 
453.0512.  
Synthesis of phthalide 6028 
 
5-(Trimethylsilyl)penta-2,4-diyn-1-yl Propiolate (S18) 
 
The following agents were added in sequence to CH2Cl2 (1.5 mL) at 0 ºC: 5-
trimethylsilyl-2,4-pentadiyn-1-ol166 (750 mg, 4.92 mmol), propiolic acid (420 mg, 6.00 
mmol), DCC (1.2 g, 5.8 mmol), and DMAP (60 mg, 0.49 mmol). The resulting 
homogeneous solution quickly became cloudy. After 3 h the resulting slurry was passed 
through a pad of Celite® (CH2Cl2) and concentrated. Purification by flash 
chromatography (hexanes:EtOAc 12:1) gave the ester S18 (513 mg, 2.51 mmol, 51%) as 
a pale yellow oil.  
1H NMR (500 MHz, CDCl3): δ 4.84 (s, 2H, CH2O), 2.95 (s, 1H, HC≡C), and 0.20 (s, 9H, 
CH3Si).  
13C NMR (125 MHz, CDCl3): δ 151.8, 89.2, 86.8, 76.2, 73.9, 72.6, 70.0, 54.0, and −0.4. 
IR (neat): 3289, 2961, 2902, 2122, 1723, 1430, 1364, 1252, 1208, 966, 859, and 847 cm-1. 
                                                
166  Hoheisel, T. N.; Frauenrath, H. A convenient Negishi protocol for the synthesis of glycosylated 
oligo(ethynylene)s. Org. Lett. 2008, 10, 4525–4528. 
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HRMS (CIMS): Calcd for C11H16NO2Si+ [M+NH4+] requires 222.0945; found 222.0968. 
Penta-2,4-diyn-1-yl Propiolate (6026) 
 
Tetra-n-butylammonium bisulfate (TBAHSO4, 10 mg, 0.03 mmol) was added to a 
vigorously stirring solution of silyl alkyne S17 (220 mg, 1.08 mmol) and NH4F (2.5 mL, 
45 wt. % in water, 30 mmol) in CH2Cl2 (5 mL) at room temperature. After 1.5 h the 
organic phase was separated from the biphasic reaction mixture and concentrated. 
Purification by flash chromatography (hexanes:EtOAc 12:1) gave the ester 6026 (72 mg, 
0.55 mmol, 50%) as a pale yellow oil. 
1H NMR (500 MHz, CDCl3): δ 4.84 (d, J = 1.0 Hz, 2H, CH2O), 2.97 (s, 1H, HC≡CC=O), 
and 2.24 (t, J = 1.0 Hz, 1H, HC≡CC≡C). 
13C NMR (125 MHz, CDCl3): δ 151.7, 76.4, 73.8, 71.9, 69.5, 68.8, 67.1, and 53.7. 
IR (neat): 3289, 2123, 1720, 1432, 1367, 1209, and 966 cm-1.  
HRMS (CIMS): Calcd for C8H8NO2+ [M+NH4+] requires 150.0550; found 150.0564. 
5-(tert-Butoxy)isobenzofuran-1(3H)-one (6028)  
 
A solution of ester 6026 (15 mg, 0.11 mmol) and 2,6-di-tert-butyl-4-methylphenol 
(butylated hydroxytoluene, BHT, 2 mg, 0.009 mmol) in t-BuOH (9 mL) was heated to 
120 ºC (external bath temperature) in a sealed tube. After 40 h the resulting solution was 
concentrated and purified by gradient flash chromatography (hexanes:EtOAc 12:1 to 5:1) 
to give the ester 6028 (16 mg, 0.078 mmol, 68%) as a clear colorless oil. 
1H NMR (500 MHz, CDCl3): δ 7.81 (dd, J = 0.4, 8.4 Hz, 1H, H7), 7.11 (ddt, J = 8.4, 2.0, 
0.9 Hz, 1H, H6), 7.04 (ddt, J = 2.0, 0.9, 0.9 Hz, 2H, H4), 5.26 (dd,  J = 0.8, 0.8 Hz, 
2H, CH2O), and 1.45 [s, 9H, C(CH3)3]. 
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13C NMR (125 MHz, CDCl3): δ 170.9, 161.7, 148.6, 126.8, 124.1, 120.0, 115.2, 80.4, 
69.2, and 29.0. 
IR (neat): 2977, 2937, 2877, 1759, 1612, 1484, 1454, 1369, 1354, 1264, 1168, 1141, 
1099, 1045, 1006, and 948 cm-1.  
HRMS (ESI-TOF): Calcd for C12H14NaO3 [M+Na+] requires 229.0835; found 229.0859.   
  Experimental 
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Synthesis of indoline precursors 7016 
 
Indoline precursors that bear different electron-withdrawing groups were synthesized 
from the common intermediate Triyne-Int. 
For 7016-Aldehyde:  
nBuLi (0.07 mL, 0.175 mmol, 1.5 equiv) was added to a stirred solution of Triyne-
Int (50 mg, 0.11 mmol) in THF (1 mL) at -78 ºC. After 1 h excess paraformaldehyde was 
added as solid in one portion at the same temperature. The reaction mixture was warmed 
up to room temperature overnight, then quenched with satd. aq. NH4Cl, diluted with H2O, 
and washed with EtOAc. The combined organic extracts were washed with brine, dried 
(Na2SO4), and concentrated. Purification by flash chromatography (hexanes:EtOAc 1:1) 
gave the ynol S18 (30 mg, 61%) as a pale yellow oil and recovered starting material 
Triyne-Int (11 mg, 26%). 
1H NMR (500 MHz, CDCl3): δ 7.80 (d, J = 8.4 Hz, 2H, ArHoSO2), 7.37 (d, J = 8.1 Hz, 
2H, ArHmSO2), 4.20 (dt, J = 6.0, 2.0 Hz, 2H, CH2OH), 3.68 (t, J = 5.9 Hz, 2H, 
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CH2OTBS), 3.50 (t, J = 7.3 Hz, 2H, NCH2), 2.56 (tt, J = 7.4, 2.1 Hz, 2H, NCH2CH2), 
2.46 (s, 3H, ArCH3), 2.40 (t, J = 7.1 Hz, 2H, CCCH2), 1.73 (tt, J = 7.0, 6.0 Hz, 2H, 
CH2CH2CH2), 1.26 (t, J = 7.2 Hz, 1H, OH), 0.90 [s, 9H, C(CH3)3], and 0.06 [s, 6H, 
Si(CH3)2]. 
To a solution of S18 (11 mg) in DCM at room temperature was added MnO2 (70 mg). 
The mixture was stirred for 3 h, filtered and concentrated. Flash chromatography (SiO2, 
hexanes:EtOAc = 5:1) gave 7016-Aldehyde as a yellow oil. 
1H NMR (500 MHz, CDCl3): δ 9.12 (s, 1H, CHO), 7.80 (d, J = 8.4 Hz, 2H, ArHoSO2), 
7.38 (d, J = 8.0 Hz, 2H, ArHmSO2), 3.68 (t, J = 5.9 Hz, 2H, CH2OTBS), 3.58 (t, J = 
7.2 Hz, 2H, NCH2), 2.77 (t, J = 7.4 Hz, 2H, NCH2CH2), 2.47 (s, 3H, ArCH3), 2.41 (t, 
J = 7.1 Hz, 2H, CCCH2), 1.74 (tt, J = 7.0, 6.1 Hz, 2H, CH2CH2CH2), 0.90 [s, 9H, 
C(CH3)3], and 0.06 [s, 6H, Si(CH3)2]. 
For 7016-Amide: 
nBuLi (0.07 mL, 0.175 mmol, 1.5 equiv) was added to a stirred solution of Triyne-
Int (50 mg, 0.11 mmol) in THF (1 mL) at -78 ºC. After 1 h excess CO2 (gas) was bubbled 
through the reaction solution at the same temperature. Without further purification, the 
reaction mixture was concentrated to give the carboxylate. 
1H NMR (500 MHz, CDCl3): δ 7.78 (d, J = 8.2 Hz, 2H, ArHoSO2), 7.33 (d, J = 8.3 Hz, 
2H, ArHmSO2), 3.64 (t, J = 5.9 Hz, 2H, CH2OTBS), 3.46 (br t, J = 5 Hz, 2H, NCH2), 
2.51 (br t, J = 5 Hz, 2H, NCH2CH2), 2.41 (s, 3H, ArCH3), 2.36 (t, J = 7.1 Hz, 2H, 
CCCH2), 1.69 (tt, J = 6.7, 6.7 Hz, 2H, CH2CH2CH2), 0.88 [s, 9H, C(CH3)3], and 0.04 
[s, 6H, Si(CH3)2]. 
EDCI and DMAP were added to a DMF solution of Et2NH (1.1 equiv) and S19 
obtained from the previous step. The reaction was worked up as usual. Flash 
chromatography (SiO2, hexanes:EtOAc = 5:1) gave 7016-Amide as a yellow oil. 
1H NMR (500 MHz, CDCl3): δ 7.79 (d, J = 8.4 Hz, 2H, ArHoSO2), 7.37 (d, J = 8.5 Hz, 
2H, ArHmSO2), 3.68 (t, J = 5.9 Hz, 2H, CH2OTBS), 3.57 (q, J = 7.2 Hz, 2H, 
NCH2aCH3a), 3.52 (t, J = 7.4 Hz, 2H), 3.40 (q, J = 7.2 Hz, 2H, NCH2bCH3b), 2.72 (t, J 
= 7.4 Hz, 2H), 2.46 (s, 3H, ArCH3), 2.40 (t, J = 7.1 Hz, 2H, CCCH2), 1.73 (tt, J = 7.1, 
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6.1 Hz, 2H, CH2CH2CH2), 1.21 (q, J = 7.1 Hz, 3H, NCH2aCH3a), 1.13 (q, J = 7.1 Hz, 
3H, NCH2bCH3b), 0.89 [s, 9H, C(CH3)3], and 0.06 [s, 6H, Si(CH3)2]. 
7016-Ketone and 7016-Ester were prepared using protocols similar to that used in 
the synthesis of S8, from acetyl chloride and methyl chloroformate, respectively.  
Synthesis of carbazoles using HDDA reaction 
 
Hsung’s ynamide synthesis method was successful in prepare indoline precursors, but 
not effective in making carbazole precursors like S20. Instead, S20 was prepared 
following General Procedure C from the known N-ethynyl-4-methyl-N-(2-
((trimethylsilyl)ethynyl)phenyl)benzenesulfonamide (160 mg, 0.44 mmol), 
bromopropargyl alcohol (1.5 equiv, 0.66 mmol), 30% aq. BuNH2 (2 mL), CuCl (10 mg), 
and Et2O (2 mL). S20 was obtained following flash chromatography as a yellow oil.  
 1H NMR (500 MHz, CDCl3): δ 7.67 (d, J = 8.3 Hz, 2H, ArHoSO2), 7.48-7.45 (m, 1H, 
ArH), 7.35-7.28 (m, 5H, ArHmSO2 and ArH), 4.35 (s, 2H, CH2OH), 2.45 (s, 3H, 
ArCH3), and 0.16 [s, 9H, Si(CH3)3]. 
A solution of S20 and MeOH or admantyl isocyanide in CDCl3 was heated at 80 °C 
for 18 h. The resulting solution was concentrated and purified with flash chromatography 
to give 7011e or 7014b as light yellow oil.  
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Chracterization data for 7011e: 
1H NMR (500 MHz, CDCl3): δ 8.34 (d, J = 8.3 Hz, 1H), 8.03 (s, 1H, ArH), 7.95 (d, J = 
7.6 Hz, 1H), 7.64 (d, J = 8.4 Hz, 2H, ArHoSO2), 7.38 (ddd, J = 8.4, 7.3, 1.1 Hz, 1H), 
7.33-7.28 (m overlapping with S20), 7.12 (d, J = 8.4 Hz, 2H, ArHmSO2), 4.85 (s, 2H, 
CH2O), 4.04 (s, 3H, CH3O), 2.29 (s, 3H, ArCH3), and 0.54 [s, 9H, Si(CH3)3]. 
Chracterization data for 7014d: 
1H NMR (500 MHz, CDCl3): δ 8.87 (s, <1H), 8.41 (d, J = 8.4 Hz, 1H), 8.10 (d, J = 7.9 
Hz, 1H), 7.76 (d, J = 8.4 Hz, 2H, ArHoSO2), 7.51 (ddd, J = 8.4, 7.3, 1.1 Hz, 1H), 7.35 
(ddd, J = 8.2, 7.3, 1.0 Hz, 1H), 7.14 (d, J = 8.4 Hz, 2H, ArHmSO2), 5.45 (s, 2H, 
CH2O), 2.28 (s, 3H, ArCH3), 2.10-1.66 (overlapping m), and 0.52 [s, 9H, Si(CH3)3]. 
 
3-(3-(2-hydroxy-5-methoxyphenyl)-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl 
acetate 
 
A solution of triyne (21 mg, 0.06 mmol) and p-cresol (70 mg, 0.74 mmol) in CHCl3 
(5 mL) was heated at 85 ºC (external bath temperature) in a sealed tube. After 14 h the 
reaction mixture was concentrated and purified by flash chromatography (hexanes:EtOAc 
5:1) to give fluorenone 7030a (23 mg, 0.052, 86%) as a bright yellow oil.  
H NMR (500 MHz, CDCl3): δ 7.61 (ddd, J = 7.3, 1.0, 1.0 Hz, 1H, H5), 7.46 (ddd, J = 
7.4, 7.4, 1.2 Hz, 1H, H6), 7.42 (ddd, J = 7.4, 1.0, 1.0 Hz, 1H, H8), 7.40 (s, 1H, H4), 
7.30 (ddd, J = 7.3, 7.3, 1.1 Hz, 1H, H7), 6.93 (d, J = 8.9 Hz, 1H, H3’), 6.88 (dd, J 
=8.9, 3.0 Hz, 1H, H4’), 6.70 (d, J = 3.0 Hz, 1H, H6’), 4.56 (s, 1H, OH), 3.86 (dt, J = 
11.0, 6.0 Hz, 1H, AcOCHaHb), 3.83 (dt, J = 11.1, 6.0 Hz, 1H, AcOCHaHb), 3.80 (s, 
3H, CH3O), 2.88 (ddd, J = 13.7, 10.9, 5.6 Hz, 1H, ArCHaCHb), 2.69 (ddd, J = 13.7, 
10.9, 5.7 Hz, 1H, ArCHaCHb), 1.89 (s, 3H, CH3C=O), 1.72-1.57 (m, 2H, 
CH2CH2CH2), and 0.49 [s, 9H, Si(CH3)3].  
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13C NMR (125 MHz, CDCl3): δ 195.2, 171.3, 153.7, 148.3, 146.2, 143.7, 143.6, 143.4, 
142.3, 140.7, 134.9, 134.0, 129.2, 129.1, 124.2, 123.9, 119.9, 116.8, 115.2, 115.1, 
64.0, 56.0, 32.1, 29.5, 21.0, and 3.0 ppm. 
 
3-(3-(2-hydroxy-5-bromophenyl)-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl 
acetate (7030f) 
 
Compound 7030f was made following the same procedure used in the synthesis of 
7030a. 
1H NMR (500 MHz, CDCl3): δ 7.62 (ddd, J = 7.3, 1.0, 1.0 Hz, 1H, H5), 7.47 (ddd, J = 
7.4, 7.4, 1.2 Hz, 1H, H6), 7.423 (ddd, J = 7.4, 1.0, 1.0 Hz, 1H, H8), 7.416 (dd, J =8.3, 
2.4 Hz, 1H, H4’), 7.37 (s, 1H, H4), 7.30 (d, J = 2.5 Hz, 1H, H6’), 7.29 (ddd, J = 7.4, 
7.4, 1.1 Hz, 1H, H7), 6.91 (d, J = 8.7 Hz, 1H, H3’), 5.08 (s, 1H, OH), 3.86 (t, J = 6.1 
Hz, 2H, AcOCH2), 2.85 (ddd, J = 13.7, 11.0, 5.4 Hz, 1H, ArCHaCHb), 2.67 (ddd, J = 
13.8, 11.0, 5.5 Hz, 1H, ArCHaCHb), 1.90 (s, 3H, CH3C=O), 1.71-1.54 (m, 2H, 
CH2CH2CH2), and 0.48 [s, 9H, Si(CH3)3].  
13C NMR (125 MHz, CDCl3): δ 195.0, 171.3, 151.7, 148.3, 143.7, 143.5, 141.1, 140.6, 
135.0, 133.9, 132.7, 132.5, 130.5, 129.4, 124.3, 123.7, 119.9, 117.9, 112.9, 63.8, 21.1, 
29.5, 21.0, and 2.9 ppm (one carbon missing). 
3-(3-(7-hydroxy-1H-indol-6-yl)-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl 
acetate (7030g) 
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Compound 7030g was made following the same procedure used in the synthesis of 
7030a. 
1H NMR (500 MHz, CDCl3): δ 8.30 (s, 1H, NH), 7.61 (d, J = 7.4, 1.1, 0.7 Hz, 1H), 7.47 
(s, 1H, H4), 7.44 (ddd, J = 7.4, 7.4, 1.0 Hz, 1H), 7.39 (ddd, J = 7.5, 1.2, 0.8 Hz, 1H), 
7.27 (ddd, J = 7.4, 7.4, 1.0 Hz, 1H), 7.21 (dd, J = 3.3, 2.3 Hz, 1H), 7.09 (dd, J = 8.2, 
1.0 Hz, 1H), 6.95 (d, J = 8.2 Hz, 1H), 6.70 (ddd, J = 3.2, 2.1, 1.0 Hz, 1H), 5.16 (s, 
1H, OH), 3.78 (dt, J = 11.4, 6.4 Hz, 1H), 3.76 (dt, J = 11.4, 6.4 Hz, 1H), 2.90 (ddd, J 
= 13.7, 9.8, 6.6 Hz, 1H, ArCHaHb), 2.74 (ddd, J = 13.6, 9.6, 6.6 Hz, 1H, ArCHaHb), 
1.66 (s, 3H, CH3C=O), 1.65-1.57 (m, 2H, CH2CH2CH2), and 0.50 [s, 9H, Si(CH3)3].  
13C NMR (HSQC, 125 MHz, CDCl3): δ 134.5 (CH), 128.9 (CH), 124.7 (CH), 124.2 
(CH), 123.9 (CH), 123.4 (CH), 119.5 (CH), 104.1 (CH), 99.9 (CH), 63.8 (CH2), 31.9 
(CH2), 29.2 (CH2), 20.5 (CH3), and 3.0 (CH3) ppm. 
 
3-(3-(6-hydroxy-1H-indol-7-yl)-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl 
acetate (7030j) 
 
Compound 7030j was made following the same procedure used in the synthesis of 
7030a 
1H NMR (500 MHz, CDCl3): δ 8.19 (s, 1H, NH), 7.61 (d, J = 7.3, 1.0, 1.0 Hz, 1H), 7.50 
(s, 1H, H4), 7.43 (ddd, J = 7.4, 7.4, 1.2 Hz, 1H), 7.38 (ddd, J = 7.4, 1.0, 1.0 Hz, 1H), 
7.33 (dd, J = 8.7, 1.0 Hz, 1H), 7.27 (ddd, J = 7.4, 7.4, 1.1 Hz, 1H), 7.19 (dd, J = 3.1, 
2.5, 0.5 Hz, 1H), 6.9 (dd, J = 8.7, 0.5 Hz, 1H), 6.11 (ddd, J = 3.1, 2.1, 0.9 Hz, 1H), 
4.68 (s, 1H, OH), 3.70 (t, J = 6.3 Hz, 1H), 2.90 (ddd, J = 13.7, 9.8, 6.6 Hz, 1H, 
ArCHaHb), 2.77 (nfom, 2H, ArCH2), 1.78 (s, 3H, CH3C=O), 1.67-1.51 (m, 2H, 
CH2CH2CH2), and 0.50 [s, 9H, Si(CH3)3].  
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13C NMR (125 MHz, CDCl3): δ 135.0 (CH), 129.6 (CH), 125.9 (CH), 124.7 (CH), 124.4 
(CH), 120.2 (CH), 112.5 (CH), 112.2 (CH), 101.9 (CH), 64.4 (CH2), 32.4 (CH2), 30.0 
(CH2), 21.2 (CH3), and 3.3 (CH3) ppm. 
HRMS (ESI-TOF): Calcd for C20H19NNaO+ [M+Na]+ requires 312.1359; found 
312.1371. 
  
  Experimental 
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1-(6-butyl-7-(hex-1-yn-1-yl)-1,3-dihydroisobenzofuran-4-yl)naphthalen-2-ol (7032e) 
 
 
1H NMR (500 MHz, CDCl3): δ 7.81 (dd, J = 6.9, 2.1 Hz, 1H), 7.80 (d, J = 8.9 Hz, 1H, 
H4), 7.36 (ddd, J = 6.9, 6.9, 1.7 Hz, 1H), 7.33 (ddd, J = 6.8, 6.8, 1.9 Hz, 1H), 7.30 
(dd, J = 7.3, 2.1 Hz, 1H), 7.23 (d, J = 8.9 Hz, 1H, H3), 7.12 (s, 1H, H5’), 5.26 (dt, J = 
13.4, 1.8 Hz, CHaHbO), 5.23 (dt, J = 13.2, 2.2 Hz, CHaHbO), 5.05 (s, 1H, OH), 4.81 
(dt, J = 12.8, 2.0 Hz, 1H, CHa’Hb’O), 4.75 (dt, J = 12.7, 2.2 Hz, 1H, CHa’Hb’O), 
2.83 (br t, J = 7.9 Hz, 2H, ArCH2), 2.52 (t, J = 7.0 Hz, 2H, CCCH2), 1.69-1.61 (m, 
4H, CH2), 1.54 (dt, J = 7.8, 7.8 Hz, 2H, CH2CH3), 1.40 (dt, J = 7.5, 7.5 Hz, 2H, 
CH2CH3), 0.99 (t, J = 7.4 Hz, 3H, CH3), and 0.94 (t, J = 7.4 Hz, 3H, CH3).  
13C NMR (HSQC, 125 MHz, CDCl3): δ 130.5 (CH), 130.0 (CH), 128.5 (CH), 127.0 
(CH), 124.3 (CH), 123.6 (CH), 117.5 (CH), 74.7 (CH2), 74.2 (CH2), 34.0 (CH2), 33.1 
(CH2), 31.0 (CH2), 22.8 (CH2), 22.1 (CH2), 19.5 (CH2), 14.1 (CH3), and 13.8 (CH3) 
ppm. 
 
Synthesis of monochlorinated fluorenones 7035a and 7035b (Scheme 7.9) 
 
3-(3-Chloro-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl acetate (7035a)  
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and 3-(4-Chloro-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl acetate (7035b) 
A solution of known triyne acetate 1 (27 mg, 0.077 mmol, 1 equiv) and Et3N•HCl (53 
mg, 0.385 mmol, 5 equiv) in CHCl3 was heated at 85 °C for 18 h. The resulting solution 
was concentrated and subjected to flash chromatography (SiO2, Hexanes:EtOAc = 5:1) to 
give a co-eluting mixture (6:1 ratio by 1H NMR analysis, 23 mg, 77%) of 7035a and 
7035b from which the following spectral data were deduced. 
Characteristic peaks for 7035a: 
 1H NMR (500 MHz, CDCl3): δ 7.59 (ddd, J = 7.3, 1.0, 1.0 Hz, 1H, H8), 7.54 (s, 1H, 
H4), 7.47 (ddd, J = 7.4, 7.4, 1.3 Hz, 1H, H6), 7.44 (ddd, J = 7.3, 1.0, 1.0 Hz, 1H, H5), 
7.29 (ddd, J = 7.3, 7.3, 1.3 Hz, 1H, H7), 4.16 (t, J = 6.4 Hz, AcOCH2), 3.05 (br t, J = 
8.3 Hz, 2H, ArCH2), 2.08 (s, 3H, CH3C=O), 1.88-1.82 (m, 2H, CH2CH2CH2), and 
0.47 [s, 9H, Si(CH3)3]. 
13C NMR (125 MHz, CDCl3): δ 194.3, 171.3, 145.6, 144.7, 144.2, 142.9, 140.9, 138.8, 
134.8, 134.1, 129.5, 124.3, 122.8, 119.9, 64.2, 30.4, 29.8, 21.2, and 3.0 ppm. 
Characteristic peaks for 7035b: 
1H NMR (500 MHz, CDCl3): δ 8.12 (ddd, J = 7.6, 0.9, 0.9 Hz, 1H, H5), 7.62 (ddd, J = 
7.3, 1.0, 1.0 Hz, 1H, H8), 7.50 (ddd, J = 7.6, 7.6, 1.3 Hz, 1H, H6), 7.31 (ddd, J = 7.3, 
7.3, 1.0 Hz, 1H, H7), 7.20 (s, 1H, H3), 4.12 (t, J = 6.5 Hz, AcOCH2), 2.84 (br t, J = 
8.0 Hz, 2H, ArCH2), 1.90-1.83 (m, 2H, CH2CH2CH2), and 0.43 [s, 9H, Si(CH3)3]. 
13C NMR (125 MHz, CDCl3, not all resonances were discernable for the minor isomer): 
δ 136.3, 135.0, 129.2, 124.2, 123.8, 63.8, 33.0, 32.2, and 2.7 ppm. 
IR (neat): 2951, 2896, 1740, 1714, 1606, 1582, 1469, 1386, 1365, 1247, 1233, and 
851cm-1. 
HRMS (ESI-TOF): Calcd for C21H23ClNaO3Si+ [M+Na]+ requires 409.0997; found 
409.1050. 
mp: 57–64 °C. 
 Synthesis of isoindoline 7038 (Scheme 7.11) 
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4-Methyl-N,N-di(nona-2,4-diyn-1-yl)benzenesulfonamide (7037) 
 
Tetrayne 7037 was prepared following General Procedure B from 4-methyl-N,N-
di(prop-2-yn-1-yl)benzenesulfonamide167 (500 mg, 2.0 mmol), 1-bromohex-1-yne168 (ca. 
3 g, 40 wt% in pentane, 1.2 g, 7.5 mmol), CuCl (60 mg, 0.6 mmol), and piperidine (5 
mL). Purification by flash chromatography (hexanes:EtOAc 12:1 to 5:1) gave the 
tetrayne 7037 (733 mg, 1.8 mmol, 90%) as a clear yellow oil.  
1H NMR (500 MHz, CDCl3): δ 7.69 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.32 (d, J = 8.2 Hz, 
2H, SO2ArHm), 4.18 (s, 4H, NCH2), 2.43 (s, 3H, ArCH3), 2.24 (t, J = 6.9 Hz, 4H, C
≡CCH2), 1.53-1.45 (m, 4H, C≡CCH2CH2), 1.44-1.35 [m, 4H, CH2CH3], and 0.91 (t, 
J s= 7.2 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 144.3, 134.9, 129.9, 128.1, 81.1, 71.2, 68.1, 64.4, 37.5, 
30.3, 22.1, 21.8, 19.1 and 13.7. 
IR: 2958, 2932, 2872, 2257, 1465, 1426, 1354, 1164, 1093, and 894 cm-1. 
HRMS (ESI-TOF): Calcd for C25H29NNaO2S+ [M+Na]+ requires 430.1811; found 
430.1813. 
5-Butyl-6,7-dichloro-4-(hex-1-yn-1-yl)-2-tosylisoindoline (7038) 
                                                
167  Oppolzer, W.; Pimm, A.; Stammen, B.; Hume, W. E. Palladium‐catalysed intramolecular cyclisations of 
olefinic propargylic carbonates and application to the diastereoselective synthesis of enantiomerically 
pure (−)-α‐thujone. Helv. Chim. Acta. 1997, 80, 623–639. 
168  Niggemann, M.; Jelonek, A.; Biber, N.; Wuchrer, M.; Plietker, B. A General, Iterative, and Modular 
Approach toward Carbohydrate Libraries Based on Ruthenium-Catalyzed Oxidative Cyclizations. J. 
Org. Chem. 2008, 73, 7028–7036. 
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Dichloride 7 was prepared by heating tetrayne 7037 (28 mg, 0.07 mmol) and 
Li2CuCl4 (0.7 mL, 1M in THF, 0.7 mmol) in THF (1.4 mL) at 68 °C for 18 hours. 
Purification by flash chromatography (hexanes:EtOAc 12:1 to 5:1) gave the dichloride 
7038 (28 mg, 0.059 mmol, 85%) as a colorless solid.  
1H NMR (500 MHz, CDCl3): δ 7.78 (d, J = 8.0 Hz, 2H, SO2ArHo), 7.34 (d, J = 8.0 Hz, 
2H, SO2ArHm), 4.66 (s, 2H, NCH2), 4.61 (s, 2H, NC'H2), 2.89 (nfom, 2H, ArCH2), 
2.47 (t, 2H, J = 6.9 Hz, C≡CCH2), 2.42 (s, 3H, ArCH3), 1.60 (m, 2H,CH2CH2CH3), 
1.49 (m, 4H, CH2CH3 and C'H2C'H2C'H3), 1.39 (tq, J = 7.3, 7.3 Hz, 2H, CH2CH3), 
0.97 (t, J = 7.3 Hz, 3H, CH2CH3), and 0.93 (t, J =7.3 Hz, 3H, C'H2C'H3). 
13C NMR (125 MHz, CDCl3): δ 144.3, 144.1, 138.3, 133.8, 133.7, 131.7, 130.2, 127.7, 
126.8, 118.6, 100.3, 75.5, 55.1, 54.6, 33.1, 31.2, 30.9, 23.0, 22.2, 21.7, 19.5, 14.1, and 
13.8. 
IR (neat): 2955, 2933, 2861, 2226, 1346, 1153, 1098, 764, and 751 cm-1.    
HRMS (ESI-TOF): Calcd for C23H25Cl2NNaO2S+ [M+Na+] requires 500.1188; found 
500.1204. 
mp: 132–134 °C. 
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Synthesis of isoindoline 7039a 
 
N,N-Bis(7-hydroxyhepta-2,4-diyn-1-yl)-4-methylbenzenesulfonamide (S21) 
 
Diol S21 was prepared by General Procedure C form 4-methyl-N,N-di(prop-2-yn-1-
yl)benzenesulfonamide (412 mg, 1.67 mmol), 4-bromobut-3-yn-1-ol (740 mg, 5 mmol), 
CuCl (33 mg, 0.33 mmol), 30% aq. nBuNH2 (4 mL), and CH2Cl2 (4 mL). Purification by 
flash chromatography (hexanes:EtOAc = 1:1) gave the diol S21 (575 mg, 1.5 mmol, 
90%) as a light yellow oil.  
1H NMR (500 MHz, CDCl3): δ 7.69 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.33 (d, J = 8.2 Hz, 
2H, SO2ArHm), 4.18 (s, 4H, NCH2), 3.73 (br dt, J = 5.3, 5.3 Hz, 4H, OCH2), 2.52 (t, J 
= 6.3 Hz, 4H, C≡CCH2), 2.44 (s, 3H, ArCH3), and 2.17 (t, J = 5.7 Hz, 2H, OH).  
13C NMR (125 MHz, CDCl3): δ 144.5, 134.7, 129.9, 128.0, 77.7, 70.9, 68.8, 66.0, 60.7, 
37.5, 23.7, and 21.8 ppm. 
IR (neat): 3374, 2943, 2888, 2258, 1597, 1420, 1348, 1329, 1160, 1092, 1045, and 750 
cm-1. 
HRMS (ESI-TOF): Calcd for C21H21NNaO4S+ [M+Na]+ requires 406.1083; found 
406.1072. 
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N,N-Bis(7-acetoxyhepta-2,4-diyn-1-yl)-4-methylbenzenesulfonamide (S22) 
 
To a solution of diol S21 (80 mg, 0.21 mmol) in DCM (1 mL) cooled at 0 °C was 
sequentially added NEt3 (80 mg, 0.8 mmol), DMAP (a few crystals), and AcCl (47 mg, 
0.6 mmol). The reaction mixture was allowed to stir at this temperature for an additional 
2 h. The resulting solution was partitioned between water and EtOAc. The organic layer 
was washed (satd. NH4Cl and brine), dried (Na2SO4), and concentrated. The resulting 
crude oil was purified by flash chromatography (hexanes:EtOAc = 1:1) to give the 
diacetate S22 (70 mg, 0.15 mmol, 71%) as a light yellow oil. 
1H NMR (500 MHz, CDCl3): δ 7.69 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.33 (d, J = 8.1 Hz, 
2H, SO2ArHm), 4.18 (s, 4H, NCH2), 4.14 (t, J = 6.7 Hz, 4H, OCH2), 2.60 (t, J = 6.7 
Hz, 4H, C≡CCH2), 2.44 (s, 3H, ArCH3), and 2.08 (s, 6H, CH3C=O).  
13C NMR (125 MHz, CDCl3): δ 170.9, 144.4, 134.8, 129.9, 128.0, 76.3, 70.8, 69.0, 65.9, 
61.7, 37.4, 21.8, 21.1, and 19.9 ppm. 
IR (neat): 2966, 2918, 2261, 1739, 1598, 1494, 1452, 1353, 1232, 1163, 1093, 1043, and 
903 cm-1. 
HRMS (ESI-TOF): Calcd for C25H25NNaO6S+ [M+Na]+ requires 490.1295; found 
490.1311. 
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2-[4-(4-Acetoxybut-1-yn-1-yl)-6,7-dichloro-2-tosylisoindolin-5-yl]ethyl acetate 
(7039a) 
 
Dichloride 7039a was prepared by heating tetrayne S22 (21 mg, 0.045 mmol) and 
Li2CuCl4 (0.45 mL, 1M in THF, 0.45 mmol) in THF (1 mL) at 68 °C for 18 hours. 
Purification by flash chromatography (hexanes:EtOAc 5:1 to 2:1) gave the dichloride 
7039a (22 mg, 0.041 mmol, 91%) as a colorless oil.  
1H NMR (500 MHz, CDCl3): δ 7.79 (d, J = 8.2 Hz, 2H, SO2ArHo), 7.35 (d, J = 8.0 Hz, 
2H, SO2ArHm), 4.67 (br s, 2H), 4.63 (br s, 2H), 4.27 (t, J = 6.6 Hz, 2H, AcOCH2), 
4.25 (t, J = 6.6 Hz, 2H, AcOC'H2), 3.28 (t, J = 6.9 Hz, 2H, ArCH2CH2), 2.82 (t, J = 
6.5 Hz, 2H, ≡CCH2CH2), 2.43 (s, 3H, ArCH3), 2.13 (s, 3H, CH3C=O), and 2.01 (s, 
3H, C'H3C=O).  
13C NMR (125 MHz, CDCl3): δ 171.01, 171.00, 144.3, 139.3, 138.7, 135.1, 133.8, 132.5, 
130.2, 127.74, 127.72, 118.7, 96.2, 76.4, 62.3, 62.1, 55.0, 54.6, 32.5, 21.8, 21.2, 21.0, 
and 20.4 ppm. 
IR (neat):  2960, 2925, 2856, 1739, 1351, 1234, 1165, 1098, 1042, and 816 cm-1. 
HRMS (ESI-TOF): Calcd for C25H25Cl2NNaO6S+ [M+Na]+ requires 560.0672; found 
560.0677. 
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Synthesis of isoindoline 7039b 
 
N,N-Bis(8-chloroocta-2,4-diyn-1-yl)-4-methylbenzenesulfonamide (S20) 
 
Tetrayne S23 was prepared following General Procedure C from 4-methyl-N,N-
di(prop-2-yn-1-yl)benzenesulfonamide (124 mg, 0.5 mmol), 1-bromo-5-chloropent-1-
yne169 (305 mg, 1.69 mmol), CuCl (15 mg, 0.15 mmol), NH2OH•HCl (a few crystals), 
CH2Cl2 (2 mL), and 30 wt% aqueous BuNH2 (1.5 mL). Purification by flash 
chromatography (hexanes:EtOAc 12:1 to 5:1) gave the tetrayne S3 (170 mg, 0.38 mmol, 
76%) as a clear yellow oil.  
1H NMR (500 MHz, CDCl3): δ 7.70 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.33 (d, J = 8.5 Hz, 
2H, SO2ArHm), 4.18 (s, 4H, CH2N), 3.62 (t, J = 6.3 Hz, 4H, CH2Cl), 2.46 (t, J = 6.8 
Hz, 4H, ≡CCH2), 2.44 (s, 3H, CH3), and 1.97 (tt, J = 6.8, 6.8 Hz, 4H, CH2CH2CH2). 
13C NMR (125 MHz, CDCl3): δ 144.4, 134.8, 129.9, 128.0, 78.9, 70.9, 68.6, 65.4, 43.5, 
37.4, 30.9, 21.8, and 16.8 ppm. 
IR (neat): 2961, 2258, 1597, 1494, 1440, 1351, 1162, 1092, 891, and 815 cm-1. 
HRMS (ESI-TOF): Calcd for C23H23Cl2NNaO2S+ [M+Na]+ requires 470.0719; found 
470.0751. 
  
                                                
169  Nicolai, S.; Sedigh-Zadeh, R.; Waser, J. Pd(0)-catalyzed alkene oxy- and aminoalkynylation with 
aliphatic bromoacetylenes. J. Org. Chem. 2013, 78, 3783–3801. 
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4,5-Dichloro-7-(5-chloropent-1-yn-1-yl)-6-(3-chloropropyl)-2-tosylisoindoline (7039b) 
 
Dichloride 7039b was prepared by heating tetrayne S23 (50 mg, 0.12 mmol) and 
Li2CuCl4 (1.2 mL, 1M in THF, 1.2 mmol) in THF (2.8 mL) at 68 °C for 18 hours. 
Purification by flash chromatography (hexanes:EtOAc 12:1 to 5:1) gave the dichloride 
7039b (50 mg, 0.097 mmol, 86%) as a colorless solid.  
1H NMR (500 MHz, CDCl3): δ 7.79 (d, J = 8.0 Hz, 2H, SO2ArHo), 7.35 (d, J = 8.0 Hz, 
2H, SO2ArHm), 4.66 (s, 2H, NCH2), 4.62 (s, 2H, NC'H2), 3.69 (t, 2H, J = 6.2 Hz, 
CH2Cl), 3.59 (t, 2H, J = 6.3 Hz, C'H2Cl), 3.07 (nfom, 2H, ArCH2), 2.70 (t, J = 6.9 Hz, 
2H, C≡CCH2), 2.42 (s, 3H, ArCH3), 2.09 (tt, J = 6.5, 6.5 Hz, 2H, C≡CCH2CH2), and 
1.99 (nfom, 2H, ArCH2CH2). 
13C NMR (125 MHz, CDCl3): δ 144.2, 142.5, 138.5, 134.5, 133.7, 131.9, 130.2, 127.7, 
127.4, 118.3, 98.7, 76.0, 55.0, 54.6, 44., 43.8, 31.7, 31.2, 30.9, 21.7, and 17.3. 
IR (neat): 2960, 2861, 2230, 1349, 1164, 1098, 1069, 764, and 751 cm-1.  
HRMS (ESI-TOF): Calcd for C23H23Cl4NNaO2S+ [M+Na+] requires 540.0096; found 
540.0087. 
mp: 138–144 °C.    
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Synthesis of isoindoline 7039c 
4,5-Dichloro-2-tosyl-6-{[(triisopropylsilyl)oxy]methyl}-7-{3-
[(triisopropylsilyl)oxy]prop-1-yn-1-yl}isoindoline (7039c) 
 
Dichloride 7039c was prepared following General Procedure C from known 
tetrayne170 (20 mg, 0.03 mmol), Li2CuCl4 (0.3 mL, 1M in THF, 0.3 mmol), and THF (0.7 
mL). Purification by flash chromatography (hexanes:EtOAc 12:1 to 5:1) gave the 
dichloride 7039c (17 mg, 0.023 mmol, 77%) as a colorless solid.  
1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.0 Hz, 2H, SO2ArHo), 7.33 (d, J = 8.0 Hz, 
2H, SO2ArHM), 4.97 (s, 2H, CH2), 4.68 (s, 2H, CH2), 4.65 (s, 2H, CH2), 4.61 (s, 2H, 
CH2), 2.42 (s, 3H, ArCH3), 1.20-1.08 (m, 2H, SiCH(CH3)2], 1.12 [d, J = 5.9 Hz, 6H, 
SiCH(CH3)2], and 1.07 [d, J = 6.5 Hz, 6H, SiCH(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 144.2, 141.3, 138.9, 136.0, 133.7, 133.5, 130.2, 128.2, 
127.8, 118.2, 97.6, 78.8, 62.5, 55.1, 54.7, 52.7, 21.8, 18.2, 12.3, and 12.2. 
IR (neat): 2944, 2891, 2863, 2362, 2343, 1463, 1356, 1167, 1100, 1068, 883, and 813 
cm-1.  
HRMS (ESI-TOF): Calcd for C37H57Cl2NNaO4SSi2+ [M+Na+] requires 760.2816; found 
760.2839. 
mp: 122–126 °C. 
                                                
170  Chen, J.; Baire, B.; Hoye, T. R. Cycloaddition reaction of azide, furan, and pyrrole units with benzynes 
generated by the hexadehydro-Diels–Alder (HDDA) reaction. Heterocycles 2014, 88, 1191–1200. 
Li2CuCl4, THF
68 ˚C, 18 h, 77%
N
OTIPS
OTIPS
N
Cl
Cl
OTIPS
OTIPS
7039c
Ts
Ts
  Experimental 
 220 
Synthesis of isoindoline 7039d 
 
Diallyl [(tosylazanediyl)bis(hexa-2,4-diyne-6,1-diyl)] bis(carbonate) (S24) 
 
To a solution of N,N-bis(6-hydroxyhexa-2,4-diyn-1-yl)-4-
methylbenzenesulfonamide170 (90 mg, 0.25 mmol) in CH2Cl2 cooled at 0 °C was 
sequentially added allyl chloroformate (90 mg, 0.75 mmol), NEt3 (100 mg, 1 mmol), and 
DMAP (5 mg, 0.04 mmol). The reaction mixture was stirred at this temperature for 2 h. 
The resulting solution was partitioned between EtOAc and aq. NH4Cl. The aqueous layer 
was washed with EtOAc two times. The combined organic layers were washed with 
brine, dried (Na2SO4), and concentrated. The resulting oil was subjected to flash 
chromatography (SiO2, hexanes:EtOAc = 12:1 to 5:1) to give carbonate S24 (90 mg, 0.17 
mmol, 68%) as a clear yellow oil. 
1H NMR (500 MHz, CDCl3): δ 7.68 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.33 (d, J = 8.0 Hz, 
2H, SO2ArHm), 5.94 (ddt, J = 17.1, 10.5, 5.8 Hz, 2H, CH2CH=C), 5.38 (ddt, J = 17.2, 
1.4, 1.4 Hz, 2H, CH=CHZHE), 5.30 (ddt, J = 10.4, 1.2, 1.2 Hz, 2H, CH=CHZHE), 4.77 
(s, 4H, OCH2), 4.66 (ddd, J = 5.8, 1.3, 1.3 Hz, 4H, CH2C=), 4.20 (s, 4H, NCH2), and 
2.44 (s, 3H). 
Li2CuCl4, THF
68 ˚C, 18 h, 80%
N
OH
OH
Ts
N
Cl
Cl
O
O
7039d
Ts O
O
O
O
N
S24
O
Ts
O
O
O
O
O
ClCO2Allyl
Et3N, DMAP
0 °C, 68%
N
OH
OH
Ts N
S24
O
Ts
O
O
O
O
O
ClCO2Allyl
Et3N, DMAP
0 °C, 68%
  Experimental 
 221 
13C NMR (125 MHz, CDCl3): δ 154.4, 144.8, 134.4, 131.2, 130.0, 127.9, 119.5, 72.8, 
72.1, 71.1, 69.9, 69.2, 55.6, 37.5, and 21.7 ppm. 
IR: 3005, 2989, 2918, 2261, 1752, 1649, 1597, 1449, 1382, 1353, 1274, 1164, 1092, 968, 
and 893 cm-1. 
HRMS (ESI-TOF): Calcd for C27H25NNaO8S+ [M+Na]+ requires 546.1193; found 
546.1201. 
  Experimental 
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Allyl {[4-(3-(((allyloxy)carbonyl)oxy)prop-1-yn-1-yl)-6,7-dichloro-2-tosylisoindolin-
5-yl]methyl} carbonate (7039d) 
 
Dichloride 7039d was prepared by heating tetrayne S24 (23 mg, 0.04 mmol) and 
Li2CuCl4 (0.4 mL, 1M in THF, 0.4 mmol) in THF (1.2 mL) at 68 °C for 18 hours. 
Purification by flash chromatography (hexanes:EtOAc 12:1 to 5:1) gave the dichloride 
7039d (20 mg, 0.034 mmol, 80%) as a colorless solid.  
1H NMR (500 MHz, CDCl3): δ 7.78 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.35 (d, J = 8.1 Hz, 
2H, SO2ArHm), 5.97 (ddt, J = 17.2, 10.4, 5.7 Hz, 1H, CH2=CH), 5.92 (ddt, J = 17.2, 
10.4, 5.8 Hz, 1H, C'H2=C'H), 5.41 (ddt, J = 17.2, 1.4, 1.4 Hz, 1H, CHZHE=CH), 5.41 
(s, 2H, ArCH2O), 5.35 (ddt, J = 17.2, 1.4, 1.4 Hz, 1H, C'HZHE=C'H), 5.32 (ddt, J = 
10.5, 1.2, 1.2 Hz, 1H, CHZHE=CH), 5.26 (ddt, J = 10.4, 1.2, 1.2 Hz, 1H, 
C'HZHE=C'H), 4.98 (s, 2H, OCH2C≡), 4.71 (ddd, J = 5.8, 1.3, 1.3 Hz, 2H, CO2CH2), 
4.69 (nfom, 2H, CH2N), 4.65 (nfom, 2H, C'H2N), 4.64 (ddd, J = 5.8, 1.3, 1.3 Hz, 2H, 
C'O2C'H2), and 2.43 (s, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 154.7, 154.5, 144.4, 139.3, 137.8, 136.0, 134.1, 133.5, 
131.6, 131.4, 130.3, 129.1, 127.7, 119.7, 119.2, 118.4, 93.1, 80.4, 69.4, 69.0, 65.6, 
55.8, 54.8, 54.7, and 21.8 ppm 
IR (neat): 2954, 2853, 1750, 1438, 1383, 1353, 1256, 1165, 1098, and 958 cm-1.  
HRMS (ESI-TOF): Calcd for C27H25Cl2NNaO8S+ [M+Na]+ requires 616.0570; found 
616.0589.  
mp: 112–116 °C. 
  
Li2CuCl4, THF
68 ˚C, 18 h, 80% N
Cl
Cl
O
O
7039d
Ts O
O
O
O
N
S24
O
Ts
O
O
O
O
O
  Experimental 
 223 
Synthesis of fluorenone 7039h 
 
1-(2-(Octa-1,3-diyn-1-yl)phenyl)-3-(trimethylsilyl)prop-2-yn-1-ol (S24) 
 
Triyne S24 was prepared following General Procedure B from 1-(2-ethynylphenyl)-3-
(trimethylsilyl)prop-2-yn-1-ol (160 mg, 0.7 mmol), 1-bromohex-1-yne (500 mg, ca. 40 
wt% in pentane, 1.25 mmol), CuCl (7 mg, 0.07 mmol), and piperidine (2 mL). 
Purification by MPLC (hexanes:EtOAc 7:1) gave the diyne S24 (153 mg, 0.5 mmol, 
71%) as a yellow oil. This sample contained ca. 10 mol% of the starting diyne, with 
which it coeluted. 
1H NMR (500 MHz, CDCl3): δ 7.69 (d, J = 8.0 Hz, 1H, H3), 7.50 (d, J = 7.5 Hz, 1H, 
H6), 7.38 (dd, J = 7.5, 7.5 Hz, 1H), 7.28 (dd, J = 8.0, 8.0 Hz, 1H), 5.83 (d, J = 5.5 Hz, 
1H, CHOH), 2.38 (t, J = 7.0 Hz, 2H, C≡CCH2), 1.57 (tt, J = 7, 7 Hz, 2H, 
C≡CCH2CH2), 1.46 (tq, J = 7, 7 Hz, 2H, CH2CH2CH3), and 0.94 (t, J  = 7.0 Hz, 3H, 
CH3). 
13C NMR (125 MHz, CDCl3): δ 143.5, 133.8, 129.5, 128.5, 127.1, 121.0, 104.3, 92.0, 
86.7, 80.0, 71.9, 65.1, 63.7, 30.4, 22.2, 19.5, 13.7, and 0.02. 
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IR: 3364, 2959, 2934, 2872, 2238, 2174, 1482, 1466, 1449, 1249, 1037, 983, and 845 
cm-1. 
HRMS (ESI-TOF): Calcd for C20H24NaOSi+ [M+Na]+ requires 331.1489; found 
331.1496. 
1-(2-(Octa-1,3-diyn-1-yl)phenyl)-3-(trimethylsilyl)prop-2-yn-1-one (S25) 
 
Activated MnO2 (300 mg, 3.44 mmol) was added to a solution of triyne S24 (150 mg, 
0.49 mmol) in CH2Cl2 (5 mL). The reaction mixture was stirred at rt until full conversion 
(within 2 h) was indicated by TLC analysis.  The mixture was then filtered through 
Celite® and the filter cake was washed with a copious amount of CH2Cl2. The filtrate was 
concentrated and the residue subjected to column chromatography (hexanes:EtOAc = 
12:1) to yield ketone S25 as a pale yellow oil (138 mg, 0.45 mmol, 92%).   
1H NMR (500 MHz, CDCl3): δ 8.08 (dd, J = 7.5, 1.5 Hz, 1H, ArH6), 7.61 (dd, J = 7.5, 
1.0 Hz, 1H, ArH3), 7.50 (ddd, J = 7.5, 7.5, and 1.5 Hz, 1H, ArH4), 7.40 (ddd, J = 7.5, 
7.5, 1.5 Hz, 1H, ArH5), 2.39 (t, J = 7.0 Hz, 2H, CCCH2), 1.56 (app p, J = 7.0 Hz, 2H, 
CH2CH2CH2), 1.45 (app sextet, J = 7.5 Hz, 2H, CH2CH2CH3), and 0.93 (t, J = 7.5 Hz, 
3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 176.8, 139.1, 135.8, 132.7, 131.9, 128.5, 122.3, 101.62, 
101.58, 87.5, 80.9, 72.8, 65.7, 30.4, 22.2, 19.6, 13.8, and -0.5 ppm 
IR: 2959, 2933, 2873, 2239, 2153, 1649, 1589, 1561, 1480, 1274, 1251, 1234, 1014, 848, 
and 755 cm-1. 
HRMS (ESI-TOF): Calcd for C20H22NaOSi+ [M+Na]+ requires 329.1332; found 
329.1329. 
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2-Butyl-3,4-dichloro-1-(trimethylsilyl)-9H-fluoren-9-one (7039h) 
 
Dichloride 7039h was prepared by heating triyne S25 (15 mg, 0.049 mmol) and 
Li2CuCl4 (0.2 mmol) in THF (2 mL) at 85 °C for 18 hours. Purification by MPLC 
(hexanes:EtOAc = 5:1) gave the dichloride 7039h (12 mg, 0.032 mmol, 65%) as a yellow 
solid.  
1H NMR (500 MHz, CDCl3): δ 8.21 (ddd, J = 7.7, 0.9, 0.9 Hz, 1H, H5), 7.64 (ddd, J = 
7.3, 0.9, and 0.9 Hz, 1H, H8), 7.52 (ddd, J = 7.6, 7.6, 1.2 Hz, 1H, H6), 7.34 (ddd, J = 
7.4, 7.4, 1.0 Hz, 1H, H7), 3.02 (br t, J = 8.0 Hz, 2H, ArCH2), 1.52-1.40 (m, 4H, 
CH2CH2CH3), 0.97 (t, J = 7.2 Hz, 3H, CH3), and 0.45 [s, 9H, Si(CH3)3]. 
13C NMR (125 MHz, CDCl3): δ 193.7, 149.4, 142.7, 141.6, 141.0, 139.8, 139.5, 134.9, 
134.1, 129.9, 129.5, 124.2, 124.1, 34.4, 33.6, 22.9, 14.2, and 3.2 ppm. 
IR: 2958, 2931, 2871, 1719, 1601, 1466, 1249, 1093, and 849 cm-1. 
HRMS (ESI-TOF): Calcd for C20H24Cl2NaOSi+ [M+Na]+ requires 399.0709; found 
399.0713. 
mp: 110–111 °C. 
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 Synthesis of isoindolines 7039i 
 
N,N-Bis[6-(benzyloxy)hexa-2,4-diyn-1-yl]-4-methylbenzenesulfonamide (S26) 
 
Tetrayne S26 was prepared following General Procedure B from 4-methyl-N,N-
di(prop-2-yn-1-yl)benzenesulfonamide (198 mg, 0.8 mmol), {[(3-bromoprop-2-yn-1-
yl)oxy]methyl}benzene171 (540 mg, 2.4 mmol), CuCl (24 mg, 0.24 mmol), and piperidine 
(2.5 mL). Purification by flash chromatography (hexanes:EtOAc 12:1 to 5:1) gave the 
tetrayne S26 (223 mg, 0.41 mmol, 52%) as a colorless solid.  
1H NMR (500 MHz, CDCl3): δ 7.70 (d, J = 8.4 Hz, 2H, SO2ArHo), 7.38-7.29 (m, 12H, 
ArH), 4.57 (s, 4H, OCH2Ar), 4.23 (s, 4H, OCH2C≡C), 4.19 (s, 4H, NCH2), and 2.39 
(s, 3H, ArCH3). 
                                                
171  Yang, X.; Zhu, Li.; Zhou, Y.; Li, Z.; Zhai, H. Efficient synthesis of monosubstituted 3-alkynylfurans via 
Suzuki coupling. Synthesis 2008, 1729–1732. 
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13C NMR (125 MHz, CDCl3): δ 144.6, 137.1, 134.7, 130.0, 128.7, 128.30, 128.27, 128.0, 
75.4, 72.0, 71.7, 70.4, 70.3, 57.6, 37.5, and 21.8 ppm. 
IR: 3031, 2865, 2255, 1597, 1495, 1454, 1351, 1164, 1091, 1073, 1027, 945, and 892 
cm-1. 
HRMS (ESI-TOF): Calcd for C33H29NNaO4S+ [M+Na]+ requires 558.1710; found 
558.1713. 
mp: 64–66 °C. 
5-((Benzyloxy)methyl)-4-(3-(benzyloxy)prop-1-yn-1-yl)-6,7-dichloro-2-
tosylisoindoline (7039i) 
 
Dichloride 7039i was prepared following General Procedure C from tetrayne S26 (50 
mg, 0.093 mmol) and Li2CuCl4 (0.9 mL, 1M in THF, 0.9 mmol) in THF (2.1 mL). 
Purification by flash chromatography (hexanes:EtOAc 12:1 to 5:1) gave the dichloride 
7039i (48 mg, 0.079 mmol, 83%) as a colorless solid.  
1H NMR (500 MHz, CDCl3): δ 7.78 (d, J = 8.0 Hz, 2H, SO2ArHO), 7.31 (m, 12H), 4.77 
(s, 2H, ArCH2OBn), 4.71 (br s, 2H, CH2N), 4.65 (br s, 2H, C'H2N), 4.63 (s, 2H, 
PhCH2O), 4.57 (s, 2H, PhCH2O), 4.38 (s, 2H, ≡CCH2OBn), and 2.41 (s, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 144.4, 138.82, 138.80, 138.0, 137.2, 136.7, 133.9, 133.5, 
130.3, 128.8, 128.53, 128.51, 128.34, 128.31, 128.00, 127.95, 127.7, 118.7, 95.2, 80.4, 
73.2, 72.1, 68.4, 57.9, 55.0, 54.7, and 21.8. 
IR (neat): 3064, 3033, 2855, 1454, 1351, 1166, 1096, 1071, 857, 827, and 817 cm-1.  
HRMS (ESI-TOF): Calcd for C33H29Cl2NNaO4S+ [M+Na+] requires 628.1087; found 
628.1204.  
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7-[3-(Benzyloxy)prop-1-yn-1-yl]-9-tosyl-6,8,9,10-tetrahydro-1H,4H-1,3a-
ethenoisochromeno[5,4-ef]isoindole (S27) 
 
A solution of tetrayne S26 (22 mg, 0.041 mmol) in CHCl3 (2 mL) was heated at 68 
°C for 18 h. The resulting solution was concentrated and subjected to flash 
chromatography (SiO2, hexanes:EtOAc = 5:1) to give isoindoline S27 (12 mg, 0.022 
mmol, 55%) as a colorless solid.  
1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.40-7.32 (m, 5H, 
C6H5), 7.31 (d, J = 8.0 Hz, 2H, SO2ArHm), 6.85 (dd, J = 6.4, 5.8 Hz, 2H, H2 and 
H12), 6.68 (d, J = 6.5, 1.5 Hz, 2H, H3 and H11), 4.81 (tt, J = 5.8, 1.5 Hz, 1H, H1), 
4.73 (br s, 2H, CH2), 4.66 (br s, 2H, CH2), 4.63 (br s, 2H, CH2), 4.58 (br s, 2H, CH2), 
4.53 (br s, 2H, CH2), 4.40 (br s, 2H, CH2), and 2.40 (s, 3H, ArCH3). 
13C NMR (125 MHz, CD3CN): δ 145.1, 144.0, 143.8, 142.9, 141.1, 138.9, 135.3, 134.3, 
132.7, 130.8, 129.3, 129.0, 128.8, 128.7, 128.5, 108.5, 93.8, 80.8, 72.1, 71.5, 66.5, 
58.5, 54.5, 53.3, 51.8, 46.8, and 21.4. 
IR (neat): 3062, 2945, 2918, 1597, 1495, 1454, 1348, 1163, 1096, 1073, 920, and 816 
cm-1.  
HRMS (ESI-TOF): Calcd for C33H29NNaO4S+ [M+Na]+ requires 558.1710; found 
558.1695. 
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Synthesis of indane 7039j 
 
Dimethyl 4,5-dichloro-6-[(3,5-dimethylphenoxy)methyl]-7-[3-(3,5-
dimethylphenoxy)prop-1-yn-1-yl]-1,3-dihydro-2H-indene-2,2-dicarboxylate (7039j) 
 
Dichloride 7039j was prepared by heating the dimethyl tetraynylmalonate (14 mg, 
0.027 mmol) and Li2CuCl4 (4 mL, 0.1 M in THF) at 110 °C for 24 h. Purification by 
flash chromatography (hexanes:EtOAc 12:1 to 5:1) gave the dichloride 7039j (9 mg, 
0.015 mmol, 55%) as a colorless solid.  
1H NMR (500 MHz, CDCl3): δ 6.64 (t of sextet, J = 0.7, 0.7 Hz, 1H, OArp), 6.61 
(overlapping br s, 3H), 6.59 (dq, J = 0.7, 0.7 Hz, 2H, OAro), 5.18 (s, 2H, ArCH2O), 
4.85 (s, 2H, ≡CCH2O), 3.77 (s, 6H, CO2CH3), 3.69 (s, 2H, CH2CCH2), 3.66 (s, 2H, 
CH2CCH2), 2.29 (ddd, J = 0.7, 0.7, 0.7 Hz, 6H, ArCH3), and 2.25 (ddd, J = 0.7, 0.7, 
0.7 Hz, 6H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 171.5, 159.2, 157.7, 143.0, 140.7, 139.44, 139.37, 136.8, 
133.2, 130.3, 123.6, 123.2, 119.7, 112.9, 112.8, 93.6, 81.9, 66.8, 58.9, 56.4, 53.5, 
41.53, 41.50, 21.7, and 21.6 ppm. 
IR:  2954, 2920, 1738, 1593, 1434, 1293, 1256, 1167, 1153, and 1061cm-1. 
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HRMS (ESI-TOF): Calcd for C33H32Cl2NaO6+ [M+Na]+ requires 617.1468; found 
617.1487. 
mp: 140–143 °C.  
Synthesis of fluorenone 7069b 
 
1-((3-Bromoprop-2-yn-1-yl)oxy)-3,5-dimethylbenzene (S28) 
 
Bromoalkyne S28 was prepared following General Procedure A from 1,3-dimethyl-5-
(prop-2-yn-1-yloxy)benzene172 (400 mg, 2.5 mmol), N-bromosuccinimide (NBS, 460 mg, 
2.6 mmol), AgNO3 (34 mg, 0.2 mmol), and acetone (25 mL). Purification by flash 
chromatography (hexanes:EtOAc 19:1) gave the bromoalkyne S28 (500 mg, 2.1 mmol, 
84%) as a clear yellow oil. 
1H NMR (500 MHz, CDCl3): δ 6.65 (s, 1H, ArH4), 6.58 (s, 2H, ArH2H6), 4.67 (s, 2H, 
CH2O), and 2.30 [s, 6H, Ar(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 157.8, 139.5, 123.6, 112.7, 75.5, 56.8, 47.5, and 21.7.  
                                                
172  Wang, Y., Ji, K., Lan, S. & Zhang, L. Rapid access to chroman-3-ones through gold-catalyzed oxidation 
of propargyl aryl ethers. Angew. Chem. Int. Ed. 2012, 51, 1915–1918. 
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IR: 2919, 2862, 2219, 1615, 1594, 1470, 1451, 1373, 1318, 1293, 1168, 1151, 1070, and 
829 cm-1.  
GC-LRMS: tR = 7.37 min. m/z: 240 (M+, 50), 238 (M+, 50), 225 (M+-CH3, 25), 223 
(M+-CH3, 25), 159 (M+-Br, 70), 131 (70), 116 (70), 91 (C7H7+, 100), and 77 (C6H5+, 
50).  
1-(2-(5-(3,5-Dimethylphenoxy)penta-1,3-diyn-1-yl)phenyl)-3-(trimethylsilyl)prop-2-
yn-1-ol (S29) 
 
Triyne S29 was prepared following General Procedure B from 1-(2-ethynylphenyl)-3-
(trimethylsilyl)prop-2-yn-1-ol (160 mg, 0.7 mmol), S28 (237 mg, 1 mmol), CuCl (7 mg, 
0.07 mmol), and piperidine (2 mL). Purification by MPLC (hexanes:EtOAc 5:1) gave the 
diyne S29 (90 mg, 0.23 mmol, 33%) as a yellow oil. 
1H NMR (500 MHz, CDCl3): δ 7.69 (d, J = 7.8 Hz, 1H, H6), 7.49 (d, J = 7.7 Hz, 1H, 
H3), 7.40 (dd, J = 7.7, 7.7 Hz, 1H, H4), 7.27 (dd, J = 7.6, 7.6 Hz, 1H, H5), 6.65 (br s, 
1H, H4’), 6.60 (br s, 2H, H2’H6’), 5.78 (br s, 1H, CHOH), 4.79 (s, 2H, CH2O), 2.52 
(br s, 1H, CHOH), 2.30 [br s, 6H, Ar(CH3)2], and 0.19 [s, 9H, Si(CH3)3]. 
13C NMR (125 MHz, CDCl3): δ 157.7, 143.7, 139.5, 133.9, 130.1, 128.5, 127.1, 123.7, 
120.0, 112.7, 104.2, 92.0, 79.2, 78.5, 75.9, 71.5, 63.4, 56.4, 21.6, and 0.0. 
IR: 3420, 2959, 2240, 2174, 1614, 1594, 1473, 1449, 1372, 1318, 1291, 1250, 1169, 
1150, 1059, and 985 cm-1.  
HRMS (ESI-TOF): Calcd for C25H26NaO2Si+ [M+Na]+ requires 409.1594; found 
409.1633. 
1-(2-(5-(3,5-Dimethylphenoxy)penta-1,3-diyn-1-yl)phenyl)-3-(trimethylsilyl)prop-2-
yn-1-one (7068b) 
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Activated MnO2 (300 mg, 3.44 mmol) was added to a solution of triyne S29 (90 mg, 
0.23 mmol) in CH2Cl2 (5 mL). The reaction mixture was stirred at rt until full conversion 
(within 2 h) was indicated by TLC analysis.  The mixture was then filtered through 
Celite® and the filter cake was washed with copious amount of CH2Cl2. The filtrate was 
concentrated and the residue subjected to column chromatography (hexanes:EtOAc = 
12:1) to yield ketone 7068b as a pale yellow oil (83 mg, 0.22 mmol, 93%).   
1H NMR (500 MHz, CDCl3): δ 8.11 (dd, J = 7.7, 1.4 Hz, 1H, H3), 7.61 (dd, J = 7.5, 1.4 
Hz, 1H, H6), 7.51 (ddd, J = 7.5, 7.5, 1.5 Hz, 1H, H5), 7.47 (ddd, J = 7.5, 7.5, 1.5 Hz, 
1H, H4), 6.65 (t of septets, J = 0.7, 0.7 Hz, 1H, H4’), 6.65 (dq, J = 0.7, 0.7 Hz, 2H, 
H2’H6’), 4.81 (s, 2H, CH2O), 2.30 [dt, J = 0.6, 0.6 Hz, 6H, Ar(CH3)2], and 0.29 [s, 
9H, Si(CH3)3]. 
13C NMR (125 MHz, CDCl3): δ 176.5, 157.8, 139.5, 139.2, 136.0, 132.8, 132.1, 129.1, 
123.7, 121.4, 112.8, 101.8, 101.4, 79.9, 79.3, 76.8, 72.0, 56.5, 21.7, and -0.5. 
IR: 2960, 2922, 2153, 1648, 1614, 1592, 1562, 1481, 1373, 1319, 1291, 1251, 1237, 
1150, 1060, 1015, and 847 cm-1.  
HRMS (ESI-TOF): Calcd for C25H24NaO2Si+ [M+Na]+ requires 407.1438; found 
407.1437. 
1,3-Dimethyl-7-(trimethylsilyl)fluoreno[2,3-c]chromen-8(6H)-one (7069b) 
 
A solution of 7068b (16 mg, 0.042 mmol) in CHCl3 (1.4 mL) was heated at 85 °C for 
18 h. The resulting mixture was directly subjected to MPLC (SiO2, hexanes:EtOAc = 9:1) 
to yield 7069b as a golden oil (14 mg, 0.036 mmol, 88%). 
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1H NMR (500 MHz, CDCl3): δ 7.80 (s, 1H, H13), 7.61 (ddd, J = 7.3, 1.0, 1.0 Hz, 1H, 
H9), 7.50 (ddd, J = 7.3, 1.0, 1.0 Hz, 1H, H12), 7.47 (ddd, J = 7.2, 7.2, 1.2 Hz, 1H, 
H11), 7.29 (ddd, J = 7.2, 7.2, 1.4 Hz, 1H, H10), 6.82 (d, J = 1.7 Hz, 1H, H2), 6.73 (d, 
J = 1.8 Hz, 1H, H4), 5.05 (s, 2H, CH2O), 2.69 (s, 3H, C1-CH3), 2.34 (s, 3H, C3-CH3), 
and 0.46 [s, 9H, Si(CH3)3]. 
13C NMR (125 MHz, CDCl3): δ 194.8, 157.1, 144.2, 144.0, 141.6, 140.2, 139.0, 137.9, 
136.0, 135.7, 134.6, 134.5, 129.2, 127.1, 124.1, 121.3, 119.7, 119.1, 115.2, 70.0, 22.4, 
21.6, and 2.3. 
IR: 2949, 2921, 2855, 1709, 1606, 1588, 1463, 1300, 1294, 1248, 1181, 1135, 1071, 974, 
961, 867, and 846 cm-1.  
HRMS (ESI-TOF): Calcd for C25H24NaO2Si+ [M+Na]+ requires 407.1438; found 
407.1435. 
 
  Experimental 
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Synthesis of isobenzofuran 7074a 
 
6-(3,5-Dimethylphenoxy)hexa-2,4-diyn-1-ol (S30) 
 
Diynol S30 was prepared following General Procedure C from 3-bromoprop-2-yn-1-
ol173 (520 mg, 3.9 mmol, 1.3 equiv), 1,3-dimethyl-5-(prop-2-yn-1-yloxy)benzene (480 
mg, 3 mmol, 1 equiv), CuCl (30 mg, 0.3 mmol, 0.1 equiv), 30% aqueous BuNH2 (12 
mL), and Et2O (12 mL). Diynol S30 was obtained as a yellow oil (350 mg, 1.64 mmol, 
55%) following purification by flash chromatography (hexanes:EtOAc = 5:1). 
1H NMR (500 MHz, CDCl3): δ 6.64 (s, 1H, ArH4), 6.57 (s, 2H, ArH2H6), 4.71 (br s, 
2H), 4.32 (br s, 2H), and 2.29 (s, 6H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 157.6, 139.5, 123.7, 112.8, 77.9, 74.8, 71.1, 70.0, 56.3, 
51.6, and 21.6. 
IR: 3600-3100, 2919, 2860, 2258, 2185, 1614, 1594, 1472, 1447, 1372, 1318, 1293, 
1168, 1150, 1062, 1022, and 829 cm-1. 
HRMS (ESI-TOF): Calcd for C14H14NaO2+ [M+Na]+ requires 237.0886; found 237.0884. 
                                                
173  Ouyang, X., Fowler, F. W. & Lauher, J. W. Single-Crystal-to-Single-Crystal topochemical 
polymerizations of a terminal diacetylene: two remarkable transformations give the same conjugated 
polymer. J. Am. Chem. Soc. 2003, 125, 12400–12401.  
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3,5-Dimethyl-1-((6-(prop-2-yn-1-yloxy)hexa-2,4-diyn-1-yl)oxy)benzene (S31) 
 
A solution of diynol S30 (214 mg, 1 mmol) in THF (2 mL) was added to a stirred 
suspension of NaH (80 mg, 60% suspension in mineral oil, 2 mmol) in THF (10 mL) at 0 
ºC. The reaction mixture was allowed to warm to rt over 1 h and propargyl bromide (0.24 
mL, 80 wt. % in toluene, 2.2 mmol) was added. After 18 h the mixture was cooled to 0 
ºC, water was added, and the aqueous layer was extracted with diethyl ether. The 
combined organic extracts were washed with brine, dried (Na2SO4), and concentrated. 
Purification by flash chromatography (hexanes:EtOAc = 20:1) gave the triyne S31 (110 
mg,  0.44 mmol, 44%) as a colorless oil. 
1H NMR (500 MHz, CDCl3): δ 6.65 (tqq, J = 0.7, 0.7, 0.7 Hz, 1H, ArH4), 6.57 (dq, J = 
0.7, 0.7 Hz, 2H, ArH2H6), 4.73 (t, J = 0.9 Hz, 2H), 4.33 (t, J = 0.9 Hz, 2H), 4.25 (d, J 
= 2.4 Hz, 2H), 2.46 (t, J = 2.4 Hz, 1H, HC≡), and 2.30 [dt, J = 0.7, 0.7 Hz, 6H, 
Ar(CH3)2] 
13C NMR (125 MHz, CDCl3): δ 157.7, 139.6, 123.8, 112.8, 78.7, 75.6, 75.1, 74.7, 71.11, 
71.06, 57.1, 56.9, 56.3, and 21.7.  
IR: 3295, 2965, 2918, 2855, 2119, 1614, 1594, 1472, 1443, 1344, 1318, 1293, 1168, 
1150, 1081, 1065, and 830 cm-1.  
HRMS (ESI-TOF): Calcd for C17H16AgO2+ [M+Ag]+ requires 359.0196; found 
359.0204 [the sample solution in MeOH was doped with AgNO3 (ca. 10-100 µM) 
prior to introduction into the ionizing chamber]. 
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Methyl 4-((6-(3,5-Dimethylphenoxy)hexa-2,4-diyn-1-yl)oxy)but-2-ynoate (S32) 
 
n-BuLi (0.072 mL, 2.5 M in hexanes, 0.18 mmol) was added to a stirred solution of 
triyne S31 (40 mg, 0.16 mmol) in THF (1 mL) at -78 ºC. The reaction mixture turned 
dark green immediately. After 20 min methyl chloroformate (0.17 mL, 1.8 mmol) was 
added. After 30 min saturated aqueous NH4Cl was added and the mixture was extracted 
with EtOAc. The combined organic extracts were washed with brine, dried (Na2SO4), and 
concentrated. Purification by flash chromatography (hexanes:EtOAc = 20:1) yielded, in 
order of elution, recovered S31 (15 mg, 0.06 mmol, 37%) and the triyne S32 (20 mg, 
0.064 mmol, 40%) as a clear amber oil. 
1H NMR (500 MHz, CDCl3): δ 6.65 (tqq, J = 0.7, 0.7, 0.7 Hz, 1H, ArH4), 6.57 (dq, J = 
0.7, 0.7 Hz, 2H, ArH2H6), 4.73 (t, J = 0.9 Hz, 2H), 4.38 (s, 2H, OCH2CCCO2Me), 
4.34 (t, J = 0.9 Hz, 2H), 3.79 (s, 3H, OMe), and 2.30 [dt, J = 0.7, 0.7 Hz, 6H, 
Ar(CH3)2] 
13C NMR (125 MHz, CDCl3): δ 157.7, 153.6, 139.6, 123.8, 112.8, 82.5, 78.7, 75.0, 74.4, 
71.7, 70.9, 57.6, 56.5, 56.3, 53.1, and 21.7.  
IR: 2954, 2919, 2853, 2239, 1718, 1614, 1594, 1535, 1345, 1318, 1293, 1255, 1169, 
1151, 1089, 1062, and 830 cm-1.  
HRMS (ESI-TOF): Calcd for C19H18NaO4+ [M+Na]+ requires 333.1097; found 333.1055. 
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Methyl 1,3-Dimethyl-8,10-dihydro-6H-isobenzofuro[5,6-c]chromene-7-carboxylate 
(7074a) 
 
A solution of triyne S32 (17 mg, 0.055 mmol) in dichlorobenzene (1.8 mL) was 
heated at 165 °C for 4.5 h. The resulting solution was cooled to rt and directly subjected 
to MPLC (hexanes:EtOAc = 5:1) to yield 7074a as a pale yellow oil (11 mg, 0.035 mmol, 
65%), which solidified upon standing. 
1H NMR (500 MHz, CDCl3): δ 7.70 (t, J = 1.0 Hz, 1H, ArH11), 6.79 (s, 1H, ArH), 6.76 
(s, 1H, ArH), 5.34 (t, J = 2.0 Hz, 2H), 5.31 (s, 2H), 5.18 (td, J = 2.0, 1.0 Hz), 3.93 (s, 
3H, OCH3), 2.59 (s, 3H, C1-CH3), and 2.33 (s, 3H, C3-CH3). 
13C NMR (125 MHz, CDCl3): δ 166.8, 156.7, 139.8, 139.37, 139.36, 136.2, 135.0, 132.0, 
127.0, 122.4, 122.0, 120.4, 115.4, 75.3, 73.6, 66.9, 52.4, 22.6, and 21.4.  
IR: 2951, 2920, 2854, 1717, 1616, 1563, 1462, 1434, 1362, 1321, 1294, 1260, 1240, 
1222, 1195, 1177, 1114, 1057, 1025, 994, 911, and 846 cm-1.  
HRMS (ESI-TOF): Calcd for C19H18NaO4+ [M+Na]+ requires 333.1097; found 333.1131. 
mp: 115-119 °C. 
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Synthesis of isobenzofuran 7074b 
 
Dimethyl 2,2-Bis(6-(3,5-dimethylphenoxy)hexa-2,4-diyn-1-yl)malonate (S33) 
 
Compound S33 was prepared following General Procedure B from dimethyl 2,2-
di(prop-2-yn-1-yl)malonate (176 mg, 0.85 mmol, 1 equiv), S28 (480 mg, 2.01 mmol, 2.4 
equiv), piperidine (2 mL), and CuCl (17 mg, 0.2 equiv). Tetrayne S33 was isolated as a 
colorless solid (250 mg, 56%) following flash chromatography (hexanes:EtOAc = 6:1).  
1H NMR (500 MHz, CDCl3): δ 6.64 (s, 2H, ArH4), 6.56 (s, 4H, ArH2H6), 4.69 (s, 4H, 
OCH2), 3.76 (s, 6H, OCH3), 3.07 (s, 4H, CCH2C), and 2.29 [s, 12H, Ar(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 168.6, 157.7, 139.5, 123.7, 112.7, 75.0, 72.3, 71.5, 68.0, 
56.7, 56.3, 53.6, 24.1, and 21.7. 
IR:  2954, 2920, 2861, 2260, 1742, 1614, 1594, 1470, 1436, 1373, 1318, 1293, 1255, 
1212, 1169, 1151, 1062, and 830 cm-1.  
HRMS (ESI-TOF): Calcd for C33H32NaO6+ [M+Na]+ requires 547.2091; found 547.2097. 
mp: 148-150 °C.  
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Dimethyl 7-(3-(3,5-Dimethylphenoxy)prop-1-yn-1-yl)-1,3-dimethyl-8,10-
dihydroindeno[5,6-c]chromene-9,9(6H)-dicarboxylate (7074b) 
 
A solution of tetrayne S33 (26 mg, 0.05 mmol) in dichloroethane (1.7 mL) was 
heated at 125 °C for 20 h. The resulting solution was concentrated and purified by MPLC 
(hexanes:EtOAc = 5:1) to yield 7074b as a colorless oil (22 mg, 0.042 mmol, 84%).  
1H NMR (500 MHz, CDCl3): δ 7.49 (s, 1H, ArH11), 6.73 (s, 1H, ArH), 6.71 (s, 1H, 
ArH), 6.68 (s, 1H, ArH), 6.66 (s, 2H, ArH), 5.00 (s, 2H, OCH2), 4.96 (s, 2H, OCH2), 
3.76 (s, 6H, OCH3), 3.65 (s, 2H, CCH2Ar), 3.64 (s, 2H, CCH2Ar), 2.58 (s, 3H, C1-
CH3), 2.32 [s, 6H, Ar(CH3)2], and 2.30 (s, 3H, C3-CH3). 
13C NMR (125 MHz, CDCl3): δ 172.1, 157.8, 156.5, 141.3, 139.4, 139.2, 138.9, 135.2, 
134.7, 130.1, 126.8, 123.6, 122.2, 120.5, 115.6, 115.3, 113.1, 92.4, 82.4, 67.2, 59.8, 
56.6, 53.3, 41.2, 40.6, 22.8, 21.7, and 21.4. 
IR: 3005, 2988, 2953, 2854, 2260, 1737, 1615, 1594, 1455, 1435, 1318, 1291, 1277, 
1260, 1246, 1199, 1166, and 764 cm-1.  
HRMS (ESI-TOF): Calcd for C33H32NaO6+ [M+Na]+ requires 547.2091; found 547.2123. 
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Synthesis of isoindoline 7074c 
 
N,N-Bis(6-(3,5-dimethylphenoxy)hexa-2,4-diyn-1-yl)-4-methylbenzenesulfonamide 
(S34) 
 
Compound S34 was prepared following General Procedure B from N,N-di(prop-2-yn-
1-yl) toluenesulfonamide167 (176 mg, 0.71 mmol, 1 equiv), bromoalkyne S28 (370 mg, 
1.78 mmol, 2.5 equiv), piperidine (1.5 mL), and CuCl (14 mg, 0.2 equiv). Tetrayne S34 
and triyne S34’ were isolated by flash chromatography (5:1 hexanes:EtOAc) as a 
coeluting mixture [pale yellow oil, 220 mg, S34 (ca. 40%) and S34’ (ca. 20%)]. Data for 
S34 are taken from spectra of the mixture in which it was the major component. 
1H NMR (500 MHz, CDCl3): δ 7.65 (d, J = 8.3, 2H, o-SO2ArH), 7.26 (d, J = 7.9 Hz, 2H, 
m-SO2ArH), 6.65 (s, 2H, ArHp), 6.54 (s, 4H, ArHo), 4.66 (s, 4H, CH2O), 4.18 (s, 4H, 
CH2N), 2.35 (s, 3H, SO2ArCH3), and 2.29 [s, 12H, Ar(CH3)2]. 
13C NMR (125 MHz, HMQC, CDCl3):  δ 129.8, 127.7, 123.6, 112.5, 56.0, 37.4, 21.5, 
21.5 (CH-containing carbons only, from the HMQC spectrum). 
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IR: 2919, 2855, 2258, 1614, 1594, 1471, 1447, 1353, 1319, 1293, 1164, 1152, 1093, 
1064, and 892 cm-1. 
HRMS (ESI-TOF): Calcd for C32H33NNaO4S+ [M+Na]+ requires 586.2023; found 
586.1998. 
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 242 
7-(3-(3,5-Dimethylphenoxy)prop-1-yn-1-yl)-1,3-dimethyl-9-tosyl-6,8,9,10-
tetrahydrochromeno[3,4-f]isoindole (7074c) 
 
A solution of S34 (50 mg, containing ca. 50 mol% of S34’, ca. 0.065 mmol) in CHCl3 
(2 mL) was heated at 65 °C for 20 h. The reaction mixture was concentrated to dryness. 
The resulting oil was initially triturated with ethanol, and the resulting slurry was 
dissolved in additional dichloromethane. The resulting solution was allowed to evaporate 
slowly. Compound 7074c precipitated as a light yellow solid. The yield of 7974c was 
determined by 1H NMR analysis of the crude oil (using S34’ as the internal standard) to 
be (≥ 90%).  
1H NMR (500 MHz, CDCl3): δ 7.74 (d, J = 8.3 Hz, 2H, o-SO2ArH), 7.43 (s, 1H, ArH11), 
7.30 (d, J = 8.4 Hz, 2H, m-SO2ArH), 6.74 (s, 1H, ArH), 6.71 (s, 1H, ArH), 6.70 (s, 
1H, ArH), 6.66 (s, 2H, ArHo), 4.96 (s, 2H, CH2O), 4.95 (s, 2H, CH2O), 4.66 (s, 2H, 
CH2N), 4.62 (s, 2H, CH2N), 2.54 (s, 3H, ArCH3), 2.40 (s, 3H, ArCH3), 2.35 [s, 6H, 
Ar(CH3)2], and 2.29 (s, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 157.6, 156.6, 144.0, 139.58, 139.55, 137.3, 135.53, 
135.48, 135.2, 133.9, 131.5, 130.1, 127.8, 127.0, 123.8, 120.3, 120.0, 115.7, 114.1, 
113.0, 93.4, 81.2, 66.9, 56.4, 54.6, 53.9, 22.8, 21.7/21.7 (2 unresolved resonances, as 
confirmed by HSQC), and 21.4. 
IR: 2953, 2919, 2854, 2254, 1615, 1594, 1457, 1349, 1292, 1164, 1098, 1066, and 910 
cm-1. 
HRMS (ESI-TOF): Calcd for C32H33NNaO4S+ [M+Na]+ requires 586.2023; found 586.2019. 
mp: 150-153 °C. 
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Synthesis of isobenzofuran 7074d 
 
6-(3,5-Dimethylphenoxy)hexa-2,4-diyn-1-yl Propiolate (S35) 
 
Triyne S35 was prepared following General Procedure D from S30 (214 mg, 1 mmol), 
propiolic acid (84 mg, 1.2 mmol), DCC (227 mg, 1.1 mmol), DMAP (12 mg, 0.1 mmol), 
and CH2Cl2 (10 mL). S35 was obtained following flash chromatography (hexanes:EtOAc 
= 12:1) as a light yellow oil (222 mg, 0.76 mmol, 76%).  
1H NMR (500 MHz, CDCl3): δ 6.65 (s, 1H, ArH4), 6.56 (s, 2H, ArH2H6), 4.84 (t, J = 
1.0 Hz, 2H), 4.73 (t, J = 1.0 Hz, 2H), 2.96 (s, 1H, CCH), and 2.30 (s, 6H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 157.6, 151.8, 139.6, 123.8, 112.7, 76.4, 75.8, 73.9, 72.0, 
71.8, 70.7, 56.2, 54.0, and 21.7. 
IR: 3280, 2920, 2124, 1723, 1615, 1594, 1472, 1445, 1363, 1318, 1293, 1206, 1169, 
1151, 1064, 980, and 830 cm-1. 
HRMS (ESI-TOF): Calcd for C17H14NaO3+ [M+Na]+ requires 289.0835; found 289.0849. 
1,3-Dimethyl-6H-isobenzofuro[5,6-c]chromen-8(10H)-one (7074d) 
 
A solution of S35 (21 mg, 0.072 mmol) in dichlorobenzene (2.4 mL) was heated at 
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165 °C for 4 h. The resulting solution was directly subjected to MPLC (hexanes:EtOAc = 
3:1) to give isobenzofuran 7074d as a colorless solid (17 mg, 0.058 mmol, 81%) 
1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 1.0 Hz, 1H), 7.76 (d, J = 1.0 Hz, 1H), 6.82 
(br s, 1H), 6.80 (br s, 1H), 5.36 (br s, 2H), 4.99 (br s, 2H), 2.66 (br s, 3H, C1-CH3), 
and 2.34 (br s, 3H, C3-CH3).  
13C NMR (125 MHz, CDCl3): δ 171.0, 157.4, 146.7, 141.0, 137.4, 136.0, 135.1, 127.3, 
123.6, 122.0, 119.9, 119.2, 116.0, 70.0, 69.2, 22.9, and 21.5. 
IR: 2959, 2917, 2857, 1757, 1615, 1593, 1451, 1355, 1355, 1315, 1287, 1195, 1180, 
1154, 1138, 1067, 1046, 1015, 1006, 908, 847, 776, and 755 cm-1.  
HRMS (ESI-TOF): Calcd for C17H14NaO3+ [M+Na]+ requires 289.0835; found 289.0849. 
mp: 154-156 °C. 
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Synthesis of isoindolones 7074e 
 
N-(6-(3,5-Dimethylphenoxy)hexa-2,4-diyn-1-yl)aniline (S36) 
 
Diyne S36 was prepared following General Procedure C from N-(prop-2-yn-1-
yl)aniline (131 mg, 1 mmol), S28 (287 mg, 1.2 mmol), CuCl (5 mg, 0.05 mmol), 30% 
aqueous BuNH2 (4 mL), and Et2O (4 mL). Compound S36 was isolated as a clear yellow 
oil (170 mg, 0.059 mmol, 59%) after purification by flash chromatography 
(hexanes:EtOAc 12:1 then 5:1).   
1H NMR (500 MHz, CDCl3): δ 7.21 (dd, J = 8.6, 7.4 Hz, 2H, NArHm), 6.80 (tt, J = 7.4, 
1.0 Hz, 1H, NArHp), 6.66 (dd, J = 8.6, 1.0 Hz, 1H, NArHo), 6.64 (s, 1H, OArHp), 
6.55 (s, 2H, OArHo), 4.68 (s, 2H, CH2O), 4.01 (s, 2H, CH2N), 3.86 (s, 1H, NH), and 
2.28 [s, 6H, Ar(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 157.7, 146.7, 139.5, 129.5, 123.7, 119.1, 113.8, 112.7, 
77.6, 73.2, 71.5, 67.4, 56.3, 34.5, and 21.7  
IR: 3052, 3020, 2918, 2860, 2255, 1602, 1596, 1504, 1472, 1439, 1374, 1350, 1316, 
1293, 1258, 1168, 1150, 1062, and 830 cm-1. 
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HRMS (ESI-TOF): Calcd for C20H19NNaO+ [M+Na]+ requires 312.1359; found 
312.1371. 
N-(6-(3,5-Dimethylphenoxy)hexa-2,4-diyn-1-yl)-N-phenylpropiolamide (S37) 
 
To a solution of S36 (289 mg, 1 mmol) and propiolic acid (84 mg, 1.2 mmol) in 
CH2Cl2 (10 mL) was added DCC (227 mg, 1.1 mmol) and DMAP (12 mg, 0.1 mmol) in 
one portion. Compound S37 was isolated using MPLC (hexanes:EtOAc = 3:1) as a clear 
yellow oil (208 mg, 0.61 mmol, 61%). 
1H NMR (500 MHz, CDCl3, as a 8:1 ratio of two rotamers): Major rotamer δ 7.46-7.40 
(m, 3H, NArHmHp), 7.35-7.31 (m, 2H, NArHo), 6.65 (s, 1H, OArHp), 6.56 (s, 2H, 
OArHo), 4.70 (s, 2H, CH2O), 4.60 (s, 2H, CH2N), 2.84 (s, 1H, C≡CH), and 2.29 [s, 
6H, Ar(CH3)2]. Minor rotamer δ 4.80 (s, 2H, CH2O), 4.75 (s, 2H, CH2N), 3.32 (s, 1H, 
C≡CH), and 2.42 [s, 6H, Ar(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 157.7, 152.8, 140.4, 139.5, 129.7, 129.2, 128.4, 123.7, 
112.7, 80.7, 75.8, 74.2, 73.8, 71.2, 68.7, 56.3, 38.8, and 21.7 (only resonances for the 
major rotamer are reported). 
IR: 3287, 2919, 2859, 2111, 1644, 1614, 1594, 1493, 1383, 1318, 1292, 1276, 1220, 
1168, 1151, 1063, 831, 765, and 750 cm-1. 
HRMS (ESI-TOF): Calcd for C23H19NNaO2+ [M+Na]+ requires 364.1308; found 
364.1311. 
  
DCC
DMAP
O
PhHN
S36
O
OH
S37
O
PhN
O
  Experimental 
 247 
1,3-Dimethyl-9-phenyl-9,10-dihydrochromeno[3,4-f]isoindol-8(6H)-one (7074e) 
 
A solution of S37 (20 mg, 0.059 mmol) in dichloroethane (2 mL) was heated at 120 
°C for 18 h. The resulting solution was concentrated and subjected to MPLC 
(hexanes:EtOAc = 3:1) to give 7074e as a colorless solid (17 mg, 0.05 mmol, 85%). 
1H NMR (500 MHz, CDCl3): δ 7.89 (dd, J = 8.9, 1.3 Hz, 2H, Ho), 7.83 (br s, 1H, H7), 
7.77 (br s, 1H, H11), 7.44 (dd, J = 8.7, 7.4 Hz, 2H, Hm), 7.19 (tt, J = 7.4, 1.2 Hz, 1H, 
Hp), 6.82 (d, J = 1.6 Hz, 1H, H2 or H4), 6.78 (d, J = 1.7 Hz, 1H, H4 or H2), 5.01 (s, 
2H, H6 or H10), 4.92 (s, 2H, H6 or H10), 2.69 (s, 3H, C1-CH3), 2.34 (s, 3H, C3-
CH3). 
13C NMR (125 MHz, CDCl3): δ 167.4, 157.2, 140.3, 140.1, 139.8, 135.7, 135.3, 134.3, 
131.3, 129.4, 127.2, 124.6, 120.5, 120.3, 120.0, 119.5, 116.0, 69.3, 51.1, 23.0, and 
21.4. 
IR: 2981, 2916, 2856, 1682, 1616, 1597, 1502, 1448, 1387, 1287, 1180, 1130, 1061, 
1011, 891, and 857 cm-1. 
HRMS (ESI-TOF): Calcd for C23H19NNaO2+ [M+Na]+ requires 364.1308; found 
364.1298. 
mp: 235-239 °C. 
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Synthesis of isoindolone 7074f 
 
3-Methyl-5-(prop-2-yn-1-yloxy)phenol (S38) 
 
K2CO3 (2.76 g, 20 mmol, 2 equiv) was added to a solution of orcinol (1.24 g, 10 
mmol, 1 equiv) and 3-bromoprop-1-yne (1.77 g, 15 mmol, 1.5 equiv) in acetone (50 mL). 
The resulting mixture was heated at 50 °C with stirring overnight. The resulting slurry 
was partitioned between EtOAc and H2O. The aqueous layer was washed with EtOAc (30 
mL x 3). The combined organic layers were washed with brine, dried (Na2SO4), and 
concentrated. The resulting oil was subjected to flash chromatography (hexanes:EtOAc = 
19:1 then 5:1 then 3:1) to give S38 as a light yellow oil (550 mg, 3.4 mmol, 34%).  
1H NMR (500 MHz, CDCl3): δ 6.38 (br dd, J = 1.8, 1.8 Hz, 1H), 6.30 (overlapping d, J = 
1.8 Hz, 2H), 4.65 (s, 1H, OH), 4.64 (d, J = 2.4 Hz, 2H, CH2O), 2.52 (t, J = 2.4 Hz, 
1H, C≡CH), and 2.28 (br s, 3H, CH3). 
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13C NMR (125 MHz, CDCl3): 
δ 159.0, 156.6, 140.9, 109.7, 108.4, 99.8, 78.8, 75.7, 56.0, and 21.8. 
IR: 3390, 3290, 2923, 2867, 2123, 1596, 1496, 1467, 1372, 1327, 1305, 1146, 1056, 
1023, and 832 cm-1. 
HRMS (ESI-TOF): Calcd for C10H9O2- [M-H]- requires 161.0608; found 161.0606.  
tert-Butyldimethyl(3-methyl-5-(prop-2-yn-1-yloxy)phenoxy)silane (S39) 
 
TBSCl (360 mg, 2.4 mmol, 1.2 equiv) and imidazole (272 mg, 4 mmol, 2 equiv) were 
sequentially added to a solution of S38 (324 mg, 2 mmol, 1 equiv) in CH2Cl2 (10 mL) at 
0 °C. The reaction mixture was allowed to warm to rt. After 3 h the reaction mixture was 
partitioned between CH2Cl2 (20 mL) and saturated aqueous NH4Cl (20 mL). The aqueous 
layer was washed with CH2Cl2 (10 mL x 2). The combined organic layers were washed 
with brine, dried (Na2SO4), and concentrated. The resulting oil was purified by flash 
chromatography (hexanes:EtOAc = 19:1) to give S39 as a clear colorless oil (510 mg, 
1.84 mmol, 92%).   
1H NMR (500 MHz, CDCl3): δ 6.40 (s, 1H, ArH), 6.32 (s, 1H, ArH), 6.30 (dd, J = 2.1, 
2.1 Hz, 1H, ArH), 4.63 (d, J = 2.4 Hz, 2H, CH2O), 2.51 (t, J = 2.4 Hz, 1H, C≡CH), 
2.27 (s, 3H, ArCH3), 0.98 [s, 9H, C(CH3)3], and 0.19 [s, 6H, Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): 
δ 158.6, 156.7, 140.3, 114.6, 108.9, 104.4, 78.9, 75.6, 56.0, 25.9, 21.9, 18.4 and -4.2. 
IR: 3307, 2957, 2930, 2859, 2124, 1590, 1471, 1463, 1370, 1324, 1254, 1154, 1061, 
1038, and 839 cm-1. 
GC-LRMS: tR = 8.29 min. m/z: 276 (M+, 100), 261 (M+-CH3, 20), 248 (M+-C2H4, 20), 
219 [M+-C(CH3)3, 90], 203 (45), 189 (65), and 145 (70). 
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Bromoalkyne S40 was prepared following General Procedure A from S39 (276 mg, 1 
mmol, 1 equiv), NBS (186 mg, 1.05 mmol, 1.05 equiv), AgNO3 (16 mg, 0.1 mmol, 0.1 
equiv), and acetone (10 mL). The reaction was closely monitored (GC analysis) to 
minimize over-bromination on the aromatic ring. S40 was obtained as a clear yellow oil 
(320 mg, 0.90 mmol, 90%) following flash chromatography (hexanes:EtOAc = 19:1). 
1H NMR (500 MHz, CDCl3): δ 6.38 (s, 1H, ArH), 6.32 (s, 1H, ArH), 6.28 (dd, J = 2.1, 
2.1 Hz, 1H, ArH), 4.65 (s, 2H, CH2O), 2.27 (s, 3H, ArCH3), 0.98 [s, 9H, C(CH3)3], 
and 0.20 [s, 6H, Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 158.5, 156.7, 140.4, 114.7, 109.0, 104.3, 75.4, 56.9, 
47.6, 25.9, 21.8, 18.4, and -4.2. 
IR: 2956, 2930, 2859, 2219, 1590, 1471, 1463, 1371, 1323, 1300, 1254, 1153, 1067, 
1042, and 839 cm-1. 
GC-LRMS: tR = 9.71 min. m/z: 356 (M+, 70), 354 (M+, 70), 299 [M+-C(CH3)3, 20], 297 
[M+-C(CH3)3, 20], 284 (15), 282 (15), 269 (20), 267 (20), 217(50), 203 (100), 189 
(40), and 73 (45). 
N-(6-(3-((tert-Butyldimethylsilyl)oxy)-5-methylphenoxy)hexa-2,4-diyn-1-yl)aniline 
(S41) 
 
Diyne S41 was prepared following General Procedure B from S40 (316 mg, 0.89 
mmol, 1.2 equiv), N-(prop-2-yn-1-yl)aniline (100 mg, 0.76 mmol, 1 equiv), CuCl (8 mg, 
0.08 mmol, 0.1 equiv), and piperidine (2 mL). S41 was obtained following flash 
chromatography (hexanes:EtOAc = 5:1) as a clear yellow oil (220 mg, 0.54 mmol, 71%). 
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1H NMR (500 MHz, CDCl3): δ 7.21 (dd, J = 8.6, 7.4 Hz, 2H, ArHm), 6.80 (tt, J = 7.3, 
1.0 Hz, 1H, ArHp), 6.67 (dd, J = 8.6, 1.0 Hz, 2H, ArHo), 6.35 (m, 1H, ArH), 6.31 (m, 
1H, ArH), 6.25 (m, 1H, ArH), 4.66 (s, 2H, CH2O), 4.01 (d, J = 6.1 Hz, 2H, NHCH2), 
3.86 (br t, J = 5.6 Hz, 1H, NHCH2), 2.26 (s, 3H, ArCH3), 0.97 [s, 9H, C(CH3)3], and 
0.18 [s, 6H, Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ  158.5, 156.7, 146.7, 140.4, 129.5, 119.1, 114.7, 113.8, 
108.9, 104.3, 77.7, 73.0, 71.6, 67.3, 56.4, 34.4, 25.9, 21.9, 18.4, and -4.2. 
IR: 3400, 2955, 2930, 2886, 2858, 2258, 1603, 1591, 1505, 1471, 1463, 1321, 1254, 
1152, 1058, 1035, and 840 cm-1. 
HRMS (ESI-TOF): Calcd for C25H31NNaO2Si+ [M+Na]+ requires 428.2016; found 
428.2011. 
N-(6-(3-((tert-Butyldimethylsilyl)oxy)-5-methylphenoxy)hexa-2,4-diyn-1-yl)-N-
phenylpropiolamide (S42) 
 
Amide S42 was prepared following General Procedure D from S41 (202 mg, 0.5 
mmol), propiolic acid (42 mg, 0.6 mmol), DCC (125 mg, 0.6 mmol), DMAP (6 mg, 0.05 
mmol), and CH2Cl2 (4 mL). Amide S42 was obtained following flash chromatography 
(hexanes:EtOAc = 3:1) as a clear yellow oil (119 mg, 0.26 mmol, 52%). 
1H NMR (500 MHz, CDCl3, as a 6.5:1 ratio of two rotamers): Major rotamer 
δ 7.47-7.40 (m, 3H, ArHoHp), 7.36-7.31 (m, 2H, ArHm), 6.36 (s, 1H, ArH), 6.32 (s, 
1H, ArH), 6.25 (s, 1H, ArH), 4.67 (s, 2H, CH2), 4.60 (s, 2H, CH2), 2.83 (s, 1H, 
C≡CH), 2.27 (s, 3H, ArCH3), 0.97 [s, 9H, C(CH3)3], and 0.19 [s, 6H, Si(CH3)2]. 
Minor rotamer δ 4.78 (s, 2H, CH2), 4.69 (s, 2H, CH2), and 3.29 (s, 1H, C≡CH). 
13C NMR (125 MHz, CDCl3): δ 158.4, 156.7, 152.7, 140.4, 140.3, 129.6, 129.2, 128.4, 
114.7, 108.8, 104.3, 80.7, 75.8, 74.2, 73.6, 71.3, 68.6, 56.3, 38.8, 25.9, 21.8, 18.4, and 
-4.2. (only resonances for the major rotamer are reported). 
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IR: 3286, 2955, 2930, 2858, 2112, 1648, 1644, 1591, 1493, 1469, 1463, 1382, 1323, 
1294, 1271, 1253, 1220, 1151, 1058, 1034, and 840 cm-1. 
HRMS (ESI-TOF): Calcd for C28H31NNaO3Si+ [M+Na]+ requires 480.1965; found 
480.1950. 
3-((tert-Butyldimethylsilyl)oxy)-1-methyl-9-phenyl-9,10-dihydrochromeno[3,4-
f]isoindol-8(6H)-one (7074f) 
 
A solution of S42 (25 mg, 0.055 mmol) in dichloroethane (1.8 mL) was heated to 120 
°C for 18 h. The resulting solution was concentrated and subjected to MPLC 
(hexanes:EtOAc = 3:1) to give 7074f as a colorless solid (21 mg, 0.046 mmol, 84%). 
1H NMR (500 MHz, CDCl3): δ 7.88 (dd, J = 8.7, 1.1 Hz, 2H, Ho), 7.77 (s, 1H, H7 or 
H11), 7.74 (s, 1H, H7 or H11), 7.43 (dd, J = 8.8, 7.4 Hz, 2H, Hm), 7.18 (tt, J = 7.4, 
1.0 Hz, 1H, Hp), 6.50 (d, J = 2.5 Hz, 1H, H2), 6.44 (d, J = 2.5 Hz, 1H, H4), 4.99 (s, 
2H, H6 or H10), 4.90 (s, 2H, H6 or H10), 2.66 (s, 3H, ArCH3), 1.00 [s, 9H, C(CH3)3], 
and 0.25 [s, 6H, Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 167.4, 158.3, 156.9, 140.2, 139.8, 137.2, 135.4, 133.6, 
130.9, 129.4, 124.6, 120.5, 119.6, 119.5, 118.4, 116.9, 106.8, 69.5, 51.1, 25.9, 23.1, 
18.4, and -4.1. 
IR: 2956, 2931, 2859, 1700, 1689, 1681, 1608, 1596, 1563, 1501, 1494, 1473, 1456, 
1441, 1405, 1380, 1316, 1254, 1175, 1154, 1067, 853, and 836 cm-1. 
HRMS (ESI-TOF): Calcd for C28H31NNaO3Si+ [M+Na]+ requires 480.1965; found 
480.1955. 
mp: 188-193 °C. 
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Synthesis of isoindolone 7074g  
 
N-(6-(4-Bromo-3,5-dimethylphenoxy)hexa-2,4-diyn-1-yl)-N-phenylpropiolamide 
(S43) 
 
NBS (15 mg, 0.085 mmol) was added to a solution of S37 (28 mg, 0.082 mmol) in 
CH3CN (0.27 mL)174. The reaction mixture was stirred for 1 h at rt and partitioned 
between H2O and EtOAc. The aqueous layer was washed with EtOAc (10 mL x 3). The 
combined organic layers were washed with brine, dried (Na2SO4), and concentrated. The 
resulting oil was purified by flash chromatography (hexanes:EtOAc = 3:1) to give S38 as 
a clear brown oil (29 mg, 0.069 mmol, 84%). 
1H NMR (500 MHz, CDCl3, as a 9:1 ratio of two rotamers): Major rotamer δ 7.46-7.39 
(m, 3H, ArHmHp), 7.33 (dd, J = 8.0, 2.1 Hz, 2H, ArHo), 6.67 (br s, 2H, ArH2/H6), 
4.68 (t, J = 0.9 Hz, 2H, OCH2  or NCH2), 4.59 (t, J = 0.9 Hz, 2H, OCH2 or NCH2), 
2.84 (s, 1H, C≡CH), and 2.39 [br s, 6H, Ar(CH3)2]. Minor rotamer δ 4.78 (br s, 2H, 
OCH2), 4.71 (br s, 2H, NCH2), and 3.30 (s, 1H, C≡CH). 
13C NMR (125 MHz, CDCl3): δ 156.0, 152.7, 140.4, 139.5, 129.7, 129.2, 128.4, 119.6, 
114.9, 80.8, 75.8, 74.4, 73.3, 71.5, 68.5, 56.5, 38.8, and 24.3. (only resonances for the 
major rotamer are reported) 
                                                
174  Eli, Z-C.; Karla, A.; Siegel, J. S. Synthesis of arylbromides from arenes and N-bromosuccinimide 
(NBS) in acetonitrile—A convenient method for aromatic bromination. Can. J. Chem. 2009, 87, 440-
447. 
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IR: 2922, 2857, 2111, 1644, 1593, 1585, 1494, 1468, 1384, 1310, 1293, 1276, 1220, 
1160, 1067, 1031, and 1017 cm-1. 
HRMS (ESI-TOF): Calcd for C23H18BrNNaO2+ [M+Na]+ requires 442.0413; found 
442.0420. 
2-Bromo-1,3-dimethyl-9-phenyl-9,10-dihydrochromeno[3,4-f]isoindol-8(6H)-one 
(7074g) 
 
A solution of S43 (15 mg, 0.036 mmol) in CHCl3 (1 mL) was heated to 120 °C for 18 
h shielded from light. The resulting solution was concentrated and subjected to MPLC 
(hexanes:EtOAc = 3:1) to give 7074g as a colorless solid (11.5 mg, 0.028 mmol, 77%). 
1H NMR (500 MHz, CDCl3): δ 7.88 (dd, J = 8.8, 1.1 Hz, 2H, Ho), 7.79 (s, 1H, H7 or 
H11), 7.73 (s, 1H, H7 or H11), 7.44 (dd, J = 8.7, 7.4 Hz, 2H, Hm), 7.20 (tt, J = 7.4, 
1.0 Hz, 1H, Hp), 6.90 (br s, 1H, H4), 5.00 (s, 2H, OCH2 or NCH2), 4.92 (s, 2H, OCH2 
or NCH2), 2.79 (s, 3H, C1-CH3), and 2.45 (br s, 3H, C3-CH3). 
13C NMR (125 MHz, CDCl3): δ 167.2, 155.7, 140.6, 140.1, 139.7, 135.5, 134.9, 134.3, 
131.9, 129.4, 124.8, 123.0, 122.8, 120.9, 120.8, 119.6, 117.2, 69.5, 51.1, 24.7, and 
24.1. 
IR: 2918, 2854, 1686, 1625, 1596, 1502, 1444, 1377, 1289, 1179, 1169, 1132, 1069, 957, 
895, and 857 cm-1. 
HRMS (ESI-TOF): Calcd for C23H18BrNNaO2+ [M+Na]+ requires 442.0413; found 
442.0434. 
mp: 272-274 °C.  
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Synthesis of isoindolone 7074h 
 
1-(But-3-yn-2-yloxy)-3,5-dimethylbenzene (S44) 
 
To a solution of but-3-yn-2-ol (560 mg, 8 mmol), 3,5-dimethylphenol (976 mg, 8 
mmol), and PPh3 (2.1 g, 8 mmol) in THF cooled at 0 °C was added diisopropyl 
azodicarboxylate (1.94 g, 9.6 mmol) dropwise. The resulting solution was stirred at this 
temperature for an additional 3 h. The resulting mixture was partitioned between H2O and 
EtOAc. The aqueous layer was washed with EtOAc (20 mL x 2). The combined organic 
layers were washed with brine, dried (Na2SO4), and concentrated. The resulting slurry 
was purified by flash chromatography (hexanes:EtOAc = 25:1) to give S44 as a light 
yellow oil (730 mg, 4.2 mmol, 53%), which solidified upon standing.   
1H NMR (500 MHz, CDCl3): δ 6.63 (overlapping s, 3H, ArH), 4.85 (qd, J = 6.5, 2.0 Hz, 
1H, CHOAr), 2.45 (d, J = 2.0 Hz, 1H, C≡CH), 2.29 [dt, J = 0.7, 0.7 Hz, 6H, 
Ar(CH3)2], and 1.64 (d, J = 6.5 Hz, 3H, CH3CH). 
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13C NMR (125 MHz, CDCl3): δ 157.5, 139.3, 123.5, 113.6, 83.4, 73.8, 63.5, 22.4, and 
21.7.  
IR: 3293, 2990, 2938, 2920, 2115, 1613, 1594, 1470, 1447, 1375, 1317, 1291, 1169, 
1154, 1127, 1091, 1054, and 830 cm-1. 
GC-LRMS: tR = 5.59 min. m/z: 174 (M+, 70), 159 (M+-CH3, 95), 122 (M+ -C4H4, 100), 
107 (M+ -C5H7, 80), 91 (C7H7+, 30), 77 (C6H5+, 28), and 53 (20). 
mp: 46-48 °C. 
1-((4-Bromobut-3-yn-2-yl)oxy)-3,5-dimethylbenzene (S45) 
 
Bromoalkyne S45 was prepared following General Procedure A from S44 (530 mg, 
3.05 mmol), NBS (563 mg, 3.20 mmol), AgNO3 (50 mg, 0.3 mmol), and acetone (20 
mL). S45 was obtained as a yellow oil (670 mg, 2.65 mmol, 87%), which solidified upon 
standing, following flash chromatography (Hexanes:EtOAc = 20:1). 
1H NMR (500 MHz, CDCl3): δ 6.63 (s, 1H, ArHp), 6.61 (s, 2H, ArHo), 4.84 (q, J = 6.6 
Hz, 1H, CHOAr), 2.29 [s, 6H, Ar(CH3)2], and 1.62 (d, J = 6.6 Hz, 3H, CH3CH). 
13C NMR (125 MHz, CDCl3): δ 157.5, 139.4, 123.5, 113.6, 79.8, 64.5, 46.0, 22.4, and 
21.7.  
IR: 2989, 2936, 2920, 2209, 1613, 1594, 1471, 1450, 1374, 1316, 1291, 1169, 1154, 
1131, 1093, 1060, and 829 cm-1. 
GC-LRMS: tR = 7.23 min. m/z: 254 (M+, 15), 252 (M+, 15), 239 (M+-CH3, 10), 237 
(M+-CH3, 10), 173 (M+-Br, 40), 145 (30), 122 (M+-BrC4H3, 100), 107 (M+-BrC4H3-
CH3, 70), 91 (C7H7+, 25), and 77 (C6H5+, 25).  
mp: 41-51 °C. 
N-(6-(3,5-Dimethylphenoxy)hepta-2,4-diyn-1-yl)aniline (S46) 
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Diyne S46 was prepared following General Procedure C from S45 (625 mg, 2.48 
mmol, 1.24 equiv), N-(prop-2-yn-1-yl)aniline (262 mg, 2 mmol, 1 equiv), CuCl (10 mg, 
0.1 mmol, 0.05 equiv), 30% aqueous BuNH2 (8 mL), and Et2O (8 mL). S46 was obtained 
as a clear yellow oil (394 mg, 1.3 mmol, 65%) following flash chromatography 
(hexanes:EtOAc = 5:1).  
1H NMR (500 MHz, CDCl3): δ 7.21 (t, J = 7.5 Hz, 2H, NArHm), 6.79 (t, J = 7.5 Hz, 1H, 
NArHp), 6.65 (d, J = 7.5 Hz, 2H, NArHo), 6.63 (s, 1H, OArHp), 6.58 (s, 1H, 
OArHo), 4.84 (q, J = 6.6 Hz, 1H, CH3CH), 3.99 (s, 2H, NCH2), 3.85 (br s, 1H, NH), 
2.28 [s, 6H, Ar(CH3)2], and 1.61 (d, J = 6.6 Hz, CH3CH). 
13C NMR (125 MHz, CDCl3): δ 157.4, 146.7, 139.4, 129.5, 123.6, 119.0, 113.7, 113.5, 
77.6, 77.4, 70.0, 67.3, 63.9, 34.4, 22.3, and 21.7  
IR: 3470-3330, 3051, 2988, 2919, 2870, 2250, 2165, 1602, 1594, 1504, 1472, 1439, 
1314, 1290, 1260, 1168, 1153, 1081, 1048, 964, and 830 cm-1. 
HRMS (ESI-TOF): Calcd for C21H21NNaO+ [M+Na]+ requires 326.1515; found 
326.1521. 
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N-(6-(3,5-Dimethylphenoxy)hepta-2,4-diyn-1-yl)-N-phenylpropiolamide (S47) 
 
To a solution of S20 (303 mg, 1 mmol, 1 equiv) and propiolic acid (84 mg, 1.2 mmol, 
1.2 equiv) in CH2Cl2 (8 mL) cooled at 0 °C was added DCC (237 mg, 1.15 mmol, 1.15 
equiv) and DMAP (6 mg, 0.05 mmol, 0.05 equiv) in one portion. Amide S47 was 
obtained following flash chromatography (hexanes:EtOAc = 3:1) as a clear brown oil 
(249 mg, 0.7 mmol, 70%). 
1H NMR (500 MHz, CDCl3, as a 8.5:1 ratio of two rotamers): Major rotamer δ 7.46-
7.30 (m, 5H, NArH), 6.64 (s, 1H, OArHp), 6.58 (s, 1H, OArHo), 4.86 (q, J = 6.6 Hz, 
1H, CH3CH), 4.57 (s, 2H, NCH2), 2.83 (s, 1H, CCH), 2.29 [s, 6H, Ar(CH3)2], and 
1.62 (d, J = 6.6 Hz, CH3CH). Minor rotamer δ 6.59 (s, 1H, OArHp), 4.59 (s, 2H, 
NCH2), 4.88 (q, J = 6.6 Hz, 1H, CH3CH), 4.76 (s, 2H, NCH2), 3.28 (s, 1H, CCH), and 
1.64 (d, J = 6.7 Hz, CH3CH). 
13C NMR (125 MHz, CDCl3): δ 157.4, 152.7, 140.5, 139.4, 129.6, 129.2, 128.4, 123.6, 
113.5, 80.7, 78.0, 75.8, 74.1, 69.8, 68.7, 63.9, 38.9, 22.2, and 21.7 (only resonances 
for the major rotamer are reported). 
IR: 3282, 2917, 2849, 2111, 1644, 1613, 1594, 1493, 1383, 1315, 1290, 1278, 1220, 
1168, 1153, 1116, 1082, 1052, 1016, and 830 cm-1. 
HRMS (ESI-TOF): Calcd for C24H21NNaO2+ [M+Na]+ requires 378.1465; found 
378.1455. 
1,3,6-Trimethyl-9-phenyl-9,10-dihydrochromeno[3,4-f]isoindol-8(6H)-one (7074h) 
 
A solution of S47 (17 mg, 0.048 mmol) in dichloroethane (1.6 mL) was heated to 120 
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°C for 18 h. The resulting solution was concentrated and subjected to MPLC 
(hexanes:EtOAc = 3:1) to give 7074h as a colorless solid (15 mg, 0.042 mmol, 88%). 
1H NMR (500 MHz, CDCl3): 7.88 (dd, J = 8.8, 1.1 Hz, 2H, Ho), 7.80 (br s, 1H, H7 or 
H11), 7.78 (br s, 1H, H7 or H11), 7.43 (dd, J = 8.6, 7.4 Hz, 2H, Hm), 7.18 (tt, J = 7.4, 
1.0 Hz, 1H, Hp), 6.79 (br d, J = 1.7 Hz, 1H, H2), 6.76 (br d, J = 1.7 Hz, 1H, H4), 5.02 
(q, J = 6.5 Hz, 1H, CHCH3), 4.91 (d, J = 16.1 Hz, 1H, H10a), 4.86 (d, J = 16.1 Hz, 
1H, H10b), 2.68 (s, 3H, C1-CH3), 2.33 (s, 3H, C3-CH3), and 1.73 (d, J = 6.5 Hz, 3H, 
CHCH3). 
13C NMR (125 MHz, CDCl3): δ 167.6, 156.2, 140.2, 139.8, 139.6, 138.5, 135.4, 135.1, 
131.4, 129.4, 127.0, 124.6, 120.3, 120.1, 119.6, 119.3, 116.2, 73.9, 51.1, 23.0, 21.5, 
and 18.8. 
IR: 2978, 2917, 2849, 1693, 1615, 1598, 1501, 1449, 1379, 1293, 1267, 1179, 1135, 
1086, 1059, 898, 846, and 767 cm-1. 
HRMS (ESI-TOF): Calcd for C24H21NNaO2+ [M+Na]+ requires 378.1465; found 
378.1455. 
mp: 171-173 °C. 
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Synthesis of isoindolone 7074i 
 
1-((3-Bromoprop-2-yn-1-yl)oxy)-3-methylbenzene (S48) 
 
Bromoalkyne S48 was prepared following General Procedure A from 1-methyl-3-
(prop-2-yn-1-yloxy)benzene172 (422 mg, 2.89 mmol, 1 equiv), NBS (553 mg, 3.18 mmol, 
1.1 equiv), AgNO3 (49 mg, 0.29 mmol, 0.1 equiv), and acetone (20 mL). S48 was 
obtained following flash chromatography (hexanes:EtOAc = 19:1) as a clear yellow oil 
(540 mg, 2.4 mmol, 83%). 
1H NMR (500 MHz, CDCl3): δ 7.18 (br dd, J = 7.4, 7.4 Hz, 1H, H5), 6.81 (d, J = 7.7 Hz, 
1H, H4), 6.77 (br s, 1H, H2), 6.76 (br d, J = 7.1 Hz, 1H, H6), 4.68 (s, 2H, CH2O), and 
2.34 (s, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 157.7, 139.8, 129.4, 122.7, 115.9, 111.8, 75.4, 56.8, 
47.6, and 21.7. 
IR: 2914, 2861, 2218, 1603, 1585, 1489, 1451, 1373, 1291, 1258, 1152, 1056, 1021, 991, 
and 770 cm-1.  
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GC-LRMS: tR = 6.80 min. m/z: 226 (M+, 25), 224 (M+, 25), 211 (M+-CH3, 20), 209 
(M+-CH3, 20), 145 (M+ -Br, 70), 117 (M+-CH3C6H4O, 100), 115 (M+-CH3C6H4O, 
90), 91 (C7H7+, 60), and 77 (C6H5+, 50).  
N-(6-(m-Tolyloxy)hexa-2,4-diyn-1-yl)aniline (S49) 
 
Diyne S49 was prepared following General Procedure C from S48 (390 mg, 1.73 
mmol, 1.4 equiv), N-(prop-2-yn-1-yl)aniline (162 mg, 1.24 mmol, 1 equiv), CuCl (6 mg, 
0.06 mmol, 0.05 equiv), 30% aqueous BuNH2 (8 mL), and Et2O (8 mL). S49 was 
obtained following flash chromatography (hexanes:EtOAc = 5:1) as a clear yellow oil 
(230 mg, 0.84 mmol, 67%). 
1H NMR (500 MHz, CDCl3): δ 7.23-7.15 (m, 3H, ArH), 6.81-6.77 (m, 2H, ArH), 6.74-
6.72 (m, 2H, ArH), 6.67-6.64 (m, 2H, ArH), 4.69 (s, 2H, OCH2), 3.99 (d, J = 5.7 Hz, 
2H, NCH2), 3.84 (br t, J = 5.7 Hz, 1H, NH), and 2.32 (s, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 157.6, 146.7, 139.8, 129.5, 129.4, 122.7, 119.0, 115.9, 
113.7, 111.8, 77.7, 73.0, 71.6, 67.3, 56.3, 34.4, and 21.7. 
IR: 3400, 3053, 2917, 2255, 1602, 1585, 1504, 1489, 1438, 1375, 1350, 1313, 1291, 
1257, 1152, 1095, 1041, 924, 875, and 771 cm-1.  
HRMS (ESI-TOF): Calcd for C19H17NNaO+ [M+Na]+ requires 298.1202; found 
298.1205. 
N-Phenyl-N-(6-(m-tolyloxy)hexa-2,4-diyn-1-yl)propiolamide (S50) 
 
To a solution of S23 (113 mg, 0.4 mmol, 1 equiv) and propiolic acid (42 mg, 0.6 
mmol, 1.5 equiv) in CH2Cl2 (2 mL) cooled at 0 °C was added DMAP (6 mg, 0.05 mmol, 
0.05 equiv) and DCC (124 mg, 0.6 mmol, 1.5 equiv) in one portion. Amide S50 was 
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obtained following flash chromatography (hexanes:EtOAc = 3:1) as a clear brown oil (84 
mg, 0.26 mmol, 64%). 
1H NMR (500 MHz, CDCl3, as a 7:1 ratio of two rotamers): Major rotamer δ 7.46-7.38 
(m, 3H, ArH), 7.33 (dd, J = 8.1, 2.0 Hz, 2H, ArHo), 7.18 (t, J = 7.5 Hz, 1H, ArH5), 
6.81 (d, J =7.3 Hz, 1H, ArH4), 6.76-6.72 (m, 2H, ArH), 4.71 (s, 2H, OCH2), 4.59 (d, 
J = 5.7 Hz, 2H, NCH2), 2.83 (s, 1H, CCH), and 2.34 (s, 3H, ArMe). Minor rotamer 
δ 4.78 (s, 2H), 4.75 (s, 2H), and 3.30 (s, 1H). 
13C NMR (125 MHz, CDCl3): δ 157.6, 152.7, 140.4, 139.9, 129.7, 129.4, 129.2, 128.4, 
122.8, 115.9, 111.8, 80.7, 75.8, 74.2, 73.7, 71.3, 68.6, 56.3, 38.8, and 21.7 (only 
resonances for the major rotamer are reported). 
IR: 3280, 2930, 2856, 2111, 1642, 1593, 1587, 1491, 1382, 1290, 1277, 1259, 1244, 
1220, 1152, 1035, 1061, 935, and 772 cm-1.  
HRMS (ESI-TOF): Calcd for C22H17NNaO2+ [M+Na]+ requires 350.1151; found 
350.1167. 
1-Methyl-9-phenyl-9,10-dihydrochromeno[3,4-f]isoindol-8(6H)-one (7074i) 
 
A solution of S50 (22 mg, 0.067 mmol) in dichloroethane (2.2 mL) was heated to 120 
°C for 18 h. The resulting solution was concentrated and subjected to MPLC 
(hexanes:EtOAc = 3:1) to give 7074i as a colorless solid (16 mg, 0.049 mmol, 73%). 
1H NMR (500 MHz, CDCl3): δ 7.88 (dd, J = 8.7, 1.1 Hz, 2H, Ho), 7.84 (s, 1H, H7 or 
H11), 7.77 (s, 1H, H7 or H11), 7.43 (dd, J = 8.9, 7.4 Hz, 2H, Hm), 7.20 (dd, J = 7.9, 
7.3 Hz, 1H, H3), 7.18 (tt, J = 7.4, 1.1 Hz, 1H, Hp), 6.98 (ddq, J = 7.6, 1.4, 0.7 Hz, 
1H, H2), 6.95 (ddq, J = 8.0, 1.3, 0.6 Hz, 1H, H4), 5.02 (s, 2H, H6 or H10), 4.90 (s, 
2H, H6 or H10), and 2.72 (br s, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 167.3, 157.2, 140.0, 139.7, 136.0, 135.0, 134.7, 131.7, 
129.8, 129.4, 126.1, 124.7, 123.1, 120.6, 120.4, 119.6, 115.5, 69.3, 51.1, and 23.0. 
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IR: 2917, 2857, 1683, 1596, 1503, 1449, 1417, 1385, 1328, 1293, 1272, 1260, 1241, 
1203, 1179, 1158, 1133, 1039, 1009, and 892 cm-1.  
HRMS (ESI-TOF): Calcd for C22H17NNaO2+ [M+Na]+ requires 350.1151; found 
350.1159. 
mp: 252-254 °C. 
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Synthesis of fluorenone 7074j 
 
3-(tert-Butyldimethylsilyl)-1-(2-ethynylphenyl)prop-2-yn-1-ol (S52) 
 
nBuLi (2.4 mL, 2.5 M solution in hexanes, 6 mmol, 1.2 equiv) was added to a 
solution of tert-butyl(ethynyl)dimethylsilane (6 mmol, 1.2 equiv) in THF (30 mL) cooled 
at -78 °C. The solution was allowed to stir for 1 h at this temperature. A solution of 2-
ethynylbenzaldehyde (650 mg, 5 mmol, 1.0 equiv) in THF (10 mL) was added dropwise. 
The resulting mixture was stirred for additional 2 h, after which saturated aqueous NH4Cl 
was added. The resulting slurry was partitioned between EtOAc and H2O. The aqueous 
layer was washed with EtOAc (15 mL x 3). The combined organic layers were washed 
with brine, dried (Na2SO4), and concentrated. The crude oil was subjected to flash 
chromatography (Hexanes:EtOAc = 5:1) to give S51 as a light yellow oil (850 mg, 3.15 
mmol, 63%).  
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1H NMR (500 MHz, CDCl3): δ 7.73 (dd, J = 7.8, 1.3 Hz, 1H, ArH), 7.51 (dd, J = 7.6, 1.2 
Hz, 1H, ArH), 7.40 (ddd, J = 7.6, 7.6, 1.4 Hz, 1H, ArH), 7.30 (ddd, J = 7.6, 7.6, 1.3 
Hz, 1H, ArH), 5.88 (d, J = 5.9, 1H, CHOH), 3.36 (s, 1H, CCH), 2.56 (d, J = 5.9 Hz, 
1H, OH), 0.94 [s, 9H, C(CH3)3], and 0.13 [s, 6H, Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 142.9, 133.4, 129.6, 128.5, 127.0, 121.0, 105.0, 90.3, 
82.8, 81.2, 63.6, 26.3, 16.8, and -4.5. 
IR: 3500, 3300, 2954, 2929, 2885, 2857, 2173, 1471, 1463, 1449, 1250, 1037, 980, and 
840 cm-1.  
HRMS (ESI-TOF): Calcd for C17H22NaOSi+ [M+Na]+ requires 293.1332; found 
293.1337. 
2,6-Dimethyl-4-(prop-2-yn-1-yloxy)pyridine (S52) 
 
K2CO3 (3.36 g, 24.4 mmol, 2 equiv), 2,6-dimethylpyridin-4-ol (1.5 g, 12.2 mmol, 1 
equiv), and 3-bromoprop-1-yne (2.37 g, 15.8 mmol, 1.3 equiv) in acetone (25 mL) were 
heated with stirring at 50 °C overnight. The resulting slurry was partitioned between 
EtOAc and H2O. The aqueous layer was extracted with EtOAc (20 mL x 3). The 
combined organic layers were washed with brine, dried (Na2SO4), and concentrated. The 
resulting dark oil (S52, 2.01 g, 102%) was used without further purification for the next 
step. A small aliquot was passed through a pad of silica gel (EtOAc) for characterization.  
1H NMR (500 MHz, CDCl3): δ 6.57 (s, 2H, ArH), 4.70 (d, J = 2.4 Hz, 2H, CH2), 2.56 (t, 
J = 2.4 Hz, 1H, CH), and 2.49 (s, 6H, CH3). 
13C NMR (125 MHz, CDCl3): δ 164.6, 159.6, 107.1, 77.8, 76.4, 55.5, and 24.9.  
IR: 3293, 2957, 2922, 2852, 2120, 1599, 1579, 1455, 1329, 1319, 1152, and 1060 cm-1.  
GC-LRMS: tR = 5.67 min. m/z: 161 (M+, 100), 146 (M+-CH3, 40), 132 (50), 118 (55), 
and 91 (70). 
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4-((3-Bromoprop-2-yn-1-yl)oxy)-2,6-dimethylpyridine (S53) 
 
Bromide S53 was prepared following General Procedure A from S52 (480 mg, 3 
mmol, 1 equiv), NBS (580 mg, 3.3 mmol, 1.1 equiv), AgNO3 (51 mg, 0.3 mmol, 1 
equiv), and acetone (20 mL). Compound S53 was obtained and used for the next step 
without column chromatography. A small aliquot was passed through a pad of silica gel 
(EtOAc) for characterization.  
1H NMR (500 MHz, CDCl3): δ 6.55 (s, 2H, ArH), 4.72 (s, 2H, CH2), and 2.49 (s, 6H, 
CH3). 
13C NMR (125 MHz, CDCl3): δ 164.6, 159.6, 107.0, 74.3, 56.3, 48.8, and 24.9. 
IR: 3083, 2962, 2921, 2865, 2225, 1600, 1579, 1465, 1452, 1372, 1327, 1217, 1158, 993, 
956, 849, and 823 cm-1.  
HRMS (ESI-TOF): Calcd for C10H11BrNO+ [M+H]+ requires 240.0019; found 240.0027. 
3-(tert-Butyldimethylsilyl)-1-(2-(5-((2,6-dimethylpyridin-4-yl)oxy)penta-1,3-diyn-1-
yl)phenyl)prop-2-yn-1-ol (S54) 
 
Triyne S54 was prepared following General Procedure C from S51 (95 mg, 0.35 
mmol, 1.2 equiv), S53 (70 mg, 0.29 mmol, 1.0 equiv), CuCl (3 mg, 0.03 mmol, 0.1 
equiv), 30% aqueous BuNH2 (1.5 mL), and Et2O (1.5 mL). Compound S54 was obtained 
following flash chromatography (hexanes:EtOAc = 1:1, then pure EtOAc) as a brown oil 
(65 mg, 0.15 mmol, 52%). 
1H NMR (500 MHz, CDCl3): δ 7.75 (d, J = 7.8 Hz, 1H, ArH), 7.50 (d, J = 7.6 Hz, 1H, 
ArH), 7.42 (dd, J = 6.9, 6.9 Hz, 1H, ArH), 7.30 (dd, J = 7.6, 7.6 Hz, 1H, ArH), 6.56 
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(s, 2H, HetArH), 5.81 (s, 1H, CHOH), 4.84 (s, 2H, CH2O), 2.49 [s, 6H, 
HetAr(CH3)2], 0.91 [s, 9H, SiC(CH3)3], and 0.10 [s, 6H, Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 164.6, 159.6, 144.3, 133.9, 130.2, 128.4, 127.1, 119.8, 
107.1, 105.3, 90.0, 77.9, 77.4, 76.8, 72.5, 63.1, 56.1, 26.2, 24.8, 16.7, and -4.5. 
IR: 2954, 2928, 2857, 2240, 2172, 1601, 1580, 1469, 1364, 1322, 1275, 1259, 1154, 
1056, 988, 909, and 840 cm-1.  
HRMS (ESI-TOF): Calcd for C27H32NO2Si+ [M+H]+ requires 430.2197; found 430.2199. 
3-(tert-Butyldimethylsilyl)-1-(2-(5-((2,6-dimethylpyridin-4-yl)oxy)penta-1,3-diyn-1-
yl)phenyl)prop-2-yn-1-one (S55) 
 
A mixture of S54 (50 mg, 0.12 mmol) and MnO2 (265 mg, 3.04 mmol) in CH2Cl2 (3 
mL) was stirred at room temperature for 3 h. The resulting solution was filtered through a 
pad of Celite® and silica gel and concentrated to give S55 as a clear yellow oil (48 mg, 
0.11 mmol, 95%). 
1H NMR (500 MHz, CDCl3): δ 8.15 (dd, J = 7.4, 1.6 Hz, 1H, ArH), 7.62 (dd, J = 7.4, 1.4 
Hz, 1H, ArH), 7.52 (ddd, J = 7.5, 7.5, 1.5 Hz, 1H, ArH), 7.49 (ddd, J = 7.5, 7.5, 1.4 
Hz, 1H, ArH), 6.57 (s, 2H, HetArH), 4.86 (s, 2H, CH2O), 2.50 [s, 6H, HetAr(CH3)2], 
1.00 [s, 9H, SiC(CH3)3], and 0.23 [s, 6H, Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 176.2, 164.5, 159.6, 139.3, 136.0, 132.8, 132.4, 129.3, 
121.1, 107.0, 102.1, 100.5, 78.6, 78.2, 77.6, 72.9, 56.1, 26.3, 24.9, 16.9, and -4.9. 
IR: 2997, 2953, 2928, 2857, 2150, 1648, 1596, 1580, 1563, 1470, 1322, 1270, 1265, 
1237, 1151, 1055, 1017, and 843 cm-1.   
HRMS (ESI-TOF): Calcd for C27H30NO2Si+ [M+H]+ requires 428.2040; found 428.2040. 
 7-(tert-Butyldimethylsilyl)-1,3-dimethylindeno[1',2':6,7]isochromeno[4,3-c]pyridin-
8(6H)-one (7074j) 
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A solution of S55 (20 mg, 0.046 mmol) in CHCl3 (1.4 mL) was heated at 95 °C for 36 
h. The resulting solution was concentrated and subjected to flash chromatography 
(hexanes:EtOAc = 1:1) to give 7074j as a yellow oil (18 mg, 0.042 mmol, 90%).  
1H NMR (500 MHz, CDCl3): δ 7.84 (s, 1H, ArH), 7.62 (d, J = 7.3 Hz, 1H, ArH), 7.55 (d, 
J = 7.4 Hz, 1H, ArH), 7.50 (dd, J = 7.4, 7.4 Hz, 1H, ArH), 7.31 (dd, J = 7.4, 7.4 Hz, 
1H, ArH), 6.69 (s, 1H, HetArH), 5.08 (s, 2H, CH2O), 2.90 (s, 3H, C1CH3), 2.53 (s, 
3H, C3CH3), 1.14 [s, 9H, SiC(CH3)3], and 0.43 [s, 6H, Si(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 193.7, 163.8, 159.1, 155.6, 145.0, 143.2, 141.1, 139.6, 
138.3, 134.7, 134.34, 134.32, 129.5, 124.2, 119.7, 118.7, 117.7, 109.0, 70.9, 28.4, 
25.5, 24.8, 19.8, and 0.8. 
IR: 2952, 2928, 2855, 1715, 1590, 1567, 1467, 1434, 1383, 1298, 1250, 1181, 1165, 
1136, 1072, and 828 cm-1.   
HRMS (ESI-TOF): Calcd for C27H30NO2Si+ [M+H]+ requires 428.2040; found 428.2068. 
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Synthesis of isobenzofuranone 7074k 
 
1-Methoxy-3-methyl-5-(prop-2-yn-1-yloxy)benzene (S56) 
 
K2CO3 (828 mg, 6 mmol, 3 equiv), S38 (324 mg, 2 mmol, 1 equiv), and MeI (568 
mg, 4 mmol, 2 equiv) in acetone (10 mL) are heated with stirring at 50 °C overnight. The 
resulting slurry was partitioned between EtOAc and H2O. The aqueous layer was washed 
with EtOAc (10 mL x 3). The combined organic layers were washed with brine, dried 
(Na2SO4), and concentrated. The resulting oil was subjected to flash chromatography 
(hexanes:EtOAc = 19 :1) to give S56 as a light yellow oil (338 mg, 1.9 mmol, 95%). 
1H NMR (500 MHz, CDCl3): δ 6.39 (br s, 1H, ArH), 6.38 (br s, 1H, ArH), 6.36 (br dd, J 
= 2.3, 2.3 Hz, 1H, ArH), 4.65 (d, J = 2.4 Hz, 2H, CH2O), 3.77 (s, 3H, CH3O), 2.52 (t, 
J = 2.4 Hz, 1H, C≡CH), and 2.31 (s, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 160.8, 158.8, 140.5, 108.3, 108.0, 98.7, 78.8, 75.6, 56.0, 
55.5, and 22.0. 
IR: 3286, 3000, 2955, 2922, 2840, 2122, 1596, 1470, 1372, 1337, 1311, 1293, 1196, 
1148, 1068, 1054, and 829 cm-1. 
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GC-LRMS: tR = 6.52 min m/z: 176 (M+, 100), 161 (M+-CH3, 90), 145 (M+-CH3O, 25), 
133 (40), 105 (30), and 77 (C6H5+, 30). 
6-(3-Methoxy-5-methylphenoxy)hexa-2,4-diyn-1-ol (S57) 
 
Diynol S57 was prepared following General Procedure C from S56 (150 mg, 0.85 
mmol, 1 equiv), 3-bromoprop-2-yn-1-ol (126 mg, 0.94 mmol, 1.1 equiv), CuCl (4 mg, 
0.04 mmol, 0.05 equiv), 30% aqueous BuNH2 (4 mL) and Et2O (4 mL). S57 was obtained 
following flash chromatography (hexanes:EtOAc = 3:1) as a clear colorless oil (108 mg, 
0.47 mmol, 55%).  
1H NMR (500 MHz, CDCl3): δ 6.39 (br d, J = 3.0 Hz, 1H, ArH), 6.37 (br d, J = 2.0 Hz, 
1H, ArH), 6.33 (dd, J = 2.5, 2.5 Hz, 1H, ArH), 4.72 (t, J = 1.0 Hz, 2H, CH2O), 4.33 
(br d, J = 4.5 Hz, 2H, CH2OH), 3.77 (s, 3H, CH3O), 2.31 (br s, 3H, ArCH3), and 1.75 
(t, J = 5.5 Hz, 1H, OH). 
13C NMR (125 MHz, CDCl3): δ 160.8, 158.7, 140.6, 108.4, 108.0, 98.7, 77.9, 74.6, 71.2, 
70.0, 56.4, 55.5, 51.6, and 22.0. 
IR: 3406, 3000, 2920, 2841, 2258, 1595, 1471, 1371, 1336, 1310, 1293, 1195, 1148, 
1068, 1048, 1023, and 828 cm-1. 
HRMS (ESI-TOF): Calcd for C14H14NaO3+ [M+Na]+ requires 253.0835; found 253.0855. 
6-(3-Methoxy-5-methylphenoxy)hexa-2,4-diyn-1-yl Propiolate (S58) 
 
Ester S58 was prepared by treating a solution of S57 (54 mg, 0.23 mmol, 1.0 equiv) 
and propiolic acid (18 mg, 0.26 mmol, 1.1 equiv) in CH2Cl2 (2 mL) with DCC (54 mg, 
0.026 mmol, 1.1 equiv) and DMAP (2 mg, 0.016 mmol, 0.07 equiv). S58 was obtained 
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following flash chromatography (hexanes:EtOAc = 12:1 then 5:1 then 3:1) as a clear 
colorless oil (40 mg, 0.14 mmol, 62%). 
1H NMR (500 MHz, CDCl3): δ 6.39 (s, 1H, ArH), 6.37 (s, 1H, ArH), 6.32 (s, 1H, ArH), 
4.83 (s, 2H, CH2), 4.72 (s, 2H, CH2), 3.77 (s, 3H, CH3O), 2.96 (s, 1H, CCH), and 2.31 
(s, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 160.9, 158.6, 151.8, 140.6, 108.5, 108.0, 98.7, 76.4, 
75.6, 73.9, 72.1, 71.7, 70.8, 56.3, 55.5, 53.9, and 22.0. 
IR: 3271, 3005, 2990, 2923, 2850, 2123, 1722, 1595, 1471, 1364, 1275, 1262, 1206, 
1148, 1069, and 1051 cm-1.  
HRMS (ESI-TOF): Calcd for C17H14NaO4+ [M+Na]+ requires 305.0784; found 
305.0767. 
3-Methoxy-1-methyl-6H-isobenzofuro[5,6-c]chromen-8(10H)-one (7074k) 
 
A solution of S58 (13 mg, 0.046 mmol) in 1,2-dichlorobenzene (1.5 mL) was heated 
at 165 °C for 3.5 h. The resulting solution was directly subjected to MPLC 
(hexanes:EtOAc = 3:1) to yield 7074k as a clear colorless oil (11 mg, 0.039 mmol, 85%). 
1H NMR (500 MHz, CDCl3): δ 7.74 (br s, 1H, H7), 7.72 (br s, 1H, H11), 6.56 (dq, J = 
2.7, 0.7 Hz, 1H, H2), 6.50 (d, J = 2.7 Hz, 1H, H4), 5.35 (s, 2H, H10), 4.99 (s, 2H, 
H6), 3.83 (s, 3H, OCH3), and 2.67 (br s, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 171.1, 161.1, 158.9, 146.8, 137.7, 137.4, 134.2, 123.0, 
121.9, 118.6, 115.7, 113.2, 100.3, 69.9, 69.3, 55.6, and 23.2. 
IR: 2958, 2925, 2850, 1756, 1716, 1609, 1592, 1570, 1453, 1412, 1356, 1320, 1295, 
1195, 1149, 1142, 1070, 1040, and 1014 cm-1. 
HRMS (ESI-TOF): Calcd for C17H14NaO4+ [M+Na]+ requires 305.0784; found 
305.0810. 
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Synthesis of isobenzofuranone 7074l 
 
7-(3,5-Dimethylphenyl)hepta-2,4-diyn-1-ol (S59) 
 
Diynol S59 was prepared following General Procedure C from 1-(but-3-yn-1-yl)-3,5-
dimethylbenzene175 (100 mg, 0.63 mmol, 1 equiv), 3-bromoprop-2-yn-1-ol (101 mg, 0.76 
mmol, 1.2 equiv), CuCl (6 mg, 0.06 mmol, 0.1 equiv), 30% aqueous BuNH2 (2.4 mL) 
and Et2O (2.4 mL). S59 was obtained following flash chromatography (hexanes:EtOAc = 
3:1) as a clear colorless oil (75 mg, 0.35 mmol, 56%).  
1H NMR (500 MHz, CDCl3): δ 6.86 (s, 1H, ArH4), 6.81 (s, 2H, ArH2H6), 4.32 (d, J = 
5.5 Hz, 2H, CH2OH), 2.77 (t, J = 7.5 Hz, 2H, CH2CH2), 2.55 (t, J = 7.5 Hz, 2H, 
CH2CH2), 2.29 [s, 6H, Ar(CH3)2], and 1.55 (t, J = 6.0 Hz, OH).  
13C NMR (125 MHz, CDCl3): δ 140.1, 138.2, 128.3, 126.4, 81.2, 74.0, 71.1, 65.1, 51.8, 
34.6, 21.7, and 21.5. 
IR: 3340, 3015, 2944, 2918, 2857, 2257, 1606, 1464, 1447, 1424, 1376, 1350, 1231, 
1017, and 846 cm-1.  
                                                
175  Zhang, L.; Kozmin, S. A. Brønsted acid-promoted cyclizations of siloxyalkynes with arenes and 
alkenes. J. Am. Chem. Soc. 2004, 126, 10204–10205. 
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HRMS (ESI-TOF): Calcd for C15H16NaO+ [M+Na]+ requires 235.1093; found 235.1092. 
7-(3,5-Dimethylphenyl)hepta-2,4-diyn-1-yl Propiolate (S60) 
 
Ester S60 was prepared by treating a solution of S33 (32 mg, 0.15 mmol, 1.0 equiv) 
and propiolic acid (11.5 mg, 0.165 mmol, 1.1 equiv) in CH2Cl2 (1 mL) cooled at 0 °C 
with DCC (34 mg, 0.165 mmol, 1.1 equiv) and DMAP (2 mg, 0.016 mmol, 0.1 equiv). 
S60 was obtained following flash chromatography (hexanes:EtOAc = 12:1) as a clear 
colorless oil (33 mg, 0.13 mmol, 83%). 
1H NMR (500 MHz, CDCl3): δ 6.86 (s, 1H, ArH4), 6.81 (s, 2H, ArH2H6), 4.82 (s, 2H, 
OCH2), 2.93 (s, 1H, CCH), 2.77 (t, J = 7.6 Hz, 2H, CH2), 2.55 (t, J = 7.6 Hz, 2H, 
CH2), and 2.29 [s, 6H, Ar(CH3)2].  
13C NMR (125 MHz, CDCl3): δ 151.9, 139.9, 138.2, 128.4, 126.3, 82.1, 76.2, 74.0, 72.9, 
68.2, 64.9, 54.3, 34.4, 21.7, and 21.5. 
IR: 3283, 3015, 2920, 2861, 2260, 2123, 1722, 1606, 1469, 1443, 1368, 1206, 979, 958, 
and 843 cm-1. 
HRMS (ESI-TOF): Calcd for C18H16NaO2+ [M+Na]+ requires 287.1043; found 
287.1058. 
1,3-Dimethyl-5,6-dihydrophenanthro[2,3-c]furan-8(10H)-one (7074l) 
 
A solution of S60 (18 mg, 0.068 mmol) in 1,2-dichlorobenzene (2.2 mL) was heated 
at 165 °C for 3.5 h. The resulting solution was directly subjected to MPLC 
(hexanes:EtOAc = 3:1) to yield 7074l as a colorless solid (12.5 mg, 0.047 mmol, 69%). 
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1H NMR (500 MHz, CDCl3): δ 7.79 (br s, 1H, H7), 7.67 (br s, 1H, H11), 7.05 (br s, 1H, 
H4), 6.99 (br s, 1H, H2), 5.34 (s, 2H, OCH2), 2.83 (dd, J = 9.4, 5.7 Hz, 2H, H5 or 
H6), 2.75 (dd, J = 9.4, 5.7 Hz, 2H, H6 or H5), 2.60 (s, 3H, C1CH3), and 2.35 (s, 3H, 
C3CH3). 
13C NMR (125 MHz, CDCl3): δ 171.5, 144.8, 141.4, 141.3, 140.8, 138.4, 135.2, 131.8, 
130.8, 126.8, 124.2, 123.4, 121.1, 69.9, 30.6, 30.4, 23.1, and 21.3. 
IR: 2942, 1756, 1622, 1611, 1449, 1353, 1304, 1274, 1132, 1043, and 1009 cm-1. 
HRMS (ESI-TOF): Calcd for C18H16NaO2+ [M+Na]+ requires 287.1043; found 
287.1051. 
mp: 129-133 °C. 
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Synthesis of isobenzofuranone 7074m 
 
tert-Butyl (3,5-dimethylphenyl)(prop-2-yn-1-yl)carbamate (S61) 
 
A solution of tert-butyl (3,5-dimethylphenyl)carbamate176 (880 mg, 4 mmol, 1 equiv) 
in 12 mL of a 1:l mixture of DMF/THF was treated with NaH (60% dispersion in mineral 
oil, 320 mg, 8 mmol, 2 equiv) at 0 °C. This resulting solution was stirred for an additional 
30 min at rt. The mixture was allowed to react with 3-bromoprop-1-yne (566 mg, 4.8 
mmol, 1.2 equiv) and the mixture was stirred at rt for 8 h. The excess NaH was quenched 
with saturated aqueous NH4Cl solution. The mixture was partitioned between EtOAc and 
H2O. The aqueous layer was extracted with EtOAc (30 mL x 3). The combined organic 
layers were washed with brine, dried (Na2SO4), and concentrated. The resulting crude oil 
was subjected to flash chromatography (hexanes:EtOAc = 3:1) to yield S61 as a yellow 
oil (930 mg, 3.59 mmol, 90%). 
1H NMR (500 MHz, CDCl3): δ 6.93 (br s, 2H, ArH2H6), 6.85 (br s, 1H, ArH4), 4.32 (d, 
J = 2.5 Hz, 2H, CH2), 2.30 [br s, 6H, Ar(CH3)2], 2.24 (t, J = 2.5 Hz, 1H, CCH), and 
1.47 [br s, 9H, C(CH3)3]. 
                                                
176  Brucelle, F.; Renaud, P. Synthesis of indolines, indoles, and benzopyrrolizidinones from simple aryl 
azides. Org. Lett. 2012, 14, 3048–3051. 
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13C NMR (125 MHz, CDCl3): δ 154.3, 142.2, 138.5, 128.2, 124.1, 81.0, 80.4, 71.7, 40.1 
(br), 28.5, and 21.5  
IR: 3293, 2976, 2923, 2866, 2121, 1700, 1610, 1598, 1473, 1455, 1433, 1422, 1376, 
1367, 1316, 1245, 1168, 1143, 1083, 878, 851, and 769 cm-1. 
HRMS (ESI-TOF): Calcd for C16H21NNaO2+ [M+Na]+ requires 282.1465; found 
282.1453. 
tert-Butyl (3,5-dimethylphenyl)(6-hydroxyhexa-2,4-diyn-1-yl)carbamate (S62) 
 
Diynol S62 was prepared following General Procedure C from S61 (300 mg, 1.15 
mmol, 1 equiv), 3-bromoprop-2-yn-1-ol (190 mg, 1.40 mmol, 1.2 equiv), CuCl (6 mg, 
0.06 mmol, 0.05 equiv), 30% aqueous BuNH2 (4 mL), and Et2O (4 mL). S62 was 
obtained following flash chromatography (hexanes:EtOAc = 3:1 then 1:1) as a clear 
colorless oil (165 mg, 0.53 mmol, 46%).  
1H NMR (500 MHz, CDCl3): δ 6.89 (br s, 2H, ArH2H6), 6.86 (br s, 1H, ArH4), 4.39 (br 
s, 2H, CH2), 4.31 (br s, 2H, CH2), 2.31 [br s, 6H, Ar(CH3)2], and 1.47 (s, 9H, tBu). 
13C NMR (125 MHz, CDCl3): δ 154.3, 142.0, 138.6, 128.4, 124.1, 81.4, 76.6, 76.2, 70.5, 
67.5, 51.7, 40.9  (br), 28.5, and 21.5.  
IR: 3428, 2977, 2923, 2255, 1698, 1683, 1610, 1597, 1472, 1455, 1430, 1390, 1368, 
1315, 1248, 1164, 1145, 1081, 1031, and 879 cm-1.  
HRMS (ESI-TOF): Calcd for C19H23NNaO3+ [M+Na]+ requires 336.1570; found 
336.1568. 
6-((tert-Butoxycarbonyl)(3,5-dimethylphenyl)amino)hexa-2,4-diyn-1-yl Propiolate 
(S63) 
N
CuCl
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Ester S63 was prepared by treating a solution of S36 (80 mg, 0.26 mmol, 1.0 equiv) 
and propiolic acid (21 mg, 0.3 mmol, 1.15 equiv) in CH2Cl2 (2 mL) cooled at 0 °C with 
DCC (60 mg, 0.29 mmol, 1.1 equiv) and DMAP (2 mg, 0.016 mmol, 0.06 equiv). S63 
was obtained following flash chromatography (hexanes:EtOAc = 12:1 then 5:1) as a clear 
colorless oil (49 mg, 0.134 mmol, 83%). This material contained ca. 10% of an 
unidentified impurity, perhaps originating from propiolic acid as judged from analysis of 
the 1H and 13C NMR data, but was of sufficient quality to be used as the substrate in the 
subsequent HDDA/ene reaction. 
1H NMR (500 MHz, CDCl3): δ 6.88 (br s, 2H, ArH2H6), 6.86 (br s, 1H, ArH4), 4.84 (br 
s, 2H, CH2OCO), 4.40 (br s, 2H, CH2N), 2.97 (s, 1H, HCC), 2.31 [br s, 6H, 
Ar(CH3)2], and 1.47 [s, 9H, C(CH3)3]. 
13C NMR (125 MHz, CDCl3): δ 154.2, 151.9, 141.9, 138.7, 128.5, 124.1, 81.4, 77.6, 
76.3, 74.0, 72.3, 70.3, 67.2, 54.1, 40.9  (br), 28.5, and 21.5.  
IR: 3221, 2977, 2933, 2857, 2121, 1723, 1698, 1659, 1609, 1598, 1475, 1458, 1429, 
1368, 1315, 1243, 1207, 1165, 1144, and 978 cm-1.  
HRMS (ESI-TOF): Calcd for C22H23NNaO4+ [M+Na]+ requires 388.1519; found 
388.1525. 
tert-Butyl 1,3-dimethyl-8-oxo-8,10-dihydrofuro[3,4-j]phenanthridine-5(6H)-
carboxylate (7074m) 
 
A solution of S65 (20 mg, 0.055 mmol) in 1,2-dichlorobenzene (1.8 mL) was heated 
at 130 °C for 16 h. The resulting solution was directly subjected to MPLC 
NBoc
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(hexanes:EtOAc = 3:1) to give 7074m as a colorless solid (11 mg, 0.03 mmol, 55%).  
1H NMR (500 MHz, CDCl3): δ 7.83 (s, 1H, ArH), 7.77, (s, 1H, ArH), 7.43-7.32 (br s, 
1H, ArH), 6.98 (s, 1H, ArH), 5.36 (s, 2H, ArCH2O), 4.71-4.64 (br s, 2H, ArCH2N), 
2.63 (s, 3H, C1CH3), 2.38 (s, 3H, C3CH3), and 1.48 [br s, 9H, C(CH3)3]. 
13C NMR (125 MHz, CDCl3): δ 171.2, 152.6, 145.8, 140.2, 139.0 (br), 138.8, 137.7 (br), 
135.3, 129.7, 125.1, 123.7, 123.5, 122.3 (br), 120.8, 81.7, 69.9, 48.0 (br), 28.5, 23.0, 
and 21.6.  
IR: 2975, 2919, 1762, 1698, 1613, 1590, 1451, 1412, 1370, 1346, 1284, 1229, 1155, 
1132, 1044, 1009, 890, 855, and 761 cm-1. 
HRMS (ESI-TOF): Calcd for C22H23NNaO4+ [M+Na]+ requires 388.1519; found 
388.1530. 
mp: 201-204 °C. 
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Synthesis of isoindolone 7074n and 7074o 
 
1-Ethyl-3-methyl-5-(prop-2-yn-1-yloxy)benzene (S64) 
 
A mixture of K2CO3 (2.76 g, 20 mmol, 2 equiv), 3-ethyl-5-methylphenol (1.36 g, 10 
mmol, 1 equiv), and 3-bromoprop-1-yne (1.77 g, 15 mmol, 1.5 equiv) were heated with 
stirring at 50 °C in acetone (50 mL) overnight. The resulting slurry was partitioned 
between EtOAc and H2O. The aqueous layer was washed with EtOAc (30 mL x 3). The 
combined layers were washed with brine, dried (Na2SO4), and concentrated. The crude 
oil was subjected to flash chromatography (hexanes:EtOAc = 19:1) to give S64 as a light 
yellow oil (1.64 g, 9.4 mmol, 94%). 
1H NMR (500 MHz, CDCl3): δ 6.66 (br s, 1H), 6.63 (br s, 1H), 6.61 (br s, 1H), 4.66 (d, J 
= 2.4 Hz, 2H, CH2O), 2.59 (q, J = 7.6 Hz, CH2CH3), 2.50 (t, J = 2.4 Hz, 1H, HC≡C), 
2.31 (s, 3H, ArCH3), and 1.22 (t, J = 7.6 Hz, 3H, CH2CH3). 
13C NMR (125 MHz, CDCl3): 
δ 157.9, 145.9, 139.5, 122.3, 112.9, 111.8, 79.1, 75.4, 55.9, 29.1, 21.7, and 15.7.  
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IR: 3288, 2965, 2921, 2872, 2122, 1611, 1594, 1457, 1330, 1288, 1168, 1151, 1078, 
1049, 1012, 941, and 844 cm-1.  
GC-LRMS: tR = 6.09 min. m/z: 174 (M+, 50), 159 (M+-CH3, 70), 145 (M+ -CH2CH3, 
100), 131 (M+ -C3H7, 40), 91 (C7H7+, 70), and 77 (C6H5+, 20). 
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1-((3-Bromoprop-2-yn-1-yl)oxy)-3-ethyl-5-methylbenzene (S65) 
 
Bromoalkyne S65 was prepared following General Procedure A from S64 (865 mg, 5 
mmol, 1 equiv), NBS (929 mg, 5.25 mmol, 1.05 equiv), AgNO3 (42 mg, 0.25 mmol, 0.05 
equiv), and acetone (40 mL). S65 was isolated following flash chromatography 
(hexanes:EtOAc = 19:1) as a clear yellow oil (1.10 g, 0.44 mmol, 88%).  
1H NMR (500 MHz, CDCl3): δ 6.67 (br s, 1H, H4), 6.60 (br s, 1H, H6), 6.59 (br s, 1H, 
H2), 4.67 (br s, 2H, CH2O), 2.59 (br q, J = 7.6 Hz, 2H, CH2CH3), 2.31 (br s, 3H, 
ArCH3), and 1.22 (t, J = 7.6 Hz, 3H, CH2CH3). 
13C NMR (125 MHz, CDCl3): δ 157.8, 146.0, 139.6, 122.4, 112.8, 111.7, 75.5, 56.8, 
47.5, 29.1, 21.7, and 15.7. 
IR: 2965, 2931, 2872, 2218, 1611, 1593, 1461, 1453, 1371, 1330, 1287, 1167, 1150, 
1079, 1054, and 843 cm-1.  
GC-LRMS: tR = 7.82 min. m/z: 254 (M+, 40), 252 (M+, 40), 239 (M+-CH3, 20), 237 
(M+-CH3, 20), 225 (M+-CH2CH3, 30), 223 (M+-CH2CH3, 30), 173 (M+-Br, 60), 158 
(50), 145 (80), 130 (50), 117 (70), 91 (C7H7+, 100), and 77 (C6H5+, 25). 
N-(6-(3-Ethyl-5-methylphenoxy)hexa-2,4-diyn-1-yl)aniline (S66) 
 
Diyne S66 was prepared following General Procedure C from S65 (506 mg, 2 mmol, 
1.3 equiv), N-(prop-2-yn-1-yl)aniline (201 mg, 1.53 mmol, 1.0 equiv), CuCl (7 mg, 0.07 
mmol, 0.05 equiv), 30% aqueous BuNH2 (7 mL), and Et2O (7 mL). S66 was obtained 
following flash chromatography (hexanes:EtOAc = 5:1) as a clear yellow oil (381 mg, 
1.26 mmol, 82%).  
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1H NMR (500 MHz, CDCl3): δ 7.20 (dd, J = 8.2, 7.7 Hz, 2H, Hm), 6.79 (t, J = 7.4 Hz, 
1H, Hp), 6.66 (d, J = 7.9 Hz, 2H, Ho), 6.65 (br s, 1H, H4), 6.58 (br s, 1H, H6), 6.56 
(br s, 1H, H2), 4.68 (br s, 2H, CH2O), 4.00 (br s, 2H, NCH2), 3.85 (br s, 1H, NH), 
2.57 (br q, J = 7.6 Hz, 2H, CH2CH3), 2.30 (br s, 3H, ArCH3), and 1.20 (t, J = 7.6 Hz, 
3H, CH2CH3). 
13C NMR (125 MHz, CDCl3): δ 157.8, 146.7, 146.0, 139.6, 129.5, 122.4, 119.1, 113.8, 
112.8, 111.7, 77.7, 73.2, 71.5, 67.3, 56.3, 34.4, 29.0, 21.7, and 15.7. 
IR: 3405, 2965, 2931, 2869, 2255, 1602, 1593, 1505, 1456, 1437, 1314, 1287, 1258, 
1167, 1150, 1075, 1046, and 752 cm-1.  
HRMS (ESI-TOF): Calcd for C21H21NNaO+ [M+Na]+ requires 326.1515; found 
326.1519. 
  Experimental 
 283 
N-(6-(3-Ethyl-5-methylphenoxy)hexa-2,4-diyn-1-yl)-N-phenylpropiolamide (S67) 
 
Amide S67 was prepared by treating a solution of S66 (303 mg, 1 mmol, 1.0 equiv) 
and propiolic acid (91 mg, 1.3 mmol, 1.3 equiv) in CH2Cl2 (10 mL) cooled at 0 °C with 
DCC (236 mg, 1.15 mmol, 1.15 equiv) and DMAP (6 mg, 0.05 mmol, 0.05 equiv). S67 
was obtained following flash chromatography (hexanes:EtOAc = 3:1) as a clear brown oil 
(355 mg, 0.93 mmol, 93%). 
1H NMR (500 MHz, CDCl3, as a 7:1 ratio of two amide rotamers): Major isomer δ 7.45-
7.40 (m, 3H, HmHp), 7.33 (dd, J = 7.9, 2.0 Hz, 2H, Ho), 6.67 (br s, 1H, H4), 6.58 (br 
s, 1H, H6), 6.57 (br s, 1H, H2), 4.70 (br s, 2H, CH2O), 4.59 (br s, 2H, NCH2), 2.83 (s, 
1H, C≡CH), 2.59 (br q, J = 7.6 Hz, 2H, CH2CH3), 2.31 (br s, 3H, ArCH3), and 1.21 (t, 
J = 7.6 Hz, 3H, CH2CH3). Minor isomer δ 4.77 (br s, 2H, CH2O), 4.72 (br s, 2H, 
NCH2), and 3.29 (s, 1H, CCH). 
13C NMR (125 MHz, CDCl3): δ 157.7, 152.7, 146.0, 140.4, 139.6, 129.6, 129.2, 128.4, 
122.5, 112.8, 111.7, 80.7, 75.8, 74.2, 73.8, 71.2, 68.7, 56.3, 38.8, 29.0, 21.7, and 15.7 
(only resonances for the major rotamer are reported). 
IR: 3283, 2965, 2923, 2873, 2111, 1643, 1611, 1593, 1492, 1456, 1414, 1383, 1330, 
1287, 1220, 1168, 1150, 1076, 1048, 1015, and 842 cm-1.  
HRMS (ESI-TOF): Calcd for C24H21NNaO2+ [M+Na]+ requires 378.1465; found 
378.1455. 
1-Ethyl-3-methyl-9-phenyl-9,10-dihydrochromeno[3,4-f]isoindol-8(6H)-one (7074n) 
and 
1-Methyl-3-ethyl-9-phenyl-9,10-dihydrochromeno[3,4-f]isoindol-8(6H)-one (7074o) 
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A solution of S67 (25 mg, 0.07 mmol) in dichloroethane (2.3 mL) was heated at 
120 °C for 18 h. The resulting solution was concentrated and subjected to MPLC 
(hexanes:EtOAc = 3:1) to yield 7074n and 7074o as a coeluting 1:2 mixture (20 mg, 
0.056 mmol, 80% combined yield). 
Characterization data for 7074n 
1H NMR (500 MHz, CDCl3): δ 7.88 (dd, J = 8.8, 1.0 Hz, 1H, Ho), 7.74 (br s, 1H, H7), 
7.73 (br s, 1H, H11), 7.42 (overlapping dd, J = 8.5, 7.5 Hz, 2H, Hm), 7.17 
(overlapping tt, J = 7.4, 1.0 Hz, 1H, Hp), 6.87 (br d, J = 1.8 Hz, 1H, H2), 6.77 (br d, J 
= 1.8 Hz, 1H, H4), 4.97 (br s, 2H, OCH2), 4.89 (br s, 2H, NCH2), 3.02 (q, J = 7.6 Hz, 
3H, CH2CH3), 2.35 (br s, 3H, C3CH3), and 1.40 (t, J = 7.6 Hz, 3H, CH2CH3). 
13C NMR (125 MHz, CDCl3, shifts deduced from HSQC): δ 128.8, 124.6, 124.0, 119.5, 
119.5, 118.9, 115.1, 68.8, 50.6, 27.1, 21.3, and 15.3 (several of the cross peaks 
overlapping with major product). 
Characterization data for 7074o 
1H NMR (500 MHz, CDCl3): δ 7.87 (dd, J = 8.8, 1.0 Hz, 1H, Ho), 7.81 (br s, 1H, H7), 
7.74 (br s, 1H, H11), 7.42 (overlapping dd, J = 8.5, 7.5 Hz, 2H, Hm), 7.17 
(overlapping tt, J = 7.4, 1.0 Hz, 1H, Hp), 6.83 (br d, J = 1.8 Hz, 1H, H2), 6.79 (br d, J 
= 1.8 Hz, 1H, H4), 5.00 (br s, 2H, OCH2), 4.88 (br s, 2H, NCH2), 2.69 (br s, 3H, 
C1CH3), 2.63 (q, J = 7.6 Hz, 3H, CH2CH3), and 1.26 (t, J = 7.6 Hz, 3H, CH2CH3). 
13C NMR (125 MHz, CDCl3, shifts deduced from HSQC): δ 128.8, 125.4, 124.0, 120.0, 
119.5, 118.9, 114.0, 68.9, 50.6, 28.2, 22.8, and 15.0 (several of the cross peaks 
overlapping with major product). 
IR: 2966, 2928, 2863, 1693, 1625, 1614, 1598, 1501, 1459, 1449, 1407, 1380, 1328, 
1293, 1270, 1175, 1130, 1077, 1057, 1015, 908, and 859 cm-1.  
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HRMS (ESI-TOF): Calcd for C24H21NNaO2+ [M+Na]+ requires 378.1465; found 
378.1439. 
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Synthesis of 7077, 7078, 7079a, and 7079b. 
 
2-Bromo-1-((3,5-dimethylbenzyl)oxy)-4-methoxybenzene (7075) 
K2CO3 (924 mg, 6.7 mmol, 2 equiv), 2-bromo-4-methoxyphenol (800 mg, 4 mmol, 
1.2 mmol), and 1-(bromomethyl)-3,5-dimethylbenzene (670 mg, 3.35 mmol, 1 equiv) in 
acetone (5 mL) was stirred at 50 °C overnight. The resulting slurry was partitioned 
between EtOAc and saturated aqueous NH4Cl. The organic layer was washed with brine, 
dried (Na2SO4), and concentrated. The resulting crude oil was subjected to MPLC 
(hexanes:EtOAc = 20:1) to give 7075 (612 mg, 57%) as a yellow oil. 
1H NMR (500 MHz, CDCl3): δ 7.13 (d, J = 3.0 Hz, 1H, H3), 7.07 (br s, 2H, H2’H6’), 
6.95 (br s, 1H, H4’), 6.87 (d, J = 9.0 Hz, 1H, H6), 6.77 (dd, J = 9.0, 3.0 Hz, 1H, H5), 
5.01 (s, 2H, CH2O), 3.76 (s, 3H, CH3O), and 2.33 [br s, 6H, Ar(CH3)2]. 
13C NMR (125 MHz, CDCl3): δ 154.6, 149.8, 138.3, 136.9, 129.7, 125.2, 119.0, 115.9, 
113.9, 113.4, 72.4, 56.1, and 21.5. 
IR: 3005, 2940, 2916, 2834, 1609, 1576, 1492, 1459, 1440, 1297, 1272, 1212, 1040, 844, 
and 786 cm-1.  
GC-LRMS: tR = 10.79 min. m/z: 322 (M+, 10), 320 (M+, 10), 119 (C9H11+, 100), 91 
(C7H7+, 8), and 77 (C6H5+, 4). 
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2-Methoxy-8,10-dimethyl-6H-benzo[c]chromene (7077) 
1-((4-Methoxyphenoxy)methyl)-3,5-dimethylbenzene (7078) 
5-((3,5-Dimethylbenzyl)oxy)-N,N-diisopropyl-2-methoxyaniline (7079a) and  
2-((3,5-Dimethylbenzyl)oxy)-N,N-diisopropyl-5-methoxyaniline (7079b) 
 
A THF solution of LDA was freshly prepared at -10 °C from nBuLi (2.5 M solution 
in hexanes, 0.4 mL, 1 mmol), HNiPr2 (101 mg, 1 mmol), and THF (2 mL).  To a solution 
of 7075 (80 mg, 0.25 mmol) in THF (5 mL) was added the freshly prepared LDA (ca. 0.4 
M, 0.7 mL, 0.28 mmol, 1.1 equiv) at rt. The reaction was monitored by TLC and GCMS. 
An additional amount of LDA (0.8 mL, 0.32 mmol, 1.3 equiv) was added 1 h later to 
drive the reaction to completion. The resulting solution was stirred for 30 min and 
quenched by addition of saturated aqueous NH4Cl solution. The mixture was partitioned 
between EtOAc and aqueous NaHCO3. The organic layer was washed with brine, dried 
(Na2SO4), and concentrated. The ratio of products (i.e., 1:14:14:21) was determined by 
analysis of the 1H NMR spectrum of this crude oil. This ratio was qualitatively consistent 
with that observed by GC-MS analysis of the sample of crude products. This oil was then 
subjected to flash chromatography (hexanes:EtOAc = 16:1 then 5:1) to give, in order of 
elution, 7077 and 7078 as a co-eluting mixture, followed by 7079a as colorless oil, and 
finally 7079b as colorless oil. The overall mass recovery was ca. 85% (70 mg isolated). 
Characterization data for 7077 (containing ca. 5 mol% of 7078) 
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1H NMR (500 MHz, CDCl3): δ 7.07 (br s, 2H, H2H6), 6.99 (br s, 1H, H4), 6.95 (d, J = 
9.0 Hz, 2H, H2’H6’), 6.86 (d, J = 9.1 Hz, 2H, H3’H5’), 4.96 (s, 2H, CH2O), 3.80 (s, 
3H, CH3O), and 2.36 (br s, 6H, Ar(CH3)2].  
13C NMR (125 MHz, CDCl3): δ 154.1, 153.3, 138.6, 137.3, 129.8, 125.6, 116.0, 114.8, 
71.1, 55.9, and 21.5. 
IR: 3002, 2948, 2917, 2865, 2833, 1610, 1592, 1507, 1463, 1442, 1228, 1040, and 825 
cm-1.  
GC-LRMS: tR = 9.69 min. m/z: 242 (M+, 30), 119 (C9H11+, 100), 91 (C7H7+, 10), and 77 
(C6H5+, 4).  
Characteristic 1H NMR peaks of 7078 
1H NMR (500 MHz, CDCl3): δ 4.92 (s, CH2O), 3.86 (s, CH3O), 2.66 (s, C10CH3), and 
2.37 (s, C8CH3). 
GC-LRMS: tR = 10.40 min. m/z: 240 (M+, 100), 225 (M+-CH3, 50), 197 (20), 182 (10), 
165 (12), 153 (12), 128 (10), and 115 (8). 
Characterization data for 7079a  
1H NMR (500 MHz, CDCl3): δ 7.05 (br s, 2H, H2’H6’), 6.92 (br s, 1H, H4’), 6.78 (d, J = 
8.9 Hz, 1H, H3), 6.75 (d, J = 3.1 Hz, 1H, H6), 6.59 (dd, J = 8.9, 3.1 Hz, 1H, H4), 
4.98 (s, 2H, CH2O), 3.75 (s, 3H, CH3O), 3.60 {septet, J = 6.4 Hz, 2H, 
N[CH(CH3)2]2}, 2.31 [br s, 6H, Ar(CH3)2], and 1.04 {d, J = 6.4 Hz, 12H, 
N[CH(CH3)2]2}. 
13C NMR (125 MHz, CDCl3): δ 153.5, 152.4, 138.31, 138.26, 138.1, 129.2, 125.1, 118.0, 
114.8, 109.6, 71.4, 55.8, 49.6, 22.0, and 21.5. 
IR: 2967, 2928, 2870, 2832, 1609, 1581, 1494, 1463, 1379, 1208, 1179, 1046, and 845 
cm-1.  
HRMS (ESI-TOF): Calcd for C22H32NO2+ [M+H]+ requires 342.2428; found 342.2448. 
Characterization data for 7079b  
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1H NMR (500 MHz, CDCl3): δ 7.05 (br s, 2H, H2’H6’), 6.95 (br s, 1H, H4’), 6.82 (d, J = 
3.1 Hz, 1H, H6), 6.78 (d, J = 8.9 Hz, 1H, H3), 6.73 (dd, J = 8.9, 3.1 Hz, 1H, H4), 
4.91 (s, 2H, CH2O), 3.76 (s, 3H, CH3O), 3.52 {septet, J = 6.4 Hz, 2H, 
N[CH(CH3)2]2}, 2.32 [br s, 6H, Ar(CH3)2], and 0.99 {d, J = 6.4 Hz, 12H, 
N[CH(CH3)2]2}. 
13C NMR (125 MHz, CDCl3): δ 153.3, 152.6, 138.3, 137.5, 137.4, 129.7, 125.8, 118.6, 
112.1, 111.1, 71.0, 56.1, 49.7, 21.49, and 21.46. 
IR: 2967, 2929, 2869, 2832, 1609, 1580, 1494, 1463, 1378, 1275, 1257, 1224, 1200, 
1179, 1038, and 846 cm-1.  
HRMS (ESI-TOF): Calcd for C22H32NO2+ [M+H]+ requires 342.2428; found 342.2437. 
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3-((3-Methyl-8-oxo-9-phenyl-6,8,9,10-tetrahydrochromeno[3,4-f]isoindol-1-
yl)methyl)dihydrofuran-2,5-dione (7086 and 7086-d3) 
 
Compound 7086 was prepared by heating amide S37 (22 mg, 0.065 mmol, 1 equiv) 
and maleic anhydride (13 mg, 0.13 mmol, 2 equiv) in dichloroethane (0.25 mL) at 120 °C 
for 18 h. Compound 7086 was isolated following flash chromatography (hexanes:EtOAc 
= 5:1 then 3:1 then 1:1) as a light yellow oil (18 mg, 0.04 mmol, 63%). The previously 
described rearomatized product 7074e was observed in the 1H NMR spectrum of the 
crude reaction mixture (ca. 20%). Compound 7086-d3 was obtained from the 
corresponding reaction using S37-d3. The relative configuration of 7086-d3 was 
determined by coupling constant analysis of the crude 1H NMR spectrum of this reaction. 
Characterization data for 7086 
1H NMR (500 MHz, CDCl3): 7.84 (dd, J = 8.8, 1.2 Hz, 2H, Ho), 7.78 (s, 1H, H7), 7.73 
(s, 1H, H11), 7.42 (dd, J = 8.7, 7.4 Hz, 2H, Hm), 7.18 (tt, J = 7.4, 1.2 Hz, 1H, Hp), 
6.86 (br d, J = 1.8 Hz, 1H, H2), 6.76 (br d, J = 1.7 Hz, 1H, H4), 4.97 (d, J = 12.7 Hz, 
H6a), 4.94 (d, J = 12.7 Hz, H6b), 4.89 (d, J = 16.5 Hz, H10a), 4.85 (d, J = 16.5 Hz, 
H10b), 4.08 (dd, J = 15.0, 4.0 Hz, 1H, H12a), 3.52 (dddd, J = 10.7, 9.8, 6.6, 4.0 Hz, 
1H, H3’), 3.16 (dd, J = 15.0, 11.0 Hz, 1H, H12b), 2.88 (dd, J = 18.9, 9.8 Hz, 1H, 
H4’a), 2.56 (dd, J = 19.0, 6.6 Hz, 1H, H4’b), and 2.35 (dd, J = 0.6, 0.6 Hz, 3H, 
ArCH3). 
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13C NMR (125 MHz, CDCl3): δ 173.6, 169.5, 166.9, 158.0, 141.3, 140.7, 139.5, 134.44, 
134.42, 133.8, 132.1, 129.4, 125.6, 124.8, 121.0, 120.2, 119.7, 119.6, 117.8, 69.3, 
51.0, 41.3, 36.0, 34.1, and 21.6. 
IR: 2919, 2859, 1862, 1780, 1690, 1615, 1598, 1501, 1459, 1448, 1383, 1293, 1268, 
1227, 1177, 1129, 1071, 1023, 922, and 760 cm-1. 
HRMS (ESI-TOF): Calcd for C27H21NNaO5+ [M+Na]+ requires 462.1312; found 
462.1319. 
1H NMR data for 7086-d3 (contaminated with excess maleic anhydride and 7074e-d2) 
1H NMR (500 MHz, CDCl3): 7.87 (dd, J = 8.8, 1.2 Hz, 2H, Ho), 7.83 (s, 1H, H7), 7.78 
(s, 1H, H11), 7.44 (dd, J = 8.7, 7.4 Hz, 2H, Hm), 7.20 (tt, J = 7.4, 1.2 Hz, 1H, Hp), 
5.01 (d, J = 12.7 Hz, H6a), 4.98 (d, J = 12.7 Hz, H6b), 4.97 (d, J = 16.5 Hz, H10a), 
4.92 (d, J = 16.5 Hz, H10b), 4.09 (dd, J = 15.0, 4.0 Hz, 1H, H12a), 3.54 (ddd, J = 
10.7, 9.7, 4.0 Hz, 1H, H3’), 3.19 (dd, J = 15.0, 10.9 Hz, 1H, H12b), 2.88 (br d, J = 9.8 
Hz, 1H, H4’a), and 2.35 (br s, 3H, ArCH3). 
  Experimental 
 292 
3-((3-Methyl-8-oxo-9-phenyl-6,8,9,10-tetrahydrochromeno[3,4-f]isoindol-1-
yl)methyl)-1-phenylpyrrolidine-2,5-dione (7087a) 
 
Compound 7087a was prepared by heating amide 38 (25 mg, 0.073 mmol, 1 equiv) 
and N-phenyl maleimide (20 mg, 0.12 mmol, 1.6 equiv) in dichloroethane (0.25 mL) at 
120 °C for 18 h. Compound 7087a was isolated following flash chromatography 
(hexanes:EtOAc = 5:1 then 3:1 then 1:1) as a clear yellow oil (25 mg, 0.049 mmol, 66%). 
The previously described rearomatized product 7074e was observed in the 1H NMR 
spectrum of the crude reaction mixture (ca. 22%).  
1H NMR (500 MHz, CDCl3): 7.93 (s, 1H, H7), 7.86 (dd, J = 8.8, 1.1 Hz, 2H, Ho), 7.78 
(s, 1H, H11), 7.46 (dd, J = 8.7, 7.3 Hz, 2H, Hm), 7.42 (dd, J = 8.7, 7.4 Hz, 2H, Hm’), 
7.39 (tt, J = 7.4, 1.3 Hz, 1H, Hp'), 7.23 (dd, J = 8.7, 1.5 Hz, 2H, Ho'), 7.18 (tt, J = 7.4, 
1.1 Hz, 1H, Hp), 6.87 (br d, J = 1.7 Hz, 1H, H2), 6.83 (br d, J = 1.7 Hz, 1H, H4), 5.01 
(d, J = 12.5 Hz, H6a), 4.98 (d, J = 13.0 Hz, H6b), 4.93 (d, J = 16.7 Hz, H10a), 4.89 
(d, J = 16.6 Hz, H10b), 4.19 (dd, J = 15.0, 3.6 Hz, 1H, H4’a), 3.36 (dddd, J = 10.5, 
8.6, 4.8, 3.6 Hz, 1H, H3’), 3.11 (dd, J = 14.9, 10.7 Hz, 1H, H4’b), 2.80 (dd, J = 18.5, 
9.2 Hz, 1H, H12a), 2.47 (dd, J = 18.5, 5.0 Hz, 1H, H12b), and 2.36 (dd, J = 0.6, 0.6 
Hz, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 178.5, 175.2, 167.1, 157.9, 141.0, 140.7, 139.6, 135.6, 
134.5, 134.2, 132.0, 131.9, 129.40, 129.38, 128.9, 126.5, 125.9, 124.8, 120.9, 120.3, 
120.1, 119.6, 117.5, 69.4, 51.1, 40.6, 36.6, 34.6, and 21.6.  
IR: 2983, 2916, 1709, 1695, 1615, 1598, 1501, 1457, 1449, 1382, 1292, 1268, 1178, 
1129, 1062, 909, and 759 cm-1. 
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HRMS (ESI-TOF): Calcd for C33H26N2NaO4+ [M+Na]+ requires 537.1785; found 
537.1790. 
  Experimental 
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Ethyl 2-Hydroxy-3-(3-methyl-8-oxo-9-phenyl-6,8,9,10-tetrahydrochromeno[3,4-
f]isoindol-1-yl)propanoate (7087b) 
 
Compound 7087b was prepared by heating amide S37 (22 mg, 0.064 mmol, 1 equiv) 
and ethyl glyoxalate (20 mg, 50 wt.% in toluene, 0.098 mmol, 1.5 equiv) in 
dichloroethane (0.3 mL) at 120 °C for 18 h. Compound 7087b was isolated following 
flash chromatography (hexanes:EtOAc = 5:1 then 1:1) as a colorless solid (19 mg, 0.043 
mmol, 67%).  
1H NMR (500 MHz, CDCl3): δ 7.98 (s, 1H, H7’), 7.86 (dd, J = 8.4, 1.0 Hz, 2H, Ho), 
7.75 (s, 1H, H11’), 7.43 (dd, J = 8.3, 7.4 Hz, 2H, Hm), 7.18 (tt, J = 7.4, 1.1 Hz, 1H, 
Hp), 6.94 (br d, J = 1.8 Hz, 1H, H2’), 6.82 (br d, J = 1.8 Hz, 1H, H4’), 4.97 (d, J = 
12.5 Hz, 1H, H6a’), 4.94 (d, J = 12.6 Hz, 1H, H6b’), 4.90 (d, J = 17.5 Hz, 1H, 
H10a’), 4.86 (d, J = 18.0 Hz, 1H, H10b’), 4.58 (ddd, J = 8.1, 5.5, 4.4 Hz, 1H, H2), 
4.22 (dq, J = 10.8, 7.2 Hz, 1H, CH3CHa), 4.14 (dq, J = 10.8, 7.2 Hz, 1H, CH3CHb), 
3.54 (dd, J = 14.7, 4.4 Hz, 1H, H3a), 3.43 (dd, J = 14.7, 8.2 Hz, 1H, H3b), 2.94 [dd, J 
= 8.6 (to H2O in the NMR sample), 5.6 Hz, 1H, OH], 2.34 (br s, 3H, ArCH3), and 
1.24 (t, J = 7.1 Hz, 3H, CH3CH2). 
1H NMR (500 MHz, DMSO): δ 8.12 (s, 1H, H7’), 7.94 (dd, J = 8.8, 1.1 Hz, 2H, Ho), 
7.80 (s, 1H, H11’), 7.45 (dd, J = 8.7, 7.4 Hz, 2H, Hm), 7.18 (tt, J = 7.4, 1.1 Hz, 1H, 
Hp), 6.99 (br d, J = 1.8 Hz, 1H, H2’), 6.80 (br d, J = 1.8 Hz, 1H, H4’), 5.74 (d, J = 
5.8 Hz, 1H, OH), 5.07 (d, J = 17.0 Hz, 1H, H6a’), 5.03 (d, J = 17.1 Hz, 1H, H6b’), 
5.01 (d, J = 13.0 Hz, 1H, H10a’), 4.98 (d, J = 13.1 Hz, 1H, H10b’), 4.43 (ddd, J = 
8.4, 5.8, 5.1 Hz, 1H, H2), 4.06 (q, J = 6.9 Hz, 1H, CH3CH2), 3.39 (dd, J = 14.6, 5.0 
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Hz, 1H, H3a), 3.32 (dd, J = 14.6, 8.4 Hz, 1H, H3b), 2.29 (br s, 3H, ArCH3), and 1.13 
(t, J = 7.1 Hz, 3H, CH3CH2). 
13C NMR (125 MHz, DMSO): δ 173.5, 166.3, 156.6, 140.8, 139.5, 139.4, 135.9, 134.1, 
133.8, 130.6, 129.0, 126.0, 124.0, 120.6, 120.5, 120.0, 119.2, 115.7, 70.9, 68.2, 60.2, 
50.6, 37.8, 20.9, and 14.0. 
IR: 3420, 2980, 2917, 2859, 1736, 1694, 1615, 1598, 1501, 1459, 1448, 1381, 1292, 
1269, 1178, 1129, 1096, 1062, 1031, 1017, 897, 852, 774, and 761 cm-1. 
HRMS (ESI-TOF): Calcd for C27H25NNaO5+ [M+Na]+ requires 466.1625; found 
466.1629. 
mp: 180-184 °C. 
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Ethyl 3,3,3-trifluoro-2-hydroxy-2-((3-methyl-8-oxo-9-phenyl-6,8,9,10-
tetrahydrochromeno[3,4-f]isoindol-1-yl)methyl)propanoate (7087c) 
 
Compound 7087c was prepared by heating amide S37 (11 mg, 0.032 mmol, 1 equiv) 
and ethyl trifluoropyruvate (6.4 mg, 0.038 mmol, 1.2 equiv) in chloroform (0.1 mL) at 
120 °C for 18 h. Compound 7087c was isolated following flash chromatography 
(hexanes:EtOAc = 5:1 then 3:1) as a clear colorless oil (14.2 mg, 0.028 mmol, 85%).  
1H NMR (500 MHz, CDCl3): δ 8.03 (s, 1H, H7’), 7.89 (dd, J = 8.8, 1.1 Hz, 2H, Ho), 
7.78 (s, 1H, H11’), 7.44 (dd, J = 8.7, 7.4 Hz, 2H, Hm), 7.19 (tt, J = 7.4, 1.1 Hz, 1H, 
Hp), 6.85 (br d, J = 1.8 Hz, 1H, H2’), 6.84 (br d, J = 1.8 Hz, 1H, H4’), 5.05 (d, J = 
12.5 Hz, 1H, H6a’), 4.94 (d, J = 16.5 Hz, 1H, H10a’), 4.90 (d, J = 16.2 Hz, 1H, 
H10b’), 4.81 (d, J = 12.4 Hz, 1H, H6b’), 4.27 (dq, J = 10.7, 7.1 Hz, 1H, CH3CHa), 
4.04 (dq, J = 10.7, 7.2 Hz, 1H, CH3CHb), 3.96 (s, 1H, OH), 3.85 (d, J = 14.5 Hz, 1H, 
ArCHa), 3.73 (d, J = 14.4 Hz, 1H, ArCHb), 2.34 (s, 3H, ArCH3), and 1.19 (t, J = 7.1 
Hz, 3H,  CH3CH2). 
13C NMR (125 MHz, CDCl3): δ 169.3, 167.3, 157.6, 140.4, 140.3, 139.7, 134.7, 134.4, 
131.7, 130.9, 129.4, 126.4, 124.7, 123.7 (q, 1JFC = 286 Hz), 122.0, 120.8, 120.7, 
119.6, 117.5, 78.5 (q, 2JFC = 28.3 Hz), 69.5, 64.1, 51.0, 34.3, 21.6, and 13.9. 
IR: 2983, 2916, 2860, 1744, 1693, 1626, 1615, 1598, 1502, 1460, 1449, 1382, 1309, 
1293, 1270, 1233, 1213, 1179, 1125, 1063, 1019, 953, 909, 858, and 758 cm-1. 
HRMS (ESI-TOF): Calcd for C28H24F3NNaO5+ [M+Na]+ requires 534.1499; found 
534.1503. 
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1-((3-Hydroxy-1-methyl-2-oxoindolin-3-yl)methyl)-3-methyl-9-phenyl-9,10-
dihydrochromeno[3,4-f]isoindol-8(6H)-one (7087d) 
 
Compound 7087d was prepared by heating amide S37 (12.5 mg, 0.037 mmol, 1 
equiv) and N-methyl isatin (6.9 mg, 0.043 mmol, 1.2 equiv) in dichloroethane (0.17 mL) 
at 120 °C for 18 h. The reaction mixture became a slurry as 7087d precipitated. The 
reaction mixture was cooled to -20 °C and filtered while cold. The filter cake (mostly 
7087d) was carefully washed with a 3:1 mixture of hexanes and EtOAc to provide 7087d 
as a colorless solid (14 mg, 0.028 mmol, 77%).  
1H NMR (500 MHz, DMSO): δ 7.94 (dd, J = 8.8, 1.2 Hz, 2H, Ho), 7.74 (s, 1H, H7), 7.68 
(s, 1H, H11), 7.46 (dd, J = 8.7, 7.4 Hz, 2H, Hm), 7.19 (tt, J = 7.4, 1.1 Hz, 1H, Hp), 
7.10 (ddd, J = 7.8, 6.9, 2.0 Hz, 1H, H6’), 6.73 (d, J = 1.9 Hz, 1H, H2), 6.69 (ddd, J = 
7.8, 0.8, 0.8 Hz, 1H, H7’), 6.63 (d, J = 1.8 Hz, 1H, H4), 6.54 (ddd, J = 7.3, 7.3, 1.0 
Hz, 1H, H5’), 6.52 (ddd, J = 7.3, 2.1, 0.6 Hz, 1H, H4’), 6.22 (s, 1H, OH), 5.15 (d, J = 
17.1 Hz, 1H, H10a), 4.95 (d, J = 17.2 Hz, 1H, H10b), 4.90 (d, J = 12.5 Hz, 1H, H6a), 
4.14 (d, J = 12.6 Hz, 1H, H6b), 4.01 (d, J = 13.2 Hz, 1H, ArCHaHb), 3.43 (d, J = 
13.1 Hz, 1H, ArCHaHb), 2.85 (s, 3H, NCH3), and 2.19 (dd, J = 0.7, 0.7 Hz, 3H, 
ArCH3). 
13C NMR (125 MHz, DMSO): δ 177.0, 166.4, 156.0, 142.9, 140.7, 139.6, 138.6, 134.2, 
134.0, 132.6, 130.3, 129.9, 129.0, 128.7, 126.5, 124.1, 123.6, 121.5, 121.0, 120.6, 
119.8, 119.2, 115.5, 107.6, 77.3, 68.2, 50.5, 40.5, 25.5, and 20.8. 
IR: 3390, 2917, 2850, 1716, 1694, 1673, 1613, 1599, 1501, 1494, 1470, 1449, 1380, 
1292, 1270, 1175, 1129, 1089, 1057, 1016, 908, and 759 cm-1. 
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HRMS (ESI-TOF): Calcd for C32H26N2NaO4+ [M+Na]+ requires 525.1785; found 
525.1775. 
mp: 273-276 °C. 
  Experimental 
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N-(1-(4-Chlorophenyl)-2-(3-methyl-8-oxo-9-phenyl-6,8,9,10-
tetrahydrochromeno[3,4-f]isoindol-1-yl)ethyl)-4-methylbenzenesulfonamide (7087e) 
 
Compound 7087e was prepared by heating amide 38 (35 mg, 0.103 mmol, 1 equiv) 
and N-(4-chlorobenzylidene)-4-methylbenzenesulfonamide177 (58 mg, 0.2 mmol, 2 equiv) 
in dichloroethane (0.35 mL) at 120 °C for 18 h. Compound 7087e was isolated following 
flash chromatography (hexanes:EtOAc = 5:1 then 1:1) as a colorless solid (53 mg, 0.083 
mmol, 82%). The previously described rearomatized product 7074e was observed in the 
1H NMR spectrum of the crude reaction mixture (ca. 4%).  
1H NMR (500 MHz, CDCl3): δ 7.86 (dd, J = 8.8, 1.1 Hz, 2H, Ho), 7.73 (s, 1H, H7), 7.72 
(s, 1H, H11), 7.42 (dd, J = 8.6, 7.4 Hz, 2H, Hm), 7.32 (d, J = 8.3 Hz, 2H, ClArH3), 
7.19 (tt, J = 7.4, 1.1 Hz, 1H, Hp), 7.03 (d, J = 8.6 Hz, 2H, ClArH2), 7.01 (d, J = 8.4 
Hz, O2SArH2), 6.77 (d, J = 8.4 Hz, O2SArH3), 6.71 (br d, J = 1.8 Hz, 1H, H2), 6.53 
(d, J = 1.8 Hz, 1H, H4), 5.08 (d, J = 6.4 Hz, 1H, NH), 4.89 (d, J = 16.4 Hz, H10a), 
4.83 (d, J = 17.0 Hz, H10b), 4.82 (d, J = 12.2 Hz, H6a), 4.72 (d, J = 12.4 Hz, H6b), 
4.51 (ddd, J = 7, 7, 7 Hz, 1H, CHNH), 3.65 (dd, J = 14.3, 7.0 Hz, ArHaHb), 3.43 (dd, 
J = 14.3, 7.0 Hz, ArHaHb), 2.33 (br s, 3H, CH3-C6H4SO2), and 2.22 (s, 3H, C3CH3). 
13C NMR (125 MHz, CDCl3): δ 167.2, 157.5, 143.6, 140.6, 140.5, 139.6, 138.8, 137.2, 
134.48, 134.45, 134.2, 133.5, 131.5, 129.5, 129.4, 128.6, 128.2, 127.0, 126.6, 124.7, 
120.8, 120.6, 120.0, 119.4, 116.9, 69.2, 58.7, 51.0, 42.4, 21.6, and 21.5. 
IR: 3250, 2925, 2863, 1679, 1615, 1598, 1501, 1493, 1449, 1384, 1326, 1292, 1269, 
1158, 1129, 1092, 1062, 1014, 812, and 760 cm-1. 
                                                
177 McNulty, J.; McLeod, D. Amine- and sulfonamide-promoted Wittig olefination reactions in water. 
Chem. Eur. J. 2001, 17, 8794–8798.  
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HRMS (ESI-TOF): Calcd for C37H31ClNNaO4SSi+ [M+Na]+ requires 657.1585; found 
657.1562. 
mp:  140-143 °C. 
  Experimental 
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3-((3-Methyl-8-oxo-8,10-dihydro-6H-isobenzofuro[5,6-c]chromen-1-yl)methyl)-1-
phenylpyrrolidine-2,5-dione (7087f) 
 
Compound 7087f was prepared by heating amide S35 (30.8 mg, 0.12 mmol, 1 equiv) 
and N-phenyl maleimide (31 mg, 0.18 mmol, 1.5 equiv) in 1,2-dichlorobenzene (0.6 mL). 
The reaction solution was stirred at 165 °C for 4 h. Compound 7087f was isolated 
following flash chromatography (hexanes:EtOAc = 5:1 then 1:1) as a clear light yellow 
oil (36 mg, 0.082 mmol, 71%). 
1H NMR (500 MHz, CDCl3): δ 7.85 (s, 1H, H7), 7.76 (s, 1H, H11), 7.46 (dd, J = 8.7, 7.3 
Hz, 2H, Hm), 7.39 (tt, J = 7.4, 1.3 Hz, 1H, Hp), 7.22 (dd, J = 8.7, 1.5 Hz, 2H, Ho), 
6.87 (br d, J = 1.7 Hz, 1H, H2), 6.85 (br d, J = 1.7 Hz, 1H, H4), 5.36 (d, J = 15.5 Hz, 
H10a), 5.32 (d, J = 15.7 Hz, H10b), 4.97 (s, 2H, H6), 4.10 (dd, J = 14.7, 3.7 Hz, 1H, 
H4’a), 3.36 (dddd, J = 10.5, 8.9, 5.0, 3.8 Hz, 1H, H3’), 3.13 (dd, J = 14.8, 10.5 Hz, 
1H, H4’b), 2.81 (dd, J = 18.4, 9.2 Hz, 1H, ArCHaHb), 2.44 (dd, J = 18.5, 5.0 Hz, 1H, 
ArCHaHb), and 2.36 (dd, J = 0.6, 0.6 Hz, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3):  178.3, 175.1, 170.7, 158.1, 147.1, 141.7, 136.2, 135.9, 
135.1, 131.8, 129.4, 128.9, 126.4, 125.8, 124.1, 122.3, 120.0, 119.4, 117.4, 69.9, 69.2, 
40.7, 36.2, 34.5, and 21.7. 
IR: 2916, 2849, 1757, 1708, 1615, 1594, 1500, 1454, 1384, 1355, 1315, 1294, 1181, 
1155, 1138, 1047, 1007, 909, and 759 cm-1. 
HRMS (ESI-TOF): Calcd for C27H21NNaO5+ [M+Na]+ requires 462.1312; found 
462.1343. 
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Dimethyl 7-(3-(3,5-Dimethylphenoxy)prop-1-yn-1-yl)-1-(2-(ethoxycarbonyl)-3,3,3-
trifluoro-2-hydroxypropyl)-3-methyl-8,10-dihydroindeno[5,6-c]chromene-9,9(6H)-
dicarboxylate (7087g) 
 
Compound 7087g was prepared following General Procedure E from amide S34 (30 
mg, 0.057 mmol, 1 equiv) and ethyl trifluoropyruvate (11.5 mg, 0.068 mmol, 1.2 equiv) 
in 1,2-dichlorobenzene (0.2 mL). The reaction solution was stirred at 115 °C for 24 h. 
Compound 7087g was isolated following flash chromatography (hexanes:EtOAc = 5:1 
then 2:1) as a clear colorless oil (33.5 mg, 0.048 mmol, 84%). 
1H NMR (500 MHz, CDCl3): 7.65 (s, 1H, H11), 6.80 (br d, J = 1.8 Hz, 1H, H2), 6.78 (br 
d, J = 1.8 Hz, 1H, H4), 6.68 (br s, 2H, Ho), 6.66 (br s, 1H, Hp), 5.21 (d, J = 13.0 Hz, 
1H, H6a), 4.96 (s, 2H, C≡CCH2), 4.64 (d, J = 13.0 Hz, 1H, H6b), 4.19 (dq, J = 10.6, 
7.1 Hz, 1H, CH3CHaHb), 3.91 (dq, J = 10.6, 7.1 Hz, 1H, CH3CHaHb), 3.81 (s, 1H, 
OH), 3.79 (d, J = 14.7 Hz, 1H, ArCHaHb), 3.77 (s, 3H, CO2CH3), 3.75 (s, 3H, 
CO2CH3), 3.65 [br s, 4H, CH2C(CO2Me)CH2], 3.56 (d, J = 14.4 Hz, 1H, ArCHaHb), 
2.32 [dt, J = 0.6, 0.6 Hz, 6H, Ar(CH3)2], and 2.28 (dd, J = 0.6, 0.6 Hz, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 172.0, 171.9, 169.4, 157.7, 156.9, 141.7, 139.8, 139.5, 
139.0, 135.0, 130.4, 129.9, 126.1, 123.7 (q, 1JFC = 286 Hz), 123.6, 122.8, 122.1, 
117.1, 115.5, 113.1, 92.5, 82.3, 78.5 (q, 2JFC = 28.4 Hz), 67.2, 63.9, 59.8, 56.6, 53.27, 
53.26, 41.1, 40.5, 34.2, 21.6, 21.5, and 13.8. 
IR: 3474, 2955, 2918, 2849, 1737, 1615, 1594, 1436, 1370, 1315, 1291, 1258, 1239, 
1202, 1179, 1168, 1152, 1138, 1121, 1064, 1017, 956, 856, and 832 cm-1. 
O
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HRMS (ESI-TOF): Calcd for C38H37F3NaO9+ [M+Na]+ requires 717.2282; found 
717.2277. 
  Experimental 
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N-(1-(4-Chlorophenyl)-2-(3-methyl-8-oxo-7-(trimethylsilyl)-6,8-dihydrofluoreno[2,3-
c]chromen-1-yl)ethyl)-4-methylbenzenesulfonamide (7087h) 
 
Compound 7087h was prepared by heating ketone 26b (21 mg, 0.054 mmol, 1 equiv) 
and N-(4-chlorobenzylidene)-4-methylbenzenesulfonamide177 (32 mg, 0.109 mmol, 2.0 
equiv) in 1,2-dichloroethane (0.2 mL) at 85 °C for 18 h. Compound 7087h was isolated 
following flash chromatography (hexanes:EtOAc = 5:1 then 2:1) as a bright yellow oil 
(32 mg, 0.047 mmol, 85%). 
1H NMR (500 MHz, CDCl3): δ 7.62 (d, J = 7.3 Hz, 1H, H9), 7.59 (s, 1H, H13), 7.47-
7.44 (nfom, 2H, H11 and H12), 7.32 (d, J = 8.2 Hz, 2H, ClArH3), 7.32-7.28 (nfom, 
1H, H10), 7.01 (d, J = 8.1 Hz, 2H, ClArH2), 6.88 (d, J = 8.3 Hz, 2H, O2SArH2), 6.69 
(br s, 1H, H2), 6.66 (br s, 1H, H4), 6.64 (d, J = 8.4 Hz, 2H, O2SArH3), 4.98 (d, J = 
6.2 Hz, 1H, NH), 4.88 (d, J = 12.8 Hz, 1H, H6a), 4.44 (d, J = 12.8 Hz, 1H, H6b), 4.41 
(ddd, J = 7, 7, 7 Hz, 1H, CHNH), 3.55 (dd, J = 13.9, 7.8 Hz, 1H, ArCHaHb), 3.50 
(dd, J = 13.9, 7.1 Hz, 1H, ArCHaHb), 2.32 (s, 3H, CH3-C6H4SO2), 2.28 (s, 3H, 
C3CH3), and 0.46 [s, 9H, Si(CH3)3]. 
13C NMR (125 MHz, CDCl3): 194.6, 157.4, 144.4, 143.61, 143.55, 141.9, 140.7, 139.5, 
138.3, 138.0, 137.1, 135.2, 134.8, 134.4, 134.0, 133.4, 129.5, 129.4, 128.4, 128.2, 
127.1, 126.4, 124.1, 122.0, 120.0, 119.0, 116.2, 69.8, 59.2, 41.6, 21.63, 21.60 and 2.2. 
IR: 3258, 3055, 2997, 2948, 2900, 1709, 1606, 1588, 1492, 1463, 1322, 1303, 1248, 
1183, 1158, 1091, 1063, 1014, 966, 901, and 859 cm-1. 
HRMS (ESI-TOF): Calcd for C39H36ClNNaO4SSi+ [M+Na]+ requires 700.1715; found 
700.1760. 
O
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(±)-(R)-1-(((R)-3-Hydroxy-1-methyl-2-oxoindolin-3-yl)methyl)-3,6-dimethyl-9-
phenyl-9,10-dihydrochromeno[3,4-f]isoindol-8(6H)-one (7087i) 
and 
(±)-(R)-1-(((S)-3-Hydroxy-1-methyl-2-oxoindolin-3-yl)methyl)-3,6-dimethyl-9-
phenyl-9,10-dihydrochromeno[3,4-f]isoindol-8(6H)-one (7087i’) 
 
Compound 7087i was prepared by heating amide S48 (19 mg, 0.054 mmol, 1 equiv) 
and N-methyl isatin (10.5 mg, 0.065 mmol, 1.2 equiv) in 1,2-dichloroethane (0.25 mL). 
The reaction solution was stirred at 120 °C for 18 h. The reaction mixture became a 
slurry as 7087i precipitated. The reaction mixture was cooled to -20 °C and filtered while 
cold. The filter cake (mostly 7087i) was carefully washed with a 3:1 mixture of hexanes 
and EtOAc to give compound 7087i as a colorless solid (16.8 mg, 0.033 mmol, 60%). 
The filtrate was concentrated, and subjected to column chromatography (hexanes:EtOAc 
= 3:1 then 1:1) to give a coeluting mixture of the minor epimer 7087i’ as a pale yellow oil 
(4.6 mg, 0.0089 mmol, 16%, containing ca. 20 mol% of 7087i, as judged from the 1H 
NMR data).  
Characterization data for 7087i 
1H NMR (500 MHz, CDCl3): δ 7.89 (dd, J = 8.8, 1.2 Hz, 2H, Ho), 7.75 (s, 1H, H7), 7.65 
(s, 1H, H11), 7.47 (dd, J = 8.7, 7.4 Hz, 2H, Hm), 7.22 (tt, J = 7.4, 1.1 Hz, 1H, Hp), 
7.12 (ddd, J = 7.7, 7.2, 1.9 Hz, 1H, H6’), 6.85 (d, J = 1.7 Hz, 1H, H2), 6.64 (dd, J = 
1.8, 0.8 Hz, 1H, H4), 6.58 (ddd, J = 7.3, 7.3, 0.9 Hz, 1H, H5’), 6.544 (dd, J = 7.3, 1.7 
Hz, 1H, H4’), 6.536 (d, J = 7.8 Hz, 1H, H7’), 5.02 (d, J = 16.2 Hz, 1H, H10a), 4.84 
(d, J = 16.3 Hz, 1H, H10b), 4.32 (d, J = 13.0 Hz, ArCHaHb), 4.02 (q, J = 6.5 Hz, 1H, 
PhN O
O
OH
PhN
OO
1 equiv 1.2 equiv
dichloroethane
120 °C
S48 7087i
76%
dr = 4.2:1
N
O
O
N O
PhN O
O
OH
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H6), 3.47 (d, J = 13.0 Hz, 1H, ArCHaHb), 2.95 (s, 3H, NCH3), 2.88 (s, 1H, OH), 2.27 
(br s, 3H, ArCH3), and 1.70 (d, J = 6.5 Hz, 3H, CHCH3). 
1H NMR (500 MHz, DMSO): δ 7.95 (dd, J = 8.8, 1.1 Hz, 2H, Ho), 7.73 (s, 1H, H7), 7.60 
(s, 1H, H11), 7.47 (dd, J = 8.7, 7.4 Hz, 2H, Hm), 7.20 (tt, J = 7.4, 1.1 Hz, 1H, Hp), 
7.09 (nfom, 1H, H6’), 6.73 (d, J = 1.8 Hz, 1H, H2), 6.69 (ddd, J = 7.8, 0.8, 0.8 Hz, 
1H, H7’), 6.60 (d, J = 1.8 Hz, 1H, H4), 6.52-6.48 (nfom, 2H, H4’H5’), 6.21 (s, 1H, 
OH), 5.18 (d, J = 17.0 Hz, 1H, H10a), 4.94 (d, J = 17.0 Hz, 1H, H10b), 4.09 (d, J = 
12.9 Hz, 1H, ArCHaHb), 4.08 (q, J = 6.5 Hz, 1H, CHCH3), 3.39 (d, J = 13.0 Hz, 1H, 
ArCHaHb), 2.85 (s, 3H, NCH3), 2.18 (dd, J = 0.7, 0.7 Hz, 3H, ArCH3), and 1.60 (d, J 
= 6.5 Hz, 3H, CHCH3). 
13C NMR (125 MHz, DMSO): δ 176.9, 166.5, 155.5, 142.9, 140.4, 139.6, 138.5, 138.0, 
134.4, 132.4, 130.6, 129.9, 129.0, 128.7, 126.1, 124.1, 123.5, 121.5, 121.0, 120.8, 
119.2, 117.9, 115.4, 107.7, 77.4, 73.2, 50.5, 40.4, 25.5, 20.8, and 17.3. 
IR: 3350, 1697, 1615, 1599, 1561, 1502, 1492, 1380, 1094, and 767 cm-1. 
HRMS (ESI-TOF): Calcd for C33H28N2NaO4+ [M+Na]+ requires 539.1941; found 
539.1928. 
mp: 297-299 °C. 
ORTEP rendering for 7087i: 
 
  Experimental 
 307 
Characterization data for 7087i’ 
1H NMR (500 MHz, CDCl3): δ 7.86 (dd, J = 8.8, 1.2 Hz, 2H, Ho), 7.70 (s, 1H, H7), 7.65 
(s, 1H, H11), 7.44 (dd, J = 8.7, 7.4 Hz, 2H, Hm), 7.19 (tt, J = 7.4, 1.2 Hz, 1H, Hp), 
7.16 (ddd, J = 7.7, 7.7, 1.4 Hz, 1H, H6’), 6.85 (d, J = 1.7 Hz, 1H, H2), 6.81 (ddd, J = 
7.5, 7.5, 1.0 Hz, 1H, H5’), 6.74 (dd, J = 7.4, 1.4 Hz, 1H, H4’), 6.72 (br d, J = 1.7 Hz, 
1H, H4), 6.64 (d, J = 6.7 Hz, 1H, H7’), 4.88 (d, J = 16.5 Hz, 1H H10a), 4.86 (q, J = 
6.7 Hz, 1H, H6), 4.85 (d, J = 16.5 Hz, 1H, H10b), 3.87 (d, J = 13.0 Hz, ArCHaHb), 
3.71 (d, J = 13.0 Hz, 1H, ArCHaHb), 3.00 (s, 3H, NCH3), 2.85 (s, 1H, OH), 2.25 (br 
s, 3H, ArCH3), and 1.49 (d, J = 6.5 Hz, 3H, CHCH3). 
1C NMR (125 MHz, CDCl3, shifts determined from HSQC data): δ 130.0, 129.3, 127.1, 
124.6, 124.6, 122.9, 120.6, 119.6, 119.5, 116.7, 108.3, 74.0, 50.8, 40.9, 26.1, 21.4, 
and 18.2.   
2,11-Dimethyl-5,11-dihydro-7H,9H-chromeno[5,4,3-cde]furo[3,4-h]chromen-7-one 
(7074d) 
 
A solution of 7090 in non-deoxygenated C6H4Cl2 was heated at 165 °C for 6 h. 
Compound 7074d was formed as a byproduct. 
1H NMR (500 MHz, CDCl3): δ 7.70 (br s, 1H), 6.89 (br s, 1H), 6.77 (br s, 1H), 5.45 (q, J 
= 6.6 Hz, 2H), 5.29 (d, J = 8.8 Hz, 1H, CHaHbO), 5.27 (d, J = 8.5 Hz, 1H, CHaHbO), 
4.97 (br s, 2H), 1.69 (d, J = 6.6 Hz, 3H, CHCH3), and 1.55 (br s, 3H, C3-CH3).  
C6H4Cl2
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7074d
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3-(9-Oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl acetate (7104)  
and 3-(9-oxo-3-(4-((tetrahydrofuran-2-yl)peroxy)butoxy)-1-(trimethylsilyl)-9H-
fluoren-2-yl)propyl acetate (7105) 
 
A solution of known acetate 7014 (20 mg, 0.057 mmol) in THF (6 mL) under N2 
atomsphere was heated to 85 °C for 18 h. The resulting solution was concentrated and 
purified using flash column chromatography (hexanes:EtOAc 15:1) to yield 7025 (15 mg, 
0.043 mmol, 75%) as a golden oil.  
If this reaction was performed under 1 atm of air, peroxide 7105 was formed as a 
byproduct, compromising the yield of 7104.  
Characterization data for 7104: 
1H NMR (500 MHz, CD3Cl): δ 7.57 (d, J = 7.3 Hz, 1H, H8), 7.42-7.46 (m, 3H, 
H4/H5/H6), 7.24-7.26 (nfom, 1H, H7), 7.22 (d, J = 7.6 Hz, 1H, H3), 4.11 (t, J = 6.5 
Hz, 2H, CH2O), 2.85 (d, J = 8.0 Hz, 2H, ArCH2), 2.07 (s, 3H, CH3CO), 1.86 (nfom, 
2H, CH2CH2O), 0.45 [s, 9H, Si(CH3)3]. 
1H NMR (500 MHz, CD3OD): δ 7.59 (ddd, J = 7.4, 1.0, 1.0 Hz, 1H, H8), 7.58 (d, J = 7.6 
Hz, 1H, H4), 7.53 (ddd, J = 7.3, 1.0, 1.0 Hz, 1H, H5), 7.51 (ddd, J = 7.5, 7.5, 1.1 Hz, 
1H, H6), 7.33 (d, J = 7.7 Hz, 1H, H3), 7.29 (ddd, J = 7.4, 7.4, 1.1 Hz, H7), 4.11 (t, J = 
6.4 Hz, 2H, CH2O), 2.89 (br t, J = 8.0 Hz, 2H, ArCH2), 2.04 (s, 3H, CH3CO), 1.87 
(nfom that includes J = 8.1 and 6.2 Hz, 2H, CH2CH2O), and 0.43 [s, 9H, Si(CH3)3]. 
13C NMR (125 MHz, CDCl3): δ 195.5, 171.3, 149.2, 144.1, 143.6, 141.2, 140.6, 135.4, 
134.7, 134.0, 128.9, 124.1, 121.1, 119.7, 63.9, 33.2, 32.5, 21.2, and 2.6 ppm. 
IR (neat): 2950, 2848, 1739, 1713, 1606, 1586, 1467, 1438, 1386, 1365, 1245, 1183, 
1043, 862, and 847 cm-1. 
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HRMS (ESI-TOF): Calcd for C21H24NaO3Si+ [M+Na]+ requires 375.1387; found 
375.1386. 
Characterization data for 7105: 
1H NMR (500 MHz, CDCl3): δ 7.53 (br d, J = 7.3 Hz, 1H, H8), 7.44-7.40 (m, 2H), 7.27-
7.23 (m, 1H), 7.01 (br s, 1H), 5.67 (dd, J = 6.2, 2.3 Hz, 1H), 4.22-4.10 (m, 6H), 3.99-
3.92 (m, 2H), 2.87 (br t, J = 8.1 Hz, 2H, ArCH2), 2.07 (s, 3H, CH3CO), 2.10-1.90 (m, 
4H), 1.90-1.75 (m, 6H), and 0.45 [s, 9H, Si(CH3)3]. 
HRMS (ESI-TOF): Calcd for C29H38NaO7Si+ [M+Na]+ requires 549.2279; found 
549.2285. 
3-(3-(4-(tert-Butylperoxy)butoxy)-9-oxo-1-(trimethylsilyl)-9H-fluoren-2-yl)propyl 
acetate (7108) 
 
When reduction of 7025 with THF was preformed in the presence of intentionally 
added tBuOOH (2 equiv) under N2 atomsphere, peroxide 7108 was formed as a 
byproduct that coelutes with 7104.  
Characterization data for 7108: 
1H NMR (500 MHz, CDCl3): δ 7.53 (ddd, J = 7.3, 1.0, 1.0 Hz, 1H, H5), 7.43-7.39 (m, 
2H), 7.00 (s, 1H), 4.14 (t, J = 6.2 Hz, 2H, CH2O), 4.12 (t, J = 6.6 Hz, 2H, CH2O), 
4.04 (t, J = 6.2 Hz, 2H, CH2O), 2.88 (br t, J = 8.0 Hz, 2H, ArCH2), 2.07 (s, 3H, 
CH3CO), 2.00-1.93 (m, 2H), 1.88-1.84 (m, 2H), 1.84-1.77 (m, 2H), 1.26 [s, 9H, 
C(CH3)3], and 0.46 [s, 9H, Si(CH3)3].  
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Synthesis of phthalide 7113d 
 
5-Phenylpenta-2,4-diyn-1-yl propiolate (S68) 
 
To a solution of 5-phenylpenta-2,4-diyn-1-ol178 (312 mg, 2.0 mmol) and propiolic 
acid (154 mg, 2.2 mmol) in dichloromethane cooled at 0 °C was added DCC (494 mg, 
2.4 mmol) and DMAP (12 mg, 0.1 mmol). The reaction mixture was stirred for an 
additional 30 min at this temperature. The resulting slurry was filtered through Celite®, 
concentrated, and purified with column chromatography (hexanes:EtOAc 12:1) to give 
ester S68 (270 mg, 1.3 mmol, 65%) as a light yellow solid.  
1H NMR (CDCl3, 500 MHz): δ 7.50 (br d, J = 7.4 Hz, 2H, ArHo), 7.38 (tt, J = 7.5, 1.4 
Hz, 1H, ArHp), 7.33 (br dd, J = 7.3, 7.3 Hz, ArHm), 4.93 (s, 2H, CH2O), and 2.97 (s, 
1H, C≡CH). 
13C NMR (CDCl3, 125 MHz): δ 151.9, 132.9, 129.8, 128.7, 121.2, 79.6, 76.3, 74.7, 74.0, 
73.0, 72.5, and 54.3 ppm. 
IR: 3283, 2932, 2856, 2250, 2121, 1722, 1649, 1596, 1491, 1441, 1368, 1209, 963, 755, 
and 689 cm-1.  
HRMS (ESI-TOF): Calcd for C14H8AgO2+ [M+Ag+] requires 314.9570; found 314.9587. 
Mp: 51-52 °C. 
                                                
178 Meng, X.; Li, C.; Han, B.; Wang, T.; Chen, B. Iron/copper promoted oxidative homo-coupling reaction 
of terminal alkynes using air as the oxidant. Tetrahedron 2010, 66, 4029–4031. 
OH propiolic acid
DCC, DMAP
O
O
O
Ocyclooctane
120 °C
S68 7113d
OH propiolic acid
DCC, DMAP
DCM, 0°C, 30 min, 65%
O
O
S68
  Experimental 
 311 
6-Phenylisobenzofuran-1(3H)-one (7113d) 
 
Phthalide 7113d was prepared following general procedure C (120 ºC, 48 h) from 
ester S68 (21 mg, 0.10 mmol) and cyclooctane (10 mL). The crude material was purified 
by flash column chromatography (hexanes:EtOAc 3:1) to yield phthalide 7113d (11 mg, 
0.053 mmol, 53%). The 1H NMR spectrum is consistent with the reported data179. 
Synthesis of isoindolinone 7113e 
 
1-Iodoundeca-2,4-diyne (S69) 
 
PPh3 (1.15 g, 4.4 mmol), I2 (1.2 g, 4.8 mmol), and imidazole (0.56 g, 8 mmol) were 
sequentially added to a stirred solution of undeca-2,4-diyn-1-ol180 (678 mg, 4.1 mmol) in 
CH2Cl2 (20 mL) at 0 °C. After 2 h the reaction mixture was diluted with CH2Cl2 and 
washed with satd. aq. Na2S2O3. The organic extract was washed with brine, dried 
                                                
179 Novak, P.; Correa, A.; Gallardo-Donaire, J.; Martin, R. Synergistic palladium-catalyzed C(sp3)-H 
activation/C(sp3)-O bond formation: A direct, step-economical route to benzolactones. Angew. Chem. 
Int. Ed. 2011, 50, 12236–12239. 
180 Montierth, J. M.; DeMario, D. R.; Kurth, M. J.; Schore, N. E. The polymer-supported Cadiot-
Chodkiewicz coupling of acetylenes to produce unsymmetrical diynes. Tetrahedron 1998, 54, 11741–
11748. 
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(Na2SO4), and concentrated. Purification by flash chromatography (hexanes:EtOAc 12:1) 
gave the iodide S69 (1.0 g, 3.7 mmol, 90%) as a pale yellow oil. This compound was 
stored in a refrigerator as a precaution toward decomposition. 
1H NMR (500 MHz, CDCl3): δ 3.75 (t, J = 1.2 Hz, 2H, CH2I), 2.27 (tt, J = 7.0, 1.1 Hz, 
2H, C≡CCH2CH2), 1.53 (tt, J = 7.3, 7.3 Hz, 2H, C≡CCH2CH2), 1.41-1.34 (m, 2H), 
1.33-1.23 (m, 4H), and 0.89 (t, J = 7.2 Hz, 3H, CH3). 
13C NMR (125 MHz, CDCl3): δ 83.2, 72.2, 70.6, 65.0, 31.5, 28.7, 28.3, 22.7, 19.6, 14.3 
and -18.1 ppm. 
IR (neat): 2953, 2929, 2857, 2248, 1460, 1378, 1255, and 1143 cm-1. 
GC-MS: Retention time 8.39 min; electron impact (70 eV), m/z (ion, rel int): 274 (M+, 
4), 203 (M+-C5H11, 5), 147 (M+-I, 7), 127 (I+, 18), 119 (C9H11+, 51), 105 (C8H9+, 
100), 91 (C7H7+, 95), and 77 (C6H5+, 66). 
N-Phenyl-N-(undeca-2,4-diyn-1-yl)propiolamide (S70) 
 
NaH (60% dispersion in mineral oil, 44 mg, 1.1 mmol) was added to a stirred solution 
of N-phenylpropiolamide181 (145 mg, 1 mmol) in THF (6 mL) pre-cooled at 0 °C. The 
resulting mixture was kept at this temperature for 30 min, after which iodide S69 (345 mg, 
1.2 mmol) in THF (1.2 mL) was added dropwise. The reaction mixture was stirred for an 
additional 3 h and quenched by addition of satd. aq. NH4Cl. The resulting mixture was 
separated and the aqueous layer washed with EtOAc. The combined organic layers were 
washed with brine, dried, and concentrated. The residue was purified by flash 
chromatography (hexanes:EtOAc 5:1) to give the amide S70 (122 mg, 0.42 mmol, 42%) 
as a pale yellow oil. 
                                                
181 Yanada, R.; Obika, S.; Kobayashi, Y.; Inokuma, T.; Oyama, M.; Yanada, K.; Takemoto, Y. 
Stereoselective synthesis of 3-Alkylideneoxindoles using tandem indium-mediated carbomallation and 
palladium-catalyzed cross-coupling reactions. Adv. Synth. Catal. 2005, 347, 1632–1642et. 
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1H NMR (500 MHz, CDCl3, as a 6:1 mixture of rotamers): major rotamer: δ 7.45-7.40 (m, 
3H, ArHmHp), 7.35 (d, J = 7.5 Hz, 2H, ArHo), 4.58 (s, 2H, NCH2), 2.82 (s, 1H, 
C≡CH), 2.45 (t, J = 7.0 Hz, 2H, C≡CCH2CH2), 1.51 (tt, J = 7.6, 7.6 Hz, 2H, 
C≡CCH2CH2), 1.37 (tt, J = 7.8, 7.8 Hz, 2H, C≡CCH2CH2CH2), 1.33-1.23 (m, 4H), 
and 0.89 (t, J = 7.1 Hz, 3H, CH3). Minor rotamer: δ 4.75 (s, NCH2), 3.28 (s, C≡CH). 
13C NMR (125 MHz, CDCl3): δ 152.7, 140.6, 129.6, 129.1, 128.5, 81.0, 80.5, 76.0, 69.9, 
69.8, 64.8, 38.9, 31.4, 28.7, 28.3, 22.7, 19.4, and 14.2 ppm. 
IR (neat): 2954, 2930, 2858, 2257, 2110, 1646, 1595, 1494, 1456, 1383, 1275, 1220, and 
697 cm-1. 
HRMS (ESI-TOF): Calcd for C20H21NNaO+ [M+Na]+ requires 314.1515; found 
314.1509. 
6-Hexyl-2-phenylisoindolin-1-one (7113e) 
 
Isoindolinone 7113e was prepared by heating amide S70 (15 mg, 0.052 mmol) in 
cyclooctane (5 mL) at 120 ºC for 20 h. The crude material was purified by flash column 
chromatography (hexanes:EtOAc 3:1) to yield the isoindolinone 7113e (9 mg, 0.03 
mmol, 58%) as a colorless solid.  
1H NMR (500 MHz, CDCl3): 7.87 (dd, J = 8.6, 1.0 Hz, 2H, PhHo), 7.74 (s, 1H, H7), 7.42 
(dd, J = 8.6, 7.5 Hz, 2H, PhHm), 7.43-7.39 (m, 2H, H4H5), 7.17 (tt, J = 7.4, 1.1 Hz, 
1H, PhHp), 4.82 (s, 2H, CH2N), 2.72 (br t, J = 7.8 Hz, 2H, ArCH2CH2), 1.69-1.62 (m, 
2H, ArCH2CH2), 1.36-1.25 (m, 6H), and 0.88 (br t, J = 7.0 Hz, CH3). 
1H NMR (500 MHz, CD3CN): 7.90 (dd, J = 8.8, 1.1 Hz, 2H, PhHo), 7.61 (dd, J = 1.6, 0.8 
Hz, 1H, H7), 7.50 (ddt, J = 7.7, 0.8, 0.8 Hz, 1H, H4), 7.48 (dd, J =7.7, 1.6 Hz, 1H, 
H5), 7.44 (dd, J = 8.8, 7.4 Hz, 2H, PhHm), 7.18 (tt, J = 7.4, 1.8 Hz, 1H, PhHp), 4.86 
(d, J = 0.8 Hz, 2H, NCH2), 2.73 (br t, J = 7.7 Hz, 2H, ArCH2), 1.65 (br tt, J = 7.5, 7.5 
Hz, 2H, ArCH2CH2), 1.38-1.26 (m, 6H), and 0.89 (br t, J = 7.0 Hz, CH3). 
cyclooctane 
120 ºC, 20 h, 58%Hex
NPh
O
NPh
O
Hex
7113eS70
7
5
4
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13C NMR (125 MHz, CDCl3): δ 168.0, 143.8, 139.9, 137.8, 133.5, 132.8, 129.3, 124.6, 
123.9, 122.5, 119.7, 50.8, 36.0, 31.9, 31.7, 29.1, 22.8, and 14.3 ppm. 
IR (neat): 2954, 2924, 2855, 1682, 1598, 1500, 1463, 1382, 1307, 1171, 1142, and 908 
cm-1. 
HRMS (ESI-TOF): Calcd for C20H23NNaO+ [M+Na]+ requires 316.1672; found 
316.1667. 
Mp: 121-123 °C. 
  
  Experimental 
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Synthesis of isoindoline 8003 and 8004 
 
N,N-Bis{6-[(4-methoxybenzyl)oxy]hexa-2,4-diyn-1-yl}-4-methylbenzenesulfonamide 
(8001) 
 
Tetrayne 8001 was prepared following General Procedure B from 4-methyl-N,N-
di(prop-2-yn-1-yl)benzenesulfonamide (150 mg, 0.6 mmol), 1-{[(3-bromoprop-2-yn-1-
yl)oxy]methyl}-4-methoxybenzene (512 mg, 2.0 mmol), CuCl (24 mg, 0.24 mmol), and 
piperidine (2 mL). Purification by flash chromatography (hexanes:EtOAc 12:1 to 5:1) 
gave the tetrayne 8001 (230 mg, 0.39 mmol, 64%) as a yellow oil.  
1H NMR (500 MHz, CDCl3): δ 7.70 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.32 (d, J = 8.4 Hz, 
2H, SO2ArHm), 7.26 (d, J = 8.6 Hz, 4H, MeOArHm), 6.88 (d, J = 8.8 Hz, 4H, 
MeOArHo), 4.50 (s, 4H, OCH2Ar), 4.23 (s, 4H, OCH2C≡C), 4.15 (s, 4H, NCH2), 3.80 
(s, 6H, OCH3), and 2.39 (s, 3H, ArCH3). 
Li2CuCl4, THF
68 ˚C, 18 h, 77%
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13C NMR (125 MHz, CDCl3): δ 159.7, 144.6, 134.6, 129.99, 129.94, 129.1, 128.0, 114.0, 
75.5, 71.6, 70.3, 70.2, 57.2, 55.4, 37.5, and 21.8 ppm.  
IR: 3010, 2838, 2365, 1612, 1586, 1513, 1350, 1303, 1249, 1163, 1071, 1033, 891, and 
817 cm-1. 
HRMS (ESI-TOF): Calcd for C35H33NNaO6S+ [M+Na]+ requires 618.1921; found 
618.1978. 
4,5-Dichloro-6-{[(3-methoxybenzyl)oxy]methyl}-7-{3-[(4-methoxybenzyl)oxy]prop-
1-yn-1-yl}-2-tosylisoindoline (8003) 
 
Dichloride 8003 was prepared by heating tetrayne 8001 (24 mg, 0.04 mmol) and 
Li2CuCl4 (0.4 mL, 1M in THF, 0.4 mmol) in THF (1 mL) at 68 °C for 18h. Purification 
by flash chromatography (hexanes:EtOAc 12:1 to 5:1) gave the dichloride 8003 (21 mg, 
0.032 mmol, 77%) as a colorless solid.  
1H NMR (500 MHz, CDCl3): δ 7.78 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.30 (d, J = 8.5 Hz, 
2H, SO2ArHm), 7.29 (d, J = 8.6 Hz, 2H, MeOArHm), 6.98 (d, J = 7.0 Hz, 2H, 
MeOAr'Hm), 6.91 (d, J = 8.6 Hz, 2H, MeOArHo), 6.83 (d, J = 7.0 Hz, 2H, 
MeOAr'Ho), 4.74 (s, 2H), 4.71 (br s, 2H), 4.65 (br s, 2H), 4.56 (s, 2H), 4.51 (s, 2H), 
4.35 (s, 2H), 3.82 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), and 2.41 (s, 3H, ArCH3).  
13C NMR (125 MHz, CDCl3): δ 159.8, 159.5, 144.3, 138.9, 138.8, 136.6, 133.9, 133.6, 
130.3, 130.2, 130.0, 129.7, 129.3, 128.5, 127.7, 118.8, 114.2, 113.9, 95.3, 80.4, 73.0, 
71.8, 68.2, 57.6, 55.52, 55.46, 55.0, 54.7, and 21.8 ppm. 
IR (neat):  2932, 2838, 1612, 1513, 1350, 1249, 1164, 1096, 1071, and 1034cm-1. 
HRMS (ESI-TOF): Calcd for C35H33Cl2NNaO6S+ [M+Na]+ requires 688.1298; found 
688.1315. 
Li2CuCl4, THF
68 ˚C, 18 h, 77%
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mp: 132–137 °C.  
1-Methoxy-7-{3-[(4-methoxybenzyl)oxy]prop-1-yn-1-yl}-9-tosyl-6,8,9,10-tetrahydro-
1H,4H-1,3a-ethenoisochromeno[5,4-ef]isoindole (8004) 
 
A solution of tetrayne 8001 (22 mg, 0.037 mmol) in THF (2 mL) was heated at 68 °C 
for 18 h. The resulting solution was concentrated and subjected to flash chromatography 
(SiO2, hexanes:EtOAc = 5:1) to give isoindoline 8004 (16 mg, 0.027 mmol, 72%) as a 
colorless solid.  
1H NMR (500 MHz, CDCl3): δ 7.78 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.30 (d, J = 8.6 Hz, 
2H, MeOArHm), 7.29 (d, J = 8.7 Hz, 2H, SO2ArHm), 6.98 (d, J = 6.9 Hz, 2H, H2 and 
H12), 6.91 (d, J = 8.7 Hz, 2H, MeOArHo), 6.63 (d, J = 6.9 Hz, 2H, H3 and H11), 4.83 
(br s, 2H, CH2), 4.71 (br s, 2H, CH2), 4.56 (br s, 2H, CH2), 4.52 (br s, 2H, CH2), 4.48 
(br s, 2H, CH2), 4.35 (br s, 2H, CH2), 3.82 (s, 3H, ArOCH3), 3.73 (s, 3H, C1OCH3), 
and 2.40 (s, 3H, ArCH3). 
13C NMR (125 MHz, CDCl3): δ 159.7, 143.7, 143.0, 141.5, 141.3, 140.7, 136.0, 134.0, 
131.5, 130.1, 130.0, 129.4, 127.8, 127.7, 114.1, 108.8, 93.1, 90.9, 80.4, 71.4, 71.1, 
66.5, 57.6, 55.5, 54.6, 53.5, 53.0, 50.2, and 21.7 ppm.  
IR: 2946, 2837, 1612, 1513, 1459, 1440, 1344, 1249, 1163, 1097, 1068, 1036, 909, and 
817 cm-1. 
HRMS (ESI-TOF): Calcd for C35H33NNaO6S+ [M+Na]+ requires 618.1921; found 
618.1915. 
mp: 185–191 °C. 
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Synthesis of 5-((Benzyloxy)methyl)-4-(3-(benzyloxy)prop-1-yn-1-yl)-6-isopropoxy-2-
tosylisoindoline (8017) 
and  
5-((Benzyloxy)methyl)-4-(3-(benzyloxy)prop-1-yn-1-yl)-7-isopropoxy-2-
tosylisoindoline (8018) 
 
A solution of 8015 (10 mg) in iPrOH (2 mL) was heated at 68 °C for 18 h. The 
resulting solution was concentrated. Analysis of the crude 1H NMR spectrum of the 
resulting residue revealed 8017 and 8108 were formed in ca. 2.6:1 ratio. 
Characteristic peaks of 8017:  
1H NMR (500 MHz, CDCl3): δ 7.75 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.38-7.20 
(overlapping m, 12H), 6.68 (s, 1H, H7), 4.47 [septet, J = 6.0 Hz, 1H, CH(CH3)2],  
2.40 (s, 3H, ArCH3), and 1.29 [d, J = 6.1 Hz, 6H, CH(CH3)2]. 
Characteristic peaks of 8018:  
1H NMR (500 MHz, CDCl3): δ 7.78 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.38-7.20 
(overlapping m, 12H), 6.89 (s, 1H, H6), 2.41 (s, 3H, ArCH3), and 1.30 [d, J = 5.7 Hz, 
6H, CH(CH3)2]. 
  
NTs
OBn
OBn
iPrOH as solvent
NTs
BnO
OBn
OiPr
NTs
BnO
OBn
OiPr
2.6:18017 80188015
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Synthesis of 4-methyl-N,N-bis(8-phenylocta-2,4-diyn-1-yl)benzenesulfonamide 
(8023) 
 
Tetrayne 8023 was prepared following General Procedure C from 4-methyl-N,N-
di(prop-2-yn-1-yl)benzenesulfonamide (124 mg, 0.5 mmol), (5-bromopent-4-yn-1-
yl)benzene (555 mg, 2.5 mmol), NH2OH•HCl (a few crystals), CuCl (20 mg, 0.2 mmol), 
30% aq. nBuNH2 (2 mL), and DCM (2 mL). Compound 8023 was isolated following 
flash chromatography (SiO2, hexanes:EtOAc = 5:1) as a yellow oil (250 mg, 0.47 mmol, 
94%).  
1H NMR (500 MHz, CDCl3): δ 7.71 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.32 (d, J = 8.7 Hz, 
2H, SO2ArHm), 7.30 (dd, J = 7.6 Hz, 4H, ArHm), 7.21 (t, J = 7.4 Hz, 2H, ArHp), 7.21 
(d, J = 7.6 Hz, 4H, ArHo), 4.21 (s, 4H, TsNCH2), 2.70 (t, J = 7.4 Hz, 4H, 
CH2CH2CH2), 2.39 (s, 3H, ArCH3), 2.25 (t, J = 6.9 Hz, 4H, CH2CH2CH2), and 1.83 
(tt, J = 7.7, 7.7 Hz, 4H, CH2CH2CH2). 
  
NTs
8023
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Ph
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Br
CuCl
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DCM
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Synthesis of 4-(5-phenylpent-1-yn-1-yl)-5-(3-phenylpropyl)-2-tosylisoindoline (8025), 
6-isopropoxy-4-(5-phenylpent-1-yn-1-yl)-5-(3-phenylpropyl)-2-tosylisoindoline 
(8026), 7-isopropoxy-4-(5-phenylpent-1-yn-1-yl)-5-(3-phenylpropyl)-2-
tosylisoindoline (8027),  
and 
(1s,3as)-7-(5-phenylpent-1-yn-1-yl)-9-tosyl-4,5,6,8,9,10-hexahydro-1H-1,3a-
ethenonaphtho[1,8-ef]isoindole (8028) 
 
Solutions of 8023 and iPrOH in various amount of CDCl3 (0.9 mL to 3.9 mL) were 
heated at 68 °C for 18 h. The resulting solutions were concentrated. The residues were 
dissolved in CDCl3. Analysis of the 1H NMR spectra gave the ratio of each compound to 
8028 at different concentrations of iPrOH.  
  
NTs NTs
NTs
OiPr
OiPr
NTs Ts N +
8023 8024 8026 8027
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Characteristic peaks of 8025: 
1H NMR (500 MHz, CDCl3): δ 7.07 (d, J = 7.9 Hz, 1H, H7), 7.07 (d, J = 7.8 Hz, 1H, 
H6). 
Characteristic peaks of 8026: 
1H NMR (500 MHz, CDCl3): δ 6.63 (s, 1H, H7), 4.44 [septet, J = 6.0 Hz, 1H, 
CH(CH3)2], 2.40 (s, 3H, ArCH3), and 1.29 [d, J = 6.0 Hz, 6H, CH(CH3)2]. 
Characteristic peaks of 8026: 
1H NMR (500 MHz, CDCl3): δ 6.54 (s, 1H, H6), 4.52 [septet, J = 6.0 Hz, 1H, 
CH(CH3)2], 2.40 (s, 3H, ArCH3), and 1.31 [d, J = 6.0 Hz, 6H, CH(CH3)2]. 
Characterization data for 8028: 
1H NMR (500 MHz, CDCl3): δ 7.76 (d, J = 8.3 Hz, 2H, SO2ArHo), 7.35-7.20 (m, 12H, 
ArH), 6.79 (dd, J = 6.3, 6.3 Hz, 2H, H2), 6.59 (dd, J = 6.6, 1.6 Hz, 2H, H2a), 4.74 (tt, 
J = 5.8, 1.6 Hz, 1H, H1), 4.66 (t, J = 1.6 Hz, 2H), 4.57 (t, J = 1.8 Hz, 2H), 2.80-2.72 
(m, 4H), 2.46-2.42 (m, 4H), 2.39 (s, 3H, ArCH3), and 1.93-1.84 (m, 4H). 
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Notes 
1) The structure for each of the compounds containing a free acyltetronic acid (ATA) 
(i.e., 6, 7, or 8) is arbitrarily (and for convenience) portrayed as an endocyclic enol; 
an internally hydrogen-bonded variant of that endocyclic enol (a rotamer about the 
C10–C11 bond) or E- or Z-exocyclic enols are also possible. 
2) The ratio of 2049 to 2050 was later estimated to be ca. 3:2. 
3) CrCl2 in the reaction mixture presumably function as a Lewis acid that catalyzes the 
IMDA reaction of 2049. 
4) The reactivity of the free tetronate (O-demethylated version) of 2.57 was not 
reported.  
5) Notably, attempted alcohol oxidation using Dess–Martin periodinane appeared to 
destroy the diene unit present in the substrate, and Parikh–Doering oxidation only 
gave a low yield of desired aldehyde.  
6) The anionic addition step occurred with >90% yield and 1:1 dr. The less than 
optimal isolated yield of 3.26 may be caused by product absorption by MnO2 in the 
second step.  
7) Besides the linear products like 3.30, those with different number of cyclopropyl 
rings could have also been formed. 
8) Takagi, R.; Tsuyumine, S.; Nishitani, H.; Miyanaga, W.; Ohkata, K. Stereoselective 
synthesis of the hydrophobic side chain of scyphostatin. Aust. J. Chem. 2004, 57, 
439–447. I prepared (+)-(2R,4S)-3.5 using slightly modified procedures. These 
involved enantioselective, lipase-catalyzed (PPL) acetylation of diol 3.13 (the 
resulting mono-alcohol was measured to have an ca. 9:1 er by Mosher ester 
analysis), TBS protection, acetate methanolysis, and iodination. The sample of (+)-
3.5 had [α]D (CHCl3, c = 2.0) = +3.1 [lit. [α]D22 (CHCl3, c = 2.09) = +3.50]. 
9) The sample of natural okilactomycin D was isolated after a final purification by 
HPLC using an eluent doped with trifluoroacetic acid. Thus, its structure is best 
formulated as 3001, having the neutral acyltetronic acid. We observed that the 1H 
NMR spectrum of the sodium salt of 3001 in CD3OD (or of the analogous cesium 
salt in CDCl3) contained a resonance for the enone β-proton (H6) that was ca. 0.6 
(or 0.2) ppm upfield of that for the sample of neutral 3001. 
10) This minor isomer was formed as a byproduct in both generations of substrate 
synthesis (see Scheme 3.5 and 3.9). 
11) It is reasonable to assume that both isomers should react at similar rate if the IMDA 
reaction occurs via a stepwise mechanism. 
12) BF3•Et2O or Cu(OTf)2 is not tolerated presumably because both reagents would 
give rise to strong protic acids when reacting with adventitious amount of water.  
13) This anti-relationship of the two carbonyls was also proposed in the transition 
structure of the IMDA reaction used in the abyssomycin C synthesis.34a  
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14) Conformers with larger dipole moments are better stabilized in polar solvents. It is 
consistent to observe that the facial selectivity is lower in CH3OH/H2O than in 
toluene by a factor of two (compare entry 1 and 2 in Scheme 3.11). 
15) Regioselective synthesis of 2-(2-hydroxyaryl)pyridines from the reactions of 
benzynes with pyridine N-oxides 
16) Benzene-diazonium-2-carboxylate is known to be explosive.  
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